0001829126-24-001847.txt : 20240325 0001829126-24-001847.hdr.sgml : 20240325 20240325083107 ACCESSION NUMBER: 0001829126-24-001847 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 73 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240325 DATE AS OF CHANGE: 20240325 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Innovative Eyewear Inc CENTRAL INDEX KEY: 0001808377 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 842794274 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41392 FILM NUMBER: 24776977 BUSINESS ADDRESS: STREET 1: 11900 BISCAYNE BLVD STREET 2: STE 630 CITY: MIAMI STATE: FL ZIP: 33181 BUSINESS PHONE: 786-910-1898 MAIL ADDRESS: STREET 1: 66 W FLAGLER ST. SUITE 900 STREET 2: STE 216 CITY: MIAMI STATE: FL ZIP: 33130 10-K 1 innovative_10k.htm 10-K
false 2023 FY 0001808377 0001808377 2023-01-01 2023-12-31 0001808377 LUCY:CommonStock0.00001ParValueMember 2023-01-01 2023-12-31 0001808377 LUCY:WarrantsToPurchaseCommonStockMember 2023-01-01 2023-12-31 0001808377 2023-06-30 0001808377 2024-03-22 0001808377 2023-10-01 2023-12-31 0001808377 2023-12-31 0001808377 2022-12-31 0001808377 2022-01-01 2022-12-31 0001808377 us-gaap:CommonStockMember 2022-12-31 0001808377 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001808377 LUCY:StockSubscriptionReceivableMember 2022-12-31 0001808377 us-gaap:RetainedEarningsMember 2022-12-31 0001808377 us-gaap:CommonStockMember 2021-12-31 0001808377 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001808377 LUCY:StockSubscriptionReceivableMember 2021-12-31 0001808377 us-gaap:RetainedEarningsMember 2021-12-31 0001808377 2021-12-31 0001808377 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001808377 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001808377 LUCY:StockSubscriptionReceivableMember 2023-01-01 2023-12-31 0001808377 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001808377 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001808377 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001808377 LUCY:StockSubscriptionReceivableMember 2022-01-01 2022-12-31 0001808377 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001808377 us-gaap:CommonStockMember 2023-12-31 0001808377 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001808377 LUCY:StockSubscriptionReceivableMember 2023-12-31 0001808377 us-gaap:RetainedEarningsMember 2023-12-31 0001808377 us-gaap:AccountsReceivableMember 2023-12-31 0001808377 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember LUCY:SingleCustomerMember 2023-01-01 2023-12-31 0001808377 LUCY:MobileKioskDisplayMember 2023-12-31 0001808377 LUCY:MobileKioskDisplayMember 2022-12-31 0001808377 us-gaap:ComputerEquipmentMember 2023-12-31 0001808377 us-gaap:ComputerEquipmentMember 2022-12-31 0001808377 us-gaap:OfficeEquipmentMember 2023-12-31 0001808377 us-gaap:OfficeEquipmentMember 2022-12-31 0001808377 LUCY:InternalUseSoftwareMember 2023-12-31 0001808377 LUCY:InternalUseSoftwareMember 2022-12-31 0001808377 LUCY:InternalUseSoftwareMember srt:MinimumMember 2023-12-31 0001808377 LUCY:InternalUseSoftwareMember srt:MaximumMember 2023-12-31 0001808377 us-gaap:PatentsMember 2023-12-31 0001808377 us-gaap:PatentsMember 2022-12-31 0001808377 LUCY:TekcapitalAndAffiliatesMember 2020-11-29 2020-12-01 0001808377 LUCY:TekcapitalAndAffiliatesMember 2021-10-29 2021-11-01 0001808377 us-gaap:IPOMember LUCY:LucydMember 2022-08-01 2022-08-15 0001808377 us-gaap:IPOMember LUCY:LucydMember 2022-08-15 0001808377 2023-01-02 2023-01-31 0001808377 LUCY:TekcapitalEuropeLtdMember 2023-01-01 2023-12-31 0001808377 LUCY:TekcapitalEuropeLtdMember 2022-01-01 2022-12-31 0001808377 LUCY:SettlementAgreementMember 2023-08-31 0001808377 us-gaap:IPOMember 2022-08-01 2022-08-17 0001808377 us-gaap:CommonStockMember 2022-08-01 2022-08-17 0001808377 us-gaap:IPOMember 2022-08-17 0001808377 us-gaap:IPOMember LUCY:MaximMember 2022-08-01 2022-08-15 0001808377 us-gaap:IPOMember LUCY:MaximMember 2022-08-15 0001808377 us-gaap:IPOMember 2022-08-01 2022-08-15 0001808377 us-gaap:IPOMember 2023-06-02 2023-06-26 0001808377 us-gaap:CommonStockMember 2023-06-02 2023-06-26 0001808377 us-gaap:IPOMember 2023-06-26 0001808377 us-gaap:WarrantMember 2023-06-02 2023-06-26 0001808377 us-gaap:WarrantMember 2023-06-26 0001808377 us-gaap:IPOMember 2022-08-16 2022-08-17 0001808377 us-gaap:CommonStockMember 2022-08-16 2022-08-17 0001808377 2023-02-01 2023-02-28 0001808377 2023-02-28 0001808377 us-gaap:WarrantMember 2023-04-01 2023-04-16 0001808377 us-gaap:WarrantMember 2023-04-16 0001808377 LUCY:InducementLetterMember 2023-04-01 2023-04-17 0001808377 LUCY:InducementLetterMember 2023-04-17 0001808377 LUCY:InducementLetterMember LUCY:NewWarrantsMember 2023-04-01 2023-04-17 0001808377 LUCY:InducementLetterMember LUCY:NewWarrantsMember 2023-04-17 0001808377 LUCY:ListedWarrantsMember 2023-12-31 0001808377 LUCY:CommonWarrantsMember 2023-12-31 0001808377 LUCY:PrivateWarrantsMember 2023-12-31 0001808377 LUCY:UnderwriterWarrantsMember 2023-12-31 0001808377 LUCY:PlacemenAgentWarrantsMember 2023-12-31 0001808377 LUCY:OfficersAndManagementMember 2023-01-01 2023-12-31 0001808377 LUCY:NonManagementDirectorsMember 2023-01-01 2023-12-31 0001808377 LUCY:EmployeesAndConsultantsMember 2023-01-01 2023-12-31 0001808377 LUCY:EmployeeMember 2023-01-01 2023-12-31 0001808377 LUCY:AConsultantMember 2023-01-01 2023-12-31 0001808377 LUCY:EmployeesAndConsultants1Member 2023-01-01 2023-12-31 0001808377 LUCY:OfficersAndManagement1Member 2023-01-01 2023-12-31 0001808377 2023-05-30 2023-06-01 0001808377 us-gaap:RestrictedStockUnitsRSUMember 2023-12-01 2023-12-03 0001808377 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-12-31 0001808377 srt:MinimumMember 2023-12-31 0001808377 srt:MaximumMember 2023-12-31 0001808377 srt:MinimumMember 2023-01-01 2023-12-31 0001808377 srt:MaximumMember 2023-01-01 2023-12-31 0001808377 us-gaap:SubsequentEventMember LUCY:TekcapitalEuropeLtdMember 2024-01-11 0001808377 us-gaap:SubsequentEventMember LUCY:TekcapitalEuropeLtdMember 2024-01-01 2024-01-11 0001808377 us-gaap:SubsequentEventMember LUCY:LucydMember 2024-02-27 2024-03-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2023

 

or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ________ to ________

 

Commission file number: 001-41392

 

INNOVATIVE EYEWEAR, INC.

 

 

(Exact Name of Registrant as Specified in its Charter)

 

Florida   85-0734861

(State or Other Jurisdiction of
Incorporation or Organization)

 

(I.R.S. Employer

Identification No.)

 

11900 Biscayne Blvd., Suite 630, North Miami, Florida   33181
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (954) 826-0329

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.00001 par value   LUCY   NASDAQ Capital Market
Warrants to purchase Common Stock   LUCYW   NASDAQ Capital Market

 

Securities registered pursuant to Section 12(g) of the Act: None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐   No ☒

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐   No ☒

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒   No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒   No ☐

 

 

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

  Large accelerated filer Accelerated filer
  Non-accelerated filer Smaller reporting company
  Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. 

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the fi ling reflect the correction of an error to previously issued financial statements. 

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐   No ☒

 

The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter was $6,916,698 based upon the closing price of such common stock on June 30, 2023.

 

As of March 22, 2024, the registrant had outstanding 12,933,544 shares of common stock, par value $0.00001 per share, which is the registrant’s only class of common stock.

 

DOCUMENTS INCORPORATED BY REFERENCE:

NONE

 

 

 

 

 

 

TABLE OF CONTENTS

 

        Page
PART I
 
Item 1.   Business   1
Item 1A.   Risk Factors   20
Item 1B.   Unresolved Staff Comments   44
Item 1C.   Cybersecurity   45
Item 2.   Properties   45
Item 3.   Legal Proceedings   45
Item 4.   Mine Safety Disclosures   45
         
PART II
 
Item 5.   Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities   46
Item 6.   Reserved   46
Item 7.   Management’s Discussion and Analysis of Financial Condition and Results of Operations   46
Item 7A.   Quantitative and Qualitative Disclosures about Market Risk   59
Item 8.   Financial Statements and Supplementary Data   59
Item 9.   Changes in and Disagreements With Accountants on Accounting and Financial Disclosure   59
Item 9A.   Controls and Procedures   59
Item 9B.   Other Information   59
Item 9C.   Disclosure Regarding Foreign Jurisdictions that Prevent Inspections   59
         
PART III
 
Item 10.   Directors, Executive Officers and Corporate Governance   60
Item 11.   Executive Compensation   64
Item 12.   Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters   70
Item 13.   Certain Relationships and Related Transactions, and Director Independence   71
Item 14.   Principal Accounting Fees and Services   73
         
PART IV
 
Item 15.   Exhibit and Financial Statement Schedules   74
Item 16.   Form 10-K Summary   75

 

i

 

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

 

Information included in this Annual Report on Form 10-K (this “Report”) contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements are not statements of historical facts, but rather reflect our current expectations concerning future events and results. We generally use the words “believes,” “expects,” “intends,” “plans,” “anticipates,” “likely,” “will” and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning our expectations, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These risks, uncertainties and factors include, but are not limited to, those factors set forth in this Report under “Item 1A. – Risk Factors” below. Except as required by applicable law, including the securities laws of the United States, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this Report.

 

CERTAIN TERMS USED IN THIS REPORT

 

References in this Report to “we,” “us,” “our,” the “Company” or “Innovative Eyewear” means Innovative Eyewear, Inc. unless otherwise indicated.

 

ii

 

 

PART I

 

Item 1. Business.

 

Our History

 

We develop and sell smart eyeglasses and sunglasses, which are designed to allow our customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Founded and headquartered in Miami, Florida, we were initially organized as a Florida limited liability company effective August 15, 2019. We were founded by Lucyd Ltd., the inventor and licensor of the technology that our products are based upon, which is a portfolio company of Tekcapital Europe Ltd. (“Tekcapital”). Tekcapital is a U.K. based university intellectual property accelerator which builds portfolio companies around new technologies. On March 26, 2020, we converted from a Florida limited liability company into a Florida corporation.

 

Our Products

 

In January 2020, we introduced our first beta product and began market testing.

 

In January 2021, we officially launched our first commercial product, Lucyd Lyte® (“Lucyd Lyte”). This initial product offering embodied our goal of creating smart eyewear for all day wear that looks like and is priced similarly to designer eyewear, but is also light weight and comfortable, and enables the wearer to remain connected to their digital lives. The product was initially launched with six styles, and in September 2021, an additional six styles were added.

 

In February 2023, we launched version 2.0 of our Lucyd Lyte eyewear with 15 different styles, incorporating several key breakthroughs for the smart eyewear product category – including a four-speaker audio array, 12-hour music playback and call time, and improved styling as well as technical upgrades. In October 2023, we launched six new styles of smart eyewear, branded as Lyte XL, bringing even more advancements – including patent-pending flexible hinges for a more comfortable fit and a wider range of suitable head sizes, significant improvements to speaker and microphone quality, thinner and more ergonomic temples, and post-consumer recycled packaging.

 

In January 2024, we launched the Nautica® Powered by Lucyd smart eyewear collection in eight different styles, along with various branded accessories including a power brick, cleaning cloth, and a slipcase adorned with the iconic Nautica sail logo.

 

Our current product offering consists of 29 different models, which offers a similar amount of style variety as many traditional eyewear collections. All styles are each available with 80+ different lens types, resulting in thousands of variations of products currently available. The Company currently has over 100 licensed patents and applications.

 

Our smartglasses enable the wearer to listen to music, take and make calls, and use voice assistants to perform many common smartphone tasks hands-free. Some of the many things our customers can do with their Lucyd Lyte glasses include:

 

1. “Send a voice message to (contact)”: this command begins the recording of an audio message to be sent to named contact.

 

2. “Send a text to (contact)”: begins recording of a speech-to-text message to be sent by SMS to named contact.

 

3. “Call (contact)”: speed-dials the named contact.

 

1

 

 

4. “Send $___ to (contact)”: this command allows the user to send money to a contact via Venmo or Apple Pay. Follow the digital assistant’s prompts to confirm.

 

5. “Check my messages”: this command reads out the user’s latest incoming text messages and offers a prompt to reply to each. Close out the digital assistant to end the readout.

 

6. “Check my mailbox”: this command announces the number of unread emails, and reads them out with a prompt to continue after each one. In the prompt after each one, the user can tell their digital assistant “Reply” and dictate an email response to the previous email.

 

7. “Find (cuisine type) food nearby”: this command reads through a list of nearby restaurants and their ratings, and prompts the user for directions or to call after each one.

 

8. “Call me an Uber”: this command prompts the user on which type of Uber ride they want, then asks to confirm to send a car to the user’s location.

 

9. “What time is it?”: announces the current time.

 

10. “Play (song/album/artist)”: this command begins playing the requested song, album, or artist via Apple Music.

 

11. “Get me directions to (location)”: this command begins navigating on phone, with audible directions on glasses.

 

12. “Take a memo”: this command begins recording a speech-to-text memo in Notes. Say “Read my Notes” to play back.

 

Since the launch of Lucyd Lyte, we witnessed interest and demand from customers throughout the United States and have sold thousands of our smart glasses. Within six months of the launch of Lucyd Lyte, several optical stores in the United States and Canada have on- boarded the product and we have had discussions with several other large eyewear chains regarding on-boarding our product. We believe smart eyewear is a product category whose time has come, and we believe we are well positioned to capitalize on and help develop this exciting new sector – where eyewear meets electronics in a user-friendly, mass market format, priced similarly to designer eyewear.

 

In first quarter of 2022 we introduced a virtual try-on kiosk for select retail stores. This device introduces our products to prospective retail customers and enables them to digitally try-on our line of smart glasses in a touch-free manner. This system was later upgraded in 2023.

 

In the fourth quarter of 2022, we completed development of core audio eyewear product improvements, such as upgrading all frames to quadraphonic sound, which have been rolled out across all of our new eyewear models.

 

We completed development of many new styles of smart eyewear for our new licensed brands in 2023, anticipating all three licensed collections to launch in 2024. In addition, we completed the following upgrades to accessory products in 2023:

 

The patent-pending Lucyd charging dock was upgraded to version 2.0 edition, featuring auto-adjusting connectors to fit any size of smart eyewear we produce, a new charging status LED, and USB data capability, enabling it to be used as a USB hub for computers in addition to a charging hub.

 

The Lucyd virtual try-on kiosk was replaced with a fully modular display system, with eight available components for stores to mix and match to suit their display needs. The display can be deployed as a countertop display or freestanding, making it suitable for almost any retail environment.

 

2

 

 

Apps

 

The Vyrb app launched in open beta on iOS and Android app stores in 2021, as the Company’s first social media platform.

 

In 2022, we introduced key features in the Vyrb app, including live broadcasts for up to 100 users in one digital “room,” and the ability to upload external audio content into Vyrb, enabling longstanding content creators to import their existing libraries swiftly into the platform.

 

In the first quarter of 2023, we introduced several new features for the Vyrb app, including market-leading audio accessibility features for social media, such as the ability to create and listen to a feed of audio content completely hands-free, using unique voice assistant commands created for the app. We plan to continue to develop the expansive Vyrb platform into a feature-rich social toolbox for customers. This includes the introduction of revenue-generating features such as native ads and in-app upgrades, as well as gamification features such as a points and rewards system. Some new features are planned to launch in 2024, including a fully upgraded user interface. Once this update to the interface is completed, the app will be considered officially launched, and the Company will begin to promote it and capitalize on it in earnest.

 

In April 2023, we introduced another major software upgrade for our glasses with the launch of the Lucyd app for iOS and Android. This free application enables the user to converse with the extremely popular ChatGPT AI language model on our glasses, to instantly gain the benefit of one of the world’s most powerful AI assistants in a hands-free ergonomic interface. The app deploys a powerful and unique Siri integration with the Open AI API for ChatGPT, developed internally by the Company. The Company has filed a patent application related to this software upgrade. We believe this development makes our Lucyd eyewear perhaps the smartest smartglasses available today, represents a significant marketing opportunity for the Company’s core smartglass product, and creates a potential in-app purchase revenue stream for the Company.

 

Our Mission

 

Our mission is to Upgrade Your Eyewear®. Our smart eyewear is a fusion of headphones with glasses, bringing vision correction and protection together with digital connectivity and clear audio, while also offering a safer solution for listening to music outdoors (as compared to in-ear headphones). The convenience of having a Bluetooth headset and comfortable glasses in one, especially for those who are already accustomed to all-day eyewear use, offers a lifestyle upgrade at a price most consumers can afford.

 

In a sense, we view this integration of technology and vison correction/protection as the next evolutionary step in the development of eyewear. Over the entire course of eyewear development and history, many of the innovations have dealt with improving the lenses of the glasses. Notably, eyewear frames have not improved much in the past 400 years, with the exception, in our view, of the utilization of plastic to reduce weight and provide a wider range of designs and finishes, and the introduction of new hinge types. We view the integration of Bluetooth technology into the arms of the glasses as one of the key next steps to Upgrade Your Eyewear®.

 

Our focus therefore is to enhance one of the world’s most important wearables: eyewear.

 

Additionally, as part of our commitment to a great customer experience, we listen to feedback from our customers, and continuously strive to improve customer satisfaction and experience with our products. Our customers’ extensive feedback pointed to a need and desire for better interaction with social media while on-the-go. We are addressing this need by developing an exciting software application called Vyrb, as described above.

 

We have made strong strides towards our goal of making smart eyewear accessible to the mass market. Several developments towards this end include developing our smart frames in multiple temple lengths; the introduction of smart eyewear specifically for women and youth, which are typically missing from similar offerings; and the introduction of smart eyewear for adults with petite or narrow faces. Our expansive product offering currently consists of 29 different models, which offers a similar amount of style variety as many traditional eyewear collections. When paired with the Vyrb application, Lucyd Lyte glasses will provide a new and safer wearable user experience suitable for everyone.

 

3

 

 

Our goal is to become a meaningful player in the smart eyewear market. Our company’s early successes have demonstrated our ability to not only compete, but to lead in the rapidly changing and expanding technological eyewear market, and we intend to continue spearheading innovation in the field.

 

Giving Back

 

We donate an optical frame for every Lucyd Lyte sold at retail.

 

We are also very active in supporting the various communities we serve through donations and support. From the beginning, Innovative Eyewear has supported those in need through our donation of glasses frames to New Eyes (https://new-eyes.org/about-us), a charity dedicated to helping children and adults in need of eyewear. We’ve partnered with New Eyes because they fit the Lucyd brand mission: enhancing the vision of people all over the world, and we believe that it simply is the right thing to do. We have also participated in a partnership with the Miami Rescue Mission to support our local community with eyewear. Our most recent donation was in December 2023 and consisted of 3000 eyeglass, sunglass, and reading glass frames.

 

Additionally, university students, educators, healthcare workers, uniformed service members, and veterans are eligible for an ongoing 18% discount off all frames and lens upgrades on www.lucyd.co.

 

Our Market Opportunity

 

One of our key opportunities is converting traditional eyeglass and sunglass wearers to smart eyewear consumers since these customers are already familiar with wearing optical products. According to a 2021 report of the Vision Council, a non-profit trade association that serves member companies of the optical industry, there are 167 million prescription and 224 million non-prescription glasses wearers in the United States. As many as four billion people worldwide wear glasses, according to an article published by Reference.com in April 2020.

 

According to Statista, the total addressable market for eyewear in the U.S. is projected to be $35.2 billion in 2024. The market for digital assistants like Siri, Google Voice, Bixby, and Alexa has grown rapidly worldwide, and is projected at $4.5 billion in revenue in 2023. We view the popularity of voice assistants as an important catalyst for the smart eyewear market since hands-free access to voice-based AI is a notable feature thereof.

 

The common denominator among markets for the hearables and digital assistant is that they facilitate real-time access to digital data, whether it is through music, calls, navigational directions, or information, among other uses. The combination of hearables and digital assistants provides a transparent, ergonomic interface between the users and their digital lives. At Innovative Eyewear, we are dedicated to a touch-free interface and untethering our customers eyes from their smartphone screens, through our smart eyewear product.

 

The synergistic fusion of these three markets (eyewear, digital assistants, and hearables) enables, in our view, an opportunity to create a completely new experience of connected eyewear, which smoothly delivers the functionality of both optical glasses and headphones, eliminating the need for either on its own. Nevertheless, several orthodoxies of the eyewear industry still hold, namely: if you want to sell a lot of eyewear, we believe it should be attractive, stylish, comfortable (e.g., lightweight, which we believe to be approximately one ounce), and cost roughly the same as traditional eyewear. This is what we have sought to achieve, and in our view have accomplished with the introduction of Lucyd Lyte eyewear.

 

A key indicator of the potential future success of smart eyewear in the consumer market is the rise of smartwatches, which as early as 2018 have intermittently surpassed traditional wristwatches in unit sales in the United States. We believe that the similarities between smartwatches and smart eyewear compared to their traditional counterparts indicate that the future of eyewear will also be smart.

 

4

 

 

Our Business Strategy

 

When we initially organized Innovative Eyewear four years ago, there was, in our view, no attractive smart eyewear that addressed the basic consumer need for good looking designer glasses that were stylish, comfortable, lightweight, and provided the functionality of hearables, and priced around the same as regular glasses.

 

At the core of our strategy are the following principles:

 

1. Consumers prefer smart eyewear that looks and feels like traditional glasses and sunglasses; this is a key element in the design of all of our frames, and makes it easier for traditional eyewear users to switch to our products.

 

2. For a smart eyewear line to achieve mass market penetration, it should cost a similar amount to traditional designer eyewear, especially while the category is still emerging and most consumers and not yet familiar with it.

 

3. Smart eyewear must be user-friendly and have an interface that is easy to navigate by the wearer, even when their hands are wet or gloved. As such, we deploy highly tactile interfaces on our eyewear.

 

4. The battery life of smart eyewear should be sufficient to support smart functionalities throughout the day without needing to be recharged mid-day.

 

5. Rather than burdening our hardware with mechanical features such as cameras and microdisplays which may be unnecessary for many users, we instead leverage software platforms that can add functionality without increasing the weight or size of the frames.

 

6. By adhering to the above principles, we can eliminate any “costs of switching” from traditional eyewear to smart eyewear, and build customer lifetime value by offering a more powerful combination of fashion, smart features, and vision correction and protection than available from other companies.

 

All of our products are designed in Miami, manufactured in China, and sold through e-commerce channels, including on our website (Lucyd.co), BestBuy.com, DicksSportingGoods.com, Brookstone.com, and Amazon.com, and sold by over 300 optical and sporting goods retailers. Additionally, we are pursuing online and in-store big box retailers, and in-store and online specialty retailers. Based on the existing demand for our products, current distribution, and recently consummated supply agreements, we anticipate that our products will be available in a significant number of new third-party retail locations in 2024.

 

We believe that people care about what they wear on their faces, and because we understand that customers have diverse preferences about the shape, size, and design of their eyewear, we aim to continuously introduce new models in an effort to offer a wide variety of designs. We continuously present new models of eyewear to our network of followers to vote on those styles they find most appealing. We view this as community approved design.

 

Competition

 

The smart eyewear industry in which we operate is competitive and subject to changes in practice. While we believe that our products are a hybrid of eyeglasses and Bluetooth audio technology, which gives us a unique product that provides us with competitive advantages, we may face competition from many different entities now and in the future. Currently, we face competition from the following products:

 

5

 

 

 

Bose Corporation’s Bose Frames. These are a Bluetooth eyewear product, but in a bulkier form factor and with what we believe to be comparable audio quality at a higher list price ($249 MSRP) than Lucyd Lyte 2.0 ($149-$199). However, Bose has recently announced plans to withdraw from the smart eyewear market.

 

Key advantages of Lucyd Lyte over Bose Frames: Our glasses are lighter weight, have twice the playback battery life, are offered in 29 styles compared to three styles for Bose, and have a more traditional optical form factor for all-day wear.

 

 

Amazon’s Carrera Echo Glasses (Third Gen). Another entry in the Bluetooth eyewear space, offered at a $329 - $389 list price. Not available directly from the manufacturer in prescription, and in only two frame shapes. The cost of the Amazon Echo Glasses is higher than Lucyd Lyte. While lightweight like Lucyd Lyte glasses, Amazon Echo Glasses have, in our view, a less fashionable form factor, and the battery life is about half of that of Lucyd Lyte.

 

Key advantages of Lucyd Lyte over Echo Glasses: Our glasses are not “always-listening” for voice commands like Echo Frames are (which raises privacy concerns and reduces battery life), our glasses are available in 29 styles compared to two for the latest Echo Frames, our glasses look more seamless so they better match the form factor of traditional eyewear, and our glasses are more affordable at $149 - $199.

 

 

Snapchat Spectacles. This is a camera-focused smart eyewear product and, in our view, not a direct competitor with our products due to its style, weight, pricing, and suitability for all-day wear. However, Snapchat Spectacles may introduce further entries in the space that may directly compete with Lucyd Lyte. Snapchat Spectacles version 3 have a list price of $380.

 

Key advantages of Lucyd Lyte over Spectacles: Our glasses have more audio and AI features, are lighter and prescription-ready, are available in many more styles than this single SKU (stock-keeping unit) line, and cost half the price.

 

 

Ray-Ban Meta Glasses. Developed in association with Facebook, these are a camera-focused smart eyewear product, and despite the fact they are available in prescription, in our view not a direct competitor. Ray-Ban may, however, introduce further entries in the space that may directly compete with Lucyd Lyte. Ray-Ban Spectacles have a well-known and respected brand, and a list price starting at $299, which makes them 100% more expensive than base models of Lucyd Lyte.

 

Key advantages of Lucyd Lyte over Meta Glasses: Stories weigh considerably more than Lucyd Lyte glasses (20% - 70% more, depending upon the Lyte model), have a shorter battery life, thicker temple profiles, are not water resistant, and the cameras and required connection to a Facebook account raise privacy concerns.

 

All of the competitors discussed above have substantially greater manufacturing, financial, research and development, personnel, and marketing resources than we do. As a result, although we believe our products are currently superior, our competitors may be able to develop superior products, and compete more aggressively and sustain their competitive advantage over a longer period of time than us. Our products may be rendered obsolete in the face of competition.

 

Our Competitive Strengths

 

A Unique Solution to a Common Problem. While immensely useful, smartphones can present a safety hazard to motorists, pedestrians, and cyclists because smartphones can distract people from the task or activity at hand. In 2022, pedestrian deaths were at a 40-year high according to the Governors Highway Safety Association, and experts believe smartphones were partially to blame. Recent data from the Governors Highway Safety Association indicates that from 2010 to 2021, the number of pedestrian deaths rose by 77%, while all other traffic deaths increased by 25% (Pedestrian Traffic Fatalities by State: 2022 Preliminary Data – (https://www.ghsa.org/resources/Pedestrians23). We believe that the distraction created by smartphones originates in two forms: (1) via headphones or earbuds, where the user is deprived of full audible situational awareness; and (2) via the visual interface of the phone, which distracts the user completely from their surroundings. Lucyd Lyte open-ear audio helps address this problem by having the speakers mounted at the temples (in the arms) of the glasses. There is nothing in the ear canal and, as a result, individuals can better maintain situational awareness, such as hearing the traffic around them, as well as nearby sounds. Many of our competitors have relatively bulky speakers enclosed within the temples, while Lucyd Lyte’s speakers and temples are thin, which allows them to look similar to traditional designer glasses. Furthermore, through the quick and easy touch controls on Lucyd Lyte glasses, the wearer can perform many tasks for which they would normally pull out their phone – thus our glasses help untether the eyes of the user from their smartphones throughout the day and enable them to remain more visually vigilant and aware of the traffic around them.

 

6

 

 

Affordable Price Point. Our Lucyd Lyte eyewear provides both optical-quality glasses and a Bluetooth headset together, at roughly the same price as a traditional pair of designer glasses, which is core to the disruptive potential of our product. Our Lucyd Lyte line of smart eyewear enables prescription and sunglass wearers to interact with digital assistants and social media without having to take their eyes off the road and are nearly hands-free, thereby improving the safety and convenience of taking calls, listening to music, and audibly accessing digital information on the go. The Manufacturer’s Suggested Retail Price (“MSRP”) for Lucyd Lyte 2.0 eyewear starts at $149, with advanced options and customizations available at higher price points, which are at the discretion of the customer. A basic prescription lens upgrade is offered for $40. By comparison, most of our U.S.-based competitors offer products that are more expensive, starting at approximately $249 or higher, with higher costs to add prescriptions.

 

Quality. All of our frames can be outfitted in-house or by optical resellers with any combination of prescription, sunglass, reading, and blue light lens formats. Our frame fronts are made with what we believe are high quality optical materials to ensure easy lens fitting by any optician.

 

Customizable Product Offering. There are 80+ lens types available for Lucyd Lyte, making it the most customizable smart eyewear in the world. Innovative Eyewear has a partnership with a high-quality optical lab in Boston to produce prescription and custom lenses for our frames quickly and affordably. Our contract with a third-party optical lab also allows us to offer direct prescription fulfillment to our customers.

 

Comfort. At just 1.0 - 1.5 ounces, our eyewear has a feather-light fit, suitable for all day vision correction or sun protection (traditional glasses weigh about 1 ounce). This is especially important while on the go. Our 1.0 ounce titanium aviators are among the lightest smart eyewear ever made.

 

Long Battery Life. At 12 hours of playback per charge, our current product offering of Lucyd eyewear outpaces most, if not all, of the competition on battery life.

 

Capital Light Business Model. All of our products are sold through multiple e-commerce channels, including on our website (Lucyd.co), BestBuy.com, DicksSportingGoods.com and Amazon.com, and are distributed through optical or other retailers (such as, but not limited to, Metro Optics Eyewear and Marca Eyewear Group, Inc.). We believe this capital light approach is highly scalable and efficient in the deployment of resources. We view “capital light” as being more efficient by obviating the need to build factories and retail stores, while partnering with existing companies in both of these groups.

 

Multiple-Channel Approach. We sell our products both through multiple online channels and multiple categories of brick-and-mortar retail stores. We believe this multi-channel approach provides us with an advantage against our competitors who sell in a narrower selection of channels.

 

Experienced Management Team. We have an experienced board of directors with more than 100 years of combined experience in the eyewear industry, and a management team with substantial experience in software and electronics engineering and operating eyewear and technology companies.

 

Sales

 

We have two major sales channels: (1) e-commerce via Lucyd.co and Amazon, and (2) our ongoing development of a network of eyewear, sporting goods, and electronics resellers, including but not limited to, BestBuy.com, DicksSportingGoods.com, and Brookstone, to offer our frames. Most of our resellers are experienced opticians who provide valuable feedback that informs the development of our product lines, which we would not receive if we were solely direct to consumer. Additionally, we have a robust presence on multiple e-commerce and social media platforms, which facilitates several customer on-ramps for the Lucyd brand, and numerous ad campaign strategies. Building on our early successes of driving traffic to Lucyd.co, the website run by a subsidiary of our largest stockholder, from Facebook, Instagram, and TikTok, we deploy high quality content on multiple platforms to continuously keep customers engaged and drive brand awareness.

 

7

 

 

We have two levels of margins, one for business to consumers (“B2C”), and one for business to business (“B2B”). The majority of our sales have been through e-commerce with current gross margins of approximately 69%; wholesale sales have gross margins of approximately 32%. Lens upgrades sold on Lucyd.co have a standardized profit margin of approximately 35%. As a company still in an early growth stage, we are investing heavily in our B2C and B2B efforts to capture as much market share as possible, which included in fiscal years 2022 and 2023 several activities which impacted the gross deficit. Among these promotional activities were various B2C discounts, heavy B2B discounts on large bulk orders, a large number of free sample units provided to media, influencers, and reviewers, and significant spending on upsells, promo items, and merchandising materials which were in many cases given to B2C and B2B customers for free. Customer retention was also a priority in 2023, so providing exchanges on orders with custom lenses that didn’t meet consumer expectations, and exchanges for frames which didn’t fit the customer properly, impacted our deficit. However, with the change to a higher quality supplier in 2023, we had a reduction in the percentage of orders that were returned, and improved user feedback. Further improvements to fit, finish and audio quality introduced with the Lyte XL line in late 2023 further improved our market reception. Our online retail sales accounted for the majority of our sales in 2023.

 

E-commerce Channels

 

1. Company website: Lucyd.co

 

Lucyd.co is our primary e-commerce point of sale. The site offers the most customization options of any of our sales channels and a full prescription lens lab, offering over 80 different lenses (21 key lens tints offered in plano, single prescription and progressive bifocal; seven types of reading lenses). Additionally, the Lucyd website ships worldwide and is used to provide a quick and smooth buying experience.

 

2. Amazon

 

Amazon.com/lucyd is our brand shop on Amazon. It drives approximately half of our online sales, but limits the number of variations we can offer on our frames (e.g., prescription lenses are not permitted on Amazon). However, through Amazon, we are still able to offer color lens sunglass variants and blue light blocker pairs, in addition to our charging dock accessory item. We continually monitor and test traffic flow to Lucyd.co versus Amazon.com to ensure our online ad spend is fully optimized.

 

3. Walmart.com, BestBuy.com, DicksSportingGoods.com, Brookstone.com, and eBay

 

In addition to our key online sales channel through Lucyd.co, our products are also sold on Walmart.com, BestBuy.com, DicksSportingGoods.com, Brookstone.com, and eBay.

 

4. Social Selling

 

Not only do we use social media to drive traffic to our main sales channels, but we also take advantage of intra-social shops as well, and have deployed shopping experiences through Facebook, Instagram, and TikTok to gain further brand awareness.

 

We also offer two affiliate platforms via Shareasale.com and Shopify for peer-driven sales. The Shareasale program is for professional affiliate and deal promotion companies, and increases revenue on Lucyd.co by offering direct commissions in exchange for converting web traffic. The Shopify affiliate program enables Lucyd brand enthusiasts to get a financial reward for sharing the brand, and operates on similar terms as the Shareasale program where we provide a commission rate in exchange for converting web traffic.

 

8

 

 

Retail Channels

 

1. Independent Eyewear Stores

 

The core of our B2B business is formed by our relationship with numerous eyewear store retailers across the United States and Canada, which provide Lucyd Lyte frames directly to their optical customers. Many of these retail stores have placed multiple stocking orders since launching our wholesale business in 2021. To support our resellers, we offer a strong co-op marketing program that includes free store display materials. As part of this strategy, we provide digital try-on kiosks to our resellers to help educate their in-store customers about Lucyd eyewear and increase our brand’s physical presence in the optical industry. In 2023, the Lucyd virtual try-on kiosk was replaced with a fully modular display system, with eight available components for stores to mix and match to suit their display needs. The display can be countertop or freestanding, making it suitable for almost any retail environment.

 

2. National Eyewear Chains

 

Lucyd eyewear is currently being evaluated by several leading eyewear retailers and distributors in the US and Canada for inclusion in their offerings, with one major optical chain currently testing our products in 10 retail locations. Following the introduction of Ray Ban Stories smart eyewear in late 2021, many retailers are now more open to introducing smart eyewear in their stores and on their e-commerce platforms. Based on our current discussion with several major optical businesses (by store size), we believe at least one additional major optical chain or national optical buying group will onboard our product line in 2024. However, there can be no assurances that any of these retailers and distributors will sell our products.

 

3. Big Box Retail Stores (Electronics, sporting goods, general merchandise)

 

In addition to mainstream optical channels, we distribute our Lucyd eyewear through leading big box stores, such as Bestbuy.com and Dickssportinggoods.com, through either their eyewear or electronics departments.

 

4. License Agreements and Specialty Retail Stores

 

We are leaving no stone unturned in our mission to bring smart eyewear mainstream. We have licensed three leading fashion brands – Nautica, Eddie Bauer, and Reebok – to produce new Powered by Lucyd cobranded frames. In January 2024, we launched the Nautica Powered by Lucyd smart eyewear collection in eight different styles, along with various branded accessories including a power brick, cleaning cloth. and a slipcase adorned with the iconic Nautica sail logo. We anticipate launching the cobranded collections with Eddie Bauer and Reebok later in 2024.

 

Manufacturing and Supply Chain

 

Our products are designed in the United States and subsequently manufactured in China. The products are designed in-house, and 3-D Computer-Aided Design (CAD) files are produced with product renderings. We then subject these rendered images to focus group review, to determine which designs we should move to the prototype development stage. Pre-production prototypes are developed by our factories in China, to our specifications. Our factories source components for the smart eyewear in China, including plastic and titanium for the frames, electronic components, speakers, microphones, and batteries. All packaging is designed in Miami and fabricated in China. Once completed, our products are tested in the United States, to assess functionality, fit, and finish. Production orders are placed and fabricated in China based on anticipated demand, whereupon they undergo a rigorous thirteen-point third-party product inspection process. This inspection is conducted on 100% of our manufactured products. Inspections include testing procedures to help ensure our customers receive only functional, high-quality products. For large bulk orders from clients, we are able to order this inventory on demand, due to the expected lead times in the traditional frame sourcing business.

 

9

 

 

All of our frames are manufactured with prefabricated, ready-to-wear sunglass or blue light lenses, and are directly shipped to the customer in this state if the customer declines to purchase custom lens upgrades. If a customer orders with prescription or specialty lenses, then the smart eyewear frames are sent to an optical contractor laboratory in Boston, Massachusetts, to have the lenses cut, ground, and mounted in the frames, whereupon they are directly shipped to customers.

 

In 2023 we retired our virtual try-on display in favor of a more engaging and affordable Modular Display System, which consists of a variety of components that can be assembled according to the functionality and needs of the partner retailer. The displays can be setup on a countertop or freestanding. This unique, proprietary system includes the following available components:

 

1. An LCD countertop video screen available in white and black with Lucyd branding, or in navy with Nautica branding.

 

2. A white shelf component which includes storage space for demo frames and a mirror for try-ons.

 

3. A rack component available in white with Lucyd branding or in navy with Nautica branding, which stores 4 frames for display and try-on.

 

4. A bookshelf component which transforms the display into a freestanding endcap unit with ample storage underneath.

 

This new system was deployed to several dozen partner stores in 2023 with near universal positive feedback from retailers, and we believe has proved useful for encouraging larger wholesale orders.

 

 

Marketing

 

We employ a 360-degree marketing strategy that encompasses both brand and user-generated content syndication across earned, owned, and paid platforms (channels where the company pays a fee to have its product advertised). Long form and video content generation are key focus points for the brand, as they allow us to better leverage both emerging and critical smart eyewear narratives through persistent search engine optimization (SEO), increasing our organic brand awareness across the board, in addition to strategic loyalty, influencer, and affiliate marketing campaigns.

 

10

 

 

Our online marketing strategy is primarily driven by pay-per-click advertisements on mainstream search engines, social media apps, and Amazon and other marketplaces. In addition, we support our primary efforts with influencer created and promoted “UGC” (user-generated content), email automations and newsletters, and website push notifications. In 2024, we plan to scale up our affiliate and email marketing efforts to augment our core social ads campaigns.

 

We believe we are trendsetters in creating relevant, omni-channel touchpoints that derive meaningful experiences and products designed for our customers.

 

Our wholesale marketing strategy is primarily focused on traditional sales email and call outreach, national and regional optical trade shows, and optical and athletic trade advertisements. We have also deployed B2B mailer and digital mailer campaigns to inform optical businesses about our new releases.

 

Strategically offering stylish optical smart eyewear, coupled with expansive end-user customization, plus our ChatGPT app, has the potential to rapidly expand our brand awareness and revenue. At Innovative Eyewear, we strive to lead and own critical narratives within the smart eyewear space, and have demonstrated our pioneering leadership and proficiency via the filing of dozens of patents on smart eyewear design and functionalities.

 

We seek to create memorable experiences and products that resonate with our customers, coupled with premium content and campaigns designed to expand our brand presence and market share. We also attend major regional eyewear and sporting goods trade shows to build awareness among our potential retail partners.

 

Our influencers

 

To accelerate brand awareness and product sales, we are embarking on an influencer strategy to engage leading figures in sports and the arts, who like and enjoy wearing Lucyd Lyte®. Our influencers promote our products on social media, provide us with product placement opportunities at sporting events and other cultural events, and have granted us contractual rights to use their names and likenesses in connection with the advertisement and sale of our products. To date, we have onboarded Chris Clark, a pro golfer; Monique Billings, a WNBA basketball player; Emmanuel Ogbah, an NFL football player; and Hadar Adora, an up-and-coming musical artist. We plan to add additional influencers to enhance awareness and sell-through for a number of key demographics.

 

Influencers are a key part of our marketing strategy, as they help our products relate to large, variable audiences. Lucyd Lyte is a perfect fit for the fitness tech and audio product spaces, so athletes and musicians are a natural fit for our brand and the active lifestyles that Lucyd products promote. We plan to add A-list musical talent to the brand in the near future, as well as a host of audio content creators to support the Vyrb experience.

 

Intellectual Property

 

We license from Lucyd Ltd., a subsidiary of our largest stockholder, an intellectual property portfolio designed to protect our unique eyewear designs and certain technological features in current and anticipated future products. Since 2021, the Company has begun filing patents under its own name. We have licensed and filed numerous patents covering all of our current product designs and certain advanced features such as Vyrb, replaceable front frames, and multi-channel Bluetooth connectivity. The Company will seek to file new intellectual property to protect new styles and features of its smart eyewear as they are introduced.

 

In January 2024, we entered into a multi-year licensing agreement with a third party (IngenioSpec, LLC) for multiple smart eyewear patents, bringing our overall portfolio of owned and licensed intellectual property to over 100 patents.

 

Our current U.S. and foreign patent portfolio is as listed below.

 

11

 

 

Pending and Registered Patent Applications Licensed from Lucyd Ltd.

 

App/Patent Number Title Country Filing Date Status Grant Date
10,908,419 Smartglasses and Methods and Systems for Using Artificial Intelligence to Control Mobile Devices Used for Displaying and Presenting Tasks and Applications and Enhancing Presentation and Display of Augmented Reality Information U.S. June 28, 2018 Issued February 2, 2021
D899,493 Smart Glasses U.S. March 22, 2019 Issued October 20, 2020
D900,203 Smart Glasses U.S. March 22, 2019 Issued October 27, 2020
D899,494 Smart Glasses U.S. March 22, 2019 Issued October 20, 2020
D899,495 Smart Glasses U.S. March 22, 2019 Issued October 20, 2020
D899,496 Smart Glasses U.S. March 22, 2019 Issued October 20, 2020
D900,204 Smart Glasses U.S. March 22, 2019 Issued October 27, 2020
D900,205 Smart Glasses U.S. March 22, 2019 Issued October 27, 2020
D900,920 Smart Glasses U.S. March 22, 2019 Issued November 3, 2020
D900,206 Smart Glasses U.S. March 22, 2019 Issued October 27, 2020
D899,497 Smart Glasses U.S. March 22, 2019 Issued October 20, 2020
D899,498 Smart Glasses U.S. March 22, 2019 Issued October 20, 2020
D899,499 Smart Glasses U.S. March 22, 2019 Issued October 20, 2020
D899,500 Smart Glasses U.S. March 22, 2019 Issued October 20, 2020
D954,135 Round Smartglasses Having Flat Connector Hinges U.S. December 12, 2019 Issued June 7, 2022
D958,234 Round Smartglasses Having Pivot Connector Hinges U.S. December 12, 2019 Issued July 19, 2022
D955,467 Sport Smartglasses Having Flat Connector Hinges U.S. December 12, 2019 Issued June 21, 2022
D954,136 Smartglasses Having Pivot Connector Hinges U.S. December 12, 2019 Issued June 7, 2022
62/941,466 Wireless Smartglasses with Quick Connect Front Frames U.S. November 27, 2019 Non-Provisional Application filed on November 25, 2020; U.S. App. No. 17/104,849 n/a

 

12

 

 

D954,137 Flat Connector Hinges for Smartglasses Temples U.S. December 19, 2019 Issued June 7, 2022
D974,456 Pivot Hinges and Smartglasses Temples U.S. December 19, 2019 Issued n/a
11,282,523 Voice Assistant Management U.S. March 25, 2020 Issued March 22, 2022
D1,010,718 Wayfarer Smartglasses U.S. July 20, 2020 Issued January 9, 2024
D951,334 Round Smartglasses U.S. July 20, 2020 Issued May 10, 2022
17/104,849 Wireless Smartglasses with Quick Connect Front Frames U.S. November 25, 2020 Pending n/a
D1,013,765 Smartglasses U.S. September 1, 2021 Issued February 6, 2024
29/806,204 Smartglasses U.S. September 1, 2021 Pending n/a
29/806,207 Smartglasses U.S. September 1, 2021 Pending n/a
29/806,209 Smartglasses U.S. September 1, 2021 Pending n/a
207516 Smartglasses Canada October 29, 2021 Issued May 23, 2023
207517 Smartglasses Canada October 29, 2021 Issued May 23, 2023
207518 Smartglasses Canada October 29, 2021 Issued May 23, 2023
207519 Smartglasses Canada October 29, 2021 Issued May 23, 2023
29/814,016 Safety Smartglasses U.S. November 2, 2021 Pending n/a
29/814,017 Safety Shields U.S. November 2, 2021 Pending n/a
63/274,920 Safety Glasses U.S. November 2, 2021 Non-Provisional Application filed on October 21, 2022; U.S. App. No. 18/048,715 n/a
207956 Safety Smartglasses Canada November 17, 2021 Issued May 23, 2023
207957 Safety Shields Canada November 17, 2021 Issued May 30, 2023
2021307950576 Safety Smartglasses China December 2, 2021 Pending n/a
ZL 2021307955902 Safety Shields China December 2, 2021 Issued May 3, 2022
18/048,715 Safety Glasses U.S. October 21, 2022 Pending n/a
3180624 Safety Glasses Canada November 1, 2022 Pending n/a
202211367067X Safety Glasses China November 2, 2022 Pending n/a
42023078694.9 Safety Glasses Hong Kong September 5, 2023 Pending n/a

 

13

 

 

Pending and Registered Patent Applications Owned by Innovative Eyewear, Inc.

 

App/Patent Number Title Country Filing Date Status Grant Date
29/815,040 Charging Cradle U.S. November 10, 2021 Pending n/a
63/297,056 Charging Cradle for Smartglasses U.S. January 6, 2022 Non-Provisional Application filed on December 29, 2022; U.S. App. No. 18/147,002 n/a
212589 Charging Cradle Canada May 9, 2022 Pending n/a
ZL 2022302715131 Charging Cradle China May 10, 2022 Issued October 21, 2022
18/147,002 Charging Cradle for Smartglasses U.S. December 27, 2022 Pending n/a
29/870,951 Smartglasses U.S. February 9, 2023 Allowed n/a
29/870,952 Smartglasses U.S. February 9, 2023 Allowed n/a
29/870,957 Smartglasses U.S. February 9, 2023 Allowed n/a
29/870,958 Smartglasses U.S. February 9, 2023 Allowed n/a
29/870,959 Smartglasses U.S. February 9, 2023 Allowed n/a
29/870,960 Smartglasses U.S. February 9, 2023 Allowed n/a
29/870,961 Smartglasses U.S. February 9, 2023 Allowed n/a
29/870,965 Smartglasses U.S. February 9, 2023 Allowed n/a
29/870,966 Smartglasses U.S. February 9, 2023 Allowed n/a
29/870,968 Smartglasses U.S. February 9, 2023 Allowed n/a
29/870,970 Smartglasses U.S. February 9, 2023 Allowed n/a
29/870,972 Smartglasses U.S. February 9, 2023 Allowed n/a
29/870,974 Smartglasses U.S. February 9, 2023 Allowed n/a
29/870,975 Smartglasses U.S. February 9, 2023 Allowed n/a
29/871,111 Smartglasses Temples U.S. February 13, 2023 Pending n/a
18/189,547 System, Apparatus, and Method For Using a Chatbot U.S. March 24, 2023 Pending n/a
18/463,465 Spring-loaded Hinges For Smartglasses U.S. September 8, 2023 Pending n/a

 

14

 

 

Registered Patent Applications Licensed from Ingeniospec, LLC

 

App/Patent Number Title Country
7,192,136 Tethered Electrical Components for Eyeglasses U.S.
7,255,437 Eyeglasses with Activity Monitoring U.S.
7,380,936 Eyeglasses with a Clock or Other Electrical Component U.S.
7,401,918 Eyeglasses with Activity Monitoring U.S.
7,438,410 Tethered Electrical Components for Eyeglasses U.S.
7,481,531 Eyeglasses with User Monitoring U.S.
7,500,746 Eyewear with Radiation Detection System U.S.
7,500,747 Eyeglasses with Electrical Components U.S.
7,581,833 Eyewear Supporting After-Market Electrical Components U.S.
7,621,634 Tethered Electrical Components for Eyeglasses U.S.
7,677,723 Eyeglasses with a Heart Rate Monitor U.S.
7,771,046 Eyewear with Monitoring Capability U.S.
7,792,552 Eyeglasses for Wireless Communications U.S.
8,109,629 Eyewear Supporting Electrical Components and Apparatus Therefor U.S.
8,337,013 Eyeglasses with RFID Tags or with a Strap U.S.
8,430,507 Eyewear with Touch-Sensitive Input Surface U.S.
8,434,863 Eyeglasses with a Printed Circuit Board U.S.
8,465,151 Eyewear with Multi-Part Temple for Supporting One or More Electrical Components U.S.
8,500,271 Eyewear Supporting After-Market Electrical Components U.S.
8,770,742 Eyewear with Radiation Detection System U.S.
8,905,542 Eyewear Supporting Bone Conducting Speaker U.S.
9,033,493 Eyewear Supporting Electrical Components and Apparatus Therefor U.S.
9,488,520 Eyewear with Radiation Detection System U.S.
9,547,184 Eyewear Supporting Embedded Electronic Components U.S.
9,690,121 Eyewear Supporting One or More Electrical Components U.S.
10,060,790 Eyewear with Radiation Detection System U.S.
10,061,144 Eyewear Supporting Embedded Electronic Components U.S.
10,310,296 Eyewear with Printed Circuit Board U.S.
10,330,956 Eyewear Supporting Electrical Components and Apparatus Therefor U.S.
10,345,625 Eyewear with Touch-Sensitive Input Surface U.S.
10,359,311 Eyewear with Radiation Detection System U.S.
10,539,459 Eyewear with Detection System U.S.
11,086,147 Eyewear Supporting Electrical Components and Apparatus Therefor U.S.
11,204,512 Eyewear Supporting Embedded and Tethered Electronic Components U.S.
11,243,416 Eyewear Supporting Embedded Electronic Components U.S.

 

15

 

 

11,326,941 Eyewear with Detection System U.S.
11,513,371 Eyewear with Printed Circuit Board Supporting Messages U.S.
11,536,988 Eyewear Supporting Embedded Electronic Components for Audio Support U.S.
11,630,331 Eyewear with Touch-Sensitive Input Surface U.S.
11,644,361 Eyewear with Detection System U.S.
11,644,693 Wearable Audio System Supporting Enhanced Hearing Support U.S.
11,733,549 Eyewear Having Removable Temples That Support Electrical Components U.S.
11,762,224 Eyewear Having Extended Endpieces to Support Electrical Components U.S.
11,803,069 Eyewear with Connection Region U.S.
11,829,518 Head-worn Device with Connection Region U.S.
ZL200510067143.5 Radiation Detection System for Eyewear and Other Products China

 

Additionally, we have acquired the exclusive rights to 11 registered trademarks and applications as follows:

 

Trademark   Trademark Number   Status   Jurisdiction
LUCYD   UK00003258030   Registered   UK
Lucyd Lens   UK00003258093   Registered   UK
Lucyd Loud   UK00003400531   Registered   UK
Upgrade your eyewear   UK00003400579   Registered   UK
GaaS   UK00003451728   Registered   UK
Vyrb   UK00003477240   Registered   UK
Lyte   UK00003526151   Registered   UK
Upgrade your eyewear   Application No. 90/407,646   Application   US
LUCYD   Application No. 90/407,723   Application   US
Lyte   Application No. 90/381051   Application   US
Vyrb   Application No. 90/820713   Application   US

 

Material Agreements

 

License Agreement between Innovative Eyewear, Inc. and Lucyd Ltd.

 

On April 1, 2020, we entered into an exclusive, worldwide license agreement with Lucyd Ltd. for all fields of use of the Lucyd® brand, and the associated intellectual property and assets (the “License Agreement”). We were founded by Lucyd Ltd., the inventor and licensor of the technology that our products are based upon, which is a portfolio company of Tekcapital, our largest stockholder. The License Agreement is a royalty-free, fully paid up, perpetual license, for the exclusive use of the following assets:

 

1. All Lucyd intellectual property, including, all patents, patent applications and any continuations of such.

 

2. All Lucyd trademarks.

 

3. All Lucyd collateral material, artwork, subscriber lists, eyeglass model and frame shots and renders, as well as 3D models.

 

4. All Lucyd logos such as, but not limited to: Lucyd® word mark, Lucyd Hexagon, Upgrade Your Eyewear® slogan and the Vyrb® trademark.

 

5. All Lucyd company developed software and any new software developed by Innovative Eyewear, utilizing the Lucyd software, will be owned by Innovative Eyewear.

 

16

 

 

6. Lucyd Store portals through Shopify, Amazon and Walmart.

 

7. Relevant websites domain names including Lucyd.co, Lucyd.net, Lucyd.eu.

 

8. All supply and endorsement agreements.

 

9. All current inventory as of the execution date of license.

 

10. All social media accounts under the Lucyd name, including, but not limited to: Twitter, Facebook and Instagram.

 

11. All advertising material and trade show displays, brochures and related materials.

 

Under the terms of the License Agreement, we have the exclusive right to effectuate sublicenses, either exclusively or non-exclusively, to any or all of our licensed intellectual property, at its sole discretion. Upon execution of the License Agreement, we paid Lucyd Ltd. £1 for the life of the licensed assets, and the License Agreement shall continue in perpetuity, unless terminated according to the terms of the agreement. Additionally, we issued 3,750,000 shares of our common stock to Lucyd Ltd. as compensation for entering into the License Agreement and for the contribution of certain other assets. Lucyd Ltd. may terminate the license with immediate effect by providing written notice to us if, among other things: we commit a material breach, as such is defined by the terms of the agreement; or, if we suspend, or threaten to suspend, payment of our debts or are unable to pay our debts.

 

The License Agreement requires us to indemnify Lucyd against all liabilities, costs, expenses, damages, and losses (including but not limited to any direct, indirect or consequential losses, loss of profit, loss of reputation and all interest, penalties, and legal costs (calculated on a full indemnity basis) and all other reasonable professional costs and expenses) suffered or incurred by Lucyd Ltd. arising out of or in connection with actual or alleged infringement of third party intellectual property rights; our breach or non-performance of or the enforcement of License Agreement. We have the right to sublicense any of our rights under the License Agreement, provided that any sublicense also shall enter into a supplemental agreement satisfactory to Lucyd Ltd.

 

On October 5, 2021, the parties to the License Agreement executed an Addendum, to the exclusive license agreement, which clarified that Innovative Eyewear shall commercialize, continue with any on-going intellectual property prosecutions and pay all maintenance or other patent fees (the “Addendum”). For all new intellectual property, Innovative Eyewear will own and control it and be responsible for all prosecution and maintenance costs. The Addendum also confirms that Innovative Eyewear issued Lucyd Ltd. 3,750,000 shares of its common stock as consideration for the license.

 

Cobranded License Agreements

 

On September 28, 2022, we entered into a multi-year global licensing agreement with Nautica Apparel, Inc., which became effective July 1, 2022. Pursuant to this agreement, we received a license to utilize the global lifestyle brand Nautica® for our smart eyewear products. We launched the first line of cobranded Nautica® Powered by Lucyd sport lifestyle audio glasses in January 2024.

 

On December 23, 2022, we entered into a multi-year global licensing agreement with Authentic Brands Group, which became effective October 1, 2022. Pursuant to this agreement, we received a license to utilize the outdoor brand Eddie Bauer® for our smart eyewear products. We plan to launch a cobranded line of Eddie Bauer® Powered by Lucyd smartglasses later in 2024.

 

On June 12, 2023, we entered into a multi-year global licensing agreement with Authentic Brands Group, which became effective April 1, 2023. Pursuant to this agreement, we received a license to utilize received a license to utilize the iconic athletic brand Reebok® for our smart eyewear products. We plan to launch a cobranded line of Reebok® Powered by Lucyd smartglasses later in 2024.

 

The aforementioned agreements require us to pay royalties based on a percentage of net retail and wholesale sales, and also require guaranteed minimum royalty payments. The agreements have base terms of 10 years but are cancellable at our option during the fifth year.

 

17

 

 

Sales Representation Agreement

 

On March 4, 2021, we entered into a commission-only, sale representation agreement with D. Landstrom Associates, Inc. for prospecting wholesale relationships with Walmart, Target, and Best Buy stores in the United States (the “Representation Agreement”). The Representation Agreement provides for D. Landstrom to act as our commission-based manufacturer’s representative, with the exclusive right to solicit offers on behalf of us to purchase our products in the United States, for the named big box stores. The term of the Representation Agreement is five years, and the contract may be terminated for “good cause” with 90 days’ notice by either party. Upon termination, commissions of orders procured will extend 180 days beyond the termination date. Thus far, the Representation Agreement has resulted in a successful launch of the Company’s products on BestBuy.com.

 

Proprietary Software Sharpens our Competitive Edge

 

Lucyd App

 

The Lucyd app was launched in April 2023 to provide voice access to ChatGPT in Lucyd eyewear. This is a simple and powerful app that provides significant new AI functionality to our glasses at no additional cost to the user, differentiating our products from other smart eyewear. The app also sports a powerful visual interface for interacting with ChatGPT in a variety of ways.

 

Additional functionalities are planned for the Lucyd app, such as the ability to hear topic-specific newsfeeds, and access audiobook and music content through voice commands. Additionally, the Company plans to add typical headphone app features such as sound mixing, warranty registration, and customization of button mappings. The Lucyd app, in addition to being an onramp into AI, is planned to be a “gearbox” for Lucyd eyewear to allow further user customization of the product experience.

 

Although we plan to continue to provide the app for free to glasses customers, we plan to add a Pro version of the app which will be a paid subscription, and free use given to glasses customers will be time limited to 6-12 months, after which the user will need to pay a nominal monthly fee for unlimited access to GPT (and potentially other AI services in the future). We believe this will enable a new software revenue stream for the business and allow us to capture revenue from users of other hearables such as Apple Airpods that want an audio interface for ChatGPT.

 

Vyrb™ Social Audio App

 

We believe smart eyewear, along with other wearables, has the potential to be a more convenient and ergonomic onramp to social media than smartphones and PCs. While digital assistants, once enabled, can provide the basis for this interaction, we believe that the ability to receive and send social media posts with an individual’s voice may greatly enhance ease of use of these platforms on the go. To facilitate this, we have been developing Vyrb, our full stack social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with an individual’s voice. The beta application launched in December 2021, and the full release is anticipated for 2024 once additional improvements to the user experience are completed. At or soon after this time, advertising and monetization features will be introduced into the app to make it a new revenue stream for our business.

 

Vyrb enhances the utility of current and future Lucyd Lyte glasses by enabling users to be untethered from their smartphones, yet still be able to hear and make social media posts. A goal of our products is to free our customers from other technologies. As such, we are designing Vyrb with a transparent, voice-centric interface, so that as soon as our customers can say “OK Google,” they are connected to a world of engaging audio content and have the ability to create audio posts and messages. We believe social interaction via smart eyewear will be instrumental in bringing new, youthful customers to our company.

 

18

 

 

The Product and Market for Vyrb

 

The Vyrb app is contemplated to feature an in-app item shop with a number of fun and useful upgrades, such as:

 

Loot Boxes — Random packs of multiple upgrade items, a best-selling in-app purchase format frequently deployed in online video games.

 

Skins — Items that alter the appearance of the app to help personalize it to the user’s preferences, such as Dark Mode.

 

Accents — Items that change the accent used by the app’s text-to-speech engine, which is employed frequently to vocalize textual content.

 

Metal Mics — Items that lengthen the maximum allowable verbal post length and image/video sizes per post for users.

 

Post Embellishments — Items that can be used to animate posts in the feed to make them more prominent.

 

Sound FX Packs — Items that increase the number of audio emojis (Sound FX) available to the user, livening up their posts.

 

Ad Tokens — Items that can be spent to expand the reach of a feed post to a larger audience.

 

Vyrb Gold — A premium, monthly subscription to the app that blocks all ads and brings additional benefits like a more prominent username.

 

Vyrb Gems — In-app currency that can be spent to tip a user’s favorite content creators, to buy premium paywalled content and to buy certain other in-app purchases. Gems can also be traded to other users for their items on the Vyrb Marketplace module. Users will also be rewarded Gems for their engagement with ads on the platform, creating a positive feedback loop that rewards app engagement with premium content and experiences.

 

Command Tokens — Items that can be spent to create new custom voice assistant commands (based on Vyrb’s Voice Command Creation Interface).

 

Mega-Tag Tokens — Items that can expand the number of mega-tags available to the user (mega-tags are a unique Vyrb feature, they are automatically applied hashtags that make a user’s posts more discoverable to others).

 

Vyrb users will be able to purchase and support content from indie and professional creators via an in-app currency (referred to as “gems” in this document, a virtual point the user typically accumulates by viewing ad content or by purchasing them). Creators will receive gems from typical users as tips during live broadcasts, and in exchange for access to premium posts. The creators will then be able to cash out these gems at an exchange rate that provides profit to Vyrb. For example, users purchase the gems, its in-app loyalty token at a rate of $1 each, but creators only receive $0.75 for each gem they cash out. A 25% effective platform fee would put the content transaction fees of Vyrb at a lower rate than most digital content marketplaces. In the case of typical livestreaming applications, a functionality Vyrb supports, they are often exorbitant, taking as much as 50% in effective fees on in-app currency transactions.

 

19

 

 

Also, we plan for users to be able to charge a fixed price to be able to access particular audio posts. For example, this feature could be used by a podcaster to sell their premium episodes, or by a recording artist to sell their music albums. In tandem with this feature, audio posts will be divisible into tracks to support long form content such as albums and audiobooks. Vyrb will take a flat percentage fee on all sales of premium content within the application by allowing creators to cash out gems they receive for selling their content. We believe the major benefit of this system is that it will provide audio content creators a new platform for rapidly creating, listing and selling their content, and help create an environment full of rich, unique and interactive audio experiences such as live “radio shows,” indie content and virtual concerts for typical Vyrb users.

 

We believe that Vyrb will effectively leverage multiple successful gamification models from the world of social media to provide a flexible and highly interactive user experience that can potentially draw high-value content creators.

 

Employees

 

As of December 31, 2023, we had 11 full time employees, spread over business development, marketing, finance, sales, app design, support and frame design. Employees are supported by a number of consultants, including two frame designers and five independent sales representatives.

 

Other Information

 

Our Internet website address is www.lucyd.co. We make available free of charge on or through our Internet website our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, proxy statements on Schedule 14A, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after we electronically file such materials with, or furnish them to, the Securities and Exchange Commission (the “SEC”). Alternatively, you may also access our reports at the SEC’s website at www.sec.gov.

 

Item 1A. Risk Factors.

 

Our business involves a high degree of risk and uncertainty, including the following.

 

Summary Risk Factors

 

The risk factors described below are a summary of the principal risk factors associated with an investment in us. These are not the only risks we face. You should carefully consider these risk factors, together with the risk factors set forth in detail below and the other reports and documents filed by us with the SEC.

 

Risks Related to our Business, Strategy and Industry

 

Our failure to meet the continued listing requirements of Nasdaq could result in a delisting of our securities.

 

We have a history of losses, and we may be unable to achieve or sustain profitability.

 

The optical industry is highly competitive, and if we do not compete successfully, our business may be adversely impacted.

 

We have limited experience in scaling a smart eyewear business. If we are unable to manage our expected growth effectively, our brand, and financial performance may suffer, which may have a material adverse effect on our business, financial condition, and operating results.

 

Increases in component costs, shipping costs, long lead times, supply shortages, and supply changes could disrupt our supply chain; factors such as wage rate increases and inflation can have a material adverse effect on our business, financial condition, and operating results.

 

20

 

 

We currently derive all of our revenue from sales of our glasses. A decline in sales of our eyewear would negatively affect our business, financial condition, and results of operation.

 

We face significant risks due to our dependency on foreign supply and manufacturing chains, geopolitical and economic changes, and changes in public perception about internationally sourced and manufactured products.

 

We rely on a limited number of contract manufacturers and logistics partners for our products. A loss of any of these partners could negatively affect our business.

 

If we fail to cost-effectively retain our existing customers or to acquire new customers, our business, financial condition, and results of operations would be harmed.

 

If we fail to successfully launch or after we launch receive sufficient revenue from our cobranded collections with Nautica, Eddie Bauer, and Reebok, our business, financial condition, and results of operations would be harmed.

 

Eyeglasses are regulated as medical devices by the FDA, and our failure, or the failure of any third-party manufacturer or optical laboratory, to obtain and maintain the necessary marketing authorizations for our products could have a material adverse effect on our business.

 

Our profitability and cash flows may be negatively affected if we are not successful in managing our supply chain and customer demands for product deliveries.

 

If we fail to maintain and enhance our brand, our ability to engage or expand our base of customers will be impaired, and our business, financial condition, and results of operations may suffer.

 

We rely heavily on our information technology systems, as well as those of our third-party vendors, business partners, and service providers, for our business to effectively operate and to safeguard confidential information; any significant failure, inadequacy, interruption, or data security incident could adversely affect our business, financial condition, and operations.

 

Our multichannel channel business faces distinct risks, and our failure to successfully manage it could have a negative impact on our profitability.

 

If we fail to adapt and respond effectively to rapidly changing technology, evolving industry standards and changing customer needs or requirements, our solutions may become less competitive.

 

We depend on highly skilled personnel to grow and operate our business, and if we are unable to hire, retain, and motivate our personnel, we may not be able to grow effectively.

 

A decline in sales of our eyewear would negatively affect our business, financial condition, and results of operations.

 

We could be adversely affected by product liability, product recall or personal injury issues.

 

21

 

 

Risks Related to our Intellectual Property

 

We license some of our technology from Lucyd Ltd., the largest stockholder of the Company, and our inability to maintain this license could materially affect our business, financial condition, and operating results.

 

Failure to adequately maintain and protect our intellectual property and proprietary rights could harm our brand, devalue our proprietary content, and adversely affect our ability to compete effectively.

 

We may incur costs to defend against, face liability or for being vulnerable to intellectual property infringement claims brought against us by others.

 

Risks Related to Our Dependence on Third Parties

 

We face risks associated with suppliers from whom our products are sourced and are dependent on a limited number of suppliers.

 

Our projects could be hindered due to our dependence on third parties to complete many of our contracts.

 

We depend on search engines, social media platforms, digital application stores, content-based online advertising, and other online sources to attract consumers to and promote our website and our mobile applications, which may be affected by third-party interference beyond our control; and, as we grow, the cost of acquiring new customers may continue to rise and become uneconomical.

 

Risks Relating to Our Business, Strategy and Industry

 

Our failure to meet the continued listing requirements of Nasdaq could result in a delisting of our securities.

 

If we fail to satisfy the continued listing requirements of Nasdaq such as the corporate governance requirements or the minimum stock price requirement, Nasdaq may take steps to delist our securities. Such a delisting would likely have a negative effect on the price of our securities and would impair your ability to sell or purchase our securities when you wish to do so. In the event of a delisting, we can provide no assurance that any action taken by us to restore compliance with listing requirements would allow our securities to become listed again, stabilize the market price or improve the liquidity of our securities, prevent our securities from dropping below the Nasdaq minimum stock price requirement, or prevent future non-compliance with Nasdaq’s listing requirements. Additionally, if our securities are not listed on, or become delisted from, Nasdaq for any reason, and are quoted on the OTC Bulletin Board, an inter-dealer automated quotation system for equity securities that is not a national securities exchange, the liquidity and price of our securities may be more limited than if we were quoted or listed on Nasdaq or another national securities exchange. You may be unable to sell your securities unless a market can be established or sustained.

 

On August 4, 2023, we received written notice from the Listing Qualifications Department of Nasdaq notifying us that, for a period of 30 consecutive business days, we failed to maintain a minimum closing bid price of $1.00 as required for continued listing on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), we had 180 calendar days, or until January 31, 2024, to regain compliance. On February 1, 2024, the Company received a letter (the “Extension Notice”) from Nasdaq notifying the Company that it had been granted an additional 180-day period, or until July 30, 2024, to regain compliance with Nasdaq Listing Rule 5550(b)(1).

 

22

 

 

The optical industry is highly competitive, and if we do not compete successfully, our business may be adversely impacted.

 

We compete directly with large, integrated optical players that sell both at the retail level and online such as Ray-Ban® that have multiple products, well regarded brands and retail banners, as well as established and well-regarded consumer electronics companies such as Bose®. This diversified and capable competition takes place both in physical retail locations as well as online, for smart glasses. To compete effectively, we must continue to create, invest in, or acquire, advanced technology, incorporate this technology into our products, obtain regulatory approvals in a timely manner where required, and process and successfully market our products.

 

Most if not all of our competitors have significantly greater financial and operational resources, longer operating histories, greater brand recognition, and broader geographic presence than we do. As a result, they may be able to outmaneuver us in the marketplace and offer capable products at more competitive prices, which may adversely affect our business. They also are able to spend far more than we do for advertising. We may be at a substantial disadvantage to larger competitors with greater economies of scale. If our costs are greater compared to those of our competitors, the pricing of our products may not be as attractive, thus depressing sales or the profitability of our products and services. Our competitors may expand into markets in which we currently operate, and we remain vulnerable to the marketing power and high level of customer recognition of these larger competitors and to the risk that these competitors or others could attract our customer base. Some of our competitors are vertically integrated and are also engaged in the manufacture and distribution of glasses and many of our competitors operate under a variety of brands and price points. These competitors can advantageously leverage this structure to better compete and access the market with significant market power could make it more difficult for us to compete. We purchase some of our product components from suppliers who may be affiliates of one or more competitors or may compete with ourselves in the future.

 

We may not continue to be able to successfully compete against existing or future competitors. Our inability to respond effectively to competitive pressures, improved performance by our competitors, and changes in the retail and e-commerce markets could result in lost market share and have a material adverse effect on our business, financial condition, and results of operations.

 

We have a history of losses, and we may be unable to achieve or sustain profitability.

 

We had a net loss of $6,616,791 for the year ended December 31, 2023, and a net loss of $5,681,833 for the year ended December 31, 2022. As of December 31, 2023, we had an accumulated deficit of $16,922,778. Because we have a limited operating history it is difficult for us to predict our future operating results. We will need to generate and sustain increased revenue and manage our costs to achieve profitability. Even if we do, we may not be able become or increase our profitability.

 

Our ability to generate profit depends on our ability to strengthen and expand our brand, continue to provide exciting products customers love, expand sales and improve margins. We are aiming to achieve profitability in the next two years, and between now and then we plan to efficiently invest in the business to bring it to scale by:

 

enhancing our products with new designs, functionality, and technology to widen our appeal and delight customers in a wide variety of demographic groups; and,

 

investing in our product development, supply chain and sales and marketing capabilities to leverage external resources as efficiently as possible to ensure that smart glasses are affordable for the majority of the world’s population who need them.

 

However, we may not succeed in any of the foregoing, and the planned investments may not result in profitability.

 

23

 

 

We have limited experience in the smart eyewear space. If we are unable to manage our growth effectively, our brand “Lucyd” and our financial performance may suffer, which may have a material adverse effect on our business, financial condition, and operating results.

 

The smart eyewear industry is newly emerging. Whilst our directors have more than 80 years of combined experience in the eyewear industry, the smart eyewear market presents numerous new challenges. To effectively manage these challenges and continue to grow, we must continue to invest in the design of new frames and technology, expand our product line and effectively integrate several new technologies into eyewear. Achieving this could strain our existing resources, and we could experience ongoing operating difficulties in managing our business and bringing it to scale. Failure to scale could harm our competitive position and future success, including our ability to retain and recruit personnel and to effectively execute our corporate objectives.

 

Our ability to generate net revenue will depend upon many factors, some of which we may have no control over.

 

The industry for stylish, affordable smart glasses, is rapidly evolving and may not develop as we expect. Even if our net revenue continues to increase, our net revenue growth rates may decline in the future as a result of a variety of factors, including macroeconomic factors, increased competition, and the maturation of our business. As a result, you should not rely on our net revenue growth rate for any prior period as an indication of our future performance. Overall growth of our net revenue will depend on a number of factors, including our ability to:

 

Increase exogenous distribution of our products in optical stores, big box retailers, specialty retailers and through multiple e-commerce channels;

 

Price our products so that we are able to attract new customers, and expand our relationships with existing customers;

 

Accurately forecast our net revenue and plan our operating expenses accordingly;

 

Successfully compete with other companies that are currently in, or may in the future enter, the smart eyewear industry or the markets in which we compete, and respond to developments from these competitors such as pricing changes and the introduction of new products and features, noting that most, if not all, of our competitors have stronger balance sheets and larger staffs to devote to their products;

 

Comply with existing and new laws and regulations applicable to our business;

 

Develop new product offerings, with services and features, including in response to new trends, competitive dynamics, or the needs of customers;

 

Successfully identify and acquire or invest in businesses, products, or technologies that we believe could complement or expand our business;

 

Avoid interruptions or disruptions in our supply chain from natural disasters and political uncertainty;

 

Provide customers with a high-quality experience and customer service and support that meets their needs;

 

Hire, integrate, and retain talented sales, customer experience, product design, and development and other personnel;

 

Effectively manage growth of our business, personnel, and operations;

 

24

 

 

Effectively manage our costs related to our business and operations; and,

 

Enhance our reputation and the value of the Lucyd brand.

 

Because we have a limited history operating our business, it is difficult to evaluate our current business and future prospects, including our ability to plan for and model future growth. Our limited operating experience combined with the rapidly evolving nature of the market in which we sell our products and services, substantial uncertainty concerning how these markets may develop, and other economic factors beyond our control, reduces our ability to accurately forecast quarterly or annual revenue. Failure to manage our future growth effectively could have an adverse effect on our business, financial condition, and operating results.

 

We also expect to continue to expend substantial financial and other resources to grow our business, and we may fail to allocate our resources in a manner that results in increased net revenue growth in our business. Additionally, we may encounter unforeseen operating expenses, difficulties, complications, delays, and other unknown factors that may result in losses in future periods. If our net revenue growth does not meet our expectations in future periods, our business, financial condition, and results of operations may be harmed, and we may not achieve or sustain profitability in the future.

 

Increases in component costs, shipping costs, long lead times, supply shortages, and supply changes could disrupt our supply chain and factors such as wage rate increases and inflation can have a material adverse effect on our business, financial condition, and operating results.

 

Meeting customer demand partially depends on our ability to obtain timely and adequate delivery of components for our products and services. All of the components that go into the manufacturing of our products and services are sourced from a limited number of third-party suppliers predominantly in the U.S., and China. Our contract manufacturers purchase and provide many of these components on our behalf, including sun lenses, demo lenses, hinge and chip sets and other electronic components, and we do not have long-term arrangements with most of our component suppliers. We are therefore subject to the risk of shortages and long lead times in the supply of these components and the risk that our suppliers discontinue or modify components used in our products. In addition, the lead times associated with certain components are lengthy and may preclude rapid changes in design, quantities, and delivery schedules. Our ability to meet temporary unforeseen increases in demand has been, and may in the future be, impacted by our reliance on the availability of components from these suppliers. We may in the future experience component shortages, and the predictability of the availability of these components may be limited in certain situations. In the event of a component shortage or supply interruption from suppliers of these components, we may experience supply chain delays. Developing alternate sources of supply for these components may be time-consuming, difficult, and costly, and we may not be able to source these components on terms that are acceptable to us, or at all, which may undermine our ability to fill our orders in a timely manner. Any interruption or delay in the supply of any of these parts or components, or the inability to obtain these parts or components from alternate sources at acceptable prices and within a reasonable amount of time, would harm our ability to timely ship our products to our customers.

 

In addition, substantially all of our components are shipped directly from our contract manufacturers to our warehouse facility in Miami or to a third-party optical laboratory in the United States, where lenses are cut and mounted into frames. These laboratories process most of the glasses ordered by our customers. Once processed at the laboratories, the finished products are then sorted and shipped using third-party carriers to our customers. Our eyeglasses are also shipped directly to our third-party distribution center in the United States for shipment directly to our customers and resellers. We depend in large part on the orderly operation of this distribution process, which depends, in turn, on adherence to shipping schedules and effective management of our optical laboratory network and third-party distribution center. Increases in transportation costs (including increases in fuel costs), issues with overseas shipments, supplier-side delays, as well as reductions in the transportation capacity of carriers, labor strikes or shortages in the transportation industry, disruptions to the national and international transportation infrastructure, and unexpected delivery interruptions or delays also have the potential to derail our distribution process.

 

25

 

 

Moreover, volatile economic conditions may make it more likely that our suppliers and logistics providers may be unable to timely deliver supplies, or at all, and there is no guarantee that we will be able to timely locate alternative suppliers of comparable quality at an acceptable price. In addition, international supply chains may be impacted by events outside of our control, and limit our ability to procure timely delivery of supplies or finished goods and services. We face additional risks related to the manufacturing facility we contract with in China and suppliers in China, including port of entry risks such as longshoremen strikes, import restrictions, foreign government regulations, trade restrictions, customs, and duties.

 

We source components from suppliers located in China. Effective September 1, 2019, the U.S. government implemented a 15% tariff on specified products imported into the U.S. from China and effective February 14, 2020, the 15% tariff was reduced to 7.5%. In June 2020, the U.S. government granted a temporary exclusion for plastic and metal frames with a retroactive effective date of September 1, 2019, and such exclusion expired in September 2020. There remains to be uncertainty as to whether there will be, and the resulting impacts of, any changes to U.S. government trade policy. If we are unable to mitigate the full impact of the enacted tariffs or if there is a further escalation of tariffs, costs on a significant portion of our products may increase further and our financial results may be negatively affected. While it is too early to predict how the current and future China tariffs will impact our business, our financial results may also be impacted by any resulting economic slowdown. The Company has researched alternate manufacturing solutions outside of China and believes it can shift production elsewhere if necessary.

 

The inability to fulfill, or any delays in processing, customer orders through third party optical laboratory optical laboratory could result in the loss of customers, issuances of refunds or credits, and may also adversely affect our income and reputation. The success of our retail and e-commerce sales depends on the timely receipt of products by our customers and any repeated, intermittent or long-term disruption in, or failures of, the operations of our distribution center and/or optical laboratories could result in lower sales and profitability, a loss of loyalty to our brands, and excess inventory.

 

Furthermore, increases in compensation, wage pressure, and other expenses for our employees may adversely affect our profitability. Increases in minimum wages and other wage and hour regulations can exacerbate this risk. These cost increases may be the result of inflationary pressures which could further reduce our sales or profitability. Increases in other operating costs may increase our cost of products sold or selling, general, and administrative expenses. Our competitive price model and pricing pressures in the optical retail industry may inhibit our ability to reflect these increased costs in the prices of our products, in which case such increased costs could have a material adverse effect on our business, financial condition, and results of operations. The Company sells prescription upgrades at an approximate 35% profit margin, which can increase our margin exposure in the event of defective returns, and render returned pairs unsellable due to the original lenses being removed. As of January 2024, the Company’s return policy was updated to prohibit discretionary returns of prescription lenses, which we believe will reduce the impact of lens returns on our margins. Lens upgrades remain an important driver of sales and increased AOV (average order value), and the Company is continuously working to keep customer satisfaction high with this offering to keep the returns as low as possible.

 

We currently derive all of our revenue from sales of our glasses. A decline in sales of our eyewear would negatively affect our business, financial condition, and results of operations.

 

We derive all of our revenue from the sale of one product line, our Lucyd Lyte smart eyewear. Our glasses are sold in highly competitive markets with limited barriers to entry. Introduction by competitors of comparable products at lower price points, a maturing product lifecycle, a decline in consumer spending, or other factors could result in a material decline in our revenue. Because we derive most of our revenue from the sale of our glasses, any material decline in sales of our glasses would have a material adverse impact on our business, financial condition, and operating results.

 

26

 

 

We face significant risks due to our dependency on foreign supply and manufacturing chains, geopolitical and economic changes, and changes in public perception about internationally sourced and manufactured products.

 

Since our component materials are sourced in China, our production may face additional risks such as, but not limited to: increased shipping costs, imposition of additional import or trade restrictions, increased custom duties and tariffs, legal or economic restrictions on our supplier and manufacturer’s ability to meet our needs, unforeseen delays in customs clearance of goods, transportation delays, issues with ports of entry, new and adverse foreign government regulations, political instability, war, natural disasters, and overall economic uncertainty. Public opinion about internationally sourced and manufactured products could be changed by negative press, which could have an impact on our customers’ confidence and satisfaction and could also have a negative impact on our public image and brand perception.

 

If we fail to cost-effectively retain our existing customers or to acquire new customers, our business, financial condition, and results of operations would be harmed.

 

The growth of our business is dependent upon our ability to continue to grow by cost-effectively retaining our existing customers and adding new customers. To a high degree, we rely on word of mouth to increase revenue. We also rely on the use of influencers which are expensive and may not provide the anticipated return on investment. Although we believe that many customers originate from word-of-mouth and paid and non-paid referrals, we expect to continue to expend resources and run marketing campaigns to acquire additional customers, all of which could impact our overall profitability. If we are not able to continue to expand our customer base, or fail to retain customers, our net revenue will grow slower than expected or decline.

 

The growth of our e-commerce channel is critical to our continued customer retention and growth. Historically, consumers have been slower to adopt online shopping for glasses than e-commerce offerings in other industries such as consumer electronics and apparel. Improving upon the consumer in-store experience through an online platform is difficult due to broad consumer demands on selection, quality, convenience, and affordability. Changing traditional optical retail habits is difficult, and if consumers and retailers do not embrace smart eyewear as we expect, our business and operations could be harmed.

 

Our ability to attract new customers and increase net revenue from existing customers also depends in large part on our ability to enhance and improve our existing products and to introduce new products and services, in each case, in a timely manner. We also must be able to identify and originate styles and trends as well as to anticipate and react to changing consumer demands in a timely manner. The success of new and/or enhanced products and services depends on several factors, including their timely introduction and completion, sufficient demand, and cost-effectiveness. New products that we develop may not be well received and could negatively impact our financial performance.

 

Our number of customers may decline materially or fluctuate as a result of many factors, including, among other things:

 

the quality, consumer appeal, price, and reliability of products and services offered by us;

 

intense competition in the optical retail industry by better financed participants;

 

negative publicity related to our brand or brand influencers; and

 

customer dissatisfaction with changes we make to our products and services.

 

In addition, if we are unable to provide high-quality support to customers or help resolve issues in a timely and acceptable manner, our ability to attract new customers and retain customers could be adversely affected. If our number of customers declines or fluctuates for any of these reasons among others, our business would suffer.

 

27

 

 

Our profitability and cash flows may be negatively affected if we are not successful in managing our inventory balances and inventory shrinkage.

 

Efficient inventory management is a key component of our business success and profitability. To be successful, we must maintain sufficient inventory levels to meet our customers’ demands without allowing those levels to increase to such an extent that the costs to hold the goods unduly impact our financial results. We must balance the need to maintain inventory levels that are sufficient to ensure competitive lead times against the risk of inventory obsolescence because of changing customer requirements, fluctuating commodity prices, changes to our products, product transfers, or the life cycle of our products. If we fail to adequately forecast demand for any product, or fail to determine the optimal product mix for production purposes, we may face production capacity issues in processing sufficient quantities of a given product. If our buying and distribution decisions do not accurately predict customer trends or spending levels in general or if we inappropriately price products, we may have to record potential write-downs relating to the value of obsolete or excess inventory. Conversely, if we underestimate future demand for a particular product or do not respond quickly enough to replenish our best performing products, we may have a shortfall in inventory of such products, likely leading to unfulfilled orders, reduced net revenue, and customer dissatisfaction. In addition, because we source components from suppliers located in China, our inventory management may be impacted by enactment or further escalation of tariffs, import restrictions, foreign government regulations, trade restrictions, customs, and duties.

 

Maintaining adequate inventory requires significant attention and monitoring of market trends, local markets, developments with suppliers, and our distribution network, and it is not certain that we will be effective in our inventory management.

 

If we fail to maintain and enhance our brand, our ability to engage or expand our base of customers will be impaired, and our business, financial condition, and results of operations may suffer.

 

Maintaining and enhancing our appeal and reputation as a stylish, innovative, and coveted brand is critical to attracting and expanding our relationships with customers. The successful promotion of our brand and the market’s awareness of our products and services will depend on a number of factors, including our marketing efforts, ability to continue to develop our products and services, and ability to successfully differentiate our offerings from competitive offerings. We expect to invest substantial resources to promote and maintain our brand, but there is no guarantee that our brand development strategies will enhance the recognition of our brand or lead to increased sales. The strength of our brand will depend largely on our ability to provide stylish, technologically enhanced products and quality services at competitive prices. Brand promotion activities may not yield increased net revenue, and even if they do, the increased net revenue may not offset the expenses we incur in promoting and maintaining our brand and reputation. In order to protect our brand, we also plan to expend substantial resources to register and defend our trademarks and to prevent others from using the same or substantially similar marks. Despite these efforts, we and Lucyd Ltd. may not always be successful in protecting the trademarks we license from Lucyd Ltd. Our trademarks may be diluted, and we may suffer harm to our reputation, or other harm to our brand. If our efforts to cost-effectively promote and maintain our brand are not successful, our results of operations and our ability to attract and engage customers, partners, and employees may be adversely affected.

 

Unfavorable publicity regarding our products, customer service, or privacy and security practices could also harm our reputation and diminish confidence in, and the use of, our products and services. In addition, negative publicity related to key brands that we have partnered with may damage our reputation, even if the publicity is not directly related to us. If we fail to maintain, protect, and enhance our brand successfully or to maintain loyalty among customers, or if we incur substantial expenses in unsuccessful attempts to maintain, protect, and enhance our brand, we may fail to attract or increase the engagement of customers, and our business, financial condition, and results of operations may suffer.

 

28

 

 

We rely heavily on our information technology systems, as well as those of our third-party vendors, business partners, and service providers, for our business to effectively operate and to safeguard confidential information; any significant failure, inadequacy, interruption, or data security incident could adversely affect our business, financial condition, and operations.

 

We rely heavily on our in-house information technology and enterprise resource planning systems for many functions across our operations, including managing our supply chain and inventory, processing customer transactions in our stores, allocating lens processing jobs to the appropriate laboratories, our financial accounting and reporting, compensating our employees, and operating our website, mobile applications and in-store systems. Our ability to effectively manage our business and coordinate the manufacturing, sourcing, distribution, and sale of our products depends significantly on the reliability and capacity of these systems. We are critically dependent on the integrity, security, and consistent operations of these systems, which are highly reliant on the coordination of our internal business and engineering teams. We also collect, process, and store sensitive and confidential information, including our proprietary business information and that of our customers, employees, suppliers, and business partners. The secure processing, maintenance, and transmission of this information is critical to our operations.

 

Our systems may be subject to damage or interruption from power outages or damages, telecommunications problems, data corruption, software errors, network failures, acts of war or terrorist attacks, fire, flood, global pandemics, and natural disasters; our existing safety systems, data backup, access protection, user management, and information technology emergency planning may not be sufficient to prevent data loss or long-term network outages. In addition, we may have to upgrade our existing information technology systems or choose to incorporate new technology systems from time to time in order for such systems to support the increasing needs of our expanding business. Costs and potential problems and interruptions associated with the implementation of new or upgraded systems and technology or with maintenance or adequate support of existing systems could disrupt or reduce the efficiency of our operations.

 

Our systems and those of our third-party service providers and business partners may be vulnerable to security incidents, attacks by hackers, acts of vandalism, computer viruses, misplaced or lost data, human errors or other similar events. If unauthorized parties gain access to our networks or databases, or those of our third-party service providers or business partners, they may be able to steal, publish, delete, use inappropriately, or modify our private and sensitive third-party information including personal health information, credit card information, and personal identification information. In addition, employees may intentionally or inadvertently cause data or security incidents that result in unauthorized release of personal or confidential information. Because the techniques used to circumvent security systems can be highly sophisticated, change frequently, are often not recognized until launched against a target, and may originate from less regulated and remote areas around the world, we may be unable to proactively address all possible techniques or implement adequate preventive measures for all situations.

 

Security incidents compromising the confidentiality, integrity, and availability of this information and our systems could result from cyber-attacks, computer malware, viruses, social engineering (including spear phishing and ransomware attacks), credential stuffing, supply chain attacks, efforts by individuals or groups of hackers and sophisticated organizations, including state-sponsored organizations, errors or malfeasance of our personnel, and security vulnerabilities in the software or systems on which we rely. We anticipate that these threats will continue to grow in scope and complexity over time and such incidents have occurred in the past, and may occur in the future, resulting in unauthorized, unlawful, or inappropriate access to, inability to access, disclosure of, or loss of the sensitive, proprietary and confidential information that we handle.

 

We also rely on a number of third-party service providers to operate our critical business systems, provide us with software, and process confidential and personal information, such as the payment processors that process customer credit card payments, which expose us to security risks outside of our direct control and our ability to monitor these third-party service providers’ data security is limited. These service providers could experience a security incident that compromises the confidentiality, integrity, or availability of the systems they operate for us or the information they process on our behalf. Cybercrime and hacking techniques are constantly evolving, and we or our third-party service providers may be unable to anticipate attempted security breaches, react in a timely manner, or implement adequate preventative measures, particularly given the increasing use of hacking techniques designed to circumvent controls, avoid detection, and remove or obfuscate forensic artifacts. While we have taken measures designed to protect the security of the confidential and personal information under our control, we cannot assure you that any security measures that we or our third-party service providers have implemented will be effective against current or future security threats.

 

29

 

 

A security breach may also cause us to breach our contractual obligations. Our agreements with certain customers, business partners, or other stakeholders may require us to use industry-standard or reasonable measures to safeguard personal information. We also may be subject to laws that require us to use industry-standard or reasonable security measures to safeguard personal information. A security incident could lead to claims by our customers, business partners, or other relevant stakeholders that we have failed to comply with such legal or contractual obligations. In addition, our inability to comply with data privacy obligations in our contracts or our inability to flow down such obligations to our vendors, collaborators, other contractors, or consultants may cause us to breach our contracts. As a result, we could be subject to legal action, or our customers or business partners could end their relationships with us. There can be no assurance that the limitations of liability in our contracts would be enforceable or adequate or would otherwise protect us from liabilities or damages.

 

In addition, any such access, disclosure or other loss or unauthorized use of information or data, whether actual or perceived, could result in legal claims or proceedings, regulatory investigations or actions, and other types of liability under laws that protect the privacy and security of personal information, including federal, state and foreign data protection and privacy regulations, violations of which could result in significant penalties and fines in the EU and United States. In addition, although we seek to detect and investigate all data security incidents, security breaches, and other incidents of unauthorized access to our information technology systems and data can be difficult to detect and any delay in identifying such breaches or incidents may lead to increased harm and legal exposure of the type described above.

 

The cost of investigating, mitigating, and responding to potential security breaches and complying with applicable breach notification obligations to individuals, regulators, partners, and others can be significant. Further, defending a suit, regardless of its merit, could be costly, divert management attention, and harm our reputation. The successful assertion of one or more large claims against us that exceed available insurance coverage, or the occurrence of changes in our insurance policies, including premium increases or the imposition of large deductible or co-insurance requirements, could adversely affect our reputation, business, financial condition, revenues, results of operations, or cash flows. Any material disruption or slowdown of our systems or those of our third-party service providers and business partners, could have a material adverse effect on our business, financial condition, and results of operations. Our risks are likely to increase as we continue to expand, grow our customer base, and process, store, and transmit increasing amounts of proprietary and sensitive data.

 

Our e-commerce and multichannel channel business faces distinct risks, and our failure to successfully manage it could have a negative impact on our profitability.

 

As an e-commerce and multichannel retailer, we encounter risks and difficulties frequently experienced by businesses with significant online and in-store sales. The successful operation of our business as well as our ability to provide a positive shopping experience that will generate orders and drive subsequent visits depends on efficient and uninterrupted operation of our e-commerce order-taking and fulfillment operations. If we are unable to allow real-time and accurate visibility to product availability when customers are ready to purchase, quickly and efficiently fulfill our customers’ orders using the fulfillment and payment methods they demand, provide a convenient and consistent experience for our customers regardless of the ultimate sales channel, or effectively manage our online sales, our ability to compete and our results of operations could be adversely affected. Risks associated with our e-commerce and multichannel business include:

 

uncertainties associated with our websites, mobile applications and in-store virtual try-on kiosks including changes in required technology interfaces, website downtime and other technical failures, costs and technical issues as we upgrade our systems software, inadequate system capacity, computer viruses, human error, security breaches, legal claims related to our systems operations, and fulfillment;

 

our partnership with select third-party apps, through which we sell a portion of our products, are subject to changes in their technology interfaces, website downtime and other technical failures, costs, and issues;

 

30

 

 

disruptions in internet service or power outages;

 

reliance on third parties for computer hardware and software, as well as delivery of merchandise to our customers;

 

rapid technology changes;

 

credit or debit card fraud and other payment processing related issues;

 

cybersecurity and consumer privacy; and

 

natural disasters or adverse weather conditions.

 

In addition, we must keep up to date with competitive technology trends, including the use of new or improved technology, creative user interfaces, virtual and augmented reality, and other e-commerce marketing tools such as paid search and mobile application, among others, which may increase our costs and which may not increase sales or attract customers. Our competitors, most of whom have significantly greater resources than we do, may also be able to benefit from changes in e-commerce technologies, which could harm our competitive position.

 

If we fail to adapt and respond effectively to rapidly changing technology, evolving industry standards and changing customer needs or requirements, our solutions may become less competitive.

 

Our success depends on our customers’ willingness to adopt and use our products, as well as our ability to adapt and enhance our products. To attract new customers and increase revenue from existing customers, we need to continue to enhance and improve our products and to meet customer needs at prices that customers are willing to pay. Such efforts will require adding new features, expanding related applications and responding to technological advancements, which will increase our research and development costs. If we are unable to develop solutions that address customers’ needs or enhance and improve our platform in a timely manner, we may not be able to increase or maintain market acceptance of our products. Further, we may make changes to our products that customers do not find useful. We may also face unexpected problems or challenges in connection with new applications or feature introductions.

 

Moreover, many competitors expend a considerably greater amount of funds on their research and development programs, and those that do not may be acquired by larger companies that would allocate greater resources to competitors’ research and development programs. If we fail to compete effectively with the research and development programs of competitors, our business could be harmed. Our ability to grow is also subject to the risk of future disruptive technologies. If new technologies emerge that are able to deliver smart eyewear products at lower prices, more efficiently, more conveniently or more securely, such technologies could adversely affect our ability to compete.

 

We depend on highly skilled personnel to grow and operate our business, and if we are unable to hire, retain, and motivate our personnel, we may not be able to grow effectively.

 

Our success and future growth depend largely upon the continued services of our management team, including our Chief Executive Officer Harrison Gross. From time to time, there may be changes in our executive management team resulting from the hiring or departure of our executives. Our executive officers are employed on an at-will basis, which means they may terminate their employment with us at any time. The loss of one or more of our executive officers, or the failure by our executive team to effectively work with our employees and lead our company, could harm our business. We do not maintain key person life insurance with respect to any member of management or other employee.

 

In addition, our future success will depend, in part, upon our continued ability to identify and hire skilled employees with the skills and technical knowledge that we require, including software design and programming, eyewear design, marketing, merchandising, operations, and other key management skills and knowledge. Such efforts will require significant time, expense, and attention as there is intense competition for such individuals.

 

31

 

 

Certain technological advances, greater availability of, or increased consumer preferences for, vision correction alternatives to prescription eyeglasses or contact lenses, and future drug development for the correction of vision-related problems may reduce the demand for our products and adversely impact our business and profitability.

 

Technological advances in vision care, including the development of new or improved products, as well as future drug development for the correction of vision-related problems, could significantly change how vision care may be conducted and make our existing products less attractive or even obsolete. The greater availability and acceptance, or reductions in the cost, of vision correction alternatives to prescription eyeglasses and contact lenses, such as corneal refractive surgery procedures, including radial keratotomy, photorefractive keratotomy, or PRK, and LASIK, may reduce the demand for our products, lower our sales, and thereby adversely impact our business and profitability.

 

We could be adversely affected by product liability, product recall or personal injury issues.

 

We could be adversely impacted by the supply of defective products, including the infiltration of counterfeit products into the supply chain or product mishandling issues. Product liability or personal injury claims may be asserted against us with respect to any of the products we sell or services we provide.

 

If the products that we sell, including those that we process, package, or label, are defective or otherwise result in product liability or personal injury claims against us, our business could be adversely affected and we could be subject to adverse regulatory action. If our products or services do not meet applicable governmental safety standards or our customers’ expectations regarding quality or safety, we could experience lost sales and increased costs, be exposed to legal and reputational risk, and face fines or penalties which could materially adversely affect our financial results.

 

Refunds, cancellations, and warranty claims could harm our business.

 

We allow our customers to return our products, subject to our refund policy, which allows any customer to return our products for any reason and receive a full refund for frames (prescription lenses excluded) within the first 7 days for sales made through our website, 30 days for sales made through Amazon, and 30 days for sales to most wholesale retailers and distributors (although certain sales to independent distributors are ineligible for returns). At the time of sale, we establish a reserve for returns, based on historical experience and expected future returns, which is recorded as a reduction of sales. Historically, we have experienced higher return rates on glasses with prescription lenses compared to glasses with non-prescription lenses, due to instances of improperly cut prescription lenses. If we experience a substantial increase in refunds, our cancellation reserve levels might not be sufficient and our business, financial condition, and results of operations could be harmed. However, updates to the Company’s prescription lens return policy in January 2024, as mentioned above, is expected to support a reduction in excessive lens costs. Additionally in January 2024, the Company instituted a standard $15 restocking fee for standard frame returns, which is deducted from applicable refunds to cover shipping and restocking costs.

 

We expect a number of factors to cause our results of operations and operating cash flows to fluctuate on a quarterly and annual basis, which may make it difficult to predict our future performance.

 

Our results of operations could vary significantly from quarter to quarter and year to year because of a variety of factors, many of which are outside of our control. As a result, comparing our results of operations on a period-to-period basis may not be meaningful. In addition to other risk factors discussed in this section, factors that may contribute to the variability of our quarterly and annual results include:

 

our ability to accurately forecast and achieve net revenues and appropriately plan our expenses;

 

changes to financial accounting standards and the interpretation of those standards, which may affect the way we recognize and report our financial results;

 

the effectiveness of our internal controls;

 

32

 

 

the early-stage nature of our business and the need to scale our operations; and

 

our ability to introduce our new cobranded products and product upgrades.

 

The impact of one or more of the foregoing and other factors may cause our results of operations to vary significantly. As such, quarter-to-quarter and year-over-year comparisons of our results of operations may not be meaningful and should not be relied upon as an indication of future performance.

 

We may require additional capital to support the growth of our business, and this capital might not be available on acceptable terms, if at all.

 

We have funded our operations since inception primarily through net proceeds from the sale of convertible loan notes common stock sales through two registered crowdfunds and our initial public offering. We cannot be certain when, or if, our operations will generate sufficient cash to fully fund our ongoing operations or the growth of our business. We intend to continue to make investments to support the development of our products and services and will require additional funds for such development. We may need additional funding for marketing expenses and to develop and expand sales resources, develop new products and improve existing products with new features or enhance our products and services with new technology, improve our operating infrastructure, or acquire complementary businesses and technologies. Accordingly, we might need or may want to engage in future equity or debt financings to secure additional funds. Additional financing may not be available on terms favorable to us, if at all. If adequate funds are not available on acceptable terms, we may be unable to invest in future growth opportunities, which could harm our business, financial condition, and results of operations. If we are unable to obtain adequate financing or financing on terms satisfactory to us, our ability to develop our products and services, support our business growth, and respond to business challenges could be significantly impaired, and our business may be adversely affected.

 

If we incur additional debt, the debt holders would have rights senior to holders of common stock to make claims on our assets, and the terms of any additional debt could include restrictive covenants that restrict our operations, including our ability to pay dividends on our common stock. Furthermore, if we issue additional equity securities, stockholders will experience dilution, and the new equity securities could have rights senior to those of our common stock. Because our decision to issue securities in the future will depend on numerous considerations, including factors beyond our control, and we cannot predict or estimate the amount, timing, or nature of any future issuances of debt or equity securities. As a result, our stockholders bear the risk of future issuances of debt or equity securities reducing the value of our common stock and diluting their interests.

 

The occurrence of any of these foregoing risks could adversely affect our business, financial condition, and results of operations and expose us to unknown risks or liabilities.

 

If we fail to successfully launch or after we launch receive sufficient revenue from our cobranded collections with Nautica, Eddie Bauer, and Reebok, our business, financial condition, and results of operations would be harmed.

 

We believe that the launch of our cobranded collections with Nautica, Eddie Bauer, and Reebok will grow our brand and company due to the global renown of those partners. If we are unable to successfully launch these cobranded collections, we may not be able to grow as currently anticipated and may be required to shift our current business plans.

 

Even if we are able to successfully launch our cobranded collections with Nautica, Eddie Bauer, and Reebok, there is no guarantee that we will receive sufficient revenue to pay the licensing fees that would be owed to Nautica, Eddie Bauer, and Reebok. Specifically, we minimally owe $14,171,210 over the next ten years in licensing fees. If we are not able to successfully market and sell our cobranded products, we will not receive sufficient revenue to pay the licensing fees and would need to use the proceeds from our other products to pay the fees.

 

33

 

 

Eyeglasses are regulated as medical devices by the FDA, and our failure, or the failure of any third-party manufacturer or optical laboratory, to obtain and maintain the necessary agency authorizations for our products could have a material adverse effect on our business.

 

We are an FDA registered eyewear importer, and we also engage in certain manufacturing, packaging, shipping and labeling activities that subject us and our overseas manufacturing partners to oversight by the FDA under the FDCA and its implementing regulations. The FDA regulates, among other things, with respect to medical devices: design, development and manufacturing, testing, labeling, content, and language of instructions for use and storage; clinical trials; product safety; establishment registration and device listing; marketing, sales and distribution; premarket clearance, classification and approval; recordkeeping procedures; advertising and promotion; recalls and field safety corrective actions; post market surveillance, including reporting of deaths or serious injuries and malfunctions that, if they were to recur, could lead to death or serious injury; post-market approval studies; and product import and export. The regulations to which we are subject are simpler than most medical products due to the relatively low risk classification of eyewear—regularly, only our lenses are reviewed for FDA clearance. Regulatory changes could result in restrictions on our ability to carry on or expand our operations, higher than anticipated costs, or lower than anticipated sales. The FDA enforces its regulatory requirements through, among other means, periodic unannounced inspections. Failure to comply with applicable regulations could jeopardize our or our contract manufacturers’ ability to manufacture and sell our products and result in FDA enforcement actions such as: warning letters; fines; injunctions; civil penalties; termination of distribution; recalls or seizures of products; delays in the introduction of products into the market; total or partial suspension of production; refusal to grant future clearances or approvals; withdrawals or suspensions of clearances or approvals, resulting in prohibitions on sales of our products; and in the most serious cases, criminal penalties.

 

Due to the nature of Vyrb as a social media application, and our collection of customer data in the process of taking orders, we are subject to rapidly changing and increasingly stringent laws, regulations, obligations, and industry standards relating to privacy, data security, and data protection. The restrictions and costs imposed by these laws and other obligations, or our actual or perceived failure to comply with them, could subject us to liabilities that adversely affect our business, operations, and financial performance.

 

We collect, process, store, and use a wide variety of data from current and prospective customers, including personal information, such as home addresses and geolocation, and health information related to their ophthalmic prescriptions. These activities are regulated by a variety of federal, state, local, and foreign privacy, data security, and data protection laws and regulations, which have become increasingly stringent in recent years.

 

Domestic privacy and data security laws are complex and changing rapidly. Many states have enacted laws regulating the online collection, use, and disclosure of personal information and requiring that companies implement reasonable data security measures. Laws in all states and U.S. territories also require businesses to notify affected individuals, governmental entities, and/or credit reporting agencies of certain security incidents affecting personal information. These laws are not consistent, and compliance with them in the event of a widespread data breach is complex and costly.

 

Further, the California Consumer Privacy Act (CCPA) took effect on January 1, 2020. The CCPA gives California residents expanded rights related to their personal information, including the right to access and delete their personal information, and receive detailed information about how their personal information is used and shared. The CCPA also created restrictions on “sales” of personal information that allow California residents to opt-out of certain sharing of their personal information and may restrict the use of cookies and similar technologies for advertising purposes. Our e-commerce platform, including our websites and mobile applications, rely on these technologies and could be adversely affected by the CCPA’s restrictions. The CCPA prohibits discrimination against individuals who exercise their privacy rights, provides for civil penalties for violations, and creates a private right of action for data breaches that is expected to increase data breach litigation. Additionally, a new California ballot initiative, the California Privacy Rights Act, or CPRA, was recently passed in California. The CPRA will restrict use of certain categories of sensitive personal information that we handle; further restrict the use of cross-context behavioral advertising techniques on

 

34

 

 

which our products may rely in the future; establish restrictions on the retention of personal information; expand the types of data breaches subject to the private right of action; and establish the California Privacy Protection Agency to implement and enforce the new law, as well as impose administrative fines. The majority of the CPRA’s provisions will go into effect on January 1, 2023, and additional compliance investment and potential business process changes will likely be required. Similar laws have been proposed in other states and at the federal level, reflecting a trend toward more stringent privacy legislation in the United States. Compliance with such laws could be difficult and costly to achieve and we could be subject to fines and penalties in the event of non-compliance.

 

Additionally, we are subject to certain health information privacy and security laws as a result of the health information that we receive in connection with our products and services. These laws and regulations include not be adequate to indemnify us for the full extent of our potential liabilities.

 

Finally, since the Vyrb social app allows users to create and share various types of multimedia content in a public space operated by the Company, the Company has a basic responsibility to ensure that illegal or otherwise personally harmful content is removed from the platform with speed, which if we fail to do so, could potentially result in legal action against the Company.

 

Our business could be adversely impacted by changes in the internet and mobile device accessibility of users. Companies and governmental agencies may restrict access to our products and services, our mobile applications, website, application stores, or the internet generally, which could negatively impact our operations.

 

Our business depends on customers accessing our products and services via a mobile device or a personal computer, and the internet. We may operate in jurisdictions that provide limited internet connectivity. Internet access and access to a mobile device or personal computer are frequently provided by companies with significant market power that could take actions that degrade, disrupt, or increase the cost of consumers’ ability to access our products and services. In addition, the internet infrastructure that we and our customers rely on in any particular geographic area may be unable to support the demands placed upon it and could interfere with the speed and availability of our products and services. Any such failure in internet or mobile device or computer accessibility, even for a short period of time, could adversely affect our results of operations.

 

Governmental agencies in any of the countries in which we or our customers are located could block access to or require a license for our mobile applications, website, or the internet generally for a number of reasons, including security, confidentiality, or regulatory concerns. In addition, companies may adopt policies that prohibit their employees from using our products and services. If companies or governmental entities block, limit, or otherwise restrict customers from accessing our products and services, our business could be negatively impacted, the number of customers could decline or grow more slowly, and our results of operations could be adversely affected.

 

From time to time, we may be subject to legal proceedings, regulatory disputes, and governmental inquiries that could cause us to incur significant expenses, divert our management’s attention, and materially harm our business, financial condition, and operating results.

 

From time to time, we may be subject to claims, lawsuits, government investigations, and other proceedings involving products liability, competition and antitrust, intellectual property, privacy, false advertising, consumer protection, securities, tax, labor and employment, commercial disputes, and other matters that could adversely affect our business operations and financial condition. As we grow, we may see a rise in the number and significance of these disputes and inquiries. Litigation and regulatory proceedings may be protracted and expensive, and the results are difficult to predict. Certain of these matters include speculative claims for substantial or indeterminate amounts of damages and include claims for injunctive relief. Additionally, our litigation costs could be significant. Adverse outcomes with respect to litigation or any of these legal proceedings may result in significant settlement costs or judgments, penalties and fines, or require us to modify our products or services, all of which could negatively affect our revenue growth. The results of litigation, investigations, claims, and regulatory proceedings cannot be predicted with certainty, and determining reserves for pending litigation and other legal and regulatory matters requires significant judgment. There can be no assurance that our expectations will prove correct, and even if these matters are resolved in our favor or without significant cash settlements, these matters, and the time and resources necessary to litigate or resolve them, could harm our business, financial condition, and results of operations.

 

35

 

 

Risks Related to Intellectual Property

 

We license some of our technology from Lucyd Ltd., the largest stockholder of the Company, and our inability to maintain this license could materially affect our business, financial condition, and operating results.

 

Some of our current intellectual property is licensed from Lucyd Ltd., the largest stockholder of the Company, pursuant to a license agreement we entered into with Lucyd Ltd. on April 1, 2020 (the “License Agreement”). Pursuant to the License Agreement, we acquired an exclusive, worldwide license that is royalty-free, fully paid up, and perpetual license for the exclusive use of certain assets of Lucyd Ltd. related to Innovative Eyewear current products and trademarks. There can be no assurance that the license will not be terminated by Lucyd Ltd. and if we are unable to continue to license the technology (because of, for example, intellectual property infringement claims brought by third-parties against us or against Lucyd Ltd.) then our business, financial condition and operating results would be adversely affected. Please see “Business—Material Agreements” for a more complete description of the License Agreement.

 

Failure to adequately maintain and protect our intellectual property and proprietary rights could harm our brand, devalue our proprietary content, and adversely affect our ability to compete effectively.

 

Our success depends to a significant degree on Lucyd Ltd.’s ability to obtain, maintain, protect, and enforce our licensed intellectual property rights, including those in our proprietary technologies, know-how, and brand. To protect our rights to our intellectual property, we rely on a combination of patent, trademark, copyright and trade secret laws, domain name registrations, confidentiality agreements, and other contractual arrangements with our employees, affiliates, clients, strategic partners, and others. However, the protective steps we have taken and plan to take may be inadequate to deter misappropriation or other violation of or otherwise protect our intellectual property rights. We may be unable to detect the unauthorized use of, or take appropriate steps to enforce, our intellectual property rights. Effective patent, trademark, copyright, and trade secret protection may not be available to us or available in every jurisdiction in which we offer or intend to offer our services. Failure to adequately protect our intellectual property could harm our brand, devalue our proprietary technology and content, and adversely affect our ability to compete effectively. Further, even if we are successful, defending our intellectual property rights could result in the expenditure of significant financial and managerial resources, which could adversely affect our business, financial condition, and results of operations.

 

If we fail to protect our intellectual property rights adequately, our competitors may gain access to our licensed intellectual property and proprietary technology and develop and commercialize substantially identical offerings or technologies. Any patents, trademarks, copyrights, or other intellectual property rights that we have or may obtain may be challenged or circumvented by others or invalidated or held unenforceable through administrative process, including re-examination, inter partes review, interference and derivation proceedings, and equivalent proceedings in foreign jurisdictions (e.g., opposition proceedings), or litigation. There can be no assurance that our patent applications will result in issued patents and we may be unable to obtain or maintain patent protection for our technology. In addition, any patents issued from pending or future patent applications or licensed to us in the future may not provide us with claims sufficiently broad to provide meaningful competitive advantages or may be successfully challenged by third parties. There is also no guarantee that our pending trademark applications for any mark will proceed to registration; our pending applications may be opposed by a third party prior to registration; and even those trademarks that are registered could be challenged by a third party, including by way of revocation or invalidity actions. For example, we have registrations in a number of foreign countries in which we are not currently offering goods or services, and those registrations could be subject to invalidation proceedings if we cannot demonstrate use of the marks by the applicable use deadlines in those countries. In addition, because patent applications in the United States are currently maintained in secrecy for a period of time prior to issuance, and patent applications in certain other countries generally are not published until more than 18 months after they are first filed, and because publication of discoveries in scientific or patent literature often lags behind actual discoveries, we cannot be certain that we were the first creator of inventions covered by our pending patent applications or that we were the first to file patent applications on such inventions. To maintain a proprietary market position in foreign countries, we may seek to protect some of our proprietary inventions through

 

36

 

 

foreign counterpart patent applications. Statutory differences in patentable subject matter may limit the protection we can obtain on some of our inventions outside of the United States. The diversity of patent laws may make our expenses associated with the development and maintenance of intellectual property in foreign jurisdictions more expensive than we anticipate. We probably will not be able to obtain the same patent protection in every market in which we may otherwise be able to potentially generate revenue. Further, the laws of some foreign countries may not be as protective of intellectual property rights as those in the United States, and mechanisms for enforcement of intellectual property rights may be inadequate. Moreover, policing unauthorized use of our technologies, trade secrets, and intellectual property may be difficult, expensive, and time-consuming. Despite our precautions, it may be possible for unauthorized third parties to copy our offerings and capabilities and use information that we regard as proprietary to create offerings that compete with ours. Third parties may apply to register our trademarks or other trademarks similar to our trademarks in jurisdictions before us, thereby creating risks relating to our ability to use and register our trademarks in those jurisdictions. In addition, there could be potential trade name or trademark ownership or infringement claims brought by owners of other rights, including registered trademarks, in our marks or marks similar to ours. Any claims of infringement, brand dilution, or consumer confusion related to our brand (including our trademarks) or any failure to renew key license agreements on acceptable terms could damage our reputation and brand identity and substantially harm our business and results of operations. The value of our intellectual property could diminish if others assert rights in or ownership of our trademarks and other intellectual property rights, or trademarks that are similar to our trademarks. We may be unable to successfully resolve these types of conflicts to our satisfaction. In some cases, litigation or other actions may be necessary to protect or enforce our trademarks and other intellectual property rights.

 

We generally enter into confidentiality and invention assignment agreements with our employees and consultants, as well as confidentiality agreements with other third parties, including suppliers and other partners. However, we cannot guarantee that we have entered into such agreements with each party that has or may have had access to our proprietary information, know-how, and trade secrets. Moreover, no assurance can be given that these agreements will be effective in controlling access to our proprietary information or the distribution, use, misuse, misappropriation, reverse engineering, or disclosure of our proprietary information, know-how, and trade secrets. Further, these agreements may not prevent our competitors from independently developing technologies that are substantially equivalent or superior to our offerings and capabilities. These agreements may be breached, and we may not have adequate remedies for any such breach.

 

We may be required to spend significant resources to monitor and protect our intellectual property rights. Litigation may be necessary in the future to enforce our intellectual property rights and to protect our trade secrets. Litigation brought to protect and enforce our intellectual property rights could be costly, time-consuming, and distracting to management, and could result in the impairment or loss of portions of our intellectual property rights. Further, our efforts to enforce our intellectual property rights may be met with defenses, counterclaims, and countersuits attacking the validity and enforceability of our intellectual property rights, and if such defenses, counterclaims, or countersuits are successful, we could lose valuable intellectual property rights. Further, any changes in law or interpretation of any such laws, particularly intellectual property laws, may impact our ability to protect, register, or enforce our intellectual property rights. Our inability to protect our proprietary technology against unauthorized copying or use, as well as any costly litigation or diversion of our management’s attention and resources, could delay further sales or the implementation of our offerings and capabilities, impair the functionality of our offerings and capabilities, delay introductions of new offerings, result in our substituting inferior or more costly technologies into our offerings, or injure our reputation.

 

Domain names generally are regulated by internet regulatory bodies, and the regulation of domain names is subject to change. Regulatory bodies have and may continue to establish additional top-level domains, appoint additional domain name registrars, or modify the requirements for holding domain names. We may not be able to, or it may not be cost-effective to, acquire or maintain all domain names that utilize the name “Lucyd Ltd.” or “Innovative Eyewear” in all of the countries in which we currently conduct or intend to conduct business. If we lose the ability to use a domain name, we could incur significant additional expenses to market our products within that country, including the development of new branding. This could substantially harm our business, results of operations, financial condition and prospects.

 

37

 

 

We may incur costs to defend against, face liability or for being vulnerable to intellectual property infringement claims brought against us by others.

 

Third parties may assert claims against us alleging that we infringe upon, misappropriate, dilute or otherwise violate their intellectual property rights, particularly as we expand our business and the number of products we offer. These risks have been amplified by the increase in third parties whose sole or primary business is to assert such claims. We may be particularly vulnerable to such claims, as companies having a substantial online presence are frequently subject to litigation based on allegations of infringement or other violations of intellectual property rights. As we gain an increasingly high public profile, the possibility of intellectual property rights claims against us grows. Our competitors and others may now and in the future have significantly larger and more mature patent portfolios than us.

 

We rely on contracts and releases for ownership of copyrighted materials and the right to use images of individuals on our webpage and marketing material, and we may be subject to claims that we did not properly obtain rights, consent, a release, or permission to use certain content or imagery. Many potential litigants have the ability to dedicate substantial resources to the assertion of their intellectual property rights. Any claim of infringement by a third party, even those without merit, could cause us to incur substantial costs defending against the claim, could distract our management from our business, could require us to cease use of such intellectual property, and could create ongoing obligations if we are subject to agreements or injunctions (stipulated or imposed) preventing us from engaging in certain acts. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, we risk compromising our confidential information during this type of litigation. Our defense of any claim, regardless of its merit, could be expensive and time consuming and could divert management resources. We cannot predict the outcome of lawsuits and cannot ensure that the results of any such actions will not have an adverse effect on our business, financial condition, or results of operations. Successful infringement claims against us could result in significant monetary liability or prevent us from selling some of our products. In addition, resolution of claims may require us to redesign or rebrand our products, license rights from third parties on potentially unfavorable terms, cease using certain brand names or other intellectual property rights altogether, make substantial payments for royalty or license fees, legal fees, settlement payments or other costs or damages, or admit liability. Such outcomes could encourage others to bring claims against us. To the extent we seek a license to continue offerings or operations found or alleged to infringe third-party intellectual property rights, such a license may be non-exclusive, and therefore our competitors may have access to the same technology licensed to us. In the event we are required to develop alternative, non-infringing technology, this could require significant time (during which we would be unable to continue to offer our affected offerings), effort and expense, and may ultimately not be successful. Any of these events could harm our business and cause our results of operations, liquidity, and financial condition to suffer.

 

Risks Related to Our Dependence on Third Parties

 

We face risks associated with suppliers from whom our products are sourced and are dependent on a limited number of suppliers.

 

We purchase all of the inputs for our products, including eyeglass frames, temples with electronics embedded within them, prescription lenses, sun lenses, demo lenses, hinges, packaging materials and other components, parts, and raw materials, directly or indirectly from domestic and international suppliers. For our business to be successful, our suppliers must be willing and able to provide us with inputs in substantial quantities, in compliance with regulatory requirements, at acceptable costs and on a timely basis. Our ability to obtain a sufficient selection or volume of inputs on a timely basis at competitive prices could suffer as a result of any deterioration or change in our supplier relationships or events that adversely affect our suppliers.

 

We typically do not enter into long-term contracts with our suppliers and, as such, we operate without significant contractual assurances of continued supply, pricing or access to inputs. Any of our suppliers could discontinue supplying us with desired inputs in sufficient quantities or offer us less favorable terms on future transactions for a variety of reasons. The benefits we currently experience from our suppliers’ relationships could be adversely affected if our suppliers:

 

38

 

 

discontinue selling products to us;

 

raise their prices;

 

increase lead times for products and/or key components

 

We also source inputs directly from suppliers outside of the United States, including China. Global sourcing and foreign trade involve numerous factors and uncertainties beyond our control including increased shipping costs, the imposition of additional import or trade restrictions, including legal or economic restrictions on overseas suppliers’ ability to produce and deliver inputs, increased custom duties and tariffs, unforeseen delays in customs clearance of goods, more restrictive quotas, loss of a most favored nation trading status, currency exchange rates, transportation delays, port of entry issues and foreign government regulations, political instability, and economic uncertainties in the countries from which we or our suppliers source our products.

 

We rely on a limited number of contract manufacturers and logistics partners for our products. A loss of any of these partners could negatively affect our business.

 

We rely on a limited number of third-party suppliers and contract manufacturers for the components that go into the manufacturing of our products. In particular, our frames are provided by only a handful of suppliers. We also assemble and fulfill prescription glasses at a single third-party optical laboratory. Our reliance on a limited number of contract manufacturers and logistics partners for our products increases our risks of being unable to deliver our products in a timely and cost-effective manner. In the event of interruption from any of our contract manufacturers or our own fulfillment capabilities, we should be able to increase capacity from other sources or develop alternate or secondary sources without incurring material additional costs or substantial delays.

 

Our business could be adversely affected if one or more of our manufacturers is impacted by a natural disaster, an epidemic, or other interruption at a particular location.

 

Additionally, we do not own or operate a warehouse or a warehouse management company or system, and we currently rely on three third-party warehouses. Because a significant percentage of our products are stored in and shipped out of third-party warehouses, we face significant risks such as, but not limited to: our operations could be disrupted and our inventory could be destroyed by earthquakes, floods, fires or other natural disasters or other events outside of our control, or the control of our third-party warehouse. Our dependence on third-party warehouses also exposes us to the risk that the warehouse may experience operational disruptions due to security or computer viruses, software and hardware failure, power interruptions and other system failures. If we encounter problems with our third-party warehouse, we may be unable to meet customer expectations, manage our inventory and fulfillment capacity, complete sales, fulfill orders in a timely fashion, and our ability to achieve objectives for operating efficiencies could be adversely affected, all of which could harm our reputation and our relationship with our customers.

 

Our projects could be hindered due to our dependence on third parties to complete many of our contracts.

 

In the current economic environment, third parties may find it difficult to obtain sufficient financing to help fund their operations. The inability to obtain financing could adversely affect a third party’s ability to provide materials, equipment or services which could have a material adverse impact on our business, financial condition, and results of operations. In addition, a failure by a third-party subcontractor, supplier or manufacturer to comply with applicable laws, regulations or client requirements could negatively impact our business and, for government clients, could result in fines, penalties, suspension or even debarment being imposed on us, which could have a material adverse impact on our business, financial condition, and results of operations.

 

39

 

 

We depend on search engines, social media platforms, digital application stores, content-based online advertising, and other online sources to attract consumers to and promote our website and our mobile applications, which may be affected by third-party interference beyond our control and as we grow our customer acquisition costs may rise.

 

Our success depends in part on our ability to attract consumers to our website, mobile applications, and retail partners to convert them into customers in a cost-effective manner. We depend, in large part, on search engines, social media platforms, digital application stores, content-based online advertising, and other online sources for traffic to our website, mobile applications, and select application partners.

 

With respect to search engines, we are included in search results as a result of both paid search listings, where we purchase specific search terms that result in the inclusion of our advertisement, and free search listings, which depend on algorithms used by search engines. For paid search listings, if one or more of the search engines or other online sources on which we rely for purchased listings modifies or terminates its relationship with us, our expenses could rise, we could lose consumers and traffic to our website could decrease, any of which could have a material adverse effect on our business, financial condition, and results of operations.

 

We plan to rely primarily on third-party insurance policies to insure our operations-related risks. If our insurance coverage is insufficient for the needs of our business or our insurance providers are unable to meet their obligations, we may not be able to mitigate the risks facing our business, which could adversely affect our business, financial condition, and results of operations.

 

We procure third-party insurance policies or plan to procure policies to cover various operations-related risks including employment practices liability, workers’ compensation, property and business interruptions, cybersecurity and data breaches, crime, directors’ and officers’ liability, and general business liabilities. We rely on a limited number of insurance providers, and should such providers discontinue or increase the cost of coverage, we cannot guarantee that we would be able to secure replacement coverage on reasonable terms or at all. If our insurance carriers change the terms of our policies in a manner not favorable to us, our insurance costs could increase. Further, if the insurance coverage we maintain is not adequate to cover losses that occur, or if we are required to purchase additional insurance for other aspects of our business, we could be liable for significant additional costs. Additionally, if any of our insurance providers becomes insolvent, it would be unable to pay any operations-related claims that we make.

 

General Risk Factors

 

Failure to establish and maintain effective internal controls in accordance with Section 404 of the Sarbanes-Oxley Act could have a material adverse effect on our business and stock price.

 

Since the completion of our initial public offering in August 2022, we have been required to comply with the SEC’s rules implementing Sections 302 and 404 of the Sarbanes-Oxley Act, which will require management to certify financial and other information in our quarterly and annual reports and provide an annual management report on the effectiveness of controls over financial reporting. Though we will be required to disclose changes made in our internal controls and procedures on a quarterly basis, we are not required to make our first annual assessment of our internal control over financial reporting pursuant to Section 404 until the year following our first annual report required to be filed with the SEC. As an “emerging growth company,” as defined in the JOBS Act, we may take advantage of certain temporary exemptions from various reporting requirements, including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes Oxley Act (and the rules and regulations of the Securities and Exchange Commission thereunder). Once we no longer qualify as an “emerging growth company” under the JOBS Act and lose the ability to rely on the exemptions related thereto discussed above and depending on our status as per Rule 12b-2 of the Securities Exchange Act of 1934, as amended, our independent registered public accounting firm may also need to attest to the effectiveness of our internal control over financial reporting under Section 404.

 

40

 

 

Based on the number of personnel available to serve the Company’s accounting function, management believes we are not able to adequately segregate responsibility over financial transaction processing and reporting. Further, the Company does not have a formal internal control environment in place and operating effectively. As such, we have identified these issues as material weaknesses in our internal control over financial reporting and insufficient controls with respect to revenue recognition, and we may identify additional material weaknesses in the future that may cause us to fail to meet our reporting obligations or result in material misstatements of our financial statements. If our remediation of such material weaknesses is not effective, or if we fail to develop and maintain an effective system of internal controls and internal control over financial reporting, our ability to produce timely and accurate financial statements or comply with applicable laws and regulations could be materially and adversely affected and the market price of our common stock could be negatively affected, which could require additional financial and management resources.

 

Changes in tax treatment of companies engaged in e-commerce may adversely affect the commercial use of our sites and our financial results.

 

Due to the global nature of the Internet, it is possible that various states or foreign countries might attempt to impose additional or new regulation on our business or levy additional or new sales, income, or other taxes relating to our activities. Tax authorities at the international, federal, state, and local levels are currently reviewing the appropriate treatment of companies engaged in e-commerce and digital services. New or revised international, federal, state, or local tax regulations or court decisions may subject us or our customers to additional sales, income and other taxes. For example, on June 21, 2018, the U.S. Supreme Court rendered a 5-4 majority decision in South Dakota v. Wayfair Inc., 17-494 where the Court held, among other things, that a state may require an out-of-state seller with no physical presence in the state to collect and remit sales taxes on goods the seller ships to consumers in the state, overturning existing court precedent. Other new or revised taxes and, in particular, digital taxes, sales taxes, VAT, and similar taxes could increase the cost of doing business online and decrease the attractiveness of selling products over the Internet. New taxes and rulings could also create significant increases in internal costs necessary to capture data and collect and remit taxes. Any of these events could have a material adverse effect on our business, financial condition, and operating results.

 

An overall decline in the health of the economy and other factors impacting consumer spending, such as recessionary conditions, governmental instability, inclement weather, and natural disasters, may affect consumer purchases, which could reduce demand for our products and harm our business, financial conditions, and results of operations.

 

Our business depends on consumer demand for our products and, consequently, is sensitive to a number of factors that influence consumer confidence and spending, such as general economic conditions, consumer disposable income, energy and fuel prices, recession and fears of recession, unemployment, minimum wages, availability of consumer credit, consumer debt levels, conditions in the housing market, interest rates, tax rates and policies, inflation, consumer confidence in future economic conditions and political conditions, war and fears of war, inclement weather, natural disasters, terrorism, outbreak of viruses or widespread illness, and consumer perceptions of personal well-being and security. However, as eyewear is a necessary medical device for a large segment of the population, we believe our business is more insulated from economic forces compared to other consumer electronics.

 

We are an “emerging growth company,” and we cannot be certain if the reduced reporting and disclosure requirements applicable to emerging growth companies will make our common stock less attractive to investors.

 

We are an “emerging growth company,” as defined in the JOBS Act, and we may take advantage of certain exemptions from reporting requirements that are applicable to other public companies that are not “emerging growth companies,” including the auditor attestation requirements of Section 404, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Pursuant to Section 107 of the JOBS

 

41

 

 

Act, as an emerging growth company, we have elected to use the extended transition period for complying with new or revised accounting standards until those standards would otherwise apply to private companies. As a result, our financial statements may not be comparable to the financial statements of issuers who are required to comply with the effective dates for new or revised accounting standards that are applicable to public companies, which may make our common stock less attractive to investors. In addition, if we cease to be an emerging growth company, we will no longer be able to use the extended transition period for complying with new or revised accounting standards.

 

We will remain an emerging growth company until the earliest of: (1) the last day of the fiscal year following the fifth anniversary of our listing; (2) the last day of the first fiscal year in which our annual gross revenue is $1.07 billion or more; (3) the date on which we have, during the previous rolling three-year period, issued more than $1 billion in non-convertible debt securities; and (4) the date on which we are deemed to be a “large accelerated filer” under the rules of the SEC.

 

We cannot predict if investors will find our common stock less attractive if we choose to rely on these exemptions. For example, if we do not adopt a new or revised accounting standard, our future results of operations may not be comparable to the results of operations of certain other companies in our industry that adopted such standards. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock, and our stock price may be more volatile.

 

If our estimates or judgments relating to our critical accounting policies prove to be incorrect, our results of operations could be adversely affected.

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in our financial statements and accompanying notes appearing elsewhere in this 10-K. We base our estimates on short duration historical experience and on various other assumptions that we believe to be reasonable under the circumstances, as provided in the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies and Estimates.” The results of these estimates form the basis for making judgments about the carrying values of assets, liabilities, and equity, and the amount of revenue and expenses. Significant estimates and judgments involve: inventory valuation; intangible assets; income taxes; valuation of our common stock and equity awards; revenue recognition, including revenue-related reserves; shipping and handling; and the computation of earnings/loss per share. Our results of operations may be adversely affected if our assumptions change or if actual circumstances differ from those in our assumptions, which could cause our results of operations to fall below the expectations of securities analysts and investors, resulting in a decline in the market price of our common stock.

 

Our current insurance coverage may not be adequate, and we may not be able to obtain insurance at acceptable rates, or at all.

 

We currently have General Liability and Product Liability policies covering our business. These policies may not provide sufficient coverage in the face of significant claims or multiple claims. Claims exceeding our insurance coverage could create significant increases in internal costs. This could even have a material adverse effect on our business, financial condition, and operating results.

 

We may decide to pursue strategic licensing deals to accelerate our growth. These potential brand acquisitions may not be successful. We may not be able to successfully integrate future IP acquisitions or generate sufficient revenues from future acquisitions, which could cause our business to suffer.

 

If we license an intellectual property (IP) from a company, there can be no assurance that we will be able to profitably manage this intellectual property or successfully integrate a new business unit without substantial costs, delays or other operational or financial problems. There can be no assurance that the IP we acquire in the future will achieve anticipated revenues and earnings. Additionally:

 

the key personnel operating the acquired IP may decide not to work with us;

 

42

 

 

we may be unable to maintain uniform standards, controls, procedures, and policies among acquired IPs;

 

we may be unable to successfully implement infrastructure, logistics and systems integration;

 

we may be held liable for legal claims (including environmental claims) arising out of activities of the acquired IP prior to our acquisitions, some of which we may not have discovered during our due diligence, and we may not have indemnification claims available to us or we may not be able to realize on any indemnification claims with respect to those legal claims;

 

we will assume risks associated with deficiencies in the internal controls of acquired IPs;

 

we may not be able to realize the cost savings or other financial benefits we anticipated; and

 

our ongoing business may be disrupted or receive insufficient management attention.

 

Future acquisitions may require us to obtain additional equity or debt financing, which may not be available on attractive terms. Moreover, to the extent an acquisition transaction financed by non-equity consideration results in additional goodwill, it will reduce our tangible net worth, which might have an adverse effect on our credit and bonding capacity.

 

Risks Related to Our Common Stock

 

The market prices of our common stock has been volatile and can fluctuate substantially, which could result in substantial losses for our investors.

 

The market price of our common stock is highly volatile, and since our initial public offering in August 2022, the market price of our common stock has ranged from $0.37 to $7.00 per share. The market price of our securities could be subject to wide fluctuations in response to a variety of factors, which include:

 

actual or anticipated fluctuations in our quarterly or annual operating results;

 

publication of research reports by securities analysts about us or our competitors or our industry;

 

the public’s reaction to our press releases, our other public announcements and our filings with the SEC;

 

our failure or the failure of our competitors to meet analysts’ projections or guidance that we or our competitors may give to the market;

 

additions and departures of key personnel;

 

strategic decisions by us or our competitors, such as acquisitions, divestitures, spin-offs, joint ventures, strategic investments or changes in business strategy;

 

the passage of legislation or other regulatory developments affecting us or our industry;

 

speculation in the press or investment community;

 

changes in accounting principles;

 

43

 

 

terrorist acts, acts of war or periods of widespread civil unrest;

 

natural disasters and other calamities; and

 

changes in general market and economic conditions.

 

In addition, the stock market has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of companies. Broad market and industry factors may negatively affect the market price of our common stock and Warrants, regardless of our actual operating performance. In the past, securities class action litigation has often been initiated against companies following periods of volatility in their stock price. This type of litigation could result in substantial costs and divert our management’s attention and resources, and could also require us to make substantial payments to satisfy judgments or to settle litigation.

 

We do not intend to pay dividends for the foreseeable future.

 

We have never declared or paid any cash dividends on our capital stock, and we do not intend to pay any cash dividends in the foreseeable future. We expect to retain future earnings, if any, to fund the development and growth of our business. Any future determination to pay dividends on our capital stock will be at the discretion of our board of directors. Accordingly, you must rely on the sale of your common stock after price appreciation, which may never occur, as the only way to realize any future gain on your investment.

 

Our quarterly operating results may fluctuate significantly and could fall below the expectations of securities analysts and investors due to the introduction of technologically more advanced products, seasonality and other factors, some of which are beyond our control, resulting in a decline in our stock price.

 

Our quarterly operating results may fluctuate significantly because of several factors, including:

 

labor availability and costs for hourly and management personnel;

 

changes in interest rates;

 

macroeconomic conditions, both nationally and locally;

 

changes in consumer preferences and competitive conditions;

 

expansion to new markets;

 

weather conditions in the regions we operate;

 

increases in infrastructure costs; and

 

fluctuations in commodity prices.

 

Unanticipated fluctuations in our quarterly operating results could result in a decline in our stock price.

 

Item 1B. Unresolved Staff Comments.

 

None.

 

44

 

 

Item 1C. Cybersecurity.

 

In the ordinary course of business, we receive, process, use, and store digitally large amounts of data, including customer data as well as confidential, sensitive, proprietary, and personal information. Maintaining the integrity and availability of our information technology systems and this information, as well as appropriate limitations on access and confidentiality of such information, is important to us and our business operations. To this end, we have implemented policies designed to assess, identify, and manage risks from potential unauthorized occurrences on or through our information technology systems that may result in adverse effects on the confidentiality, integrity, and availability of these systems and the data residing in them. While we have taken measures designed to protect the security of the confidential and personal information under our control, we cannot provide absolute assurance that any security measures that we or our third-party service providers have implemented will be effective against current or future security threats.

 

Our cybersecurity program is managed by our executive management team, including our Chief Executive Officer and Chief Technology Officer, and includes mechanisms, controls, technologies, systems, policies, and other processes designed to prevent or mitigate data loss, theft, misuse, or other security incidents or vulnerabilities affecting the systems and data residing in them. We consult with and received analysis reports from a cybersecurity advisor, and generally rely upon outside advisors and experts to assist us with assessing, identifying, and managing cybersecurity risks.

 

We consider cybersecurity, along with other significant risks that we face, within our overall enterprise risk management framework. Our Board of Directors has oversight for the most significant risks facing us and for our processes to identify, prioritize, assess, manage, and mitigate those risks. The Company intends to provide the Board of Directors with periodic updates on cybersecurity and information technology matters and related risk exposures from management.

 

All customer and app user information is stored directly within Shopify, Amazon Seller, and Amazon Web Services platforms, which provide market-leading data security for their centralized servers. On occasion, limited amounts of customer information such as names and emails are exported from these systems solely for the purposes of accounting and filings, and is never shared outside of the Company and its contracted accounting consultants, which are under confidentiality agreements. Highly sensitive customer payment information is generally never revealed to the Company in any capacity and is hidden by payment processors for security purposes, with the sole exception being some wholesale accounts who provide written or digital copies of credit card information for payment processing on agreed upon terms. Such information is secured on locked Company computers and never distributed.

 

Item 2. Properties.

 

Our executive offices are located at 11900 Biscayne Blvd., Suite 630, North Miami, Florida 33181. Our executive offices are provided to us by Tekcapital. We consider our current office space adequate for our operations.

 

Prior to February 1, 2022, we were provided with rent-free office space by Tekcapital pursuant to the terms of a management service agreement. Effective February 1, 2022, the management services agreement was amended such that (among other things) the office space provided by Tekcapital is no longer rent-free. Tekcapital now bills us for an allocation of rent paid by Tekcapital on our behalf. Our agreement with Tekcapital does not stipulate a specific end date, and can be terminated with 30 calendar days written notice by any party.

 

Item 3. Legal Proceedings.

 

We are not currently the subject of any material pending legal proceedings; however, we may from time to time become a party to various legal proceedings arising in the ordinary course of business.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

45

 

 

PART II

 

Item 5. Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

 

Market Information

 

Our common stock and Warrants trade on the NASDAQ Capital Market under the symbols “LUCY” and “LUCYW,” respectively since August 15, 2022. Prior to that date, there was no public market for our common stock or Warrants.

 

Holders

 

As of December 31, 2023, the approximate number of holders of record of our common stock was 3,780 and the closing price of our common stock was $0.42 per share. As of December 31, 2023, the approximate number of holders of record of our Warrants was 1 and the closing price of our Warrants was $0.05 per Warrant.

 

Securities Authorized for Issuance Under Equity Compensation Plans

 

See “Item 11. Executive Compensation.”

 

Dividend Policy

 

No cash dividends have been paid on our common stock since our inception. We have no present intention to pay any cash dividends in the foreseeable future.

 

Recent Sales of Unregistered Securities

 

There were no sales of unregistered securities during the three months ended December 31, 2023.

 

Purchases of Securities by the Issuer and Affiliated Purchasers

 

On April 12, 2023, an individual cashlessly exercised of 300,000 stock options and received 85,638 shares of common stock.

 

Item 6. Reserved.

 

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

You should read the following discussion and analysis of our financial condition and results of operations together with the accompanying “Index to Consolidated Financial Statements” included within this Annual Report on Form 10-K. Except for historical information, the matters discussed in this Management’s Discussion and Analysis of Financial Condition and Results of Operations are forward-looking statements that involve risks and uncertainties and are based upon judgments concerning factors that are beyond our control.

 

Overview

 

We develop and sell cutting-edge smart eyeglasses and sunglasses, which are designed to allow our customers to remain connected to their digital lives, while also offering vision correction and protection. Our flagship product, Lucyd Lyte, enables the wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform many common smartphone tasks hands-free.

 

46

 

 

Our mission is to Upgrade Your Eyewear®. Our smart eyewear is a fusion of headphones with glasses, bringing vision correction and protection together with digital connectivity and clear audio, while also offering a solution for listening to music outdoors (as compared to in-ear headphones). The convenience of having a Bluetooth headset and comfortable glasses in one, especially for those who are already accustomed to all-day eyewear use, offers a lifestyle upgrade at a price most consumers can afford.

 

Since the initial launch of Lucyd Lyte in 2021, we have sold thousands of our smartglasses, and have significantly upgraded and expanded our product offerings – including the launch of Lucyd Lyte 2.0 and Lyte XL smartglasses in 2023, and most recently with the launch of the Nautica® Powered by Lucyd smart eyewear collection in January 2024. We plan to further expand our product offerings through the launch of new cobranded collections with Eddie Bauer and Reebok later in 2024.

 

All of our products are designed in Miami, manufactured in Asia, and currently sold through two major types of channels:

 

1. E-commerce – primarily via our website (Lucyd.co) and Amazon.com, as well as through Walmart.com, BestBuy.com, DicksSportingGoods.com, Brookstone.com, and eBay; and,

 

2. A growing network of retail stores, including independent eyewear stores and national eyewear chains – we currently have approximately 350 retail stores selling our products (across just over 300 unique wholesale accounts), and are continually working to expand our network.

 

We apply a manufacturer suggested retail price (“MSRP”) of $149 – $199 for non-prescription, polarized sunglass, and blue light blocking glasses across all of our online channels, with our wholesale pricing offering volume discounts to these prices. Please refer to discussion in the Components of Results of Operations for more details regarding our pricing structure.

 

We view our business model as capital light, as we have elected not to build our own manufacturing facilities and Company-owned retail distribution, but rather contract with existing sources of production and proven consumer-facing retail distribution.

 

Key Factors Affecting Performance

 

Expansion of retail points of purchase

 

In addition to sustained growth of our e-commerce business, our future revenues are correlated positively with our placement of Lucyd glasses in optical stores, as well as sporting goods stores and other specialty stores. To address this, we have assembled a team with decades of experience in the eyewear industry and are offering a strong co-op marketing program and reordering incentives program. We currently offer an expansive line of 29 different styles and several accessories, and are in the process of expanding our product offerings to include cobranded eyewear with well-known brands like Nautica, Eddie Bauer, and Reebok. In total, the Company expects to offer 38 total smart eyewear SKUs across these brands and Lucyd by the end of 2024.

 

During 2023, we added approximately 136 new wholesale accounts, primarily independent optical stores.

 

Retail store client retention and re-orders

 

Our ability to sustain and increase revenue is correlated positively with our ability to receive re-orders from stores, either directly or through our wholesale distributors. To support our sales to retail stores directly, we offer a strong co-op marketing program that includes free and paid store display materials. As part of this strategy, we have launched a new modular display system with engaging video screens and audio testing capabilities for our resellers to help educate their in-store customers about Lucyd Lyte and enable customers to try them on. This proprietary display system is central to our efforts to introduce traditional retail customers to Lucyd eyewear, and we are planning further enhancements to our merchandising displays to enable more immersive experiences. Additionally, we consistently incorporate retail partner feedback directly into our frames to better serve our end users. As of December 31, 2023, 45 display systems have been deployed so far to retailers.

 

47

 

 

Investing in business growth

 

We believe that people care about what they wear on their faces, and because we understand that customers have diverse preferences about the shape, size, and design of their eyewear, we aim to continuously invest in the design and development of new models in an effort to provide the consumer with a wide selection of styles, colors, and finishes.

 

We are offering a strong co-op marketing program with retail stores, and intend to expand our sales, marketing, and brand ambassador teams to broaden our brand awareness and online presence.

 

Key Performance Indicators

 

Store Count (B2B)

 

We believe that one of the key indicators for our business is the number of retail stores onboarded to sell Lucyd Lyte. We started onboarding our first retail stores in June 2021. Currently, we have approximately 350 retail stores selling Lucyd Lyte primarily in the United States and Canada, across just over 300 unique wholesale accounts. Based on the existing demand for our products, current distribution, and recently consummated supply agreements, we anticipate that our products will be available in a significant number of new third-party retail locations in 2024.

 

Customer Ratings (B2C)

 

The Lucyd Lyte version 2.0 product is receiving higher ratings online compared to our previous products, indicating that customers are appreciative of improvements in product design, functionality, and build quality. Many of our version 2.0 variants carry a 4.0/5 rating or higher, compared to most products with an approximate 3.5/5 rating from our previous collection. This is a strong signal of positive feedback on our products that indicates our ability to grow and scale with America’s largest online retailer and other platforms.

 

Number of online orders (B2C)

 

For our e-commerce business, we track the number of online orders as an indicator of the success of our online marketing efforts. As of December 31, 2023, we had over 20,000 cumulative total orders from customers online since inception, up from a cumulative total of approximately 12,000 as of December 31, 2022. We believe that the addition of new styles, as well as further investment in brand awareness, product ambassadors, and influencer campaigns, will enable continued growth of online orders in the foreseeable future. We expect to allocate a significant portion of our advertising expenditures towards influencer marketing programs.

 

Components of Results of Operations

 

Net Revenue

 

Our revenue is generated from the sales of prescription and non-prescription optical glasses and sunglasses, and shipping charges associated with these purchases, which are charged to the customer. We sell products through our retail store resellers, distributors, on our own website Lucyd.co, and on Amazon.com.

 

Our newest flagship Lucyd Lyte XL brand frames are priced at $179 on acetate models and $199 on titanium models for non-prescription glasses across all of our online channels.

 

When adding a prescription lens upgrade to our glasses on the Lucyd.co website, the price can increase from between $40 for a basic clear prescription lens, all the way up to $500 for our proprietary Blueshift Polarized transitional blue light lenses in a progressive format. Glasses with prescription lenses are provided by the Company through our website Lucyd.co, while our sales through Amazon and to our e-commerce partners only include non-prescription glasses (with rare exceptions, such as a reseller ordering a customized unit for display purposes).

 

48

 

 

U.S. consumers enjoy free USPS first class postage, with faster delivery options available for extra cost, for sales processed through our website. For Amazon sales, shipping is free for U.S consumers while international customers pay shipping charges. Any costs associated with fees charged by the online platforms (Shopify for our Lucyd.co website and Amazon.com) are not recharged to customers. We charge applicable state sales taxes for online channels and all other marketplaces on which sell.

 

Our wholesale pricing for eyewear sold to retail store partners and distributors includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale retail orders, no e-commerce fees are applicable.

 

Cost of Goods Sold

 

Cost of goods sold includes the costs incurred to acquire materials, assemble, and sell our finished products.

 

For retail sales placed on one of our e-commerce channels, these costs include (i) product costs held at the lesser of cost and net realizable value and inclusive of inventory reserves, (ii) freight, import, and inspection costs, (iii) optical laboratory costs for prescription glasses, (iv) merchant fees, (v) fees paid to third-party e-commerce platforms, and (vi) cost of shipping the product to the consumer.

 

For wholesale sales these costs include (i) product costs stated at the lesser of cost and net realizable value and inclusive of inventory reserves, (ii) freight, import, and inspection costs, and (iii) credit card fees.

 

When consumers place their orders directly on our online store, we save approximately 12% - 15% on marketplace fees, compared to when consumers place their orders directly from third-party platforms like Amazon and eBay.

 

We expect our cost of goods sold to fluctuate as a percentage of net revenue primarily due to product mix, customer preferences and resulting demand, customer shipping costs, and management of our inventory and merchandise mix.

 

Over time we expect our total cost of goods sold on a per unit basis to decrease as a result of an increase in scale. Increase in scale is achieved as a result of increase in volumes from both business to consumer and business to business (retail store) orders. We continue to expand our products with line extensions and new models and broaden our presence in retail stores carrying our products.

 

Gross Profit and Gross Margin

 

We define gross profit as net revenues less cost of goods sold. Gross margin is gross profit expressed as a percentage of net revenues. Our gross margin may fluctuate in the future based on a number of factors, including the cost at which we can obtain, transport, and assemble our inventory, the rate at our vendor network expands, and how effective we can be at controlling costs in any given period.

 

We anticipate our cost of goods sold, on a per unit basis, will decrease with scale, and this will likely have a positive impact on our gross margins.

 

Gross margins in 2022 and the first half of 2023 were adversely impacted by supply chain challenges with our previous manufacturer. We received a high number of defective frames in 2022 despite our rigorous inspection procedure, which involves a third-party inspection agency reviewing 100% of new units as they come off the production line, and testing every pair of glasses for sound quality and basic functionality. Despite this, a large number of inaccurately-tested frames made it to our customers, precipitating a large number of replacement units and lenses which negatively impacted margins. To address this problem, we immediately underwent a new manufacturer search program in 2022 which we believe yielded two higher-quality factories, that are now producing all of our glasses to a higher quality standard. These issues were resolved and remediated by the end of the second quarter of 2023, and we do not expect such impacts on our gross margins going forward.

 

49

 

 

Additionally, in late 2022, the cost of nearly all lenses produced by our supplier increased by approximately 10% from previous levels, which adversely impacted our gross margins in 2023; we do not anticipate similar increases in the cost of lenses in the foreseeable future.

 

We have numerous products at different price points which impact the gross margins on each pair sold. Although price points of Lucyd-branded frames have been reduced from their peak at the launch of the Lyte 2.0 in February 2023, while also costing slightly more to manufacture, the Company has reduced the size of discounts available, and has needed to send fewer warranty replacements due to improvements in product durability and comfort. Therefore, we do not believe the increase in cost of goods sold has a material effect on our gross margins year over year.

 

Operating Expenses

 

Our operating expenses consist primarily of:

 

general & administrative expenses that include primarily consulting and payroll expenses, IT & software, legal, and other administrative expenses;

 

sales and marketing expenses including cost of online and TV advertising, marketing agency fees, influencers, trade shows, and other initiatives;

 

related party management fees for a range of back-office services provided by Tekcapital LLC; and

 

research and development expenses related to (i) development of new styles and features of our smart eyewear, (ii) development and improvement of our e-commerce website, and (iii) development of our Vyrb social media app for wearables.

 

Interest and Other Income, Net

 

Interest and other income, net, primarily includes interest, dividends, and investment returns from our investments in money market funds and U.S. Treasury bills, and interest expense paid on convertible note loan due to Tekcapital (which was repaid in full in February 2023).

 

Provision for Income Taxes

 

Provision for income taxes consists of income taxes related to foreign and domestic federal and state jurisdictions in which we conduct business, adjusted for allowable credits, deductions, and valuation allowance against deferred tax assets.

 

Results of Operations

 

Years Ended December 31, 2023 (“current year”) and December 31, 2022 (“prior year”)

 

    Year ended
December 31,
2023
          Year ended
December 31,
2022
          Change
between the
year ended
December 31,
2023 and 2022
       
Revenues, net   $ 1,152,479       100 %   $ 659,788       100 %   $ 492,691       75 %
Less: Cost of Goods Sold     (1,271,808 )     110 %     (716,077 )     109 %     (555,731 )     78 %
Gross Deficit     (119,329 )     -10 %     (56,289 )     -9 %     (63,040 )     112 %
                                                 
Operating Expenses:                                                
General and administrative     (3,886,960 )     337 %     (2,796,669 )     424 %     (1,090,291 )     39 %
Sales and marketing     (2,047,069 )     178 %     (2,059,012 )     312 %     11,943       -1 %
Research & development     (662,184 )     57 %     (524,692 )     80 %     (137,492 )     26 %
Related party management fee     (140,000 )     12 %     (140,000 )     21 %     -       0 %
Total Operating Expenses     (6,736,213 )     584 %     (5,520,373 )     837 %     (1,215,839 )     22 %
                                                 
Other Income (Expense)     195,150       -17 %     -               195,150       n/m  
 Interest Expense     (3,036 )     0 %     (105,171 )     16 %     102,135       -97 %
Total Other Income (Expense), net     192,114       -17 %     (105,171 )     16 %     297,285       -283 %
                                                 
Net Loss   $ (6,663,428 )     578 %   $ (5,681,833 )     861 %   $ (981,595 )     17 %

 

50

 

 

Revenue

 

Our revenues for the year ended December 31, 2023, were $1,167,479, representing an increase of approximately 77% as compared to revenues of $659,788 during the year ended December 31, 2022.

 

The increase in revenue was primarily attributable to the combination of higher unit volumes, favorable channel mix as described more fully below, and a larger number of styles available in 2023. These positive factors were partially offset by significant discounts offered during the current year in order to help drive unit sales and grow our market share. Key competing products dropped their prices to or below the price point of Lucyd frames during temporary and extended discount sales; to help respond to the ramp-up in the competition’s discounts, we introduced several promotions in 2023 to support our continued market share growth. The imminent diversification of our products with the new cobranded Powered by Lucyd lines (including Nautica, which launched in January 2024, and Eddie Bauer and Reebok, which are expected to launch later in 2024) is expected to reduce the need for discounting to support customer acquisition in the future, due to the global renown of our partner brands.

 

Overall, we believe that the significant increase in revenues in the current year is reflective of the high quality and cutting-edge technology of our Lucyd Lyte 2.0 and Lyte XL smartglasses, and our investment in marketing to grow our brand and our company.

 

For the year ended December 31, 2023, approximately 47% of sales were processed on our online store (Lucyd.co), 33% on Amazon.com, and 20% with reseller partners. This product mix represents the fact that the e-commerce channels have grown more rapidly than our wholesale business. This sales channel mix positively impacted our revenue for the current year as compared with the prior year, due to the fact we charge additional $35 to $275 for our prescription lenses available only on Lucyd.co. For the year ended December 31, 2023, we generated $978,405 of revenue from sales of non-prescription frames and accessories, and $189,074 from sales of frames with prescription lenses. All of the $384,293 in sales generated on Amazon.com during the current year were for non-prescription frames and accessories, as we only offer prescription lenses through our website and our optical store partners. Of the $554,060 in online sales generated through Lucyd.co, $189,074 was related to frames with prescription lenses and $364,986 was related to glasses with non-prescription lenses. E-commerce sales are the most material portion of our sales to date since inception.

 

For the year ended December 31, 2022, approximately 32% of sales were processed on our online store (Lucyd.co), 38% on Amazon.com, and 30% with reseller partners. For the year ended December 31, 2022, we generated $579,214 of revenue from sales of non-prescription frames and accessories and $80,574 was generated from sales of frames with prescription lenses. All of the $252,799 in sales generated on Amazon.com during the prior year were for non-prescription frames and accessories, as we only offer prescription lenses through our website. Of the $208,447 in online sales generated through Lucyd.co, $80,574 related to frames with prescription lenses and $127,873 of glasses sold were with non-prescription lenses. E-commerce sales are the most material portion of our sales to date since inception.

 

Over time, we expect that the online portion of our sales will gradually decrease on a percentage basis but remain an important component of our total sales as we onboard more retail stores. We currently have a retail store presence in approximately 350 stores, up from over 250 stores as of December 31, 2022. We anticipate that a partnership with a major eyeglass distributor will substantially increase our wholesale sales.

 

Cost of goods sold

 

Our total cost of goods sold increased to $1,240,171 for the year ended December 31, 2023, as compared to $716,077 for the year ended December 31, 2022. This increase was primarily driven by higher volumes of products sold during the current year.

 

51

 

 

This increase was primarily driven by increased cost of lenses and frames largely as a result of higher volumes of products sold in the current year. The increase in the cost of lenses was also driven by (i) a 10% increase in the production cost of lenses sourced through supplier in late 2022, and (ii) the introduction of our new proprietary Blueshift premium lenses in August 2023, which are more expensive than other lenses to produce. Cost of goods sold was also impacted by sales channel mix, as a higher relative proportion of our sales in the current year were through our online store (Lucyd.co), and the cost of prescription lenses attributable to this channel increased our cost of goods sold while not impacting cost of goods sold for sales realized through Amazon or retail store partners. Also contributing to the increase in cost of goods sold in the current year were replacement products provided to customers free of charge (which could be due to warranty, improperly cut prescription lenses, or improperly fitting frames), and about 500 product samples distributed as promotional and content generation pieces to influencers, investors, online and traditional media, and other press outlets for the purpose of gaining various forms of brand awareness, investor interest, and site traffic.

 

We believe our product margins are competitive relative to other smartglasses. This provides ample margins to support the higher cost of customer acquisition for an emerging product category. Our relationship with a new supplier with lower cost of goods than our main supplier has enabled us to plan to launch the Reebok and Smart Safety lines at even more competitive prices than our current offering.

 

Smart eyewear is a highly specialized product that has the combined specifications and component requirements of a wireless Bluetooth headset and optical eyewear in one, meaning it is expensive to manufacture in small quantities of a few thousand at a time. As demand and awareness for smart eyewear continues to grow, the Company expects that its per unit cost will decrease as its order volumes increase and we realize economies of scale.

 

Key components of cost of goods sold for the year ended December 31, 2023 included, but were not limited to, the cost of frames of $756,795, which was made much larger due to the high number of warranty replacements for product flaws which have since been eliminated. Cost of prescription lenses incurred with our third-party vendor of $271,229, affiliate referral fees, sales commission expense, and e-commerce platform fees of $190,326, and quality assurance costs related to our products sold of $13,100. Out of our total cost of goods sold for the year ended December 31, 2023, $271,229 related to orders with prescription lenses, while $969,064 pertained to non-prescription orders.

 

Key components of cost of goods sold for the year ended December 31, 2022 included, but were not limited to, the cost of frames of $478,020, cost of prescription lenses incurred with our third-party vendor of $104,217, affiliate referral fees, sales commission expense, and e-commerce platform fees of $128,340, and quality assurance costs related to our products sold of $5,500. Out of our total cost of goods sold for the year ended December 31, 2022, $113,024 related to orders with prescription lenses, while $639,294 pertained to non-prescription orders.

 

Over time, we expect third-party retail stores to become our primary sales channel as we onboard additional stores. Consequently, we expect sales of prescription lens, offered through our website to decrease, as our third-party retail partners outfit our Lyte frames with more prescriptions. As a result, over time we expect prescription lens costs to gradually decrease as a percentage of our overall cost of goods sold.

 

We anticipate growth in both wholesale and e-commerce channel sales in 2024. We also expect corresponding growth in total cost of goods sold, primarily from additional product related costs. As we continue to refine our SKU mix with sales data, we anticipate reducing our unit costs by reducing the variety of SKUs produced per product line compared to the past, to focus only on the highest volume styles. Additionally, we have been informed by key suppliers that significant price reductions over 10% are possible as we continue to scale our production quantities.

 

Gross profit (deficit)

 

Our gross profit was negative $72,692 for the year ended December 31, 2023, as compared to negative $56,289 for the year ended December 31, 2022. This decrease was primarily driven by the factors outlined above.

 

We expect gross profit for the fiscal year ending December 31, 2024, to improve, primarily due to economies of scale from large, anticipated orders. As we expect retail stores to eventually become our primary sales channel as we onboard new stores, we also expect our overall gross margin to improve, since no e-commerce platform fees or prescription lens costs apply in wholesale channels.

 

52

 

 

Operating expenses

 

Our operating expenses increased by 22% to $6,736,213 for the year ended December 31, 2023, as compared to $5,520,373 for the year ended December 31, 2022. This increase was primarily due to the following:

 

General and administrative expenses

 

Our general and administrative expenses increased by 39% to $3,886,960 for the year ended December 31, 2023, as compared to $2,796,669 for the year ended December 31, 2022. This increase was primarily attributable to (i) an increase of approximately $560,000 in employee-related costs, resulting from increases in our staffing and new employment agreements entered into with executives, (ii) increased costs associated with being a publicly-traded company, including directors’ remuneration, insurance expense, public and investor relations, and filing fees, which altogether resulted in an increase in expense of approximately $430,000, (iii) higher license costs, which increased approximately $146,000, and (iv) and increase in depreciation and amortization expense of approximately $53,000. These increased expenses were partially offset by recoveries of bad debts, and lower costs related to consultants and other outside service providers.

 

Sales and marketing expenses

 

Our sales and marketing expenses were essentially flat year-over-year at $2,047,069 for the year ended December 31, 2023, as compared with $2,059,012 in the prior year.

 

During the first quarter of the current year, we temporarily paused and postponed our marketing spending while we restructured our e-commerce business, and management made a tactical decision to preserve a significant portion of our marketing budget for later in the year, in order to better align the timing of marketing spending with major new product launches and thus maximize impact. Our overall actual spending on advertising and promotions in 2023 increased significantly over prior year, particularly in the areas of spending on paid ads on websites and social media platforms, as well as spending on influencers, but was largely offset by the reversal of approximately $309,000 of previously-recognized stock-based compensation for certain individuals within the Company’s sales and marketing function whose awards expired during the current year without ever having vested, as the related performance conditions (sales quotas) for those awards were not met.

 

We anticipate our marketing costs to increase in 2024 as we continue to invest in and build our brand, expand the number of e-commerce platforms on which we sell our products, invest in retail store co-op marketing programs and displays to help educate in-store customers about our products, and increase our brand’s physical presence and role in the eyewear industry.

 

Related party management fee

 

Our related party management fee was $140,000 for each of the years ended December 31, 2023 and 2022, based on the terms of the management services agreement between us and Tekcapital.

 

Research and development costs

 

Our research and development costs increased by 26% to $662,184 for the year ended December 31, 2023, as compared with $524,692 the year ended December 31, 2022.

 

This increase was primarily attributable to a large number of new temple and frontplate molds as we expand our core offering, an expansion of the Company’s software initiatives to include the Lucyd app, and therefore increased the portion of the work hours spent by the CEO and CTO (as well as a portion of their stock-based compensation expense) on new software development on the Vyrb app, the new Lucyd app, and our glasses, as well as the hiring of an additional full-time software engineer to support our CTO. Some planned features for our Lucyd app include the ability to access AI other than ChatGPT, the addition of an audio content library for users to enjoy, and further enhancements to the core AI functionality. In terms of the Vyrb app, we are planning launching a full peer-to-peer content marketplace in the style of Patreon, but with a focus on audio and content designed on and for wearables.

 

53

 

 

Liquidity and Capital Resources

 

Cash Flow Data:

 

    Year ended
December 31,
2023
    Year ended
December 31,
2022
 
Net cash flows from operating activities   $ (5,766,303 )   $ (3,224,418 )
Net cash flows from investing activities     (198,753 )     (219,951 )
Net cash flows from financing activities     6,661,394       6,955,751  
Net Change in Cash   $ 696,338     $ 3,511,382  

 

Operating Activities

 

Net cash flows used in operating activities for the years ended December 31, 2023 and 2022 are primarily reflective of our net losses, resulting from our operating costs to support and grow our business, including employee-related costs, sales and marketing, research and development, and various costs associated with being a publicly-traded company. Additionally, our operating asset levels grew significantly during 2023 as we have procured additional inventory to position us for future anticipated sales growth.

 

Investing Activities

 

During the current year, the Company used low-risk bonds and similar investment instruments for the purpose of earning interest on its cash balance. The Company also continued to invest in its growing intellectual property portfolio, making expenditures to file for various new patents.

 

Financing Activities

 

Net cash flows provided by financing activities for year ended December 31, 2023 are mainly driven by the various capital-raising activities undertaken during the current year, including our second public offering completed in June 2023 and exercises of warrants by stockholders earlier in the year, partially offset by repayment of advances and convertible debt to related parties.

 

Net cash flows provided by financing activities for the year ended December 31, 2022 are mainly driven by our initial public offering completed in August 2022, and, to a lesser extent, by net proceeds from related party borrowings through convertible debt.

 

Initial Public Offering

 

On August 17, 2022, the Company closed on its initial public offering of 980,000 units, consisting of 980,000 shares of its common stock and 1,960,000 warrants to purchase 1,960,000 shares of common stock, at a combined offering price of $7.50 per unit in exchange for gross proceeds of approximately $7.35 million, before deducting underwriting discounts and offering expenses. Each share of common stock was sold together with two warrants, each warrant to purchase one share of common stock at an exercise price of $7.50 per share. In addition, the Company granted the underwriters a 45-day option to purchase up to an additional 147,000 shares of common stock and/or warrants to purchase up to an additional 294,000 shares of common stock to cover over-allotments, of which the underwriter exercised its option to purchase additional warrants to purchase 294,000 shares of common stock.

 

The net proceeds received by the Company from this offering amounted to $6,189,734. We used the proceeds from this offering primarily on (i) sales and marketing, (ii) expanding our inventory, (iii) updating and developing our in-store displays, (iv) developing new smart eyewear styles and sizes, as well as further development and commercialization of the Vyrb app, and (v) working capital and other general corporate purposes.

 

54

 

 

Second Public Offering

 

On June 26, 2023, the Company closed on a public offering of 4,500,000 units consisting of 4,500,000 shares of its common stock and 4,500,000 warrants to purchase 4,500,000 shares of common stock (the “Common Warrants”) at a combined offering price of $1.05 per unit in exchange for gross proceeds of approximately $4.73 million, before deducting underwriting discounts and offering expenses. Each share of common stock was sold together with one warrant. Each Common Warrant is exercisable to purchase one share of common stock at an initial exercise price of $1.05 per share, subject to certain adjustments as set forth in the warrant agreement. In addition, pursuant to the terms of the placement agency agreement for the offering, the Company issued to the placement agent certain other warrants to purchase up to 180,000 shares of the Company’s common stock at an exercise price of $1.31 per share.

 

The net proceeds received by the Company from this offering amounted to $4,115,688. We intend to use the net proceeds of this offering primarily for working capital and general purposes.

 

New Convertible Loan Note

 

Effective March 1, 2024, the Company issued a convertible note to Lucyd Ltd., the largest stockholder of the Company, for up to $1,250,000 that bears interest at 10% per annum, which includes the option to convert the debt into the Company’s common stock at market price. The note can be converted into shares of common stock of the Company upon the occurrence of certain events, as defined in the note, or for any reason at the sole discretion of Lucyd Ltd. The note has a maturity date of September 1, 2025, at which time all outstanding principal and accrued interest is payable in full. As of the date of this Annual Report on Form 10-K, we have not borrowed any amounts under this convertible note.

 

Other Factors

 

We expect that operating losses could continue in the foreseeable future as we continue to invest in the expansion and development of our business. We believe our existing cash and cash equivalents (including the proceeds from the aforementioned second public offering and proceeds received from investors’ exercises of warrants), plus planned capital-raising activities will be sufficient to fund our operations for at least the next twelve months.

 

However, our future capital requirements will depend on many factors, including, but not limited to, growth in the number of retail store customers, the needs of our e-commerce business and retail distribution network, expansion of our product and software offerings, and the timing of investments in technology and personnel to support the overall growth of our business. To the extent that current and anticipated future sources of liquidity are insufficient to fund our future business activities and requirements, we may be required to seek additional equity or debt financing. The sale of additional equity would result in additional dilution to our stockholders. The incurrence of debt financing would result in debt service obligations and the instruments governing such debt could provide for operating and financing covenants that would restrict our operations. There can be no assurances that we will be able to raise additional capital. In the event that additional financing is required from outside sources, we may not be able to negotiate terms acceptable to us or at all. Current geopolitical and macroeconomic factors have caused disruption in the global financial markets, which could reduce our ability to access capital and negatively affect our liquidity in the future. If we are unable to raise additional capital when required, or if we cannot expand our operations or otherwise capitalize on our business opportunities because we lack sufficient capital, our business, results of operations, financial condition, and cash flows would be adversely affected.

 

Off-Balance Sheet Arrangements

 

As of December 31, 2023, we did not have any off-balance sheet arrangements.

 

55

 

 

Critical Accounting Policies and Significant Developments and Estimates

 

Management’s discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared in accordance with GAAP. The preparation of our financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, as well as the reported revenue generated and expenses incurred during the reporting periods, as well as related disclosures. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities and the amount of revenue and expenses that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions, and any such differences may be material. We believe that the accounting policies discussed below are critical to understanding our historical and future performance, as these policies relate to the more significant areas involving management’s judgments and estimates.

 

We believe that our application of accounting policies, and the estimates inherently required therein, are reasonable. We periodically re-evaluate these accounting policies and estimates and make adjustments when facts and circumstances dictate a change. Historically, we have found our application of accounting policies to be appropriate, and actual results have not differed materially from those determined using necessary estimates.

 

Inventory

 

Our inventory includes purchased eyewear and is stated at the lower of cost or net realizable value, with cost determined on a specific identification method of inventory costing which attaches the actual cost to an identifiable unit of product. Provisions for excess, obsolete, or slow-moving inventory are recorded after periodic evaluation of historical sales, current economic trends, forecasted sales, estimated product life cycles, and estimated inventory levels. No provisions were determined as needed as of December 31, 2023 and 2022.

 

As of December 31, 2023 and 2022, we recorded an inventory prepayment in the amount of $323,520 and $197,750, respectively, related to down payment on eyewear purchased from the manufacturer, prior to shipment of the product that occurred after the respective balance sheet dates.

 

Intangible Assets

 

Intangible assets relate to:

 

Internally-developed and licensed utility and design patents. We amortize these assets over the estimated useful life of the patents.

 

Capitalized software costs incurred due to development of the Vyrb app. We amortize these assets over the estimated useful life of the software application.

 

We review our intangible assets for impairment whenever changes in circumstances indicate that the carrying amount of the assets may not be recoverable.

 

Income Taxes

 

We are taxed as a C corporation. We comply with Financial Accounting Standards Board (FASB) ASC 740 for accounting for uncertainty in income taxes recognized in a company’s financial statements, which prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. FASB ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, and disclosure. Based on our evaluation, we have concluded that there are no significant uncertain tax positions requiring recognition in our financial statements. We believe that our income tax positions would be sustained on audit and do not anticipate any adjustments that would result in a material change to the Company’s financial position.

 

56

 

 

We have incurred taxable losses since inception but are current in our tax filing obligations. We are not presently subject to any income tax audit in any taxing jurisdiction.

 

Stock-Based Compensation

 

We account for stock-based compensation to employees and directors in accordance with FASB ASC Topic 718, which requires that compensation expense be recognized in the financial statements for stock-based awards based on the grant date fair value.

 

For stock option awards, the Black-Scholes-Merton option pricing model is used to estimate the fair value of share-based awards. The Black-Scholes-Merton option pricing model incorporates various and highly subjective assumptions, including expected term and share price volatility.

 

The expected term of the stock options was estimated based on the simplified method as allowed by Staff Accounting Bulletin 107 (SAB 107).

 

The share price volatility at the grant date is estimated using historical stock prices based upon the expected term of the options granted, using stock prices of comparably profiled public companies.

 

The risk-free interest rate assumption is determined using the rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued.

 

For options granted after our initial public offering on August 17, 2022, the fair value of common stock used in the option pricing model is based on the quoted market price of our common shares on the NASDAQ stock exchange.

 

For options granted prior to our initial public offering, the fair value of common stock used in the option pricing model was determined using the most recent price paid by independent investors through a Regulation Crowdfunding (“CF”) securities offering undertaken by the Company.

 

For restricted stock units, the fair value of the share-based award is based on the quoted market price of our common shares on the NASDAQ stock exchange.

 

Revenue Recognition

 

Our revenue is generated from the sales of prescription and non-prescription optical glasses, sunglasses, and shipping charges, which are charged to the customer, associated with these purchases. We sell products through our retail store resellers, distributors, on our own website Lucyd.co, and on Amazon.com.

 

To determine revenue recognition, we perform the following steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. At contract inception, we assess the goods or services promised within each contract and determine those that are performance obligations, and also assess whether each promised good or service is distinct. We then recognize as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. In instances where the collectibility of contractual consideration is not probable at the time of sale, the revenue is deferred on our balance sheet as a contract liability, and the associated cost of goods sold is deferred on our balance sheet as a contract asset; subsequently, we recognize such revenue and cost of goods sold as payments are received. During the year ended December 31, 2023, we recognized $17,500 of revenue that was included in the contract liability balance as of January 1, 2023.

 

All revenue, including sales processed online and through our retail store resellers and distributors, is reported net of sales taxes collected from customers on behalf of taxing authorities, returns, and discounts.

 

57

 

 

For sales generated through our e-commerce channels, we identify the contract with a customer upon online purchase of our eyewear and transaction price at the manufacturer suggested retail price (“MSRP”) for non-prescription, polarized sunglass and blue light blocking glasses across all of our online channels. Our e-commerce revenue is recognized upon meeting of the performance obligation when the eyewear is shipped to end customers. Only U.S. consumers enjoy free USPS first class postage, with faster delivery options available for extra cost, for sales processed through our website and on Amazon. For Amazon sales, shipping is free for U.S consumers while international customers pay shipping charges on top of MSRP. Any costs associated with fees charged by the online platforms (Shopify for Lucyd.co website and Amazon) are not recharged to customers and are recorded as a component of cost of goods sold as incurred. The Company charges applicable state sales taxes in addition to the MSRP for both online channels and all other marketplaces on which the company sells products.

 

For sales to our retail store partners, we identify the contract with a customer upon receipt of an order of our eyewear through our Shopify wholesale portal or direct purchase order. Our revenue is recognized upon meeting the performance obligation, which is delivery of the Company’s eyewear products to the retail store and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to the retail store partners includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale retail orders, no e-commerce fees are applicable.

 

For sales to distributors, we identify the contract with a customer upon receipt of an order of our eyewear through a direct purchase order. If collectability of substantially all of the contract consideration is probable, our revenue is recognized upon meeting the performance obligation, which is delivery of our eyewear products to the distributor, and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to distributors includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale distributor orders, no e-commerce fees are applicable.

 

Our sales do not contain any variable consideration.

 

We allow our customers to return our products, subject to our refund policy, which allows any customer to return our products for any reason within the first:

 

  7 days for sales made through our website (Lucyd.co)

 

  30 days for sales made through Amazon

 

  30 days for sales to most wholesale retailers and distributors (although certain sales to independent distributors are ineligible for returns)

 

For all of our sales, at the time of sale, we establish a reserve for returns, based on historical experience and expected future returns, which is recorded as a reduction of sales. Additionally, we review all individual returns received in the month following the balance sheet date pertaining to orders processed prior to the balance sheet date in order to determine whether an allowance for sales returns is necessary. We recorded an allowance for sales returns of $25,933 and $24,897 as of December 31, 2023 and 2022, respectively.

 

Shipping and Handling

 

Costs incurred for shipping and handling are included in cost of revenue at the time the related revenue is recognized. Amounts billed to a customer for shipping and handling are reported as revenues.

 

Earnings/loss per share

 

We present earnings and loss per share data by calculating the quotient of earnings/(loss) divided by the weighted average number of common shares outstanding during the period as required by ASC 260-10-50. As of December 31, 2023 and December 31, 2022, all shares underlying the related party convertible debt and common stock options were excluded from the earnings per share calculation, due to their anti-dilutive effect.

 

58

 

 

Item 7A. Quantitative and Qualitative Disclosures About Market Risk.

 

Not required for smaller reporting companies.

 

Item 8. Financial Statements and Supplementary Data.

 

See accompanying “Index to Consolidated Financial Statements.”

 

Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.

 

None.

 

Item 9A. Controls and Procedures.

 

Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rule 13a-15 and 15d-15 of the Exchange Act. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of the end of fiscal year 2023.

 

Management’s Report on Internal Control Over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act. Our management, including the principal executive officer and principal financial officer, does not expect that our internal controls over financial reporting will prevent all errors and all fraud. A control system, no matter how well designed and operated, cannot provide full assurance that the objectives of the control system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements for external purposes in accordance with generally accepted accounting principles.

 

Under the supervision and with the participation of our management, including the principal executive officer and principal financial officer, we conducted an evaluation as to the effectiveness of our internal control over financial reporting as of December 31, 2022. In making this assessment, our management used the criteria for effective internal control set forth by the Committee of Sponsoring Organizations of the Treadway Commission in the 2013 Internal Control – Integrated Framework. Based on this assessment, our management concluded that our internal control over financial reporting was not effective as of December 31, 2023.

 

This Annual Report on Form 10-K does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s independent registered public accounting firm pursuant to a permanent exemption of the Commission that permits the Company to provide only management’s report in this Annual Report on Form 10-K. Accordingly, our management’s assessment of the effectiveness of our internal control over financial reporting as of December 31, 2023 has not been audited by our auditors, Cherry Bekaert LLP.

 

Changes in Internal Control Over Financial Reporting

 

There were no changes in our internal control over financial reporting during the fourth quarter of fiscal year 2023 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

Item 9B. Other Information.

 

None.

 

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.

 

Not applicable.

 

59

 

 

PART III

 

Item 10. Directors, Executive Officers and Corporate Governance.

 

The following table sets forth certain information regarding our board of directors, our executive officers, and some of our key employees.

 

Name   Age   Position
Harrison R. Gross   31   Chief Executive Officer and Director
Konrad Dabrowski   41   Chief Financial Officer
David Eric Cohen   51   Chief Technology Officer
Kristen Mclaughlin   51   Director
Louis Castro   65   Director
Olivia C. Bartlett   65   Director

 

Harrison Gross is one of the founders of Innovative Eyewear and has served as our Chief Executive Officer and as a director since August 2019, where he guides the company’s product and brand development. Prior to his employment at Innovative Eyewear, from August 2017 to August 2019, Mr. Gross served in various positions, including chief executive officer and media & UX lead, of Lucyd Ltd., our largest stockholder and the licensor of our technology which is also a smart eyewear development company where he developed the Lucyd brand identity and oversaw general operations and product development. Additionally, from November 2015 to August 2021, Mr. Gross served as the Digital Media Manager of Tekcapital PLC (“Tekcapital”) (LON: TEK), a university intellectual property investment firm that is the parent company of Tekcapital Europe Limited, and Lucyd Ltd, the holding company for Tekcapital’s shares in Innovative Eyewear, where he created, developed and marketed for the company’s licensed properties. Prior to that, from October 2013 to September 2014, Mr. Gross worked as a credit analyst for a Verizon, Inc. contractor, where he managed credit systems and provided support to Verizon agents. Mr. Gross is a graduate of Columbia University with a BA in Writing and received a BA in Jewish Studies from the Jewish Theological Seminary. Mr. Gross is well qualified to serve as a director due to his substantial knowledge of our product and his experience in marketing, product and app development.

 

Konrad Dabrowski has served as our Chief Financial Officer on a part-time basis since August 2019. Between June 2017 and July 2020, Mr. Dabrowski has served as the group controller, and starting on July 2020 the chief financial officer of Tekcapital PLC (“Tekcapital”), where he co-manages the group’s investment strategy and oversees financial reporting for all of its portfolio companies. Prior to his employment at Tekcapital, from March 2016 to June 2017, Mr. Dabrowski was a Global Accounting Manager for Restaurant Brands International (NYSE:QSR), a multinational fast food holding company, where he oversaw accounting and tax projects for Burger King within the Europe Middle East and Africa (EMEA) market. Prior to his employment at Restaurant Brands International, Mr. Dabrowski was an Audit Manager at Deloitte, where he managed end-to-end accounting audits for a portfolio of public and private corporate clients. Mr. Dabrowski has a Master’s in Finance and Banking from the Warsaw School of Economics and is a Certified Public Accountant.

 

David Eric Cohen is one of the founders of Innovative Eyewear and has served as our Chief Technology Officer since September 2019. Prior to his employment at Innovative Eyewear, from August 2017 to August 2019, Mr. Cohen served as the chief technology officer of Lucyd Ltd., a smart eyewear development company, where he led the company’s technological advancements and digital ad campaigns. Also, prior to his employment at Innovative Eyewear, from September 2009 to October 2019, Mr. Cohen served as President of Emaze Design Agency, a digital design agency, where he led the development of web and applications for e-commerce, web performance monitoring, website design and mobile applications. Prior to his employment at Emaze Design Agency, Mr. Cohen was lead Business Intelligence Specialist at Jewish General Hospital where he assisted with the data solutions and business processes and requirements. He received a BS in Computer Science from the Academy of Bordeaux and an MS in Advanced Technician & Information Systems Management from Hadassah University.

 

60

 

 

Kristen Mclaughlin has served as one of our directors since August 2021. Ms. Mclaughlin has 25 years’ experience launching, managing and developing products in the eyewear, accessories, cosmetics and skincare industries. Kristen is currently the Director of Marketing at Tura, Inc., a leading eyewear design and distribution company based in New York City, a position she has held since October 2021. From March 2019 to April 2020, Ms. Mclaughlin served as the Global Marketing Director at DePasquale Companies, a skincare, hair care and cosmetics manufacturer, where she led the global marketing strategy and new product development. Prior to her employment at DePasquale Companies, from March 2000 to January 2019, Ms. Mclaughlin was employed at Silhouette International, an eyewear manufacturer, where she served as the Director of Marketing: Eyewear Manufacturer, Regional Sales Manager, and Brand Manager: Daniel Swarovski Crystal Eyewear. While at Silhouette International, Ms. Mclaughlin led the company’s brand portfolio in the U.S. and its brand direction, product development and campaign content. She has a BS and MBA from Ramapo College of New Jersey. Ms. Mclaughlin is well qualified to serve as a director due to her substantial experience in the eyewear industry and her experience in brand and product development.

 

Louis Castro has served as one of our directors since August 2021. Mr. Castro is an experienced public company director and chartered accountant. Mr. Castro is currently on the board of directors of the following public companies: (1) Tekcapital, where he has been a director since December 2019, (2) Orosur Mining Inc. (TSX-V & AIM:OMI), a company exploring for minerals in South America, where he has been chairman of the board since April 2020, (3) Tomco Energy plc (LON:TOM), an oil exploration and technology company, where he has been a director since April 2021, and (4) Veteran Capital Corp. (TSX-V:VCC), a capital pool company, where he has been a director since January 2021. From September 2012 to June 2016, Mr. Castro was a director and, from September 2014 to June 2016 served as the Chief Financial Officer, of Eland Oil & Gas plc, a Nigerian focused upstream oil and natural gas exploration and production company, where he was responsible for the company’s finance, legal and corporate finance activities. Prior to his employment at Eland, from May 2011 to May 2014, Mr. Castro served as Head of Capital Markets and then as Chief Executive Officer of Northland Capital Partners, an investment bank, where he was responsible for the investment banks day-to-day activities. He is a fellow of the Institute of Chartered Accountants of England & Wales, has a double degree in Engineering Production and Economics from Birmingham University and attended the Postgraduate Advanced Course in Production Management and Methods at Cambridge University. Mr. Castro is well qualified to serve as a director due to his substantial experience as a director of public companies and his distinction as chartered accountant.

 

Olivia C. Bartlett has served as one of our directors since August 2021. Ms. Bartlett has been in the eyewear industry for over 40 years holding various roles including optician, optical manager, marketing manager, and operations management. She is currently an optical industry consultant. Ms. Bartlett served as Chief Operation Officer of Todd Rogers Eyewear, a specialty eyewear company, from 2015 to 2021, where she managed the day-to-day operations of the company. Prior to her time at Todd Rogers Eyewear, Ms. Bartlett was the sales representative for eyewear sales in the northeast of Massachusetts for Safilo USA and REM Eyewear, both specialty eyewear companies. Additionally, Ms. Bartlett is an Adjunct Professor at Franklin Cummings Institute of Technology in Boston, Massachusetts. She is a past President (2020 – 2022) of the Opticians Association of America, a national organization representing the professional, business, educational, legislative, and regulatory interests of opticianry, where she held a board position for 12 years. Prior to that, Ms. Bartlett was President of the Opticians Association of Massachusetts, where she currently holds the position of Treasurer. Ms. Bartlett has received a number of awards through her time in the industry, including but not limited to, the 2020 Eyecare Business Game Changer Award, and the 2020 and 2018 Vision Monday Most Influential Woman Executive. Ms. Bartlett received her Massachusetts Opticians license in 1987 and is ABO certified and is an ABO certified speaker. Ms. Bartlett received her BA in Political Science from Clark University. Ms. Bartlett is well qualified to serve as a director due to her substantial experience in the optical industry.

 

Number and Terms of Office of Officers and Directors

 

Our board of directors consists of four members. Our directors are appointed for one-year terms to hold office until the next annual general meeting of our stockholders or until removed from office in accordance with our second amended and restated bylaws.

 

Our officers are appointed by the board of directors and serve at the discretion of the board of directors, rather than for specific terms of office. Our board of directors is authorized to appoint persons to the offices set forth in our second amended and restated bylaws, as it deems appropriate.

 

61

 

 

Director Independence and Committees of the Board of Directors

 

Director Independence

 

Of our directors, we have determined that Mr. Louis Castro, Ms. Kristen Mclaughlin, and Ms. Olivia Bartlett are “independent” directors under NASDAQ listing standards, while Mr. Harrison Gross is not independent under such standards. We have also determined that each of the three members of the Audit Committee is “independent” for purposes of Section 10A(m)(3) of the Exchange Act and the rules promulgated thereunder and under the NASDAQ listing standards. Further, the Board has determined that each of the two members of both the Compensation Committee and the Nominating and Corporate Governance Committee is “independent” under NASDAQ listing standards.

 

Board Committees

 

We have three standing committees of the Board: Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee. Each of the board committees act pursuant to a separate written charter adopted by our board of directors, each of which is available on our website at www.lucyd.co. Our board of directors may at any time or from time to time appoint certain other committees in its sole discretion as it deems necessary or appropriate to carry out its functions.

 

Audit Committee

 

The Audit Committee consists of Mr. Louis Castro (Chair), Ms. Kristen Mclaughlin, and Ms. Olivia Bartlett. The Board has determined that all of the members of the Audit Committee are “independent,” as defined by NASDAQ listing standards and by applicable SEC rules. In addition, the Board has determined that Mr. Castro is an audit committee financial expert, as that term is defined by the SEC rules, by virtue of having the following attributes through relevant experience: (i) an understanding of generally accepted accounting principles and financial statements; (ii) the ability to assess the general application of such principles in connection with the accounting for estimates, accruals, and reserves; (iii) experience preparing, auditing, analyzing, or evaluating financial statements that present a breadth and level of complexity of accounting issues that are generally comparable to the breadth and complexity of issues that can reasonably be expected to be raised by the Company’s financial statements, or experience actively supervising one or more persons engaged in such activities; (iv) an understanding of internal controls and procedures for financial reporting; and (v) an understanding of audit committee functions.

 

The function of the Audit Committee relates to oversight of the auditors, the auditing, accounting, and financial reporting processes, and the review of the Company’s financial reports and information. In addition, the functions of the Audit Committee will include, among other things, recommending to the Board the engagement or discharge of independent auditors, discussing with the auditors their review of the Company’s quarterly results and the results of their audit, and reviewing the Company’s internal accounting controls.

 

Compensation Committee

 

The Compensation Committee consists of Ms. Kristen Mclaughlin (Chair) and Mr. Louis Castro. The Board has determined that all of the members of the Compensation Committee are “independent,” as defined by NASDAQ listing standards. The responsibility of the Compensation Committee is to review and approve the compensation and other terms of employment of our President and Chief Executive Officer and our other executive officers, including all of the executive officers named in the Summary Compensation Table under the heading “Executive Compensation” below (the “named executive officers”). Among its other duties, the Compensation Committee oversees all significant aspects of the Company’s compensation plans and benefit programs. The Compensation Committee annually reviews and approves corporate goals and objectives for the President and Chief Executive Officer’s compensation and evaluates the Chief Executive Officer’s performance in light of those goals and objectives. The Compensation Committee also recommends to the Board the compensation and benefits for members of the Board. The Compensation Committee has also been appointed by the Board to administer our 2021 Equity Incentive Plan. The Compensation Committee does not delegate any of its authority to other persons.

 

62

 

 

Nominating and Corporate Governance Committee

 

The Nominating and Corporate Governance Committee consists of Ms. Olivia Bartlett (Chair) and Ms. Kristen Mclaughlin. All of the committee members are independent under applicable NASDAQ rules and regulations. The Nominating and Corporate Governance Committee is responsible for, among other things, considering potential board members, making recommendations to the full board as to nominees for election to the board, assessing the effectiveness of the board, and implementing our corporate governance guidelines.

 

Section 16(a) Beneficial Ownership Reporting Compliance

 

Section 16(a) of the Exchange Act requires that our directors and executive officers and persons who beneficially own more than 10% of our common stock (referred to herein as the “reporting persons”) file with the SEC various reports as to their ownership of and activities relating to our common stock. Such reporting persons are required by the SEC regulations to furnish us with copies of all Section 16(a) reports they file.

 

Based solely upon a review of copies of Section 16(a) reports and representations received by us from reporting persons, and without conducting any independent investigation of our own, in fiscal year 2023, all Forms 3, 4 and 5 were timely filed with the SEC by such reporting persons.

 

Code of Ethics

 

We have adopted a formal code of ethics that applies to our directors and principal executives and financial officers or persons performing similar functions. A copy of our Code of Ethical Conduct can be found on our website under “Investors” at www.lucyd.co.

 

Nasdaq Board Diversity Matrix

 

Board Diversity Matrix as of December 31, 2023  
Total Number of Directors   4  
    Female     Male     Non-Binary     Did Not Disclose Gender  
Part I: Gender Identity                            
Directors   2     2              
Part II: Demographic Background                            
African American or Black                            
Alaskan Native or Native American                            
Asian                            
Hispanic or Latinx                            
Native Hawaiian or Pacific Islander                            
White   2     2                  
Two or More Races or Ethnicities                            
LGBTQ+                            
Did Not Disclose Demographic Background                            

 

63

 

 

Item 11. Executive Compensation.

 

The following table sets forth the aggregate compensation paid to our named executive officers for the fiscal years ended December 31, 2023 and 2022. Individuals we refer to as our “named executive officers” include our Chief Executive Officer, our Chief Financial Officer, and our Chief Technology Officer.

 

Summary Compensation Table

 

 

Name and Principal Position   Year   Salary(1)
($)
    Bonus
($)
    Stock Awards
($)
   

Option
Awards(2)(3)

($)

    Nonequity
Incentive Plan
Compensation
($)
    Nonqualified
Deferred
Compensation
Earnings
($)
    All Other
Compensation(4)
($)
    Total
($)
 
Harrison Gross,   2023     154,102       -       -       129,800       -       -       5,545       289,447  
Chief Executive Officer   2022     114,758       -       -       -       -       -       -       114,758  
                                                                     
Konrad Dabrowski,   2023     105,347       -       -       121,357       -       -       95       226,799  
Chief Financial Officer   2022     105,500       -       -       -       -       -       -       105,500  
                                                                     
David Eric Cohen,   2023     143,297       -       -       78,090       -       -       4,241       225,628  
Chief Technology Officer   2022     70,270       -       -       -       -       -       -       70,270  

 

 
(1) Salary amounts shown for Mr. Cohen include $34,500 paid in 2022, respectively, to Mr. Cohen as an independent consultant, prior to his hire as an employee on October 1, 2022.
(2) Includes stock options granted to Messrs. Gross, Dabrowski, and Cohen on January 13, 2023 to purchase 90,000, 90,000, and 60,000 shares of the Company’s common stock, respectively, at an exercise price of $1.275 per share.
(3) Includes stock options granted to Messrs. Gross, Dabrowski, and Cohen on December 18, 2023 to purchase 150,000, 120,000, and 70,000 shares of the Company’s common stock, respectively, at an exercise price of $0.45 per share.
(4) Includes the Company-paid portion of health and welfare benefits.

 

Refer to Note 2 and Note 9 of the Company’s audited financial statements as included in Item 8 of this Annual Report on Form 10-K for disclosure of the various assumptions made in the valuation of stock options.

 

Employment Arrangements with our Executive Officers

 

Harrison Gross

 

On August 11, 2021, we entered into an employment agreement with Harrison Gross to serve in the capacity of the Chief Executive Officer of the Company. We agreed to pay Mr. Gross an annual base salary of $85,800 for the remainder of 2021, and we also agreed that from the initial public offering date in August 2022, we increased his base salary to $150,000 per year. Pursuant to the terms of the employment agreement, our Board may exercise its sole discretion to grant Mr. Gross an annual bonus, the amount of which bonus shall be determined in the sole discretion of our Board.

 

The employment agreement has an initial term of three years, and will terminate on the third anniversary of the effective date unless Mr. Gross and the Company agree otherwise in writing. If we terminate the employment agreement for any reason other than for cause (as such is defined in the agreement) or Mr. Gross terminates his employment for good reason (as such is defined in the agreement): (1) Mr. Gross shall be entitled to payment of his base salary for the balance of the agreement’s term; (2) if Mr. Gross elects to continue group health insurance benefits, we shall reimburse Mr. Gross for any COBRA premiums he pays for the duration of COBRA’s coverage; and, (3) we shall provide Mr. Gross with payment of all accrued amounts (as defined in the agreement).

 

64

 

 

Konrad Dabrowski

 

On August 11, 2021, we entered into an employment agreement with Konrad Dabrowski to serve as the Chief Financial Officer of the Company on a part-time basis, which agreement became effective on September 1, 2021. Mr. Dabrowski devotes 50% of his business time to our Company. We agreed to pay Mr. Dabrowski an annual base salary of $100,000. Pursuant to the terms of the employment agreement, we may exercise our discretion to grant Mr. Dabrowski an annual bonus, the amount of which bonus shall be determined in the sole discretion of the Company.

 

Following the effective date, the employment agreement shall continue, unless terminated by Mr. Dabrowski or the Company. Mr. Dabrowski’s employment is at-will, which may be terminated by the Company or by Mr. Dabrowski at any time and for any reason. Pursuant to the terms of the employment agreement, a sixty days’ written notice of termination or resignation is required. If Mr. Dabrowski notifies us of his resignation, or if we terminate Mr. Dabrowski’s employment agreement, the Company reserves the right to determine, in its sole discretion, whether Mr. Dabrowski will be required to actively work during the sixty-day notice period; however, Mr. Dabrowski will be entitled to receive his base salary for the duration of the sixty day notice period. The Company has the right to terminate Mr. Dabrowski’s employment agreement for cause (as defined in the agreement), which termination shall be effective immediately.

 

David Eric Cohen

 

David Cohen was an independent consultant for the company from inception until October 1, 2022, when we offered him a full-time letter of employment. He accepted and has been the full-time Chief Technology since then. The company pays him $140,000 annually to serve in this role. Pursuant to the terms of the employment agreement, we may exercise our discretion to grant Mr. Cohen an annual bonus, the amount of which bonus shall be determined in the sole discretion of the Company.

 

Following the effective date, the employment agreement shall continue, unless terminated by Mr. Cohen or the Company. Mr. Cohen’s employment is at-will, which may be terminated by the Company or by Mr. Cohen at any time and for any reason. Pursuant to the terms of the employment agreement, a sixty days’ written notice of termination or resignation is required. If Mr. Cohen notifies us of his resignation, or if we terminate Mr. Cohen’s employment agreement, the Company reserves the right to determine, in its sole discretion, whether Mr. Cohen will be required to actively work during the sixty-day notice period; however, Mr. Cohen will be entitled to receive his base salary for the duration of the sixty day notice period. The Company has the right to terminate Mr. Cohen’s employment agreement for cause (as defined in the agreement), which termination shall be effective immediately.

 

Compensation of Directors

 

The following table sets forth all compensation paid to our non-management Board members during the year ended December 31, 2023:

 

Name   Fees Earned
or Paid in
Cash
($)
    Stock Awards
($)
    Option Awards
($)
    Non-Equity
Incentive Plan
Compensation
($)
    Change in
Pension Value
and Nonqualified
Deferred
Compensation
Earnings
($)
    All Other
Compensation
($)
    Total
($)
 
Frank Rescigna     5,000       -       -       -       -       -       5,000  
Kristen Mclaughlin     55,000       -       20,393       -       -       -       75,393  
Louis Castro     30,000       -       35,688       -       -       -       65,688  
Olivia C. Bartlett     12,500       -       20,393       -       -       -       32,983  

 

65

 

 

Mr. Rescigna is no longer a Board member as of December 31, 2023.

 

On January 13, 2023, we granted stock options to Ms. Mclaughlin, Mr. Castro, and Ms. Bartlett to purchase 20,000, 35,000, and 20,000 shares of the Company’s common stock, respectively, at an exercise price of $1.275 per share.

 

During the year ended December 31, 2023, option awards to purchase 20,000 shares of common stock that had been previously granted to Mr. Castro in 2021, were modified to extend their expiration date from July 21, 2023 to July 21, 2024. The incremental fair value (recognized as additional stock-based compensation expense for the year ended December 31, 2023) was approximately $1,300, which is not included in the table above.

 

The total number of option awards to our non-management Board members outstanding at December 31, 2023 was 170,000 in aggregate.

 

Outstanding Equity Awards

 

The following table sets forth outstanding equity awards to our named executive officers as of December 31, 2023.

 

    Option awards   Stock awards  
Name   Number of securities underlying unexercised options
(#)
exercisable
    Number of securities underlying unexercised options
(#)
unexercisable
    Equity incentive plan awards: Number of securities underlying unexercised unearned options
(#)
    Option exercise price
($)
    Option
expiration date
  Number of shares or units of stock that have not vested
(#)
    Market value of shares of units of stock that have not vested
($)
    Equity incentive plan awards: Number of unearned shares, units or other rights that have not vested
(#)
    Equity incentive plan awards: Market or payout value of unearned shares, units or other rights that have not vested
($)
 
Harrison Gross     375,000       -       -     $ 1.00     04/01/2024     -       -       -       -  
      400,000       200,000       -     $ 3.56     05/05/2025     -       -       -       -  
      77,756       22,244       -     $ 3.56     11/11/2024     -       -       -       -  
      30,000       60,000       -     $ 1.28     01/13/2028     -       -       -       -  
      50,000       100,000       -     $ 0.45     12/18/2028     -       -       -       -  
                                                                     
Konrad Dabrowski     46,648       13,352       -     $ 3.56     11/11/2024     -       -       -       -  
      30,000       60,000       -     $ 1.28     01/13/2028     -       -       -       -  
      40,000       80,000       -     $ 0.45     12/18/2028     -       -       -       -  
                                                                     
David Eric Cohen     46,648       13,352       -     $ 3.56     12/01/2024     -       -       -       -  
      20,000       40,000       -     $ 1.28     01/13/2028     -       -       -       -  
      23,333       46,667       -     $ 0.45     12/18/2028     -       -       -       -  

 

66

 

 

Option Exercises and Stock Vested

 

There were no options exercised by our executive officers during the years ended December 31, 2023 or 2022.

 

Employee Benefit Plans

 

We currently provide health insurance coverage to our full-time W-2 employees, as well as free prescription eyeglasses to them and their immediate families. The Company also provides a complimentary gym membership to full-time staff.

 

Non-qualified Deferred Compensation

 

None of our employees participate in or have account balances in non-qualified defined contribution plans or other non-qualified deferred compensation plans maintained by us. Our Compensation Committee may elect to provide our officers and other employees with non-qualified defined contribution or other non-qualified compensation benefits in the future if it determines that doing so is in the Company’s best interest.

 

2021 Equity Incentive Plan

 

General

 

Our 2021 Equity Incentive Plan was adopted by the Board and approved by our shareholders on July 1, 2021. The general purposes of the 2021 Equity Incentive Plan are to (i) enable the Company and its subsidiaries to attract and retain the types of employees, consultants, and directors who will contribute to the Company’s long-range success; (ii) provide incentives that align the interests of employees, consultants, and directors with those of our shareholders; and (iii) promote the success of the Company’s business.

 

Description of the 2021 Equity Incentive Plan

 

The following description of the principal terms of the 2021 Equity Incentive Plan is a summary and is qualified in its entirety by the full text of the 2021 Equity Incentive Plan.

 

Administration. The 2021 Equity Incentive Plan is administered by a committee appointed by our Board, or in the Board’s discretion, by the Board (as applicable, the “Incentive Plan Administrator”). Subject to the terms of the 2021 Equity Incentive Plan, the Incentive Plan Administrator has the authority to (a) determine the eligible individuals who are to receive awards, (b) determine the terms and conditions of each award, including exercise price, vesting or performance criteria, performance period, and terms of the award, (c) determine whether vesting and performance criteria have been achieved, (d) accelerate the vesting or exercisability of, payment for or lapse of restrictions on, or otherwise modify or amend awards, (e) construe and interpret the 2021 Equity Incentive Plan, including the ability to reconcile any inconsistency in, correct any defect in and/or supply any omission in the plan and award agreement; any instrument or agreement, (f) promulgate, amend, and rescind rules and regulations relating to the administration of the 2021 Equity Incentive Plan, and (g) exercise discretion to make any and all other determinations which it determines to be necessary or advisable for the administration of the 2021 Equity Incentive Plan and awards granted thereunder. The Incentive Plan Administrator may also delegate its authority to a subcommittee or to one or more officers of the Company, subject to terms and conditions determined by the Incentive Plan Administrator. All decisions made by the Incentive Plan Administrator are final and binding on the Company and the participants.

 

Types of Awards. The 2021 Equity Incentive Plan provides for the grant of stock options, which may be incentive stock options (“ISOs”) or nonqualified stock options (“NSOs”), stock appreciation rights (“SARs”), restricted stock, restricted stock units (“RSUs”), performance share awards, and other cash-based or equity-based awards, or collectively, awards.

 

67

 

 

Share Reserve. A total equal to 20% of our issued and outstanding common stock shall be available for the grant of awards under the 2021 Equity Incentive Plan.

 

If options, stock appreciation rights, restricted stock units or any other awards are forfeited, cancelled or expire before being exercised or settled in full, the shares subject to such awards will again be available for issuance under the 2021 Equity Incentive Plan. If restricted stock or shares issued upon exercise of an option are reacquired by the Company pursuant to a forfeiture provision, repurchase right or for any other reason, then such shares will again be available for issuance under the 2021 Equity Incentive Plan. Notwithstanding the foregoing, shares applied to pay the exercise price of an option or satisfy withholding taxes related to any award will not become available for issuance under the 2021 Equity Incentive Plan.

 

Shares issued under the 2021 Equity Incentive Plan may be authorized but unissued shares or treasury shares.

 

As of December 31, 2023, awards covering 2,959,720 shares of Common Stock were outstanding, of which 1,185,000 option awards were granted by the Company prior to the approval of the Plan, 1,709,500 option awards were granted subject to the Plan, and 65,220 were RSU awards were granted subject to the Plan.

 

As of December 31, 2023, there were 992,728 shares of Common Stock available for future award grants under the Plan.

 

Incentive Stock Option Limit. No more than 25,000,000 shares of Common Stock may be issued under the 2021 Equity Incentive Plan upon the exercise of ISOs.

 

Eligibility. Employees (including officers), non-employee directors, and consultants who render services to the Company or a parent or subsidiary thereof (whether now existing or subsequently established) are eligible to receive awards under the 2021 Equity Incentive Plan. ISOs may only be granted to employees of the Company or a parent or subsidiary thereof (whether now existing or subsequently established).

 

Stock Options. A stock option is the right to purchase a certain number of shares of stock at a fixed exercise price which, pursuant to the 2021 Equity Incentive Plan, may not be less than 100% of the fair market value of Common Stock on the date of grant. Subject to limited exceptions, an option may have a term of up to 10 years and will generally expire sooner if the optionholder’s service terminates. Options will vest at the rate determined by the Incentive Plan Administrator. An optionholder may pay the exercise price of an option in cash, or, with the Incentive Plan Administrator’s consent, with shares of stock the optionholder already owns, with proceeds from an immediate sale of the option shares, through a net exercise procedure or by any other method permitted by applicable law.

 

Tax Limitations on Incentive Stock Options. The aggregate fair market value, determined at the time of grant, of the Common Stock with respect to ISOs that are exercisable for the first time by an optionholder during any calendar year under all of the Company’s stock plans may not exceed $100,000. Options or portions thereof that exceed such limit will generally be treated as NSOs. No ISO may be granted to any person who, at the time of the grant, owns or is deemed to own stock possessing more than 10% of the Company’s total combined voting power or that of any of the Company’s affiliates unless (a) the option exercise price is at least 110% of the fair market value of Common Stock on the date of grant and (b) the term of the ISO does not exceed five years from the date of grant.

 

Stock Appreciation Rights. A stock appreciation right provides the recipient with the right to the appreciation in a specified number of shares of stock. The Incentive Plan Administrator determines the exercise price of stock appreciation rights granted under the 2021 Equity Incentive Plan, which may not be less than 100% of the fair market value of Common Stock on the date of grant. A stock appreciation right may have a term of up to 10 years and will generally expire sooner if the recipient’s service terminates. SARs will vest at the rate determined by the Incentive Plan Administrator. Upon exercise of a SAR, the recipient will receive an amount in cash, stock, or a combination of stock and cash determined by the Incentive Plan Administrator, equal to the excess of the fair market value of the shares being exercised over their exercise price.

 

68

 

 

Restricted Stock Awards. Shares of restricted stock may be issued under the 2021 Equity Incentive Plan and may be subject to vesting, as determined by the Incentive Plan Administrator. Recipients of restricted stock generally have all of the rights of a shareholder with respect to those shares, including voting rights and dividends, except as provided in the award agreement.

 

Restricted Stock Units. A restricted stock unit is a right to receive a share, at no cost to the recipient, upon satisfaction of certain conditions, including vesting conditions, established by the Incentive Plan Administrator. RSUs vest at the rate determined by the Incentive Plan Administrator and any unvested RSUs will generally be forfeited upon termination of the recipient’s service. Settlement of restricted stock units may be made in the form of cash, stock or a combination of cash and stock, as provided in the award agreement and as determined by the Incentive Plan Administrator. Recipients of restricted stock units generally will have no voting or dividend rights prior to the time the vesting conditions are satisfied, and the award is settled.

 

Performance Share Award. A performance share award is a right to receive a share or share units based upon the Company’s performance during a specified performance period, as determined by the Incentive Plan Administrator. The Incentive Plan Administrator has the discretion to determine: (i) the number of shares or stock-denominated units subject to a Performance Share Award granted to any recipient; (ii) the performance period applicable to any award; (iii) the conditions that must be satisfied for a recipient to earn an award; and (iv) the other terms, conditions and restrictions of the award.

 

Cash Awards and Other Equity-Based Awards. The Incentive Plan Administrator may grant cash awards and other awards based in whole or in part by reference to Common Stock, either alone or in tandem with other awards. The Incentive Plan Administrator will determine the terms and conditions of any such awards.

 

Changes to Capital Structure. In the event of certain changes in capitalization, including a stock split, reverse stock split, stock dividend, or an extraordinary corporate transaction such as any recapitalization, reorganization, merger, consolidation, combination, or exchange, proportionate adjustments will be made in the number and kind of shares available for issuance under the 2021 Equity Incentive Plan, the limit on the number of shares that may be issued under the 2021 Equity Incentive Plan as ISOs, the number and kind of shares subject to each outstanding award and/or the exercise price of each outstanding award.

 

Change in Control. If the Company is party to certain change in control transactions, each outstanding award will be treated as the Incentive Plan Administrator determines, which may include the continuation, assumption or substitution of an outstanding award, the cancellation of an outstanding award after an opportunity to exercise or the cancellation of an outstanding award in exchange for a payment equal to the value of the shares subject to such award less any applicable exercise price.

 

Transferability of Awards. Unless the Incentive Plan Administrator determines otherwise, an award generally will not be transferable other than by beneficiary designation, a will or the laws of descent and distribution. The Incentive Plan Administrator may permit transfer of an award in a manner consistent with applicable law.

 

Amendment and Termination. The Board may amend or terminate the 2021 Equity Incentive Plan at any time. Any such amendment or termination will not affect outstanding awards. If not sooner terminated, the 2021 Equity Incentive Plan will automatically terminate 10 years after its adoption by the Board. Shareholder approval is not required for any amendment of the 2021 Equity Incentive Plan, unless required by applicable law, government regulation or exchange listing standards.

 

69

 

 

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

 

Based solely upon information made available to us, the following table sets forth information as of March 22, 2024, regarding the beneficial ownership of our common stock:

 

each person known by us to be the beneficial owner of more than 5% of our outstanding shares of common stock;

 

each of our named executive officers and directors; and

 

all our executive officers and directors as a group.

 

The address of each holder listed in the following table, except as otherwise indicated, is 11900 Biscayne Blvd., Suite 630, North Miami, Florida, 33181.

 

Percentage ownership shown in the following table is based on 12,917,239 shares of our common stock outstanding.

 

Name of Beneficial Owner   Shares of
Common Stock
Beneficially
Owned
(1)
    Percent of
Common Stock
Beneficially
Owned
 
Named Executive Officers and Directors                
Harrison Gross(2)     1,226,641       8.67 %
Konrad Dabrowski(3)     194,978       1.49 %
David Eric Cohen(4)     141,645       1.08 %
Kristen McLaughlin(5)     31,667       * %
Louis Castro(6)     56,667       * %
Olivia Bartlett(7)     31,667       * %
All directors and executive officers as a group (6 persons)     1,683,265       11.53 %
5% Stockholders                
Lucyd Ltd.(8)     5,189,085       40.17 %

 

 
* Less than 1%.
(1) We have determined beneficial ownership in accordance with Rule 13d-3 under the Securities Exchange Act of 1934, as amended, which is generally determined by voting power and/or dispositive power with respect to securities. Unless otherwise noted, the shares of common stock listed above are owned as of the date of this 10-K, and are owned of record by each individual named as beneficial owner and such individual has sole voting and dispositive power with respect to the shares of common stock owned by each of them.
(2) Includes 1,226,641 shares of common stock issuable upon exercise of stock options held by Mr. Gross exercisable within 60 days of the date of this 10-K.
(3) Includes 194,978 shares of common stock issuable upon exercise of stock options held by Mr. Dabrowski exercisable within 60 days of the date of this 10-K.
(4) Includes 141,645 shares of common stock issuable upon exercise of stock options held by Mr. Cohen exercisable within 60 days of the date of this 10-K.
(5) Includes 31,667 shares of common stock issuable upon exercise of stock options held by Ms. McLaughlin exercisable within 60 days of the date of this 10-K.
(6) Includes 56,667 shares of common stock issuable upon exercise of stock options held by Mr. Castro exercisable within 60 days of the date of this 10-K.
(7) Includes 31,667 shares of common stock issuable upon exercise of stock options held by Ms. Bartlett exercisable within 60 days of the date of this 10-K.
(8) Tekcapital plc, a public company listed on the London Stock Exchange, owns all issued and outstanding securities of Tekcapital Europe Ltd., which owns all issued and outstanding securities of Lucyd Ltd. As such, Tekcapital plc may be deemed to beneficially own the shares held by Lucyd Ltd. by virtue of their control over Lucyd Ltd. Tekcapital plc disclaims beneficial ownership of the shares held by Lucyd Ltd. Mr. Clifford Gross, the Chief Executive Officer of Tekcapital plc, is the father of Mr. Harrison Gross, our Chief Executive Officer.

 

70

 

 

Item 13. Certain Relationships and Related Transactions, and Director Independence.

 

On occasion we may engage in certain related party transactions. All prior related party transactions were approved by our Board of Directors and a majority of our issued and outstanding shares of capital stock. Our policy is that all related party transactions will be reviewed and approved by the Audit Committee of our Board of Directors prior to our entering into any related party transactions.

 

License Agreement

 

On April 1, 2020, we entered into an exclusive, worldwide license agreement with Lucyd Ltd., the largest stockholder of the Company, for the use of the Lucyd brand, and the associated intellectual property and assets (the “License Agreement”). The License Agreement is royalty-free, fully paid up, and perpetual license for the exclusive use of certain assets of Lucyd Ltd. related to Innovative Eyewear current products and trademarks. As compensation for entrance into the License Agreement, we issued Lucyd Ltd. 3,750,000 shares of our common stock. On October 5, 2021, the parties to the License Agreement executed an Addendum, to the exclusive license agreement, which clarified that Innovative Eyewear shall commercialize, continue with any on-going intellectual property prosecutions and pay all maintenance or other patent fees (the “Addendum”). For all new intellectual property, Innovative Eyewear will own control it and be responsible for all prosecution and maintenance costs. The Addendum also confirms that Innovative Eyewear issued Lucyd Ltd. 3,750,000 shares of its common stock as consideration for the license. Please see “Business — Material Agreements” for a more complete description of the License Agreement and Addendum.

 

Management Service Agreement

 

On June 1, 2020, we entered into a management service agreement with Tekcapital Europe Ltd., an affiliate of our largest stockholder, Lucyd Ltd., whose Chief Executive Officer is the father of our Chief Executive Officer, pursuant to which we agreed to pay Tekcapital Europe Ltd. $25,000 per fiscal quarter for rent-free office space, utilities, advisory services, and any other services in accordance with Tekcapital Europe Ltd.’s areas of expertise. The management agreement provided for a perpetual term, with the right of either party to terminate for any reason with 30 days’ notice.

 

Effective February 1, 2022, the original management service agreement was amended to have us billed at $35,000 quarterly for advisory and other services, and in addition, Tekcapital Europe Ltd. began to bill us for an allocation of rent paid by Tekcapital Europe Ltd. on our behalf.

 

We incurred $140,000 during each of the years ended December 31, 2023 and 2022 under our management services agreement with Tekcapital Europe Ltd.; we also recognized $91,672 and $74,442 of rent expense for the years ended December 31, 2023 and 2022, respectively.

 

Convertible Note Financing

 

On December 1, 2020, we issued a convertible note for an aggregate principal amount of up to $2,000,000 to Lucyd Ltd., the largest stockholder of the Company (the “Note”).

 

On June 1, 2021, we completed the partial conversion of an aggregate of $778,500 of the outstanding balance on the Note, at $1.00 per share, into an aggregate of 778,500 shares of common stock. On September 5, 2021, we completed the partial conversion of an aggregate of $500,002 of the outstanding balance on the Note, at $3.56 per share, into an aggregate of 140,449 shares of common stock.

 

On November 1, 2021, we executed an amended and restated Note, increasing the amount of available financing from $2,000,000 to $3,000,000. On November 16, 2021, we completed the partial conversion of an aggregate of $901,271 of the outstanding balance of the Note, at $3.56 per share, into an aggregate of 253,166 shares of common stock. As of December 31, 2021, $289,029 remained outstanding on the Note.

 

71

 

 

On August 15, 2022, in connection with our initial public offering, we completed the partial conversion of an aggregate of $2,002,280 of the outstanding balance of the Note, at $7.50 per share, into an aggregate of 266,970 shares of common stock. As of December 31, 2022, $61,356 remained outstanding on the Note.

 

In January 2023, we borrowed an additional $48,143 under such convertible notes, and subsequently repaid the outstanding balance of the Note in full in February 2023. No further amounts were borrowed under the Note, and the Note matured on December 1, 2023 with no amounts outstanding.

 

The Note was unsecured, had an interest rate of 10.0% per annum, and provided for conversion (including both principal and accrued but unpaid interest) into our common stock at the election of Lucyd Ltd. upon certain equity financing events (as defined in the Note) or the holder determining to convert the Note. The Note could be converted by the holder using the price of either (i) the per share purchase price paid for by investors under the terms of recent equity financing, (ii) the closing price of our trading shares on the relevant public exchange for the day immediately preceding the date of conversion of the Note, or (iii) the valuation of the last equity investment.

 

Intercompany Loan

 

On January 11, 2024, we entered into an intercompany loan agreement (as lender) with Tekcapital Europe Ltd. (as borrower), an affiliate of our largest stockholder, Lucyd Ltd., whose Chief Executive Officer is the father of our Chief Executive Officer, and Tekcapital Plc, the parent of Tekcapital Europe Ltd. Pursuant to this agreement, we loaned 600,000 British pounds sterling to Tekcapital Europe Ltd. The loan bears simple interest at a rate of 10% per annum and is required to be repaid on or before April 11, 2024. Tekcapital Plc executed the agreement as guarantor for Tekcapital Europe Ltd. on the full amount of the loan. Tekcapital Europe Ltd. repaid the loan in full in March 2024.

 

Employment Agreements

 

See “Item 11. Executive Compensation” regarding the employment agreements with Harrison Gross and Konrad Dabrowski.

 

Statement of Policy

 

All future transactions between us and our officers, directors, or five percent stockholders, and respective affiliates will be on terms no less favorable than could be obtained from unaffiliated third parties and will be approved by a majority of our independent directors who do not have an interest in the transactions and who had access, at our expense, to our legal counsel or independent legal counsel.

 

To the best of our knowledge, during the past three fiscal years, other than as set forth above, there were no material transactions, or series of similar transactions, or any currently proposed transactions, or series of similar transactions, to which we were or are to be a party, in which the amount involved exceeds the lesser of $120,000 or one percent of the average of our total assets at year-end for the last two completed financial years, and in which any director or executive officer, or any security holder who is known by us to own of record or beneficially more than 5% of any class of our common stock, or any member of the immediate family of any of the foregoing persons, has an interest (other than compensation to our officers and directors in the ordinary course of business).

 

72

 

 

Item 14. Principal Accounting Fees and Services.

 

Audit Fees

 

The aggregate fees billed for professional services rendered by our Independent Registered Public Accounting Firm, Cherry Bekaert LLP, for the audit of our annual financial statements, review of our consolidated financial statements included in our quarterly reports, and other fees that are normally provided by the accounting firm in connection with statutory and regulatory filings or engagements for the years ended December 31, 2023 and December 31, 2022 were approximately $117,600 and $88,000, respectively.

 

Audit-Related Fees

 

There were approximately $58,700 of fees billed by our Independent Registered Public Accounting Firm for audit-related services for the fiscal year ended December 31, 2022, which included consent and comfort letter procedures related to our Form S-1filings, initial public offering, and due diligence procedures. There were no fees billed by our Independent Registered Public Accounting Firm for audit-related services for the fiscal year ended December 31, 2023.

 

Tax Fees

 

There were no fees billed for professional services rendered by our Independent Registered Public Accounting Firm for tax compliance, tax advice, and tax planning for the fiscal years ended December 31, 2023 and 2022.

 

All Other Fees

 

There were no fees billed for non-audit services by our Independent Registered Public Accounting Firm for the fiscal years ended December 31, 2023 and 2022.

 

Audit Committee Determination

 

The Audit Committee considered and determined that the services performed are compatible with maintaining the independence of the independent registered public accounting firm.

 

Policy on Audit Committee Pre-Approval of Audit and Permissible Non-Audit Services of Independent Auditor

 

The Audit Committee is responsible for pre-approving all audit and permitted non-audit services to be performed for us by our Independent Registered Public Accounting Firm as outlined in its Audit Committee charter. Prior to engagement of the Independent Registered Public Accounting Firm for each year’s audit, management or the Independent Registered Public Accounting Firm submits to the Audit Committee for approval an aggregate request of services expected to be rendered during the year, which the Audit Committee pre-approves. During the year, circumstances may arise when it may become necessary to engage the Independent Registered Public Accounting Firm for additional services not contemplated in the original pre-approval. In those circumstances, the Audit Committee requires specific pre-approval before engaging the Independent Registered Public Accounting Firm. The engagements of our Independent Registered Public Accounting Firm were approved by the Company’s Audit Committee.

 

73

 

 

PART IV

 

Item 15. Exhibits, Financial Statement Schedules.

 

(a)(1)(2) Financial Statement Schedules

 

See accompanying “Index to Consolidated Financial Statements.”

 

(b) Exhibits

 

Exhibit No.   Description
1.1*   Underwriting Agreement by and among Innovative Eyewear, Inc. and Maxim Group LLC, as representative of the several underwriters, dated August 14, 2022, (Incorporated by reference to Exhibit 1.1 to the Current Report on Form 8-K (File No. 001-41392) filed with the Securities and Exchange Commission August 18, 2022)
3.1*   Second Amended and Restated Articles of Incorporation of Innovative Eyewear, Inc., (Incorporated by reference to Exhibit 3.1 to the Amended Registration Statement filed on Form S-1/A 1 (File No. 333-261616) filed with the Securities and Exchange Commission on January 10, 2022)
3.2*   Amended and Restated Bylaws of innovative Eyewear, Inc., (Incorporated by reference to Exhibit 3.1 to the Amended Registration Statement filed on Form S-1/A 1 (File No. 333-261616) filed with the Securities and Exchange Commission on January 10, 2022)
4.1*   Form of Representative’s Warrant Agreement (Incorporated by reference to Exhibit 4.1 to the Amended Registration Statement filed on Form S-1/A 2 (File No. 333-261616) filed with the Securities Exchange Commission January 20, 2022)
4.2*   Representative’s Warrant issued to Maxim Group LLC., dated August 17, 2022, (Incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K (File No. 001-41392) filed with the Securities and Exchange Commission August 18, 2022)
4.3*   Form of Common Stock Purchase Warrant, (Incorporated by reference to Exhibit 4.2 to the Amended Registration Statement filed on Form S-1/A 2 (File No. 333-261616) filed with the Securities Exchange Commission January 20, 2022)
4.4*   Form of Warrant (incorporated by reference to Exhibit 4.6 to the Registration Statement on Form S-1 (File No. 333-272737) filed with the SEC on June 16, 2023)
4.5*   Form of Placement Agent Warrant (incorporated by reference to Exhibit 4.7 to the Registration Statement on Form S-1 (File No. 333-272737) filed with the SEC on June 16, 2023)
4.6*   Form of Warrant Agency Agreement (incorporated by reference to Exhibit 4.8 to the Registration Statement on Form S-1 (File No. 333-272737) filed with the SEC on June 16, 2023)
4.7   Description of Securities
10.1*   License Agreement between Innovative Eyewear, Inc. and Lucyd Ltd., dated April 1, 2020, (Incorporated by reference to Exhibit 10.1 to the Registration Statement filed on Form S-1 (File No. 333-261616) filed with the Securities and Exchange Commission on January 10, 2022)
10.2*   Addendum to License Agreement between Innovative Eyewear, Inc. and Lucyd Ltd., dated December 7, 2021, (Incorporated by reference to Exhibit 10.2 to the Registration Statement filed on Form S-1 (File No. 333-261616) filed with the Securities and Exchange Commission on January 10, 2022)
10.3   Management Agreement between Innovative Eyewear, Inc. and Tekcapital Europe Ltd., dated June 1, 2020, (Incorporated by reference to Exhibit 10.3 to the Registration Statement filed on Form S-1 (File No. 333-261616) filed with the Securities and Exchange Commission on January 10, 2022)
10.7*   Employment Agreement by and between Innovative Eyewear, Inc. and Harrison Gross, dated August 11, 2021, (Incorporated by reference to Exhibit 10.6 to the Registration Statement filed on Form S-1 (File No. 333-261616) filed with the Securities and Exchange Commission on January 10, 2022)
10.8*   Employment Agreement by and between Innovative Eyewear, Inc. and Konrad Dabrowski, dated August 11, 2021, (Incorporated by reference to Exhibit 10.7 to the Registration Statement filed on Form S-1 (File No. 333-261616) filed with the Securities and Exchange Commission on January 10, 2022)

 

74

 

 

10.9*   Innovative Eyewear, Inc., 2021 Equity Incentive Plan, (Incorporated by reference to Exhibit 10.10 to the Registration Statement filed on Form S-1 (File No. 333-261616) filed with the Securities and Exchange Commission on January 10, 2022)
10.10*   Sales Representation Agreement by and between Innovative Eyewear, Inc. and D. Landstrom Associates, Inc., dated March 4, 2021, (Incorporated by reference to Exhibit 10.11 to the Registration Statement filed on Form S-1 (File No. 333-261616) filed with the Securities and Exchange Commission on January 10, 2022)
14.1*   Form of Code of Ethics of innovative Eyewear, Inc. (Incorporated by reference to Exhibit 14.1 to the Registration Statement filed on Form S-1 (File No. 333-261616) filed with the Securities and Exchange Commission on January 10, 2022)
19.1   Insider trading policy
23.1   Consent of Cherry Bekaert LLP, Independent Registered Public Accounting Firm
24.1   Power of Attorney
31.1   Certification of Principle Executive Officer Pursuant to Securities Exchange Act Rules 13A-14(A)and 15D-14(A)
31.2   Certification of Principle Financial Officer Pursuant to Securities Exchange Act Rules 13A-14(A)and 15D-14(A)
32.1   Certification of Principle Executive Officer Pursuant to 18 U.S.C. Section 1350
32.2   Certification of Principle Financial Officer Pursuant to 18 U.S.C. Section 1350
97.1   Innovative Eyewear, Inc., Executive Compensation Clawback Policy
101.ins   XBRL Instance Document
101.sch   XBRL Taxonomy Extension Schema Document
101.cal   XBRL Taxonomy Calculation Linkbase Document
101.def   XBRL Taxonomy Definition Linkbase Document
101.lab   XBRL Taxonomy Label Linkbase Document
101.pre   XRL Taxonomy Presentation Linkbase Document

 

 
* Previously filed

 

Item 16. Form 10-K Summary.

 

The Company has elected not to include a summary pursuant to this Item 16.

 

75

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Innovative Eyewear, Inc.
     
  By: /s/ Harrison Gross
    Harrison Gross
March 25, 2024   Chief Executive Officer

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the date indicated.

 

  By: /s/ Harrison Gross
    Harrison Gross
    Chief Executive Officer and Director
March 25, 2024   (Principal Executive Officer)
     
  By: /s/ Konrad Dabrowski
    Konrad Dabrowski
    Chief Financial Officer
March 25, 2024   (Principal Financial and Accounting Officer)
     
  By: /s/ Kristen McLaughlin
    Kristen McLaughlin
March 25, 2024   Director
     
  By: /s/ Louis Castro
    Louis Castro
March 25, 2024   Director
     
  By: /s/ Olivia C. Bartlett
    Olivia C. Bartlett
March 25, 2024   Director

 

76

 

 

 

Report of Independent Registered Public Accounting Firm

 

To the Board of Directors and Stockholders

Innovative Eyewear, Inc.

Miami, Florida

 

Opinion on the Financial Statements

We have audited the accompanying balance sheets of Innovative Eyewear, Inc. (the “Company”) as of December 31, 2023 and 2022, and the related statements of operations, stockholders’ equity, and cash flows for each of the years then ended and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the years then ended in conformity with accounting principles generally accepted in the United States of America.

 

Emphasis of Matter

The accompanying financial statements have been prepared assuming the Company will continue as a going concern. As more fully described in Note 3 to the financial statements, the Company has incurred losses and negative cash flows from operations. Management’s plans regarding liquidity matters are also described in Note 3. Our opinion is not modified with respect to this matter.

 

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

 

We have served as the Company’s auditor since 2021.

 

Tampa, Florida

March 25, 2024

 

 

 

 

 

cbh.com

 

F-1

 

 

INNOVATIVE EYEWEAR, INC.

BALANCE SHEETS

December 31, 2023 and 2022

 

                 
    2023     2022  
TOTAL ASSETS                
Current Assets                
Cash and cash equivalents   $ 4,287,447     $ 3,591,109  
Accounts receivable, net of allowances of $25,772 and $92,646, respectively     93,211       110,258  
Prepaid expenses     313,648       210,673  
Inventory prepayment     323,520       197,750  
Inventory     533,239       94,701  
Due from Tekcapital and Affiliates     6,256       -  
Other current assets     59,447       36,240  
Total Current Assets     5,616,768       4,240,731  
                 
Non-Current Assets                
Patent costs, net     286,429       137,557  
Capitalized software costs     110,073       110,073  
Property and equipment, net     132,848       119,744  
Other non-current assets     72,644       81,779  
TOTAL ASSETS   $ 6,218,762     $ 4,689,884  
                 
LIABILITIES AND STOCKHOLDERS’ EQUITY                
Liabilities                
Current Liabilities                
Accounts payable and accrued expenses   $ 581,986     $ 275,660  
Deferred revenue     42,500       30,000  
Due to Tekcapital and Affiliates     -       232,989  
Related party convertible debt     -       61,356  
Total Current Liabilities     624,486       600,005  
                 
Non-Current Liabilities                
Deferred revenue     35,450       65,450  
TOTAL LIABILITIES     659,936       665,455  
                 
Commitments and contingencies (Note 7)     -       -  
                 
Stockholders’ Equity                
Common stock (par value $0.00001, 50,000,000 shares authorized, and 12,917,239 and 7,307,157 shares issued and outstanding as of December 31, 2023 and 2022, respectively)     129       73  
Additional paid-in capital     22,528,112       14,330,343  
Accumulated deficit     (16,969,415 )     (10,305,987 )
TOTAL STOCKHOLDERS’ EQUITY     5,558,826       4,024,429  
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY   $ 6,218,762     $ 4,689,884  

 

See accompanying Notes to the Financial Statements.

 

F-2

 

 

INNOVATIVE EYEWEAR, INC.

STATEMENTS OF OPERATIONS

For the years ended December 31, 2023 and 2022

 

                 
    Year Ended
December 31,
 
    2023     2022  
Revenues, net   $ 1,152,479     $ 659,788  
Less: Cost of Goods Sold     (1,271,808 )     (716,077 )
Gross Deficit     (119,329 )     (56,289 )
                 
Operating Expenses:                
General and administrative     (3,886,960 )     (2,796,669 )
Sales and marketing     (2,047,069 )     (2,059,012 )
Research and development     (662,184 )     (524,692 )
Related party management fee     (140,000 )     (140,000 )
Total Operating Expenses     (6,736,213 )     (5,520,373 )
                 
Other Income (Expense)     195,150       -  
Interest Expense     (3,036 )     (105,171 )
Total Other Income (Expense), net     192,114       (105,171 )
                 
Net Loss   $ (6,663,428 )   $ (5,681,833 )
                 
Weighted average number of shares outstanding     10,515,995       6,528,959  
Loss per share, basic and diluted   $ (0.63 )   $ (0.87 )

 

See accompanying Notes to the Financial Statements.

 

F-3

 

 

INNOVATIVE EYEWEAR, INC.

STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

For the years ended December 31, 2023 and 2022

 

                                                 
    Common Stock     Additional
Paid In
    Stock
Subscription
    Accumulated     Total
Stockholders’
 
    # Shares     Amount     Capital     Receivable     Deficit     Equity  
Balances as of January 1, 2023     7,307,157     $ 73     $ 14,330,343     $ -     $ (10,305,987 )   $ 4,024,429  
                                                 
Exercises of stock options     230,362       2       17,648       -       -       17,650  
Exercises of warrants by stockholders (see Note 8)     729,720       7       2,736,443       -       -       2,736,450  
Second public offering (see Note 8)     4,500,000       45       4,115,643       -       -       4,115,688  
Exercises of warrants related to private placement transaction (see Note 8)     150,000       2       391,266       -       -       391,268  
Stock-based compensation (see Note 9)     -       -       936,769       -       -       936,769  
Net loss     -       -       -       -       (6,663,428 )     (6,663,428 )
Balances as of December 31, 2023     12,917,239     $ 129     $ 22,528,112     $ -     $ (16,969,415 )   $ 5,558,826  
                                                 
Balances as of January 1, 2022     6,060,187     $ 60     $ 4,842,836     $ (11,226 )   $ (4,624,154 )   $ 207,516  
                                                 
Collection of stock subscription receivable     -       -       -       6,684       -       6,684  
Write-off of uncollectible stock subscription receivable     -       -       (4,542 )     4,542       -       -  
Initial public offering (see Note 8)     980,000       10       6,015,908       -       -       6,015,918  
Shares issued for conversion of related party convertible note (see Note 6)     266,970       3       2,002,277       -       -       2,002,280  
Stock-based compensation (see Note 9)     -       -       1,473,864       -       -       1,473,864  
Net loss     -       -       -       -       (5,681,833 )     (5,681,833 )
Balances as of December 31, 2022     7,307,157     $ 73     $ 14,330,343     $ -     $ (10,305,987 )   $ 4,024,429  

 

See accompanying Notes to the Financial Statements.

 

F-4

 

 

INNOVATIVE EYEWEAR, INC.

STATEMENTS OF CASH FLOWS

For the years ended December 31, 2023 and 2022

 

                 
    2023     2022  
Operating Activities                
Net Loss   $ (6,663,428 )   $ (5,681,833 )
Adjustments to reconcile net loss to net cash used in operating activities:                
Depreciation     61,093       22,101  
Amortization     24,164       10,466  
Non-cash interest expense     3,036       105,171  
Stock-based compensation expense     936,769       1,473,864  
Expenses paid by Tekcapital and Affiliates     299,061       960,362  
(Recovery of) provision for doubtful accounts     (14,725 )     116,230  
Realized gain on debt securities (U.S. Treasury bills)     (50,796 )     -  
Loss on sale of assets     2,316       -  
                 
Changes in operating assets and liabilities:                
Accounts receivable     (3,678 )     (183,094 )
Accounts payable and accrued expenses     303,290       67,951  
Prepaid expenses     (102,975 )     (142,292 )
Inventory     (564,308 )     47,765  
Other current assets     -       1,460  
Contract assets and liabilities     3,878       (22,569 )
Net cash flows from operating activities     (5,766,303 )     (3,224,418 )
                 
Investing Activities                
Purchases of debt securities (U.S. Treasury bills)     (1,949,204 )     -  
Proceeds from redemption of debt securities (U.S. Treasury bills)     2,000,000       -  
Patent costs     (173,036 )     (60,717 )
Purchases of property and equipment     (78,463 )     (121,561 )
Proceeds from sale of property and equipment     1,950       -  
Capitalized software expenditures     -       (37,673 )
Net cash flows from investing activities     (198,753 )     (219,951 )
                 
Financing Activities                
Proceeds from initial public offering (see Note 8)     -       6,127,067  
Proceeds from second public offering (see Note 8)     4,115,688       -  
Proceeds from exercises of warrants (see Note 8)     3,127,718       -  
Proceeds from exercise of stock options     17,650       -  
Collection of stock subscription receivable     -       6,684  
Proceeds from related party convertible debt (see Note 6)     -       1,475,000  
Repayment of related party convertible debt (see Note 6)     (109,499 )     (653,000 )
Repayment of amounts due to Tekcapital and Affiliates     (490,163 )     -  
Net cash flows from financing activities     6,661,394       6,955,751  
                 
Net Change In Cash     696,338       3,511,382  
Cash at Beginning of Year   $ 3,591,109     $ 79,727  
Cash at End of Year   $ 4,287,447     $ 3,591,109  
                 
Significant Non-Cash Transactions                
Expenses paid for by Tekcapital and Affiliates, reported as increase in Due to/from Tekcapital and Affiliates and related party convertible debt     299,061       960,362  
Write-off of uncollectible stock subscription receivable     -       (4,542 )
Issuance of shares from conversion of related party convertible debt     -       2,002,280  

 

See accompanying Notes to the Financial Statements.

 

F-5

 

 

INNOVATIVE EYEWEAR, INC.

NOTES TO THE FINANCIAL STATEMENTS

December 31, 2023 and 2022

 

NOTE 1 – GENERAL INFORMATION

 

Innovative Eyewear, Inc. (the “Company,” “us,” “we,” or “our”) is a corporation organized under the laws of the State of Florida that develops and sells cutting-edge eyeglasses and sunglasses, which are designed to allow our customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. The Company was founded by Lucyd Ltd., a portfolio company of Tekcapital Plc through Tekcapital Europe, Ltd. (collectively, together with Lucyd Ltd., “Tekcapital and Affiliates”), which owned approximately 40% of our issued and outstanding shares of common stock and was our largest stockholder as of December 31, 2023. Innovative Eyewear licensed the exclusive rights to the Lucyd® brand from Lucyd Ltd., which includes the exclusive use of all of Lucyd’s intellectual property, including our main product, Lucyd Lyte® glasses.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and in accordance with the accounting rules under Regulation S-X, as promulgated by the Securities and Exchange Commission (“SEC”). In the opinion of management, all adjustments considered necessary for the fair presentation of the financial statements for the years presented have been included. The results of operations for the years ended December 31, 2023 and 2022 are not necessarily indicative of the results to be expected for future periods.

 

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates, particularly given the significant uncertainties associated with the current geopolitical and economic environment.

 

Cash Equivalents

All highly liquid investments with original maturities of three months or less, including money market funds, certificates of deposit, and U.S. Treasury bills purchased three months or less from maturity, are considered cash equivalents.

 

Receivables and Credit Policy

Trade receivables from customers are uncollateralized customer obligations due under normal trade terms. For direct-to-consumer sales, payment is required before product is shipped. Trade receivables are stated at the amount billed to the customer. Payments of trade receivables are allocated to the specific invoices identified on the customer’s remittance advice or, if unspecified, are applied to the earliest unpaid invoice. The Company, by policy, routinely assesses the financial strength of its customers. To comply with industry standards, we offer “net 30” payments on wholesale orders of $1,500 or more. For wholesale orders, to acquire an order on net 30 terms, the customer is provided a credit check application as well as a credit card authorization form. The authorization form explicitly states when and for much we will bill the customer via credit card.

 

Accounts receivable are reported net of the allowance for doubtful accounts. The allowance for doubtful accounts is determined based upon a variety of judgments and factors. Factors considered in determining the allowance include historical collection, write-off experience, and management’s assessment of collectibility from customers, including current conditions, reasonable forecasts, and expectations of future collectibility and collection efforts. Management continuously assesses the collectibility of receivables and adjusts estimates based on actual experience and future expectations based on economic indicators. Receivable balances are written-off against the allowance when such balances are deemed to be uncollectible. The Company recognized bad debt expense of $30,275 and $116,230 for the years ended December 31, 2023 and 2022, respectively.

 

F-6

 

 

A roll forward of the allowance for doubtful accounts for the year ended December 31, 2023 is as follows:

 

         
Balance at December 31, 2022   $ 92,646  
Bad debt expense     30,275  
Write-offs(1)     (52,149 )
Recoveries(1)     (45,000 )
Balance at December 31, 2023   $ 25,772  

 

 
(1) During the year ended December 31, 2023, the Company entered into a settlement agreement with a former wholesale customer. As a result of this settlement, $47,646 of accounts receivable were written-off as uncollectible, while the $45,000 collected under the settlement agreement was reflected as a gain within general and administrative expenses in the statement of operations.

 

Inventory

Our inventory includes purchased eyewear and is stated at the lower of cost or net realizable value, with cost determined on a specific identification method of inventory costing which attaches the actual cost to an identifiable unit of product. Provisions for excess, obsolete, or slow-moving inventory are recorded after periodic evaluation of historical sales, current economic trends, forecasted sales, estimated product life cycles, and estimated inventory levels. No provisions were determined as needed as of December 31, 2023 and 2022.

 

As of December 31, 2023 and 2022, the Company recorded an inventory prepayment in the amount of $323,520 and $197,750, respectively, related to down payment on eyewear purchased from the manufacturer, prior to shipment of the product that occurred after the respective balance sheet dates.

 

Intangible Assets

Intangible assets relate to patent costs received in conjunction with the initial capitalization of the Company and internally developed utility and design patents. The Company amortizes these assets over the estimated useful life of the patents. The Company reviews its intangible assets for impairment whenever changes in circumstances indicate that the carrying amount of the assets may not be recoverable.

 

Capitalized Software

The Company has incurred software development costs related to development of the Vyrb app, and has capitalized these costs in accordance with Accounting Standards Codification (“ASC”) 985-20, “Software – Costs of Software to be Sold, Leased, or Marketed,” considering it is the Company’s intention to market and sell the software externally. Planning, designing, coding, and testing occurred necessary to meet Vyrb’s design specifications; as such, all coding, development, and testing costs incurred subsequent to establishing technical feasibility were capitalized.

 

We launched an open beta version of the Vyrb application (for both iOS and Android) in December 2021 as the Company’s first social media platform, demonstrating the functionality of the software. The app has had several new features introduced in 2023, including live audio chatrooms for users of the Company’s smart eyewear, and offers market-leading audio accessibility features for social media, including the ability to create and listen to a feed of audio content completely hands-free, using unique voice assistant commands created for the app. The Company plans to continue to develop the expansive Vyrb platform into a feature-rich social toolbox for its customers. This includes the introduction of revenue-generating features such as native ads and in-app upgrades, as well as gamification features such as a points and rewards system.

 

However, as the Company diverted most of its software development resources in 2023 to the development and launch of the Lucyd app (which provides groundbreaking Generative AI features to our smart eyewear), the revenue-generating features for the Vyrb app were delayed, and are now planned to launch in 2024. Amortization of the capitalized software costs related to the Vyrb app will begin once revenue-generating operations associated with the software have commenced. No software development costs have been capitalized with respect to the Lucyd app.

 

F-7

 

 

Property and Equipment

Property and equipment are depreciated using the straight-line method over the estimated useful lives or lease terms if shorter. Depreciation expense for the years ended December 31, 2023 and 2022 was $61,093 and $22,101, respectively. For income tax purposes, accelerated depreciation methods are generally used. Repair and maintenance costs are expensed as incurred.

 

                     
    December 31,     December 31,     Estimated
Useful Lives
 
Property & Equipment   2023     2022     (in Years)  
Mobile Kiosk Display   $ 127,333     $ 63,395     3 years  
Computer Equipment     44,901       44,901     3 Years  
Office Equipment     10,291       17,273     3 Years  
Internal-Use Software     31,300       16,775     3 to 5 Years  
Property and equipment, gross     213,825       142,343        
Less: Accumulated depreciation     (80,977 )     (22,599 )      
Property and equipment, net   $ 132,848     $ 119,744        

 

Income Taxes

The Company accounts for income taxes under an asset and liability approach that recognizes deferred tax assets and liabilities based on the difference between the financial statement carrying amounts and the tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.

 

The Company follows a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken, or expected to be taken, in a tax return. Any interest and penalties accrued related to uncertain tax positions are recorded in tax expense.

 

The Company assesses the realizability of its net deferred tax assets on an annual basis. If, after considering all relevant positive and negative evidence, it is more likely than not that some portion or all of the net deferred tax assets will not be realized, the Company will reduce the net deferred tax assets by a valuation allowance. The realization of net deferred tax assets is dependent on several factors, including the generation of sufficient taxable income prior to the expiration of net operating loss carryforwards.

 

Fair Value of Financial Instruments

For certain of the Company’s financial instruments, including cash, cash equivalents, accounts receivable, accounts payable, and cash advances provided by Tekcapital and Affiliates, the carrying amounts approximate fair value due to the short-term maturities of these instruments.

 

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents, and accounts receivable. The Company limits its credit risk with respect to cash by maintaining cash and cash equivalent balances with high quality financial institutions. At times, the Company’s cash balances may exceed federally insured limits. Concentrations of credit risk with respect to accounts receivable are generally considered minimal due to collection history. However, as of December 31, 2023, $77,950 or approximately 50% of the Company’s gross accounts receivable balance was related to a single customer under a long-term instalment arrangement; the Company manages its risk related to this counterparty via other contractual arrangements with such counterparty, and incentivization through stock-based compensation.

 

F-8

 

 

Stock-Based Compensation

The Company accounts for stock-based compensation to employees and directors and others in accordance with FASB ASC Topic 718, which requires that compensation expense be recognized in the financial statements for stock-based awards based on the grant date fair value. Forfeitures are accounted for as a reduction of compensation expense in the period when such forfeitures occur.

 

For stock option awards, the Black-Scholes-Merton option pricing model was used to estimate the fair value of share-based awards. The Black-Scholes-Merton option pricing model incorporates various and highly subjective assumptions, including expected term and share price volatility.

 

The expected term of the stock options was estimated based on the simplified method as allowed by Staff Accounting Bulletin 107 (SAB 107).

 

The share price volatility at the grant date is estimated using historical stock prices based upon the expected term of the options granted, using stock prices of comparably profiled public companies.

 

The risk-free interest rate assumption is determined using the rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued.

 

For restricted stock units, the fair value of the share-based award is based on the quoted market price of our common shares on the NASDAQ stock exchange.

 

Revenue Recognition

Our revenue is generated from the sales of prescription and non-prescription optical glasses, sunglasses, and shipping charges, which are charged to the customer, associated with these purchases. We sell products through our retail store resellers, distributors, on our own website Lucyd.co, and on Amazon.com.

 

To determine revenue recognition, we perform the following steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. At contract inception, we assess the goods or services promised within each contract and determine those that are performance obligations, and also assess whether each promised good or service is distinct. We then recognize as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. In instances where the collectibility of contractual consideration is not probable at the time of sale, the revenue is deferred on our balance sheet as a contract liability, and the associated cost of goods sold is deferred on our balance sheet as a contract asset; subsequently, we recognize such revenue and cost of goods sold as payments are received. During the year ended December 31, 2023, we recognized $17,500 of revenue that was included in the contract liability balance as of January 1, 2023.

 

All revenue, including sales processed online and through our retail store resellers and distributors, is reported net of sales taxes collected from customers on behalf of taxing authorities, returns, and discounts.

 

For sales generated through our e-commerce channels, we identify the contract with a customer upon online purchase of our eyewear and transaction price at the manufacturer suggested retail price (“MSRP”) for non-prescription, polarized sunglass and blue light blocking glasses across all of our online channels. Our e-commerce revenue is recognized upon meeting of the performance obligation when the eyewear is shipped to end customers. Only U.S. consumers enjoy free USPS first class postage, with faster delivery options available for extra cost, for sales processed through our website and on Amazon. For Amazon sales, shipping is free for U.S consumers while international customers pay shipping charges on top of MSRP. Any costs associated with fees charged by the online platforms (Shopify for Lucyd.co website and Amazon) are not recharged to customers and are recorded as a component of cost of goods sold as incurred. The Company charges applicable state sales taxes in addition to the MSRP for both online channels and all other marketplaces on which the company sells products.

 

F-9

 

 

For sales to our retail store partners, we identify the contract with a customer upon receipt of an order of our eyewear through our Shopify wholesale portal or direct purchase order. Our revenue is recognized upon meeting the performance obligation, which is delivery of the Company’s eyewear products to the retail store and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to the retail store partners includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale retail orders, no e-commerce fees are applicable.

 

For sales to distributors, we identify the contract with a customer upon receipt of an order of our eyewear through a direct purchase order. If collectability of substantially all of the contract consideration is probable, our revenue is recognized upon meeting the performance obligation, which is delivery of our eyewear products to the distributor, and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to distributors includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale distributor orders, no e-commerce fees are applicable.

 

The Company’s sales do not contain any variable consideration.

 

We allow our customers to return our products, subject to our refund policy, which allows any customer to return our products for any reason within the first:

 

  7 days for sales made through our website (Lucyd.co)

 

  30 days for sales made through Amazon

 

  30 days for sales to most wholesale retailers and distributors (although certain sales to independent distributors are ineligible for returns)

 

For all of our sales, at the time of sale, we establish a reserve for returns, based on historical experience and expected future returns, which is recorded as a reduction of sales. Additionally, we review all individual returns received in the month following the balance sheet date pertaining to orders processed prior to the balance sheet date in order to determine whether an allowance for sales returns is necessary. The Company recorded an allowance for sales returns of $25,933 and $24,897 as of December 31, 2023 and 2022, respectively.

 

Shipping and Handling

Costs incurred for shipping and handling are included in cost of revenue at the time the related revenue is recognized. Amounts billed to a customer for shipping and handling are reported as revenues.

 

Recently Adopted Accounting Pronouncements

Effective January 1, 2023, the Company adopted the provisions of Accounting Standards Update (“ASU”) 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (as amended by ASU 2018-19 in November 2018, ASU 2019-05 in May 2019, ASU 2019-10 and 2019-11 in November 2019, ASU 2020-02 in February 2020, and ASU 2022-02 in March 2022). This standard requires entities to estimate lifetime expected credit losses for financial instruments, including trade and other receivables, which will generally result in earlier recognition of credit losses. The adoption of this new guidance did not have a significant impact on our results of operations, cash flows, or financial condition.

 

Recently Issued Accounting Pronouncements

In October 2023, the FASB issued ASU 2023-06, Disclosure Improvements. This ASU amends the presentation and disclosure of a variety of topics in the ASC, including derivatives, diluted earnings per share, changes in reporting entity, preferred stock, certain industry-specific items, and various other topics, in order to align them with SEC regulations. The amendments to the various topics should be applied prospectively, and the effective date will be determined for each individual disclosure based on the effective date of the SEC’s removal of the related disclosure requirement from Regulation S-X or Regulation S-K. We do not anticipate that the adoption of this ASU will have a significant impact on our financial statements.

 

F-10

 

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. ASU 2023-07 improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. In addition, the ASU enhances interim disclosure requirements, clarifies circumstances in which an entity can disclose multiple segment measures of profit or loss, and contains other disclosure requirements. The ASU does not change how an entity identifies its operating segments, aggregates those operating segments, or applies the quantitative thresholds to determine its reportable segments. ASU 2023-07 is required to be applied retrospectively to all periods presented in the financial statements, and is effective for Innovative Eyewear, Inc. for fiscal years beginning after December 15, 2023 (i.e., January 1, 2024) and interim periods within fiscal years beginning after December 15, 2024 (i.e., January 1, 2025). We do not anticipate that the adoption of this ASU will have a significant impact on our financial statements.

 

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. ASU 2023-09 requires disclosure of additional categories of information about federal, state, and foreign income taxes in the rate reconciliation table and requires entities to provide more details about the reconciling items in some categories if items meet a quantitative threshold. The ASU also requires entities to disclose income taxes paid, net of refunds, disaggregated by federal (national), state, and foreign taxes for annual periods and to disaggregate the information by jurisdiction based on a quantitative threshold. The guidance makes several other changes to the disclosure requirements. The ASU is required to be applied prospectively, with the option to apply it retrospectively. The ASU is effective for Innovative Eyewear, Inc. for fiscal years beginning after December 15, 2024. We do not anticipate that the adoption of this ASU will have a significant impact on our financial statements.

 

Subsequent Events

In connection with the preparation of these financial statements, the Company has evaluated subsequent events through March 24, 2024, which is the date the financial statements were available to be issued. See Note 11 for additional information.

 

NOTE 3 – GOING CONCERN

 

The Company has a limited operating history. The Company’s business and operations are sensitive to general business and economic conditions in the United States. A host of factors beyond the Company’s control could cause fluctuations in these conditions. Adverse conditions may include recession, downturn, or otherwise, changes in regulations or restrictions in imports, competition, or changes in consumer taste. These adverse conditions could affect the Company’s financial condition and the results of its operations.

 

The Company meets its day-to-day working capital requirements using monies raised through sales of eyewear and issuances of equity, including our initial public offering completed in August 2022, a secondary public offering completed in June 2023, and exercises of warrants by stockholders (see Note 8 for additional details). The Company also previously issued a convertible note held by Tekcapital and Affiliates, which was repaid in full during the year ended December 31, 2023 (see Note 6). Effective March 1, 2024, the Company issued a new 18-month convertible note to Tekcapital and Affiliates (see Note 11 for details).

 

Management expects that operating losses could continue in the foreseeable future as we continue to invest in the expansion and development of our business. Management’s forecasts and projections indicate that the Company’s existing cash and cash equivalents (including the proceeds from the aforementioned second public offering and proceeds received from investors’ exercises of warrants), plus planned capital-raising activities in 2024, will be sufficient to fund operations through at least end of March 2025.

 

F-11

 

 

NOTE 4 – INCOME TAX PROVISION

 

The following is a reconciliation of tax computed at the statutory federal rate to the income tax benefit in the statements of operations:

 

               
    2023     2022  
Income tax benefit at the statutory federal rate   $ 1,389,526     $ 1,193,185  
State income tax benefits, net of federal benefit     50,907       35,149  
Change in valuation allowance     (1,440,433 )     (1,228,334 )
Total   $ -     $ -  

 

The components of the Company’s deferred tax assets are as follows:

 

               
    2023     2022  
Deferred tax assets:                
Stock-based compensation   $ 877,645     $ 610,530  
Other – net     219,723       122,133  
Net operating losses – federal     2,483,530       1,346,823  
Net operating losses – state     148,177       81,911  
 Deferred tax assets Gross     3,729,075       2,161,397  
Less Valuation Allowance     (3,729,075 )     (2,161,397 )
Net deferred tax assets   $ -     $ -  

 

Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities. Deferred tax assets or liabilities at the end of each period are determined using the tax rate expected to be in effect when taxes are actually paid or recovered.

 

A valuation allowance is established when it is more likely than not that all or a portion of a deferred tax asset will not be realized. A review of all available positive and negative evidence is considered, including the Company’s current and past performance, the market environment in which the Company operates, length of carryback and carryforward periods, and existing contracts that will result in future profits. After reviewing all the evidence, the Company has recorded a full valuation allowance against its deferred tax assets.

 

At December 31, 2023, the Company had federal net operating loss carryforwards of $11,826,332 and state net operating loss carryforwards of $6,515,176, both of which do not expire.

 

The Company files Federal and Florida tax returns. The years that remain subject to examination are the years ended December 31, 2020, 2021, 2022, and 2023. As of December 31, 2023 and 2022, the Company does not believe that is has any liabilities for uncertain tax positions.

 

NOTE 5 – INTANGIBLE ASSETS

 

               
Finite-lived intangible assets   December 31,
2023
    December 31,
2022
 
Patent Costs   $ 329,232     $ 156,196  
Intangible assets, gross     329,232       156,196  
Less: Accumulated amortization     (42,803 )     (18,639 )
Intangible assets, net   $ 286,429     $ 137,557  

 

These costs are amortized using the straight-line method over a period of 10 years. Amortization expense totalled $24,164 and $10,466 for the years ended December 31, 2023 and 2022, respectively. Future amortization is expected to approximate $30,000 per year.

 

F-12

 

 

NOTE 6 – RELATED PARTY TRANSACTIONS

 

Convertible Note and Due to Tekcapital and Affiliates

During the year ended December 31, 2022 and through December 1, 2023, the Company had the availability of, but not the contractual right to, intercompany financing from Tekcapital and Affiliates in the form of either cash advances or borrowings under a convertible note (as discussed below).

 

On December 1, 2020, the Company issued a convertible note to Tekcapital and Affiliates for up to $2,000,000 that bears interest at 10% per annum, which includes the option to convert the debt into the Company’s common stock at market price. The note can be converted into shares of common stock of the Company upon occurrence of certain conversion events, as defined. On November 1, 2021, the Company amended and restated the convertible note agreement with Tekcapital and Affiliates, increasing the amount of available financing from $2,000,000 to $3,000,000.

 

On August 15, 2022, in connection with the Company’s initial public offering (see Note 8), the Company converted related party borrowings totalling $2,002,280 into 266,970 shares of common stock at $7.50 per share.

 

The convertible notes balances were $61,356 at December 31, 2022. In January 2023, the Company borrowed an additional $48,143 under such convertible notes, and subsequently repaid the outstanding balances of the convertible notes in full in February 2023. No further amounts were borrowed under the convertible notes, and the convertible notes matured on December 1, 2023 with no amounts outstanding.

 

Subsequent to the year ended December 31, 2023 (effective March 1, 2024), the Company issued a new 18-month convertible note to Tekcapital and Affiliates; see Note 11 for details.

 

Management Service Agreement

In 2020, the Company entered into a management services agreement with Tekcapital Europe Ltd. (an affiliate of our largest stockholder, Lucyd Ltd., whose Chief Executive Officer is the father of our Chief Executive Officer), for which the Company was billed $25,000 quarterly. Effective February 1, 2022, the original management services agreement was amended to have the Company billed at $35,000 quarterly. While the agreement does not stipulate a specific maturity date, it can be terminated with 30 calendar days written notice by any party.

 

The related party provides the following services:

 

  Support and advice to the Company in accordance with their area of expertise;

 

  Research, technical review, legal review, recruitment, software development, marketing, public relations, and advertisement; and

 

  Advice, assistance, and consultation services to support the Company or in relation to any other related matter.

 

The Company incurred $140,000 during each of the years ended December 31, 2023 and 2022 under this management services agreement.

 

Rent of Office Space

Prior to the February 1, 2022 amendment of the aforementioned management services agreement, the Company was provided with rent-free office space by Tekcapital and Affiliates. Effective February 1, 2022, Tekcapital began to bill the Company for an allocation of rent paid by Tekcapital on the Company’s behalf; the underlying lease between Tekcapital and its landlord has an end date of January 31, 2025. The Company recognized expense related to this arrangement of $91,672 and $74,442 of for the years ended December 31, 2023 and 2022, respectively.

 

F-13

 

 

NOTE 7 – COMMITMENTS AND CONTINGENCIES

 

Legal Matters

In August 2023, the Company entered into a settlement agreement with a former wholesale customer who owed the Company $92,646. As a result of this settlement, $47,646 of accounts receivable were written-off as uncollectible, while the $45,000 collected under the settlement agreement was reflected as a gain within general and administrative expenses in the statement of operations.

 

In November 2023, a third party filed a complaint before the International Trade Commission, alleging that certain of our products (as well as certain products of our competitors) infringed on patents held by the third party. In December 2023, the International Trade Commission instituted an investigation against the Company. As of December 31, 2023, the Company recorded a liability of approximately $103,000 related to this matter. This matter was subsequently settled and resolved in January 2024; refer to Note 11 for details.

 

Additionally, the Company is currently pursuing collection of $41,452 from an individual who was both a former member of management and a former member of our board of directors. The amount owed to us represents the remaining balance of an advance against future commissions that was previously paid to such individual under a contractual agreement. We desire to resolve this matter amicably and expeditiously; accordingly, we have presented this individual with a demand for repayment, and are exploring all options available to us with the assistance of legal counsel. No amounts related to this matter have been recorded on the balance sheet and statement of operations as of and for the year ended December 31, 2023.

 

Leases

Our executive offices are located at 11900 Biscayne Blvd., Suite 630 Miami, Florida 33181. Our executive offices are provided to us by the Tekcapital and Affiliates (see Note 6). We consider our current office space adequate for our current operations.

 

License Agreements

During the years ended December 31, 2023 and 2022, we entered into several multi-year license agreements which grant us the right to sell certain branded smart eyewear, including the Nautica, Eddie Bauer, and Reebok brands worldwide. These agreements require us to pay royalties based on a percentage of net retail and wholesale sales during the period of the license, and also require guaranteed minimum royalty payments. The agreements have base terms of 10 years but are cancellable at the option of the Company during the fifth year.

 

The aggregate future minimum payments due under these license agreements are as follows:

 

       
2024   $ 161,210  
2025     436,000  
2026     834,000  
2027     1,290,000  
2028     1,543,000  
Thereafter (through 2032)     9,907,000  
Total   $ 14,171,210  

 

Other Commitments

See related party management services agreement discussed in Note 6.

 

F-14

 

 

NOTE 8 – STOCKHOLDERS’ EQUITY

 

Pursuant to a corporate resolution on July 1, 2021, the Company has authority to issue up to 15,000,000 shares of preferred stock and 50,000,000 shares of common stock. There were no shares of preferred stock issued or outstanding as of December 31, 2023 and 2022.

 

Initial Public Offering

On August 17, 2022, the Company closed on its initial public offering of 980,000 units consisting of 980,000 shares of its common stock and 1,960,000 warrants to purchase 1,960,000 shares of common stock at a combined offering price of $7.50 per unit in exchange for gross proceeds of approximately $7.35 million, before deducting underwriting discounts and offering expenses. Each share of common stock was sold together with two warrants. Each warrant is exercisable to purchase one share of common stock at an initial exercise price of $7.50 per share, subject to certain adjustments as set forth in the warrant agreement. In addition, the Company granted the underwriters a 45-day option to purchase up to an additional 147,000 shares of common stock and/or warrants to purchase up to an additional 294,000 shares of common stock to cover over-allotments, of which the Underwriter exercised its option to purchase additional warrants to purchase 294,000 shares of common stock concurrently with the closing.

 

The shares of common stock and warrants began trading on The Nasdaq Capital Market on August 15, 2022, under the symbols “LUCY” and “LUCYW,” respectively.

 

Also, pursuant to the terms of the underwriting agreement for the offering, the Company issued by the Underwriter certain other warrants to purchase up to 58,800 shares of the Company’s common stock at an exercise price of $8.228 per share.

 

The net proceeds received by the Company from this offering amounted to $6,015,918.

 

Second Public Offering

On June 26, 2023, the Company closed on a public offering of 4,500,000 units consisting of 4,500,000 shares of its common stock and 4,500,000 warrants to purchase 4,500,000 shares of common stock (the “Common Warrants”) at a combined offering price of $1.05 per unit in exchange for gross proceeds of approximately $4.73 million, before deducting underwriting discounts and offering expenses. Each share of common stock was sold together with one warrant. Each Common Warrant is exercisable to purchase one share of common stock at an initial exercise price of $1.05 per share, subject to certain adjustments as set forth in the warrant agreement. In addition, pursuant to the terms of the placement agency agreement for the offering, the Company issued to the placement agent certain other warrants to purchase up to 180,000 shares of the Company’s common stock at an exercise price of $1.31 per share. The net proceeds received by the Company from this offering amounted to $4,115,688.

 

Warrants

On August 17, 2022, as part of the Company’s initial public offering described above, the Company issued a total of 2,254,000 warrants to purchase 2,254,000 shares of common stock, which began trading and are currently trading on the Nasdaq Capital Market, under the symbol “LUCYW” (which we refer to as the “Listed Warrants”).

 

In February 2023, holders of the Company’s Listed Warrants exercised such warrants to purchase an aggregate of 408,600 shares of the Company’s common stock, at an adjusted exercise price of $3.75 per share, resulting in cash proceeds to the Company of $1,532,250.

 

Between April 1, 2023 and April 16, 2023, holders of the Company’s Listed Warrants exercised such warrants to purchase an aggregate of 321,120 shares of the Company’s common stock, at an adjusted exercise price of $3.75 per share, resulting in cash proceeds to the Company of $1,204,200.

 

F-15

 

 

On April 17, 2023, the Company entered into a warrant exercise inducement letter agreement (“Inducement Letter”) with certain accredited investors that were existing holders of the Company’s Listed Warrants to purchase an aggregate of 150,000 shares of the Company’s common stock for cash, wherein the investors agreed to exercise all of their existing Listed Warrants at an exercise price of $3.75 per share. The gross proceeds to the Company from this transaction, before deducting estimated expenses and fees, was $562,000; the net proceeds received by the Company amounted to $391,268. In consideration for the immediate exercise of the existing Listed Warrants for cash, the exercising holders received new warrants to purchase up to an aggregate of 300,000 shares of common stock (the “Private Warrants”) in a private placement pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended. The Private Warrants are immediately exercisable upon issuance at an exercise price of $3.75 per common share and will expire on April 19, 2028. Although the Private Warrants were offered in a private placement pursuant to an applicable exemption from the registration requirements of the Securities Act and, along with the shares of common stock issuable upon their exercise, were not registered under the Securities Act, subsequently in May 2023 the shares of common stock issuable upon exercise of these warrants were registered with the SEC through a Form S-1 filing.

 

The only exercises of warrants to date have been those exercises of Listed Warrants in February and April of 2023 as described above. As of December 31, 2023, none of the Common Warrants, Private Warrants, nor any of the warrants issued to underwriters and placement agents have been exercised.

 

As of December 31, 2023, the Company’s outstanding warrants are as follows:

 

                     
Warrant Type   Warrants
Outstanding
    Exercise
Price
    Expiration
Date
 
Listed Warrants     1,374,280     $ 3.75     8/17/2027  
Common Warrants     4,500,000     $ 1.05     6/26/2028  
Private Warrants     300,000     $ 3.75     4/19/2028  
Underwriter warrants     58,800     $ 8.23     8/12/2027  
Placement agent warrants     180,000     $ 1.05     6/26/2028  
Total     6,413,080                

 

F-16

 

 

NOTE 9 – STOCK-BASED COMPENSATION

 

On July 1, 2021, an Equity Incentive Plan was approved, allowing for total of 20% of our issued and outstanding common stock, less the number of outstanding option grants, to be available for the grant of awards under the Plan. There were 1,685,000 option awards granted by the Company prior to the approval of the Plan, while 1,800,500 option awards have been granted under the Plan from July 1, 2021 through December 31, 2023.

 

Summary information regarding the number of options, exercise price, and remaining contractual life as of and during the years ended December 31, 2023 and 2022 is as follows:

 

                       
    Weighted Average
Exercise Price
per share
$
    Options
(Number)
    Weighted Average
Remaining
Contractual Life
(Years)
 
As at January 1, 2022     2.61       2,332,500          
Granted     -       -          
Exercised     -       -          
Forfeited     -       -          
As at December 31, 2022     2.61       2,332,500       1.68  
                         
As at January 1, 2023     2.61       2,332,500          
Granted     0.92       1,153,000          
Exercised     1.01       (316,000 )        
Forfeited / Expired     2.94       (275,000 )        
As at December 31, 2023     2.08       2,894,500       2.22  
Exercisable as at December 31, 2023     2.39       1,795,219       1.40  

 

As of December 31, 2023, the aggregate intrinsic value for all options outstanding as well as all options exercisable was zero.

 

During the year ended December 31, 2023, we granted the following option awards:

 

Options to purchase an aggregate of 330,000 shares of common stock at $1.275 per share were issued to the Company’s officers and management, of which 1/3 vested immediately, 1/3 shall vest on January 13, 2024, and the remaining 1/3 shall vest on January 13, 2025. The options expire on January 13, 2028.

 

Options to purchase an aggregate of 75,000 shares of common stock at $1.275 per share were issued to non-management directors, which vest evenly over three years, whereby 1/3 shall vest on each of January 13, 2024, January 13, 2025, and January 13, 2026. The options expire on January 13, 2028.

 

Options to purchase an aggregate of 162,000 shares of common stock at $1.275 per share were issued to certain employees and consultants, which vest evenly over three years, whereby 1/3 shall vest on each of January 13, 2024, January 13, 2025, and January 13, 2026. The options expire on January 13, 2028.

 

F-17

 

 

Options to purchase an aggregate of 75,000 shares of common stock at $1.275 per share were issued to an employee, which would have vested evenly over three years (whereby 1/6 of the options would have vested every six months). During the year ended December 31, 2023, however, all of these options were forfeited.

 

Options to purchase an aggregate of 6,000 shares of common stock at $1.275 per share were issued to a consultant, which vested immediately. These options were all exercised during the year ended December 31, 2023.

 

Options to purchase an aggregate of 15,000 shares of common stock at $0.66 per share were issued to certain employees and consultants, which vest evenly over two years, whereby 1/4 of the options shall vest every six months. The options expire on September 5, 2028.

 

Options to purchase an aggregate of 490,000 shares of common stock at $0.45 per share were issued to the Company’s officers and management, of which 1/3 vested immediately, 1/3 shall vest on December 18, 2024, and the remaining 1/3 shall vest on December 18, 2025. The options expire on December 18, 2028.

 

There were no option awards granted during the year ended December 31, 2022.

 

The fair value of options granted is calculated using the Black-Scholes-Merton option pricing model. The underlying assumptions used in the option pricing model for stock option awards granted in 2023 were as follows:

 

     
Attribute      
Share price at date of grant   $0.43 - $1.28  
Expected term (in years)   3 - 4  
Risk free rate   3.74% - 4.65 %
Expected volatility   106% - 133 %
Expected dividend yield   0  
Grant date fair value of options   $0.28 - $1.02  

 

The weighted average grant date fair value of options outstanding was $1.49 and $1.84 as of December 31, 2023 and 2022, respectively.

 

As of December 31, 2023, unrecognized stock option expense of approximately $721,000 remains to be recognized over next 1.12 years.

 

Award Modifications

On June 1, 2023, we modified the terms of certain options previously awarded in 2021 to purchase an aggregate of 140,000 shares of common stock, in order to extend their expiration dates from July 21, 2023 to July 21, 2024. There were no changes to the exercise price or other terms of these stock options, and these options were already fully vested prior to the modification. As a result of this modification, we recognized incremental stock option expense of $9,188 for the year ended December 31, 2023.

 

Restricted Stock Unit Awards

On December 3, 2023, we entered into an endorsement agreement with an influencer for a one-year term, which included the award of an aggregate of 65,220 restricted stock units. These restricted stock units vest according to the following schedule: 16,305 shares on December 3, 2023 (which will be issued on or before March 31, 2024), 16,305 shares on March 2, 2024 (which will be issued on or before March 31, 2024), 16,305 shares on May 31, 2024, and 16,305 shares on August 29, 2024. Total stock-based compensation related to this award, based on the market price of the Company’s common stock on the date of grant, amounts to $27,066. We recognized $8,458 of expense related to this award during the year ended December 31, 2023, and will recognize the remaining expense of $18,608 on a straight-line basis over the remaining term of the agreement in 2024.

 

F-18

 

 

NOTE 10 – EARNINGS PER SHARE

 

The Company calculates earnings/(loss) per share data by calculating the quotient of earnings/(loss) divided by the weighted average number of common shares outstanding during the respective period as required by ASC 260-10-50. Due to the net losses for the years ended December 31, 2023 and 2022, all shares underlying the related party convertible debt, common stock warrants, and common stock options were excluded from the earnings per share calculation due to their anti-dilutive effect.

 

Calculation of net earnings per common share — basic and diluted:

 

           
    For the
year ended
 
    December 31,     December 31,  
    2023     2022  
Basic and diluted:                
Net loss   $ (6,663,428 )   $ (5,681,833 )
Weighted-average number of common shares     10,515,995       6,528,959  
Basic and diluted net loss per common share   $ (0.63 )   $ (0.87 )

 

NOTE 11 – SUBSEQUENT EVENTS

 

Settlement and License Agreement

On January 3, 2024, we settled and resolved certain matters with a third party, including a complaint that had been brought before the International Trade Commission and an investigation instituted by the International Trade Commission in 2023, and entered into a multi-year non-exclusive license agreement covering multiple smart eyewear patents. Pursuant to this license agreement, the Company added licenses for 46 new patents to its portfolio of owned and licensed patents and applications.

 

Loan to Tekcapital Europe, Ltd.

On January 11, 2024, we entered into an intercompany loan agreement (as lender) with Tekcapital Europe, Ltd. (as borrower), an affiliate of our largest stockholder, Lucyd Ltd., whose Chief Executive Officer is the father of our Chief Executive Officer, and Tekcapital Plc, the parent of Tekcapital Europe Ltd. Pursuant to this agreement, the Company loaned 600,000 British pounds sterling (equivalent to approximately $765,000) to Tekcapital Europe Ltd. The loan bears simple interest at a rate of 10% per annum and is required to be repaid on or before April 11, 2024. Tekcapital Plc executed the agreement as guarantor for Tekcapital Europe Ltd. on the full amount of the loan. Tekcapital Europe Ltd. repaid the loan in full in March 2024.

 

New Convertible Note

Effective March 1, 2024, the Company issued a convertible note to Lucyd Ltd., the largest stockholder of the Company, for up to $1,250,000 that bears interest at 10% per annum, which includes the option to convert the debt into the Company’s common stock at market price. The note can be converted into shares of common stock of the Company upon the occurrence of certain events, as defined in the note, or for any reason at the sole discretion of Lucyd Ltd. The note has a maturity date of September 1, 2025, at which time all outstanding principal and accrued interest is payable in full. As of the date these financial statements were available to be issued, the Company has not borrowed any amounts under this convertible note.

 

F-19

EX-4.7 2 innovativeeye_ex4-7.htm EXHIBIT 4.7

 

Exhibit 4.7

 

DESCRIPTION OF SECURITIES

REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES

EXCHANGE ACT OF 1934

Description of CAPITAL STOCK

 

Pursuant to our second amended and restated articles of incorporation, our authorized capital stock consists of fifty million (50,000,000) shares of Common Stock, $0.00001 par value and fifteen million (15,000,000) shares of preferred stock, $0.00001 par value. As of March 22, 2024, there are 12,933,544 shares of common stock outstanding. Our authorized but unissued shares of common stock and preferred stock are available for issuance without further action by our stockholders, unless such action is required by applicable law or the rules of any stock exchange or automated quotation system on which our securities may be listed or traded in the future. The following description summarizes the material terms of our capital stock. This summary is a description of the material terms of, and is qualified in its entirety by, reference to our Articles of Incorporation, a copy of which is filed as an exhibit to our previous filings with the SEC and incorporated by reference to the Annual Report on Form 10-K of which this Description of Securities is attached as an exhibit.

 

Common Stock

 

As of March 22, 2024, 12,933,544 shares of common stock were issued and outstanding held by 3,780 stockholders of record. Holders of our common stock are entitled to one vote for each share held on all matters submitted to a vote of stockholders and are not entitled to cumulative voting rights.

 

Holders of our common stock are entitled to receive ratably such dividends, if any, as may be declared by our Board of Directors out of funds legally available therefor, subject to any preferential distribution rights of third parties. Upon our liquidation, dissolution or winding up, the holders of our common stock are entitled to receive ratably our net assets available after the payment of all debts and other liabilities.

 

Holders of our common stock have no preemptive, subscription, redemption or conversion rights. There are no redemption or sinking fund provisions applicable to the common stock. All of the outstanding shares of our common stock are fully-paid and nonassessable. The rights, preferences and privileges of holders of our common stock are subject to, and may be adversely affected by, the rights of the holders of any indebtedness of our company.

 

Warrants Issued in our Initial Public Offering

 

In connection with our initial public offering, we sold Listed Warrants to purchase up to 2,254,000 shares of our common stock, of which [1,080,280] remain outstanding as of the date of this filing. The Listed Warrants are currently listed on Nasdaq and trade under the symbol “LUCYW.” The terms of the Listed Warrants sold in our initial public offering are described below. The following summary of certain terms and provisions of the warrants offered in our initial public offering is not complete and is subject to, and qualified in its entirety by the provisions of the form of warrant, which was filed as an exhibit to the registration statement of which this prospectus forms a part.

 

Exercisability

 

The Warrants were exercisable immediately upon issuance and at any time up to the date that is five years from the date of issuance. The Warrants are exercisable, at the option of each holder, in whole or in part by delivering to us a duly executed exercise notice accompanied by payment in full for the number of shares of common stock purchased upon such exercise. Each Warrant entitles the holder thereof to purchase one share of common stock. Warrants are not exercisable for a fraction of a share and may only be exercised into whole numbers of shares. In lieu of fractional shares, we will, pay the holder an amount in cash equal to the fractional amount multiplied by the exercise price and round down to the nearest whole share. Unless otherwise specified in the Warrant, the holder will not have the right to exercise the Warrants, in whole or in part, if the holder (together with its affiliates) would beneficially own in excess of 4.99% (or 9.99% at the holder’s election) of the number of our shares of common stock outstanding immediately after giving effect to the exercise, as such percentage is determined in accordance with the terms of the Warrant. However, any holder may increase or decrease such percentage to any other percentage not in excess of 9.99% upon at least 61 days’ prior notice from the holder to us.

 

 

 

 

Exercise Price

 

The exercise price per share of common stock purchasable upon exercise of the Warrants is $7.50 per share and is subject to adjustments for stock splits, reclassifications, subdivisions, and other similar transactions. In addition to the exercise price per share of common stock, and other applicable charges and taxes are due and payable upon exercise. Subject to certain exemptions outlined in the Warrant, for a period of two years from the date of issuance of the Warrant, if the Company shall sell, enter into an agreement to sell, or grant any option to purchase, or sell, enter into an agreement to sell, or grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any option to purchase or other disposition) any shares of common stock or Convertible Security (as defined in the Warrant), at an effective price per share less than the exercise price of the Warrant then in effect, the exercise price of the Warrant shall be reduced to equal the effective price per share in such dilutive issuance; provided, however, in no event shall the exercise price of the Warrant be reduced to an exercise price lower than 50% of public offering price per Unit in this offering. In addition, on the ninety (90) day anniversary of the issuance date of the Warrants, the exercise price of the Warrants will adjust to be equal to the greater of $3.75 per share and 100% of the last volume weighted average price per share of common stock immediately preceding the 90th day following the issuance date of the Warrant, provided that such value is less than the exercise price in effect on that date.

 

Warrant Agent; Global Certificate

 

The Warrants were issued in registered form under a warrant agency agreement between the warrant agent and us. The Warrants were initially be represented only by one or more global warrants deposited with the warrant agent, as custodian on behalf of The Depository Trust Company, or DTC, and registered in the name of Cede & Co., a nominee of DTC, or as otherwise directed by DTC.

 

The name, address and telephone number of the warrant agent is VStock Transfer, LLC, 18 Lafayette Pl, Woodmere, New York 11598, (212) 828-8436.

 

Listing; Transferability

 

Our Warrants will be listed on NASDAQ. However, without an active trading market, the liquidity of the Warrants will be limited. We intend to have the Warrants issued in registered form under the warrant agency agreement between us and the warrant agent. Subject to applicable laws, the Warrants may be transferred at the option of the holders upon surrender of the Warrants to the warrant agent, together with the appropriate instruments of transfer.

 

Adjustments; Fundamental Transaction

 

The exercise price and the number of shares underlying the Warrants are subject to appropriate adjustment in the event of stock splits, stock dividends on our shares of common stock, stock combinations or similar events affecting our shares of common stock. In addition, in the event we consummate a merger or consolidation with or into another person or other reorganization event in which our shares of common stock are converted or exchanged for securities, cash or other property, or we sell, lease, license, assign, transfer, convey or otherwise dispose of all or substantially all of our assets or we or another person acquire 50% or more of our outstanding shares of common stock (each, a Fundamental Transaction), then following such Fundamental Transaction the holders of the Warrants will be entitled to receive upon exercise of the Warrants the same kind and amount of securities, cash or property which the holders would have received had they exercised the Warrants immediately prior to such Fundamental Transaction. Any successor to us or surviving entity will assume the obligations under the Warrants. Additionally, as more fully described in the Warrant, in the event of certain Fundamental Transactions, the holders of the Warrants will be entitled to receive consideration in an amount equal to the Black Scholes value of the Warrants on the date of consummation of such transaction.

 

Rights as a Shareholder

 

Except by virtue of such holder’s ownership of our common stock, the holder of a Warrant does not have rights or privileges of a shareholder, including any voting rights, until the holder exercises such Warrant.

 

2

 

 

Right of Participation

 

Subject to certain exceptions, for a period of two years from the date of issuance of the Warrant, a holder of at least 150,000 Warrants as of the time the Company engages in a Subsequent Placement (as defined in the Warrant) will be entitled to participate in such Subsequent Placement subject to the terms and conditions set forth in the Warrant.

 

Redemption

 

The Warrants are callable by us in certain circumstances. Subject to certain exceptions, if, after 13 months from the initial exercise date of the Warrants, (i) the volume weighted average price of our shares of common stock for 10 consecutive trading days (the “Measurement Period”), which Measurement Period shall not have commenced until 13 months after the initial exercise date of the Warrants, exceeds the greater of 300% of the initial exercise price and 400% of the then exercise price, (ii) the average daily trading volume of our shares of common stock for such Measurement Period exceeds $1,000,000 per trading day, and (iii) the holders of the Warrants are not in possession of any information that constitutes or might constitute, material non-public information which was provided by us, then we may, within one trading day of the end of such Measurement Period, upon notice to the holders of the Warrants (a “Call Notice”), call for cancellation of all of the Warrants for which a notice of exercise has not yet been delivered, or a Call, for consideration equal to $0.001 per warrant share. Any portion of a Warrant subject to such Call Notice for which a notice of exercise shall not have been received by us on the Call Date will be cancelled at 6:30 p.m. (New York City time) on the thirtieth day after the date the Call Notice is received by the holder (such date and time, the “Call Date”). Our right to call the Warrants will be exercised with respect to all of the then issued and outstanding Warrants.

 

Representative’s Warrants Issued in our Initial Public Offering

 

In connection with our initial public offering, we agreed to sell to the representative of the underwriters, for nominal consideration, warrants to purchase 58,800 shares of our common stock as additional consideration to the underwriters. The underwriters’ warrants have an exercise price of $8.228 per share and are exercisable for a period of five years and contain customary “cashless” exercise and registration rights provisions. The warrant issued to the underwriters were exercisable as of February 10, 2023.

 

JUNE 2023 PUBLIC OFFERING

 

In connection with our June 2023 public offering, we sold 4,500,000 shares of our common stock and Common Warrants to purchase up to 4,500,000 shares of common stock. No warrant for fractional shares of common stock will be issued, rather warrants will be issued only for whole shares of common stock.

 

Common Warrants Issued in our June 2023 Public Offering

 

The following is a summary of certain terms and provisions of the Common Warrants that are were issued, hereby is not complete and is subject to, and qualified in its entirety by, the provisions of the Common Warrant, the form of which will be filed as an exhibit to the Company’s Annual Report on Form 10-K. The following summary of certain terms and provisions of the warrants offered in our June 2023 public offering is not complete and is subject to, and qualified in its entirety by the provisions of the form of warrant, which was filed as an exhibit to the Company’s Annual Report on Form 10-K.

 

Duration and Exercise Price

 

Each Common Warrant offered has an exercise price equal to $1.05. The Common Warrants were immediately exercisable and may be exercised until the fifth anniversary of the issuance date. The exercise price and number of shares of common stock issuable upon exercise is subject to appropriate adjustment in the event of stock dividends, stock splits, reorganizations or similar events affecting our common stock and the exercise price. The Common Warrants will be issued separately from the common stock, and may be transferred separately immediately thereafter. The Common Warrants will be issued in certificated form only.

 

3

 

 

Exercisability

 

The Common Warrants will be exercisable, at the option of each holder, in whole or in part, by delivering to us a duly executed exercise notice accompanied by payment in full for the number of shares of our common stock purchased upon such exercise (except in the case of a cashless exercise as discussed below). A holder (together with its affiliates) may not exercise any portion of such holder’s Common Warrants to the extent that the holder would own more than 4.99% of the outstanding common stock immediately after exercise, except that upon at least 61 days’ prior notice from the holder to us, the holder may increase the amount of ownership of outstanding stock after exercising the holder’s Common Warrants up to 9.99% of the number of shares of our common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the Common Warrants.

 

Cashless Exercise

 

If, at the time a holder exercises its Common Warrants, a registration statement registering the issuance or resale of the shares of common stock underlying the Common Warrants under the Securities Act is not then effective or available for the issuance of such shares, then in lieu of making the cash payment otherwise contemplated to be made to us upon such exercise in payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise (either in whole or in part) the net number of shares of common stock determined according to a formula set forth in the Common Warrant.

 

Fundamental Transactions

 

In the event of any fundamental transaction, as described in the Common Warrants and generally including any merger or consolidation with or into another entity, sale of all or substantially all of our assets, tender offer or exchange offer, or reclassification of our common stock, then upon any subsequent exercise of a Common Warrant, the holder will have the right to receive as alternative consideration, for each share of our common stock that would have been issuable upon such exercise immediately prior to the occurrence of such fundamental transaction, the number of shares of common stock of the successor or acquiring corporation or of our company, if it is the surviving corporation, and any additional consideration receivable upon or as a result of such transaction by a holder of the number of shares of our common stock for which the Common Warrant is exercisable immediately prior to such event. Notwithstanding the foregoing, in the event of a fundamental transaction, the holders of the Common Warrants have the right to require us or a successor entity to redeem the Common Warrants for cash in the amount of the Black-Scholes Value (as defined in each Common Warrant) of the remaining unexercised portion of the Common Warrants on the date of the consummation of such fundamental transaction, concurrently with or within 30 days following the consummation of a fundamental transaction.

 

However, in the event of a fundamental transaction which is not in our control, including a fundamental transaction not approved by our board of directors, the holders of the Common Warrants will only be entitled to receive from us or our successor entity, as of the date of consummation of such fundamental transaction the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of the Common Warrant that is being offered and paid to the holders of our common stock in connection with the fundamental transaction, whether that consideration is in the form of cash, stock or any combination of cash and stock, or whether the holders of our common stock are given the choice to receive alternative forms of consideration in connection with the fundamental transaction.

 

Transferability

 

Subject to applicable laws, a Common Warrant may be transferred at the option of the holder upon surrender of the Common Warrant to us together with the appropriate instruments of transfer.

 

Fractional Shares

 

No fractional shares of common stock will be issued upon the exercise of the Common Warrants. Rather, the number of shares of common stock to be issued will, at our election, either be rounded up to the nearest whole number or we will pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the exercise price.

 

4

 

 

Trading Market

 

There is no established trading market for the Common Warrants, and we do not expect an active trading market to develop. We do not intend to apply to list the Common Warrants on any securities exchange or other trading market. Without a trading market, the liquidity of the Common Warrants will be extremely limited.

 

Right as a Stockholder

 

Except as otherwise provided in the Common Warrants or by virtue of the holder’s ownership of shares of our common stock, such holder of Common Warrants does not have the rights or privileges of a holder of our common stock, including any voting rights, until such holder exercises such holder’s Common Warrants.

 

Waivers and Amendments

 

No term of the Common Warrants may be amended or waived without the written consent of the majority of the holders of the Common Warrants purchased in this offering.

 

Placement Agent’s Warrants Issued in our June 2023 Public Offering

 

In connection with our June 2023 public offering, we agreed to sell to the placement agent, for nominal consideration, warrants to purchase 180,000 shares of our common stock as additional consideration to the placement agent. The placement agent’s warrants have an exercise price of $1.3125 per share and are exercisable for a period of five years and contain customary “cashless” exercise and registration rights provisions. The warrant issued to the underwriters were exercisable as of December 19, 2023.

 

5

EX-19.1 3 innovativeeye_ex19-1.htm EXHIBIT 19.1

 

Exhibit 19.1

 

Insider Trading Compliance Manual

 

INNOVATIVE EYEWEAR INC.

 

Adopted August 17, 2022

 

In order to take an active role in the prevention of insider trading violations by its officers, directors, employees, consultants, advisors and other related individuals, the Board of Directors (the “Board”) of Innovative Eyewear Inc., a Florida Corporation (the “Company”) has adopted the policies and procedures described in this Insider Trading Compliance Manual.

 

I.Adoption of Insider Trading Policy.

 

Effective as of the date first written above, the Board has adopted the Insider Trading Policy attached hereto as Exhibit A (as the same may be amended from time to time by the Board, the “Policy”), which prohibits trading based on material, nonpublic information regarding the Company or any company whose securities are listed for trading or quotation in the United States (“Material Non-Public Information”). This Policy covers all officers and directors of the Company and its subsidiaries, all other employees of the Company and its subsidiaries, and consultants or contractors to the Company or its subsidiaries who have or may have access to Material Non-Public Information and members of the immediate family or household of any such person. This Policy (and/or a summary thereof) is to be delivered to all new employees, consultants and related individuals who are within the categories of covered persons upon the commencement of their relationships with the Company.

 

II.Designation of Certain Persons.

 

A. Section 16 Individuals. All directors and executive officers of the Company are subject to the reporting and liability provisions of Section 16 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the rules and regulations promulgated thereunder (“Section 16 Individuals”). Attached hereto as Exhibit B is a separate memorandum which discusses the relevant terms of Section 16. Impacted individuals should read these provisions closely as Section 16 obligations are personal in nature (i.e., they are not Company obligations).

 

B. Other Persons Subject to Policy. In addition, certain employees, consultants and advisors of the Company as described in Section I above have, or are likely to have, from time to time access to Material Non-Public Information and together with the Section 16 Individuals, are subject to the Policy, including the pre-clearance requirement described in Section IV. A. below.

 

III.Appointment of Insider Trading Compliance Officer.

 

By the adoption of this Policy, the Board has appointed an Insider Trading Compliance Officer (the “Compliance Officer”). The identity of the current Compliance Officer is Konrad Dabrowski.

 

 

 

 

IV.Duties of the Compliance Officer.

 

The Compliance Officer has been designated by the Board to handle any and all matters relating to the Company’s Insider Trading Compliance Program. Certain of those duties may be delegated to outside counsel with special expertise in securities issues and relevant law. The duties of the Compliance Officer shall include the following:

 

A. Pre-clearing all transactions involving the Company’s securities by the Section 16 Individuals and those individuals having regular access to Material Non-Public Information (defined for these purposes to include employees of the Company and its subsidiaries, and consultants or contractors to the Company or its subsidiaries who have or may have access to Material Non-Public Information and members of the immediate family or household of any such person) in order to determine compliance with the Policy, insider trading laws, Section 16 of the Exchange Act and Rule 144 promulgated under the Securities Act of 1933, as amended (“Rule 144”). Attached hereto as Exhibit C is a Pre-Clearance Checklist to assist the Compliance Officer’s performance of this duty.

 

B. Assisting in the preparation and filing of Section 16 reports (Forms 3, 4 and 5) for all Section 16 Individuals, bearing in mind, however, that the preparation of such reports is undertaken by the Company as a courtesy only and that the Section 16 Individuals alone (and not the Company, its employees or advisors) shall be solely responsible for the content of such reports and for any violations of Section 16 under the Exchange Act and related rules and regulations.

 

C. Serving as the designated recipient at the Company of copies of reports filed with the Securities and Exchange Commission (“SEC”) by Section 16 Individuals under Section 16 of the Exchange Act.

 

D. Performing periodic reviews of available materials, which may include Forms 3, 4 and 5, Form 144, officer and director questionnaires, and reports received from the Company’s stock administrator and transfer agent, to determine trading activity by officers, directors and others who have, or may have, access to Material Non-Public Information.

 

E. Circulating the Policy (and/or a summary thereof) to all covered employees, including Section 16 Individuals, on an annual basis, and providing the Policy and other appropriate materials to new officers, directors and others who have, or may have, access to Material Non-Public Information.

 

F. Assisting the Board in the implementation of the Policy and all related Company policies.

 

G. Coordinating with the Company’s internal or external legal counsel regarding all securities compliance matters.

 

H. Retaining copies of all appropriate securities reports, and maintaining records of his or her activities as Compliance Officer.

 

2

 

 

ACKNOWLEDGMENT

 

I hereby acknowledge that I have received a copy of Innovative Eyewear Inc.’s Insider Trading Compliance Manual (the “Insider Trading Manual”). Further, I certify that I have reviewed the Insider Trading Manual, understand the policies and procedures contained therein and agree to be bound by and adhere to these policies and procedures.

 

Dated:      
      Signature
       
      Name:

 

3

 

 

Exhibit A

 

Innovative Eyewear Inc.

 

Insider Trading Policy

 

and Guidelines with Respect to Certain Transactions in Company Securities

 

APPLICABILITY OF POLICY

 

This Policy applies to all transactions in the Company’s securities, including shares of common stock, options, warrants to purchase common stock and rights to receive common stock and any other securities the Company may issue from time to time, such as preferred stock and convertible notes, as well as to derivative securities relating to the Company’s stock, whether or not issued by the Company, such as exchange-traded options. It applies to all officers and directors of the Company, all other employees of the Company and its subsidiaries, all secretaries and assistants supporting such directors, officers, and employees, and consultants or contractors to the Company or its subsidiaries who have or may have access to Material Nonpublic Information (as defined below) regarding the Company and members of the immediate family or household of any such person. This group of people is sometimes referred to in this Policy as “Insiders.” This Policy also applies to any person who receives Material Nonpublic Information from any Insider.

 

Any person who possesses Material Nonpublic Information regarding the Company is an Insider for so long as such information is not publicly known.

 

DEFINITION OF MATERIAL NONPUBLIC INFORMATION

 

It is not possible to define all categories of material information. However, information should be regarded as material if there is a reasonable likelihood that it would be considered important to an investor in making an investment decision regarding the purchase or sale of the Company’s securities. Material Nonpublic Information is information that has not been previously disclosed to the general public and is otherwise not available to the general public.

 

While it may be difficult to determine whether particular information is material, there are various categories of information that are particularly sensitive and, as a general rule, should always be considered material. In addition, material information may be positive or negative. Examples of such information may include:

 

Financial results;

 

Entry into a material agreement or discussions regarding entry into a material agreement;

 

Projections of future earnings or losses;

 

Joint ventures/commercial partnerships with third parties;

 

News of the disposition of material assets;

 

New product or project announcements of a significant nature;

 

A-1

 

 

Information regarding regulatory review of Company products;

 

Intellectual property and other proprietary information;

 

Major contract awards, cancellations or write-offs;

 

Research milestones and related payments or royalties;

 

Impending bankruptcy or financial liquidity problems;

 

Gain or loss of a substantial customer or supplier or manufacturer;

 

Significant pricing changes;

 

Stock splits;

 

New equity or debt offerings;

 

Significant litigation exposure due to actual or threatened litigation;

 

Changes in senior management or the Board of Directors of the Company;

 

Capital investment plans; and

 

Any delays in delivery or manufacturing of products.

 

STATEMENT OF POLICY

 

General Policy

 

It is the policy of the Company to prohibit the unauthorized disclosure of any nonpublic information acquired in the workplace and the misuse of Material Nonpublic Information in securities trading related to the Company or any other company.

 

Specific Policies

 

1. Trading on Material Nonpublic Information. With certain exceptions, no Insider shall engage in any transaction involving a purchase or sale of the Company’s or any other company’s securities, including any offer to purchase or offer to sell, during any period commencing with the date that he or she possesses Material Nonpublic Information concerning the Company, and ending at the close of business on the second Trading Day following the date of public disclosure of that information, or at such time as such nonpublic information is no longer material. However, see Section 2 under “Permitted Trading Period” below for a full discussion of trading pursuant to a pre-established plan or by delegation.

 

As used herein, the term “Trading Day” shall mean a day on which national stock exchanges are open for trading.

 

A-2

 

 

2. Tipping. No Insider shall disclose (“tip”) Material Nonpublic Information to any other person (including family members) where such information may be used by such person to his or her profit by trading in the securities of companies to which such information relates, nor shall such Insider or related person make recommendations or express opinions on the basis of Material Nonpublic Information as to trading in the Company’s securities.

 

Regulation FD (Fair Disclosure) is an issuer disclosure rule implemented by the SEC that addresses selective disclosure of Material Nonpublic Information. The regulation provides that when the Company, or person acting on its behalf, discloses material nonpublic information to certain enumerated persons (in general, securities market professionals and holders of the Company’s securities who may well trade on the basis of the information), it must make public disclosure of that information. The timing of the required public disclosure depends on whether the selective disclosure was intentional or unintentional; for an intentional selective disclosure, the Company must make public disclosures simultaneously; for a non-intentional disclosure the Company must make public disclosure promptly. Under the regulation, the required public disclosure may be made by filing or furnishing a Form 8-K, or by another method or combination of methods that is reasonably designed to effect broad, non-exclusionary distribution of the information to the public.

 

It is the policy of the Company that all public communications of the Company (including, without limitation, communications with the press, other public statements, statements made via the Internet or social media outlets, or communications with any regulatory authority) be handled only through the Company’s Chief Executive Officer (the “CEO”), an authorized designee of the CEO or the Company’s public or investor relations firm. Please refer all press, analyst or similar requests for information to the CEO and do not respond to any inquiries without prior authorization from the CEO. If the CEO is unavailable, the Company’s Chief Financial Officer (or the authorized designee of such officer) will fill this role.

 

3. Confidentiality of Nonpublic Information. Nonpublic information relating to the Company is the property of the Company and the unauthorized disclosure of such information (including, without limitation, via email or by posting on Internet message boards, blogs, or social media) is strictly forbidden.

 

4. Duty to Report Inappropriate and Irregular Conduct. All employees, and particularly managers and/or supervisors, have a responsibility for maintaining financial integrity within the Company, consistent with generally accepted accounting principles and both federal and state securities laws. Any employee who becomes aware of any incidents involving financial or accounting manipulation or irregularities, whether by witnessing the incident or being told of it, must report it to their immediate supervisor and to any member of the Company’s Audit Committee. In certain instances, employees are allowed to participate in federal or state proceedings. For a more complete understanding of this issue, employees should consult their employee manual and or seek the advice of counsel. Our general Corporate and Securities Counsel is Ellenoff Grossman & Schole LLP, attention: Justin Grossman, at (212)370-1300, email: jgrossman@egsllp.com.

 

A-3

 

 

POTENTIAL CRIMINAL AND CIVIL LIABILITY

AND/OR DISCIPLINARY ACTION

 

1. Liability for Insider Trading. Insiders may be subject to penalties of up to $5,000,000 and up to ten (10) years in jail for engaging in transactions in the Company’s securities at a time when they possess Material Nonpublic Information regarding the Company. In addition, the SEC has the authority to seek a civil monetary penalty of up to three times the amount of profit gained or loss avoided by illegal insider trading. “Profit gained” or “loss avoided” generally means the difference between the purchase or sale price of the Company’s stock and its value as measured by the trading price of the stock a reasonable period after public dissemination of the nonpublic information.

 

2. Liability for Tipping. Insiders may also be liable for improper transactions by any person (commonly referred to as a “tippee”) to whom they have disclosed Material Nonpublic Information regarding the Company or to whom they have made recommendations or expressed opinions on the basis of such information as to trading in the Company’s securities. The SEC has imposed large penalties even when the disclosing person did not profit from the trading. The SEC, the stock exchanges and the Financial Industry Regulatory Authority, Inc. use sophisticated electronic surveillance techniques to monitor trading and uncover insider trading.

 

3. Possible Disciplinary Actions. Individuals subject to the Policy who violate this Policy shall also be subject to disciplinary action by the Company, which may include suspension, forfeiture of perquisites, ineligibility for future participation in the Company’s equity incentive plans and/or termination of employment.

 

PERMITTED TRADING PERIOD

 

1. Black-Out Period and Trading Window.

 

To ensure compliance with this Policy and applicable federal and state securities laws, the Company requires that all officers, directors, employees, members of the immediate family or household of any such person and others who are subject to this Policy refrain from conducting any transactions involving the purchase or sale of the Company’s securities, other than during the period in any fiscal quarter commencing at the close of business on the second Trading Day following the date of public disclosure of the financial results for the prior fiscal quarter or year and ending on the twenty-fifth day of the third month of the fiscal quarter (the “Trading Window”). If such public disclosure occurs on a Trading Day before the markets close, then such date of disclosure shall be considered the first Trading Day following such public disclosure.

 

Notwithstanding the foregoing, persons subject to this Policy may submit a request to the Company to purchase or sell the Company’s securities outside the Trading Window on the basis that they do not possess any Material Nonpublic Information. The Compliance Officer shall review all such requests and may grant such requests on a case-by-case basis if he or she determines that the person making such request does not possess any Material Nonpublic Information at that time.

 

It is the Company’s policy that the period when the Trading Window is “closed” is a particularly sensitive period of time for transactions in the Company’s securities from the perspective of compliance with applicable securities laws. This is because Insiders, as any quarter progresses, are increasingly likely to possess Material Nonpublic Information about the expected financial results for the quarter. The purpose of the Trading Window is to avoid any unlawful or improper transactions or the appearance of any such transactions.

 

A-4

 

 

It should be noted that even during the Trading Window any person possessing Material Nonpublic Information concerning the Company shall not engage in any transactions in the Company’s (or any other company’s, as applicable) securities until such information has been known publicly for at least two Trading Days. The Company has adopted the policy of delaying trading for “at least two Trading Days” because the securities laws require that the public be informed effectively of previously undisclosed material information before Insiders trade in the Company’s securities. Public disclosure may occur through a widely disseminated press release or through filings, such as Forms 10-Q and/or 8-K, with the SEC. Furthermore, in order for the public to be effectively informed, the public must be given time to evaluate the information disclosed by the Company. Although the amount of time necessary for the public to evaluate the information may vary depending on the complexity of the information, generally two Trading Days is a sufficient period of time.

 

From time to time, the Company may also require that Insiders suspend trading because of developments known to the Company and not yet disclosed to the public. In such event, such persons may not engage in any transaction involving the purchase or sale of the Company’s securities during such period and may not disclose to others the fact of such suspension of trading.

 

Although the Company may from time to time require during a Trading Window that Insiders and others suspend trading because of developments known to the Company and not yet disclosed to the public, each person is individually responsible at all times for compliance with the prohibitions against insider trading. Trading in the Company’s securities during the Trading Window should not be considered a “safe harbor,” and all directors, officers and other persons should use good judgment at all times.

 

Notwithstanding these general rules, Insiders may trade outside of the Trading Window provided that such trades are made pursuant to a pre-established plan or by delegation; these alternatives are discussed in the next section.

 

 2. Trading According to a Pre-established Plan or by Delegation.

 

Trading which is not “on the basis of” material non-public information may not give rise to insider trading liability. The SEC has adopted Rule 10b5-1 under which insider trading liability can be avoided if Insiders follow very specific procedures. In general, such procedures involve trading according to pre-established instructions, plans or programs (a “10b5-1 Plan”).

 

10b5-1 Plans must:

 

(a) Be documented by a contract, written plan, or formal instruction which provides that the trade take place in the future. For example, an Insider can contract to sell his or her shares on a specific date, or simply delegate such decisions to an investment manager, 401(k) plan administrator or similar third party. This documentation must be provided to the Company’s Insider Trading Compliance Officer or legal counsel;

 

A-5

 

 

(b) Include in its documentation the specific amount, price and timing of the trade, or the formula for determining the amount, price and timing. For example, the Insider can buy or sell shares in a specific amount and on a specific date each month, or according to a pre-established percentage (of the Insider’s salary, for example) each time that the share price falls or rises to pre-established levels. In the case where trading decisions have been delegated, the specific amount, price and timing need not be provided;

 

(c) Be implemented at a time when the Insider does not possess material non-public information. As a practical matter, this means that the Insider may set up a 10b5-1 Plan, or delegate trading discretion, only during a “Trading Window” (discussed in Section 1, above); and,

 

(d) Remain beyond the scope of the Insider’s influence after implementation. In general, the Insider must allow the 10b5-1 Plan to be executed without changes to the accompanying instructions, and the Insider cannot later execute a hedge transaction that modifies the effect of the 10b5-1 Plan. An Insider wishing to change the amount, price or timing of a 10b5-1 Plan can do so only during a “Trading Window” (discussed in Section 1, above). Termination of a 10b5-1 Plan may be undertaken at any time, provided that the termination must be approved in advance by the Company’s Insider Trading Compliance Officer in order to ensure that the Insider is not in possession of Material Nonpublic Information. If the Insider has delegated decision-making authority to a third party, the Insider cannot subsequently influence the third party in any way and such third party must not possess material non-public information at the time of any of the trades.

 

Prior to implementing a pre-established plan for trading, all officers and directors must receive the approval for such plan from the Company’s Insider Trading Compliance Officer or legal counsel.

 

3. Pre-Clearance of Trades.

 

Even during a Trading Window, all Insiders must comply with the Company’s “pre-clearance” process prior to trading in the Company’s securities, implementing a pre-established plan for trading, or delegating decision-making authority over the Insider’s trades. To do so, each Insider must contact the Company’s Insider Trading Compliance Officer or legal counsel prior to initiating any of these actions. The Company may also find it necessary, from time to time, to require compliance with the pre-clearance process from others who may be in possession of Material Nonpublic Information.

 

4. Individual Responsibility.

 

Every person subject to this Policy has the individual responsibility to comply with this Policy against insider trading, regardless of whether the Company has established a Trading Window applicable to that Insider or any other Insiders of the Company. Each individual, and not necessarily the Company, is responsible for his or her own actions and will be individually responsible for the consequences of their actions. Therefore, appropriate judgment, diligence and caution should be exercised in connection with any trade in the Company’s securities. An Insider may, from time to time, have to forego a proposed transaction in the Company’s securities even if he or she planned to make the transaction before learning of the Material Nonpublic Information and even though the Insider believes he or she may suffer an economic loss or forego anticipated profit by waiting.

 

A-6

 

 

5. Exceptions to the Policy.

 

Any exceptions to this Policy may only be made by advance written approval of each of: (i) the Company’s Chief Executive Officer, (ii) the Insider Trading Compliance Officer and (iii) the Chairman of the Audit Committee of the Board. Any such exceptions shall be immediately reported to the remaining members of the Board.

 

APPLICABILITY OF POLICY TO MATERIAL NONPUBLIC INFORMATION

REGARDING OTHER COMPANIES

 

This Policy and the guidelines described herein also apply to Material Nonpublic Information relating to other companies, including the Company’s customers, vendors or suppliers (“business partners”), when that information is obtained in the course of employment with, or other services performed on behalf of the Company. Civil and criminal penalties, as well as termination of employment, may result from trading on Material Nonpublic Information regarding the Company’s business partners. All Insiders should treat Material Nonpublic Information about the Company’s business partners with the same care as is required with respect to information relating directly to the Company.

 

PROHIBITION AGAINST BUYING AND SELLING

COMPANY COMMON STOCK WITHIN A SIX-MONTH PERIOD

Directors, Officers and 10% Stockholders

 

Purchases and sales (or sales and purchases) of Company common stock occurring within any six-month period in which a mathematical profit is realized result in illegal “short-swing profits.” The prohibition against short-swing profits is found in Section 16 of the Exchange Act. Section 16 was drafted as a rather arbitrary prohibition against profitable “insider trading” in a company’s securities within any six-month period regardless of the presence or absence of material nonpublic information that may affect the market price of those securities. Each executive officer, director and 10% stockholder of the Company is subject to the prohibition against short-swing profits under Section 16. Such persons are required to file Forms 3, 4 and 5 reports reporting his or her initial ownership of the Company’s common stock and any subsequent changes in such ownership. The Sarbanes-Oxley Act of 2002 requires executive officers and directors who must report transactions on a Form 4 to do so by the end of the second business day following the transaction date. Profit realized, for the purposes of Section 16, is calculated generally to provide maximum recovery by the Company. The measure of damages is the profit computed from any purchase and sale or any sale and purchase within the short-swing (i.e., six-month) period, without regard to any setoffs for losses, any first-in or first-out rules, or the identity of the shares of common stock. This approach sometimes has been called the “lowest price in, highest price out” rule.

 

In order to avoid trading activity that could inadvertently trigger a short-swing profit, it is the Company’s policy that no executive officer, director and 10% shareholder of the Company who has a 10b5-1 Plan in place may engage in voluntary purchases or sales of Company securities outside of and while such 10b5-1 Plan remains in place.

 

INQUIRIES

 

Please direct your questions as to any of the matters discussed in this Policy to the Company’s Insider Trading Compliance Officer or legal counsel.

 

A-7

 

 

Exhibit B

 

Section 16 Memorandum

 

To: All Officers, Directors and 10% Stockholders (“Section 16 Individuals”)

 

Re: Overview of Section 16 under the Securities Exchange Act of 1934, as Amended

 

 

 

A.Introduction.

 

This Memorandum provides an overview of Section 16 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the related rules promulgated by the SEC.

 

Each executive officer, director and 10% stockholder (commonly called an “Insider”) of McLaren Technology Acquisition Corp. (the “Company”) is personally responsible for complying with the provisions of Section 16, and failure by an Insider to comply strictly with his or her reporting requirements will result in obligations on the part of the Company to publicly disclose such failure. Moreover, Congress has granted to the SEC authority to seek monetary court-imposed fines on Insiders who fail to timely comply with their reporting obligations.

 

Section 16(a) of the Exchange Act provides that insiders of a corporation with a class of securities registered under Section 12 of the Exchange Act: (i) must file an initial report of their beneficial ownership of equity securities of the corporation (including derivative securities such as options, warrants, rights and stock appreciation rights) as of the later of the date on which the corporation becomes subject to Section 12 of the Exchange Act or ten days after the date they attain insider status, and (ii) must report subsequent changes in their beneficial ownership of equity and derivative securities of the corporation. Section 16(b) provides that insiders are liable to the corporation for any profits made on six-month short-swing transactions in the corporation’s securities. Section 16(c) prohibits insiders from engaging in both traditional short sales of the corporation’s securities and certain other transactions that are economically or functionally equivalent to a short sale.

 

B.Reporting Requirements under Section 16(a).

 

1. General. An Insider must disclose his or her holdings at the time he or she attains insider status and must disclose all subsequent changes in such holdings during the time the individual is an Insider (and, in certain circumstances, for up to six months after the individual ceases to be an Insider). Disclosure is made on one of three forms: the Initial Statement of Beneficial Ownership of Securities on Form 3; the Statement of Changes in Beneficial Ownership of Securities on Form 4; and the Annual Statement of Changes in Beneficial Ownership of Securities on Form 5.

 

2. Method of Filing.

 

(a) SEC. The Sarbanes-Oxley Act mandates that all Forms 3, 4 and 5 must be filed electronically.

 

B-1

 

 

(b) Company. The rules under Section 16 require that a copy of the applicable Form be sent to the person at the Company designated by the Company to receive such reports at the same time that copies are sent to the SEC. If no such person has been designated, reports are to be sent to the Corporate Secretary at the Company’s principal executive offices.

 

(c) Filing Date. In order to be able to demonstrate that an Insider’s filing has been timely made, it is essential that the Insider file the form with the SEC by 10:00 pm Eastern time on the applicable date of filing. In the event that a due date falls on a weekend or SEC holiday, the Form will be deemed timely filed if it is received (or receipt is guaranteed) by the next business day after such weekend or holiday.

 

(d) Securities to be Reported. A person who is subject to Section 16 must only report as beneficially owned those securities in which he or she has a pecuniary interest. See the discussion of “beneficial ownership” below at Section D.

 

3. Initial Report of Ownership - Form 3. Under Section 16(a), Insiders are required to make an initial report on Form 3 to the SEC of their holdings of all equity securities of the corporation (whether or not such equity securities are registered under the Exchange Act). This would include all traditional types of securities, such as common stock, preferred stock and junior stock, as well as all types of derivative securities, such as warrants to purchase stock, rights to receive stock, options to purchase stock, puts and calls. Even Insiders who do not beneficially own any equity securities of the Company must file a report on Form 3 to that effect.

 

(a) Initial Filing Deadline. The initial statement of ownership for persons who become officers, directors or 10% stockholders of the Company must be filed within ten days after the date on which they become an officer, director or 10% stockholder, and should reflect ownership as of the date they became such an Insider.

 

(b) One-Time Filing. An Insider is required to file an initial statement of beneficial ownership on Form 3 only once, unless such person ceases to be an Insider and later becomes an Insider again. Thus, an additional statement on such Form is not required when either (1) the Insider attains a second “Insider” position (such as the election of the President to the Board), or (2) an additional class of equity securities of the Company is registered under Section 12.

 

4. Changes in Ownership - Form 4. An Insider should use Form 4 to report (i) all transactions that are not exempt from Section 16(b) and (ii) all exercises and conversions of derivative securities (e.g. stock options) regardless of whether they are exempt. Directors, officers and 10% stockholders of U.S. public companies are required to file their Form 4 reports under Section 16 of the Exchange Act by the second business day after execution of a transaction.

 

(a) Prior Transactions. Insiders of the Company need not report transactions that occurred prior to the date they first became an officer, director or 10% stockholder, and those transactions may not become a basis for short-swing profit liability under Section 16(b). However, a director or officer who becomes subject to Section 16 solely as a result of the issuer first registering a class of its equity securities pursuant to Section 12 of the Exchange Act is subject to the reporting and liability provisions of Section 16 with respect to any transactions conducted in the six months prior to the first transaction requiring a filing on Form 4 after such registration.

 

B-2

 

 

(b) Termination of Insider Status. If a person ceases to be an officer or director, he or she continues to be subject to the reporting and liability provision of Section 16 for up to six months following termination of such status. As a result, he or she must file a Form 4 with respect to any non-exempt change in beneficial ownership which occurs within six months after any change in ownership which occurred before he or she ceased to be an officer or director. Such an individual must also file a Form 5 after his or her termination to report exempt and previously unreported transactions for that portion of the issuer’s fiscal year during which he or she was an officer or director, as well as to report exempt and previously unreported transactions occurring within six months of the last transaction conducted while the person was an officer or director subject to Section 16.

 

A 10% stockholder whose beneficial ownership (under the Section 13(d) voting or investment control test) drops below 10% need not report any subsequent transactions on Form 4 after reporting less than 10% but must file a Form 5 with respect to any exempt or previously unreported transactions that occurred during the portion of the fiscal year that such person was a 10% stockholder.

 

Both Form 4 and Form 5 have an exit box that should be checked when the Insider reports a transaction that takes him or her under 10% ownership.

 

(c) What Constitutes a Change in Beneficial Ownership. Generally, an Insider is deemed to have acquired (or disposed of) beneficial ownership of a security at the time he or she makes a firm commitment to acquire (or dispose of) the security. (Please see Section D below for a complete definition of “Beneficial Ownership.”) If it is necessary that certain conditions outside the Insider’s control be satisfied prior to the consummation of the purchase or sale and if it is uncertain whether such conditions will be satisfied, the Insider will not be deemed to have acquired beneficial ownership or to have divested himself or herself until such time as the conditions prescribed are satisfied and the undertaking to purchase or sell becomes a firm commitment.

 

An Insider is deemed to have acquired ownership of a derivative security (whether issued by the Company or a third party) upon grant or acquisition, regardless of when it becomes exercisable. Similarly, an Insider is deemed to have disposed of ownership of a derivative security upon its sale, cancellation or expiration. See Sections B.6 and C below.

 

(d) Report Each Change of Ownership. Except for certain exempt transactions that may be reported on a Form 5, every change of ownership must be reported on Form 4.

 

5. Special Transactional Reporting Requirements. Changes in beneficial ownership that constitute exempt transactions under Section 16(a) or Section 16(b), other than the exercise of an option, need not be reported currently on Form 4. Such transactions fall into two categories: (i) those which must be reported in the annual filing on Form 5, and (ii) those which need not be reported at all. The following are some examples of transactions in these categories.

 

B-3

 

 

(i) Annual Filing on Form 5

 

(a) Small Acquisitions. Reporting an acquisition of an equity security not exceeding $10,000 in market value, or of the right to acquire such securities, may be deferred until the annual filing on Form 5, so long as (A) total acquisitions of the same class of security (including securities underlying derivative securities) within the preceding six months do not exceed $10,000 in market value, and (B) the person making the acquisition does not within six months thereafter make any disposition that is not exempt from Section 16(b) of the Exchange Act. Once either of the conditions described in (A) and (B) is not met, the small acquisition must be reported on Form 4 before the end of the second business day following the day in in which the condition(s) fail.

 

(b) Gifts and Inheritance. Acquisitions and dispositions of the Company’s securities pursuant to bona fide gifts or by will or the laws of descent and distribution are exempt from the liability provisions of Section 16(b). Insiders need not report such acquisitions or dispositions until the Form 5 for the fiscal year in which such transaction occurs.

 

(c) Option Grants under Rule 16b-3. The grant of an option to an Insider pursuant to Rule 16b-3 is exempt from liability and is reportable on Form 4. See Section C below.

 

(ii) No Reporting Required.

 

(a) Stock Splits and Stock Dividends. Insiders need not report the acquisition or disposition of stock via stock splits or stock dividends that are provided pro rata to all security holders, and such acquisitions and dispositions are exempt from the liability provision of Section 16(b). It is advisable for Insiders to use the extra space provided on Form 4 or Form 5 to explain any change in their holdings resulting from such events.

 

(b) Pro Rata Rights. Acquisitions of stockholder rights granted pro rata to all holders of a class of registered equity securities (including so-called “poison pill” stockholder rights) are exempt from the reporting and liability provisions of Section 16.

 

6. Year-End Filing - Form 5. An Insider must file a Form 5 within 45 days after the end of the issuer’s fiscal year (February 14) unless all holdings and transactions that are required to be reported on Form 5 (including exempt transactions) have already been reported as of the date the Form 5 is due.

 

If not previously reported, the following transactions must be reported on Form 5: (a) any transaction during the last fiscal year that was exempt from the operation of the short-swing profit recovery rules under Section 16(b) (such as grants of options under Rule 16b-3); and (b) any holdings or transactions that should have been reported during the Company’s last fiscal year (two fiscal years for the first Form 5 filed) on a Form 3 or Form 4, but were not reported. The Form 5 filing requirements apply to each person who was an Insider during any portion of the applicable fiscal year.

 

B-4

 

 

7. Reporting Obligations Regarding Certain Transactions in Derivative Securities. In general, the acquisition or disposition of any option, warrant, put or call, whether or not transferable or then exercisable, is a reportable purchase or sale of the underlying security to which such derivative security relates, and requires the filing of a Form 4.

 

(a) Grant of Option or Warrant. If a derivative security is granted pursuant to Rule 16b-3, the otherwise reportable purchase is exempt and need not be reported until the annual filing on Form 5. If an Insider receives a derivative security other than pursuant to Rule 16b-3, the acquisition is deemed to be a purchase for Section 16 purposes and must be currently reported on Form 4.

 

(b) Exercise or Conversion of Option, Warrant or Other Right. The exercise of any option, warrant or other right to purchase securities must be currently reported on Form 4.

 

(c) Pledges. The right of a pledgee or borrower of securities to sell the pledged or borrowed securities is not a derivative security or “option” for purposes of Section 16, and the acquisition or disposition of such a right does not require the filing of a Form 4. Moreover, the SEC Staff has taken the position that bona fide pledges or loans of securities do not represent changes in beneficial ownership and need not be reported by the pledgor or lender. However, the sale of the pledged or borrower securities by the pledgee or borrower must be reported by the pledgor or lender and may result in Section 16(b) liability for the pledgor or lender.

 

C.Securities Acquired Pursuant to Rule 16b-3.

 

1. General. Rule 16b-3 generally provides exemptions from Section 16(b) for non-discretionary transactions by Insiders (e.g., not at the volition of the Insider). Rule 16b-3 provides that a grant or award of equity securities is exempt from Section 16 if any of the following conditions are met:

 

(1) the transaction is approved in advance by the board of directors or a committee of the board composed solely of two or more non-employee directors;

 

(2) the transaction is approved in advance by the stockholders, or subsequently ratified by the stockholders by the date of the next annual meeting of stockholders; or

 

(3) the securities so acquired are held by the officer or director for six months following the date of such acquisition.

 

2. Transactions Must Comply with Rule 16b-3. Individual transactions must meet certain general requirements in order to qualify for beneficial treatment under Rule 16b-3.

 

D.Determining Beneficial Ownership.

 

The issue of beneficial ownership arises in two contexts under Section 16:

 

1. Determining Who is a Ten Percent Holder. Beneficial ownership in the Section 16 context is determined by reference to Rule 13d-3, which provides that a person is the beneficial owner of securities if that person has or shares voting or dispositive power with respect to such securities, or can acquire such power within 60 days through the exercise or conversion of derivative securities.

 

B-5

 

 

2. Determining Beneficial Ownership for Reporting and Short-Swing Profit Liability. For all Section 16 purposes other than determining who is a ten percent holder, beneficial ownership means a direct or indirect pecuniary interest in the subject securities through any contract, arrangement, understanding, relationship or otherwise. “Pecuniary interest” means the opportunity, directly or indirectly, to profit or share in any profit derived from a transaction in the subject securities. Discussed below are several of the situations that may give rise to an indirect pecuniary interest.

 

(a) Family Holdings. An Insider is deemed to have an indirect pecuniary interest in securities held by members of the Insider’s immediate family sharing the same household. Immediate family includes grandparents, parents (and step-parents), spouses, siblings, children (and step-children) and grandchildren, as well as parents-in-law, siblings-in-law, children-in-law and all adoptive relationships. An Insider may disclaim beneficial ownership of shares held by members of his or her immediate family, but the burden of proof will be on the Insider to uphold the lack of a pecuniary interest.

 

(b) Partnership Holdings. Beneficial ownership of a partnership’s securities is attributed to the general partner of a limited partnership in proportion to such person’s partnership interest. Such interest is measured by the greater of the general partner’s share of partnership profits or of the general partner’s capital account (including any limited partnership interest held by the general partner).

 

(c) Corporate Holdings. Beneficial ownership of securities held by a corporation will not be attributed to its stockholders who are not controlling stockholders and who do not have or share investment control over the corporation’s portfolio securities.

 

(d) Derivative Securities. Ownership of derivative securities (warrants, rights, stock appreciation rights, convertible securities, options and the like) is treated as indirect ownership of the underlying equity securities. Acquisition of derivative securities must be reported, although the timing of such reporting depends upon the Rule 16b-3 status of the employee plan under which the grant was made.

 

E.Delinquent Filings.

 

1. Disclosure Requirements. Item 405 of Regulation S-K requires the Company to disclose in its proxy statements, information statements and Annual Reports on Form 10-K information regarding delinquent filings under Section 16(a) by Insiders. The Company must identify by name its Insiders who, during the fiscal year, reported transactions late or failed to file required reports, and must disclose the number of delinquent filings and transactions for each such Insider. The Company does not have an obligation to research and make inquiry regarding the delinquent Section 16(a) filings but may rely on the information disclosed on Forms 3, 4 and 5. The Company may also rely on a written representation from the Insider that no Form 5 filing is required but should retain the representation for two years.

 

B-6

 

 

2. Correcting Late Filings. If a particular transaction or holding has not been reported, the Insider must file a new form or the Insider must amend the original filing by filing a new form. The transaction reported in an untimely manner would be disclosed pursuant to Item 405 for the fiscal year in which the report was filed, even if the transaction related to and should have been reported in a prior fiscal year.

 

3. Potential Liability. The SEC has been empowered by Congress to seek civil penalties against those who fail to comply with the reporting requirements of Section 16. Penalties for failure to timely file may range from $5,000 to $100,000 per violation. Moreover, if the SEC obtains a cease-and-desist order prohibiting future violations of the reporting requirements under Section 16, each day that a filing is late may be treated as a separate offense, thereby multiplying the penalty amount by the number of days that the form is delinquent.

 

F.Other Prohibited Insider Transactions Under Section 16(c).

 

Section 16(c) of the Exchange Act provides that it is unlawful for an Insider to sell any equity security (including a derivative security) of a corporation if the person selling the security (1) does not own the security sold, or (2) owns the security but does not deliver it against such sale within 20 days thereafter, or does not, within five days after such sale, deposit it in the mails or other usual channels of transportation.

 

Clause (1) above is directed to the traditional “short sale” where the seller borrows stock to make delivery on sale and repays his or her loan with securities purchased thereafter.

 

Clause (2) above is directed to either long sales or “short sales against the box” where delivery is not made within the required time limits.

 

The interactions of Section 16(c) with the derivative securities concept is not entirely clear, but the establishment of or increase in a “put equivalent position” (a broadly defined term that includes any type of short position) is considered functionally and economically equivalent to a prohibited short sale if the Insider does not own underlying securities sufficient to cover the put equivalent position.

 

B-7

 

 

Exhibit C

 

Innovative Eyewear Inc.

 

 Insider Trading Compliance Program - Pre-Clearance Checklist

 

Individual Proposing to Trade: _________________________

 

Number of Shares covered by Proposed Trade: _________________________

 

Date: _________________________

 

Trading Window. Confirm that the trade will be made during the Company’s “trading window.”

 

Section 16 Compliance. Confirm, if the individual is subject to Section 16, that the proposed trade will not give rise to any potential liability under Section 16 as a result of matched past (or intended future) transactions. Also, ensure that a Form 4 has been or will be completed and will be timely filed.

 

Prohibited Trades. Confirm, if the individual is subject to Section 16, that the proposed transaction is not a “short sale,” put, call or other prohibited or strongly discouraged transaction.

 

Rule 144 Compliance (as applicable). Confirm that:

 

Current public information requirement has been met;

 

Shares are not restricted or, if restricted, the one year holding period from the closing of the Company’s initial business combination has been met;

 

Volume limitations are not exceeded (confirm that the individual is not part of an aggregated group);

 

The manner of sale requirements have been met; and

 

The Notice of Form 144 Sale has been completed and filed.

 

Rule 10b-5 Concerns. Confirm that (i) the individual has been reminded that trading is prohibited when in possession of any material information regarding the Company that has not been adequately disclosed to the public, and (ii) the Insider Trading Compliance Officer has discussed with the individual any information known to the individual or the Insider Trading Compliance Officer which might be considered material, so that the individual has made an informed judgment as to the presence of inside information.

 

   
Signature of Insider Trading Compliance Officer

 

C-1

EX-23.1 4 innovativeeye_ex23-1.htm EXHIBIT 23.1

 

Exhibit 23.1

 

 

Consent of Registered Independent Public Accounting Firm

 

Innovative Eyewear, Inc.

Miami, Florida

 

We consent to the incorporation by reference in the Registration Statement of Innovative Eyewear, Inc. (the “Company”) on Form S-8 (File No. 333-267677) and Form S-3 (File No. 333-276938), of our report dated March 25, 2024 with respect to our audit of the financial statements of the Company as of December 31, 2023 and 2022, and for each of the years then ended, which report is included in this Annual Report on Form 10-K of the Company for the year ended December 31, 2023.

 

 

Tampa, Florida

March 25, 2024

 

 

 

 

 

cbh.com

 

 

EX-31.1 5 innovativeeye_ex31-1.htm EXHIBIT 31.1

 

Exhibit 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO SECURITIES EXCHANGE ACT RULES 13A-14(A) AND 15D-14(A)

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Harrison Gross, Chief Executive Officer of Innovative Eyewear, Inc., certify that:

 

1. I have reviewed this Annual Report on Form 10-K of Innovative Eyewear, Inc.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 25, 2024 /s/ Harrison Gross
  Harrison Gross
  Chief Executive Officer

 

 

EX-31.2 6 innovativeeye_ex31-2.htm EXHIBIT 31.2

 

Exhibit 31.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO SECURITIES EXCHANGE ACT RULES 13A-14(A) AND 15D-14(A)

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Konrad Dabrowski, Chief Financial Officer of Innovative Eyewear, Inc., certify that:

 

1. I have reviewed this Annual Report on Form 10-K of Innovative Eyewear, Inc.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 25, 2024 /s/ Konrad Dabrowski
  Konrad Dabrowski
  Chief Financial Officer

 

 

EX-32.1 7 innovativeeye_ex32-1.htm EXHIBIT 32.1

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Pursuant to Section 1350 of Title 18 of the United States Code, the undersigned, Harrison Gross, Chief Executive Officer of Innovative Eyewear, Inc. (the “Company”), hereby certifies that:

 

1. The Company’s Form 10-K Annual Report for the fiscal year ended December 31, 2023 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
   
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: March 25, 2024 /s/ Harrison Gross
  Harrison Gross
  Chief Executive Officer

 

 

EX-32.2 8 innovativeeye_ex32-2.htm EXHIBIT 32.2

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Pursuant to Section 1350 of Title 18 of the United States Code, the undersigned, Konrad Dabrowski, Chief Financial Officer of Innovative Eyewear, Inc. (the “Company”), hereby certifies that:

 

1. The Company’s Form 10-K Annual Report for the fiscal year ended December 31, 2023 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
   
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: March 25, 2024 /s/ Konrad Dabrowski
  Konrad Dabrowski
  Chief Financial Officer

 

 

EX-97.1 9 innovativeeye_ex97-1.htm EXHIBIT 97.1

 

Exhibit 97.1

 

INNOVATIVE EYEWEAR INC.

 

EXECUTIVE COMPENSATION CLAWBACK POLICY

 

Adopted as of October 27, 2023

 

The Board of Directors (the “Board”) of Innovative Eyewear Inc., (the “Company”) has adopted the following executive compensation clawback policy (this “Policy”). This Policy shall supplement any other clawback or compensation recovery policy or policies adopted by the Company or included in any agreement between the Company, or any subsidiary of the Company, and a person covered by this Policy. If any such other policy or agreement provides that a greater amount of compensation shall be subject to clawback, such other policy or agreement shall apply to the amount in excess of the amount subject to clawback under this Policy.

 

This Policy shall be interpreted to comply with Securities and Exchange Commission (“SEC”) Rule 10D-1 and Listing Rule 5608 (the “Listing Rule”) of The Nasdaq Stock Market, LLC (“Nasdaq”), as may be amended or supplemented and interpreted from time to time by Nasdaq. To the extent this Policy is any manner deemed inconsistent with the Listing Rule, this Policy shall be treated as having been amended to be compliant with the Listing Rule.

 

1. Definitions. Unless the context otherwise the following definitions apply for purposes of this Policy:

 

(a) Executive Officer. An executive officer is the Company’s chief executive officer and/or president, principal financial officer, principal accounting officer (or if there is no such accounting officer, the controller), any vice-president of the Company in charge of a principal business unit, division, or function (such as sales, administration, or finance), any other officer who performs a policy-making function, or any other person who performs similar policy-making functions for the Company. Executive officers of the Company’s parent(s) or subsidiaries are deemed executive officers of the Company if they perform such policy making functions for the Company. Policy-making function is not intended to include policy-making functions that are not significant. Identification of an executive officer for purposes of the Listing Rule would include at a minimum executive officers identified in the Listing Rule.

 

(b) Financial Reporting Measures. Financial reporting measures are measures that are determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, and any measures that are derived wholly or in part from such measures. Stock price and total shareholder return are also financial reporting measures. A financial reporting measure need not be presented within the financial statements or included in a filing with the SEC and may be such financial measures as may be determined by the Board or the Compensation Committee thereof (the “Compensation Committee”).

 

(c) Incentive-Based Compensation. Incentive-based compensation is any compensation that is granted, earned or vested based wholly or in part upon the attainment of a financial reporting measure.

 

(d) Received. Incentive-based compensation is deemed “received” in the Company’s fiscal period during which the financial reporting measure specified in the incentive-based compensation award is attained, even if the payment or grant of the incentive-based compensation occurs after the end of that period.

 

 

 

 

2. Application of this Policy. This recovery of Incentive-Based Compensation from an Executive Officer as provided for in this Policy shall apply only in the event that the Company is required to prepare an accounting restatement due to the material noncompliance of Company with any financial reporting requirement under the United States securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period.

 

3. Recovery Period.

 

(a) The Incentive-Based Compensation subject to recovery is the Incentive-Based Compensation Received during the three (3) completed fiscal years immediately preceding the date that the Company is required to prepare an accounting restatement as described in Section 2 above, provided that the person served as an Executive Officer at any time during the performance period applicable to the Incentive-Based Compensation in question. The date that the Company is required to prepare an accounting restatement shall be determined pursuant to the Listing Rule.

 

(b) Notwithstanding the foregoing, this Policy shall only apply if the Incentive-Based Compensation is Received (i) while the Company has a class of securities listed on Nasdaq and (ii) on or after October 2, 2023.

 

(c) The provisions of the Listing Rule shall apply with respect to Incentive-Based Compensation received during a transition period arising due to a change in the Company’s fiscal year.

 

4. Erroneously Awarded Compensation. The amount of Incentive-Based Compensation subject to recovery from the applicable Executive Officers under this Policy (“Erroneously Awarded Compensation”) shall be equal to the amount of Incentive-Based Compensation Received that exceeds the amount of Incentive Based-Compensation that otherwise would have been Received had it been determined based on the restated amounts and shall be computed without regard to any taxes paid. For Incentive-Based Compensation based on stock price or total shareholder return, where the amount of Erroneously Awarded Compensation is not subject to mathematical recalculation directly from the information in an accounting restatement: (a) the amount shall be based on a reasonable estimate by the Company’s Chief Financial Officer (or principal accounting officer, if the office of Chief Financial Officer is not then filled) of the effect of the accounting restatement on the stock price or total shareholder return upon which the Incentive-Based Compensation was received, which estimate shall be subject to the review and approval of the Compensation Committee; and (b) the Company must maintain reasonable documentation of the determination of that reasonable estimate and provide such documentation to Nasdaq if requested. Notwithstanding the foregoing, if the proposed Incentive-Based Compensation recovery would affect compensation paid to the Company’s Chief Financial Officer, the determination shall be made by the Compensation Committee.

 

5. Timing of Recovery. The Company shall recover any Erroneously Awarded Compensation reasonably promptly except to the extent that the conditions of paragraphs (a), (b), or (c) below apply. The Compensation Committee shall determine the repayment schedule for each amount of Erroneously Awarded Compensation in a manner that complies with this “reasonably promptly” requirement. Such determination shall be consistent with any applicable legal guidance by the SEC, Nasdaq, judicial opinion, or otherwise. The determination of “reasonably promptly” may vary from case to case and the Compensation Committee is authorized to adopt additional rules or policies to further describe what repayment schedules satisfy this requirement.

 

2

 

 

(a) Erroneously Awarded Compensation need not be recovered if the direct expense paid to a third party to assist in enforcing (or making determinations in connection with the enforcement of) this Policy would exceed the amount to be recovered and the Compensation Committee has made a determination that recovery would be impracticable. Before concluding that it would be impracticable to recover any amount of Erroneously Awarded Compensation based on expense of enforcement, the Company shall (i) make a reasonable attempt to recover such Erroneously Awarded Compensation, (ii) document such reasonable attempt or attempts to recover, and (iii) provide appropriate documentation to the Compensation Committee or Nasdaq, if requested.

 

(b) Erroneously Awarded Compensation need not be recovered if recovery would violate home country law where that law was adopted prior to November 28, 2022. Before concluding that it would be impracticable to recover any amount of Erroneously Awarded Compensation based on a violation of home country law, the Company shall obtain an opinion of home country counsel, in form an substance that would be reasonably acceptable to Nasdaq, that recovery would result in such a violation and shall provide such opinion to Nasdaq, if requested.

 

(c) Erroneously Awarded Compensation need not be recovered if recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of 26 U.S.C. 401(a)(13) or 26 U.S.C. 411(a) and the regulations thereunder (as such provision may be amended, modified or supplemented).

 

6. Compensation Committee Decisions. Decisions of the Compensation Committee with respect to this Policy shall be final, conclusive and binding on all Executive Officers subject to this Policy.

 

7. No Indemnification. Notwithstanding anything to the contrary in any other policy of the Company or any agreement between the Company and an Executive Officer, no Executive Officer shall be indemnified by the Company against the loss arising from the recovery of any Erroneously Awarded Compensation.

 

8. Agreement to Policy by Executive Officers. The Company shall take reasonable steps to inform Executive Officers of this Policy and obtain their express agreement to this Policy, which steps may constitute the inclusion of this Policy as an attachment to any award that is accepted by an Executive Officer. This Policy shall be deemed to apply to each employment or grant agreement between the Company or any of its subsidiaries and any Executive Officer subject to this Policy.

 

 

# # #

 

3

GRAPHIC 10 img_001.jpg GRAPHIC begin 644 img_001.jpg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img_002.jpg GRAPHIC begin 644 img_002.jpg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end GRAPHIC 12 fin_001.jpg GRAPHIC begin 644 fin_001.jpg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end GRAPHIC 13 fin_002.jpg GRAPHIC begin 644 fin_002.jpg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ex23-1_001.jpg GRAPHIC begin 644 ex23-1_001.jpg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end GRAPHIC 15 ex23-1_002.jpg GRAPHIC begin 644 ex23-1_002.jpg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lucy-20231231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 995512 - Disclosure - GENERAL INFORMATION link:presentationLink link:calculationLink link:definitionLink 995513 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 995514 - Disclosure - GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - INCOME TAX PROVISION link:presentationLink link:calculationLink link:definitionLink 995516 - Disclosure - INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 995517 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 995518 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 995519 - Disclosure - STOCKHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 995520 - Disclosure - STOCK-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 995521 - Disclosure - EARNINGS PER SHARE link:presentationLink link:calculationLink link:definitionLink 995522 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 995523 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 995524 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - INCOME TAX PROVISION (Tables) link:presentationLink link:calculationLink link:definitionLink 995526 - Disclosure - INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 995527 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) link:presentationLink link:calculationLink link:definitionLink 995528 - Disclosure - STOCKHOLDERS’ EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 995529 - Disclosure - STOCK-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 995530 - Disclosure - EARNINGS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 995531 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 995532 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) link:presentationLink link:calculationLink link:definitionLink 995533 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995534 - Disclosure - INCOME TAX PROVISION (Details) link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - INCOME TAX PROVISION (Details 1) link:presentationLink link:calculationLink link:definitionLink 995536 - Disclosure - INCOME TAX PROVISION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995537 - Disclosure - INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 995538 - Disclosure - INTANGIBLE ASSETS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995539 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995540 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) link:presentationLink link:calculationLink link:definitionLink 995541 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995542 - Disclosure - STOCKHOLDERS' EQUITY (Details) link:presentationLink link:calculationLink link:definitionLink 995543 - Disclosure - STOCKHOLDERS’ EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995544 - Disclosure - STOCK BASED COMPENSATION (Details) link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - STOCK BASED COMPENSATION (Details 1) link:presentationLink link:calculationLink link:definitionLink 995546 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995547 - Disclosure - EARNINGS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 995548 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 17 lucy-20231231_cal.xml XBRL CALCULATION FILE EX-101.DEF 18 lucy-20231231_def.xml XBRL DEFINITION FILE EX-101.LAB 19 lucy-20231231_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock, $0.00001 par value Warrants to purchase Common Stock Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Stock Subscription Receivable [Member] Retained Earnings [Member] Concentration Risk Benchmark [Axis] Accounts Receivable [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Customer [Axis] Single Customer [Member] Long-Lived Tangible Asset [Axis] Mobile Kiosk Display [Member] Computer Equipment [Member] Office Equipment [Member] Internal Use Software [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Finite-Lived Intangible Assets by Major Class [Axis] Patents [Member] Related Party, Type [Axis] Tekcapital And Affiliates [Member] Sale of Stock [Axis] IPO [Member] Lucyd [Member] Tekcapital Europe Ltd [Member] Transaction Type [Axis] Settlement Agreement [Member] Maxim [Member] Class of Warrant or Right [Axis] Warrant [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Inducement Letter [Member] New Warrants [Member] Listed Warrants [Member] Common Warrants [Member] Private Warrants [Member] Underwriter Warrants [Member] Placemen Agent Warrants [Member] Title of Individual [Axis] Officers And Management [Member] Non Management Directors [Member] Employees And Consultants [Member] Employee [Member] Warrants to purchase Common Stock Employees And Consultants 1 [Member] Officers And Management 1 [Member] Award Type [Axis] Restricted Stock Units (RSUs) [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] ICFR Auditor Attestation Flag Document Financial Statement Error Correction [Flag] Auditor Name Auditor Firm ID Auditor Location Statement of Financial Position [Abstract] TOTAL ASSETS Current Assets Cash and cash equivalents Accounts receivable, net of allowances of $25,772 and $92,646, respectively Prepaid expenses Inventory prepayment Inventory Due from Tekcapital and Affiliates Other current assets Total Current Assets Non-Current Assets Patent costs, net Capitalized software costs Property and equipment, net Other non-current assets TOTAL ASSETS LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities Current Liabilities Accounts payable and accrued expenses Deferred revenue Due to Tekcapital and Affiliates Related party convertible debt Total Current Liabilities Non-Current Liabilities Deferred revenue TOTAL LIABILITIES Commitments and contingencies (Note 7) Stockholders’ Equity Common stock (par value $0.00001, 50,000,000 shares authorized, and 12,917,239 and 7,307,157 shares issued and outstanding as of December 31, 2023 and 2022, respectively) Additional paid-in capital Accumulated deficit TOTAL STOCKHOLDERS’ EQUITY TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY Allowance Common stock, par value (in Dollars per share) Common stock, shares authorized Common stock, shares issued Common stock, shares Outstanding Income Statement [Abstract] Revenues, net Less: Cost of Goods Sold Gross Deficit Operating Expenses: General and administrative Sales and marketing Research and development Related party management fee Total Operating Expenses Other Income (Expense) Interest Expense Total Other Income (Expense), net Net Loss Weighted average number of shares outstanding Loss per share, basic Loss per share, diluted Beginning balance, value Beginnig balance, shares Collection of stock subscription receivable Write-off of uncollectible stock subscription receivable Initial public offering (see Note 8) Initial public offering, shares Shares issued for conversion of related party convertible note (see Note 6) InitiShares issued for conversion of related party convertible note, shares Exercises of stock options Exercises of stock options, Shares Exercises of warrants by stockholders (see Note 8) Exercise of warrants by stockholders, shares Second public offering (see Note 8) Second public offering, shares Exercises of warrants related to private placement transaction (see Note 8) Exercises of warrants related to private placement transaction, shares Stock-based compensation (see Note 9) Net loss Ending balance, value Ending balance, shares Statement of Cash Flows [Abstract] Operating Activities Net Loss Adjustments to reconcile net loss to net cash used in operating activities: Depreciation Amortization Non-cash interest expense Stock-based compensation expense Expenses paid by Tekcapital and Affiliates (Recovery of) provision for doubtful accounts Realized gain on debt securities (U.S. Treasury bills) Loss on sale of assets Changes in operating assets and liabilities: Accounts receivable Accounts payable and accrued expenses Prepaid expenses Inventory Other current assets Contract assets and liabilities Net cash flows from operating activities Investing Activities Purchases of debt securities (U.S. Treasury bills) Proceeds from redemption of debt securities (U.S. Treasury bills) Patent costs Purchases of property and equipment Proceeds from sale of property and equipment Capitalized software expenditures Net cash flows from investing activities Financing Activities Proceeds from initial public offering (see Note 8) Proceeds from second public offering (see Note 8) Proceeds from exercises of warrants (see Note 8) Proceeds from exercise of stock options Collection of stock subscription receivable Proceeds from related party convertible debt (see Note 6) Repayment of related party convertible debt (see Note 6) Repayment of amounts due to Tekcapital and Affiliates Net cash flows from financing activities Net Change In Cash Cash at Beginning of Year Cash at End of Year Significant Non-Cash Transactions Expenses paid for by Tekcapital and Affiliates, reported as increase in Due to/from Tekcapital and Affiliates and related party convertible debt Write-off of uncollectible stock subscription receivable Issuance of shares from conversion of related party convertible debt Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance [Table Text Block] Company Selected Measure Name Named Executive Officers, Footnote [Text Block] Peer Group Issuers, Footnote [Text Block] Changed Peer Group, Footnote [Text Block] PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote [Text Block] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Equity Valuation Assumption Difference, Footnote [Text Block] Compensation Actually Paid vs. Total Shareholder Return [Text Block] Compensation Actually Paid vs. Net Income [Text Block] Compensation Actually Paid vs. Company Selected Measure [Text Block] Total Shareholder Return Vs Peer Group [Text Block] Compensation Actually Paid vs. Other Measure [Text Block] Tabular List [Table Text Block] Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Attributable to Parent Company Selected Measure Amount Other Performance Measure Amount Adjustment to Compensation Amount PEO Name Measure Name Non-GAAP Measure Description [Text Block] Additional 402(v) Disclosure [Text Block] Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date [Axis] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis [Text Block] Stock Price or TSR Estimation Method [Text Block] Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined [Text Block] Forgone Recovery, Individual Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability [Text Block] Outstanding Recovery, Individual Name Outstanding Recovery Compensation Amount Restatement Does Not Require Recovery [Text Block] Awards Close in Time to MNPI Disclosures [Table] Award Timing MNPI Disclosure [Text Block] Award Timing Method [Text Block] Award Timing Predetermined [Flag] Award Timing MNPI Considered [Flag] Award Timing, How MNPI Considered [Text Block] MNPI Disclosure Timed for Compensation Value [Flag] Awards Close in Time to MNPI Disclosures [Table Text Block] Awards Close in Time to MNPI Disclosures, Individual Name Award Underlying Securities Amount Award Exercise Price Award Grant Date Fair Value Underlying Security Market Price Change, Percent Insider Trading Arrangements [Line Items] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted Adoption Date Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated Termination Date Arrangement Duration Aggregate Available Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted [Flag] Insider Trading Policies and Procedures Not Adopted [Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] GENERAL INFORMATION Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES GOING CONCERN Income Tax Disclosure [Abstract] INCOME TAX PROVISION Goodwill and Intangible Assets Disclosure [Abstract] INTANGIBLE ASSETS Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Equity [Abstract] STOCKHOLDERS’ EQUITY STOCK-BASED COMPENSATION Earnings Per Share [Abstract] EARNINGS PER SHARE Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of Presentation Use of Estimates Cash Equivalents Receivables and Credit Policy Inventory Intangible Assets Capitalized Software Property and Equipment Income Taxes Fair Value of Financial Instruments Concentrations of Credit Risk Stock-Based Compensation Revenue Recognition Shipping and Handling Recently Adopted Accounting Pronouncements Recently Issued Accounting Pronouncements Subsequent Events Schedule of allowance for doubtful account Schedule of estimated useful lives of property and equipment Schedule of reconciliation of federal statutory tax rate Schedule of deferred tax assets Schedule of intangible assets Schedule of future minimum payments due Schedule of stockholder’s equity Schedule fair value of options granted Schedule of number of share options and the weighted average exercise price outstanding Calculation of net earnings per common share - basic and diluted Balance at beginning Bad debt expense Write-offs Recoveries Balance at ending Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property and equipment, gross Property, Plant and Equipment, Useful Life Less: Accumulated depreciation Schedule of Product Information [Table] Product Information [Line Items] Bad debt expenses Depreciation expense Accounts receivable Concentrations of Credit Risk Revenue recognized Allowance for sales returns Income tax benefit at the statutory federal rate State income tax benefits, net of federal benefit Change in valuation allowance Total Deferred tax assets: Stock-based compensation Other – net Net operating losses – federal Net operating losses – state  Deferred tax assets Gross Less Valuation Allowance Net deferred tax assets Federal net operating loss carryforwards State net operating loss carryforwards Liabilities for uncertain tax positions Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets [Line Items] Intangible assets, gross Less: Accumulated amortization Intangible assets, net Amortization expense Future amortization Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Interest rate Convertible debt issued Conversion of stock, amount Number of shares converted Conversion Price Convertible notes balances Management fee Rent expenses 2024 2025 2026 2027 2028 Thereafter (through 2032) Total Offsetting Assets [Table] Offsetting Assets [Line Items] Settlement amount Accounts receivable written-off Net account receivable Legal matters liability Base term Class of Warrant or Right [Table] Class of Warrant or Right [Line Items] Warrants outstanding Exercise price Expiration Date Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary, Sale of Stock [Line Items] Preferred stock , shares authorized Preferred stock , shares issued Preferred stock, shares Outstanding Issauance of common stock Share Price Proceeds from offering Underwriters description Number of warrants purchased Cash proceeds Number of warrant exercised Sale of transaction Weighted avaerage exercise price per share, Option Outstanding at beginnig Option Outstanding at beginnig Weighted avaerage exercise price per share, Option Granted Option Granted Weighted avaerage exercise price per share, Option Exercised Option Exercised Weighted avaerage exercise price per share, Option Forfeited Option Forfeited Weighted avaerage exercise price per share, Option Outstanding at ending Option Outstanding at ending Weighted avaerage remaining contractual life (Years) Option Exercised Option Forfeited Weighted avaerage exercise price per share, Option Exercisable Option Exercisable Weighted avaerage remaining contractual life (Years), Option Exercisable Share price at date of grant Options life in years Risk free rate Expected volatility Expected dividend yield Grant date fair value of options Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table] Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] Stock granted Number of options purchased Exercise price Weighted average grant date fair value of options outstanding Unrecognized stock compensation expense Unrecognized stock compensation expense, term Number of common stock purchased Options outstanding intrinsic value Options exercisable intrinsic value Number of restricted stock units granted Restricted stock units vested description Stock-based compensation Straight line basis Basic and diluted: Net loss Weighted-average number of common shares Basic and diluted net loss per common share Subsequent Event [Table] Subsequent Event [Line Items] Loans payable Maturity date Number of stock issued Warrants to purchase Common Stock [Default Label] Assets, Current Assets Liabilities, Current Deferred Revenue, Noncurrent Liabilities [Default Label] Equity, Attributable to Parent Liabilities and Equity Cost of Revenue Gross Profit General and Administrative Expense Selling and Marketing Expense Research and Development Expense Operating Expenses Interest Expense Nonoperating Income (Expense) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Shares, Outstanding Debt Securities, Realized Gain (Loss) Gain (Loss) on Disposition of Assets for Financial Service Operations Increase (Decrease) in Accounts Receivable Increase (Decrease) in Accounts Payable and Accrued Liabilities Increase (Decrease) in Prepaid Expense Increase (Decrease) in Inventories Increase (Decrease) in Other Current Assets ContractAssetsAndLiabilities Net Cash Provided by (Used in) Operating Activities PurchasesOfDebtSecurities ProceedsFromRedemptionOfDebtSecurities PaymentToAcquirePatentCosts Payments to Acquire Property, Plant, and Equipment Payments to Acquire Intangible Assets Net Cash Provided by (Used in) Investing Activities CollectionOfStockSubscriptionReceivable Repayments of Convertible Debt RepaymentOfAmountsDueToTekcapitalAndAffiliates Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents WriteoffOfUncollectibleStockSubscriptionReceivables Inventory, Policy [Policy Text Block] Accounts Receivable, Allowance for Credit Loss, Writeoff Accounts Receivable, Allowance for Credit Loss, Recovery Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Concentration Risk, Percentage Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Income Tax Expense (Benefit) Deferred Tax Assets, Valuation Allowance Lessee, Operating Lease, Liability, to be Paid Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Period Increase (Decrease), Weighted Average Exercise Price EX-101.PRE 20 lucy-20231231_pre.xml XBRL PRESENTATION FILE XML 22 R1.htm IDEA: XBRL DOCUMENT v3.24.1
Cover - USD ($)
12 Months Ended
Dec. 31, 2023
Mar. 22, 2024
Jun. 30, 2023
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2023    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2023    
Current Fiscal Year End Date --12-31    
Entity File Number 001-41392    
Entity Registrant Name INNOVATIVE EYEWEAR, INC.    
Entity Central Index Key 0001808377    
Entity Tax Identification Number 85-0734861    
Entity Incorporation, State or Country Code FL    
Entity Address, Address Line One 11900 Biscayne Blvd.    
Entity Address, Address Line Two Suite 630    
Entity Address, City or Town North Miami    
Entity Address, State or Province FL    
Entity Address, Postal Zip Code 33181    
City Area Code 954    
Local Phone Number 826-0329    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Elected Not To Use the Extended Transition Period false    
Entity Shell Company false    
Entity Public Float     $ 6,916,698
Entity Common Stock, Shares Outstanding   12,933,544  
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Auditor Name Cherry Bekaert LLP    
Auditor Firm ID 677    
Auditor Location Tampa, Florida    
Common Stock, $0.00001 par value      
Title of 12(b) Security Common Stock, $0.00001 par value    
Trading Symbol LUCY    
Security Exchange Name NASDAQ    
Warrants to purchase Common Stock      
Title of 12(b) Security Warrants to purchase Common Stock    
Trading Symbol LUCYW    
Security Exchange Name NASDAQ    
XML 23 R2.htm IDEA: XBRL DOCUMENT v3.24.1
BALANCE SHEETS - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 4,287,447 $ 3,591,109
Accounts receivable, net of allowances of $25,772 and $92,646, respectively 93,211 110,258
Prepaid expenses 313,648 210,673
Inventory prepayment 323,520 197,750
Inventory 533,239 94,701
Due from Tekcapital and Affiliates 6,256
Other current assets 59,447 36,240
Total Current Assets 5,616,768 4,240,731
Non-Current Assets    
Patent costs, net 286,429 137,557
Capitalized software costs 110,073 110,073
Property and equipment, net 132,848 119,744
Other non-current assets 72,644 81,779
TOTAL ASSETS 6,218,762 4,689,884
Current Liabilities    
Accounts payable and accrued expenses 581,986 275,660
Deferred revenue 42,500 30,000
Due to Tekcapital and Affiliates 232,989
Related party convertible debt 61,356
Total Current Liabilities 624,486 600,005
Non-Current Liabilities    
Deferred revenue 35,450 65,450
TOTAL LIABILITIES 659,936 665,455
Commitments and contingencies (Note 7)
Stockholders’ Equity    
Common stock (par value $0.00001, 50,000,000 shares authorized, and 12,917,239 and 7,307,157 shares issued and outstanding as of December 31, 2023 and 2022, respectively) 129 73
Additional paid-in capital 22,528,112 14,330,343
Accumulated deficit (16,969,415) (10,305,987)
TOTAL STOCKHOLDERS’ EQUITY 5,558,826 4,024,429
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 6,218,762 $ 4,689,884
XML 24 R3.htm IDEA: XBRL DOCUMENT v3.24.1
BALANCE SHEETS (Parenthetical) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Allowance $ 25,772 $ 92,646
Common stock, par value (in Dollars per share) $ 0.00001 $ 0.00001
Common stock, shares authorized 50,000,000 50,000,000
Common stock, shares issued 12,917,239 7,307,157
Common stock, shares Outstanding 12,917,239 7,307,157
XML 25 R4.htm IDEA: XBRL DOCUMENT v3.24.1
STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Revenues, net $ 1,152,479 $ 659,788
Less: Cost of Goods Sold (1,271,808) (716,077)
Gross Deficit (119,329) (56,289)
Operating Expenses:    
General and administrative (3,886,960) (2,796,669)
Sales and marketing (2,047,069) (2,059,012)
Research and development (662,184) (524,692)
Related party management fee (140,000) (140,000)
Total Operating Expenses (6,736,213) (5,520,373)
Other Income (Expense) 195,150
Interest Expense (3,036) (105,171)
Total Other Income (Expense), net 192,114 (105,171)
Net Loss $ (6,663,428) $ (5,681,833)
Weighted average number of shares outstanding 10,515,995 6,528,959
Loss per share, basic $ (0.63) $ (0.87)
Loss per share, diluted $ (0.63) $ (0.87)
XML 26 R5.htm IDEA: XBRL DOCUMENT v3.24.1
STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Stock Subscription Receivable [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2021 $ 60 $ 4,842,836 $ (11,226) $ (4,624,154) $ 207,516
Beginnig balance, shares at Dec. 31, 2021 6,060,187        
Collection of stock subscription receivable 6,684 6,684
Write-off of uncollectible stock subscription receivable (4,542) 4,542
Initial public offering (see Note 8) $ 10 6,015,908 6,015,918
Initial public offering, shares 980,000        
Shares issued for conversion of related party convertible note (see Note 6) $ 3 2,002,277 2,002,280
InitiShares issued for conversion of related party convertible note, shares 266,970        
Stock-based compensation (see Note 9) 1,473,864 1,473,864
Net loss (5,681,833) (5,681,833)
Ending balance, value at Dec. 31, 2022 $ 73 14,330,343 (10,305,987) 4,024,429
Ending balance, shares at Dec. 31, 2022 7,307,157        
Exercises of stock options $ 2 17,648 17,650
Exercises of stock options, Shares 230,362        
Exercises of warrants by stockholders (see Note 8) $ 7 2,736,443 2,736,450
Exercise of warrants by stockholders, shares 729,720        
Second public offering (see Note 8) $ 45 4,115,643 4,115,688
Second public offering, shares 4,500,000        
Exercises of warrants related to private placement transaction (see Note 8) $ 2 391,266 391,268
Exercises of warrants related to private placement transaction, shares 150,000        
Stock-based compensation (see Note 9) 936,769 936,769
Net loss (6,663,428) (6,663,428)
Ending balance, value at Dec. 31, 2023 $ 129 $ 22,528,112 $ (16,969,415) $ 5,558,826
Ending balance, shares at Dec. 31, 2023 12,917,239        
XML 27 R6.htm IDEA: XBRL DOCUMENT v3.24.1
STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Operating Activities    
Net Loss $ (6,663,428) $ (5,681,833)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 61,093 22,101
Amortization 24,164 10,466
Non-cash interest expense 3,036 105,171
Stock-based compensation expense 936,769 1,473,864
Expenses paid by Tekcapital and Affiliates 299,061 960,362
(Recovery of) provision for doubtful accounts (14,725) 116,230
Realized gain on debt securities (U.S. Treasury bills) (50,796)
Loss on sale of assets 2,316
Changes in operating assets and liabilities:    
Accounts receivable (3,678) (183,094)
Accounts payable and accrued expenses 303,290 67,951
Prepaid expenses (102,975) (142,292)
Inventory (564,308) 47,765
Other current assets 1,460
Contract assets and liabilities 3,878 (22,569)
Net cash flows from operating activities (5,766,303) (3,224,418)
Investing Activities    
Purchases of debt securities (U.S. Treasury bills) (1,949,204)
Proceeds from redemption of debt securities (U.S. Treasury bills) 2,000,000
Patent costs (173,036) (60,717)
Purchases of property and equipment (78,463) (121,561)
Proceeds from sale of property and equipment 1,950
Capitalized software expenditures (37,673)
Net cash flows from investing activities (198,753) (219,951)
Financing Activities    
Proceeds from initial public offering (see Note 8) 6,127,067
Proceeds from second public offering (see Note 8) 4,115,688
Proceeds from exercises of warrants (see Note 8) 3,127,718
Proceeds from exercise of stock options 17,650
Collection of stock subscription receivable 6,684
Proceeds from related party convertible debt (see Note 6) 1,475,000
Repayment of related party convertible debt (see Note 6) (109,499) (653,000)
Repayment of amounts due to Tekcapital and Affiliates (490,163)
Net cash flows from financing activities 6,661,394 6,955,751
Net Change In Cash 696,338 3,511,382
Cash at Beginning of Year 3,591,109 79,727
Cash at End of Year 4,287,447 3,591,109
Significant Non-Cash Transactions    
Expenses paid for by Tekcapital and Affiliates, reported as increase in Due to/from Tekcapital and Affiliates and related party convertible debt 299,061 960,362
Write-off of uncollectible stock subscription receivable (4,542)
Issuance of shares from conversion of related party convertible debt $ 2,002,280
XML 28 R7.htm IDEA: XBRL DOCUMENT v3.24.1
Pay vs Performance Disclosure - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Pay vs Performance Disclosure [Table]    
Net Income (Loss) Attributable to Parent $ (6,663,428) $ (5,681,833)
XML 29 R8.htm IDEA: XBRL DOCUMENT v3.24.1
Insider Trading Arrangements
3 Months Ended
Dec. 31, 2023
Insider Trading Arrangements [Line Items]  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 30 R9.htm IDEA: XBRL DOCUMENT v3.24.1
GENERAL INFORMATION
12 Months Ended
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
GENERAL INFORMATION

NOTE 1 – GENERAL INFORMATION

 

Innovative Eyewear, Inc. (the “Company,” “us,” “we,” or “our”) is a corporation organized under the laws of the State of Florida that develops and sells cutting-edge eyeglasses and sunglasses, which are designed to allow our customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. The Company was founded by Lucyd Ltd., a portfolio company of Tekcapital Plc through Tekcapital Europe, Ltd. (collectively, together with Lucyd Ltd., “Tekcapital and Affiliates”), which owned approximately 40% of our issued and outstanding shares of common stock and was our largest stockholder as of December 31, 2023. Innovative Eyewear licensed the exclusive rights to the Lucyd® brand from Lucyd Ltd., which includes the exclusive use of all of Lucyd’s intellectual property, including our main product, Lucyd Lyte® glasses.

 

XML 31 R10.htm IDEA: XBRL DOCUMENT v3.24.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and in accordance with the accounting rules under Regulation S-X, as promulgated by the Securities and Exchange Commission (“SEC”). In the opinion of management, all adjustments considered necessary for the fair presentation of the financial statements for the years presented have been included. The results of operations for the years ended December 31, 2023 and 2022 are not necessarily indicative of the results to be expected for future periods.

 

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates, particularly given the significant uncertainties associated with the current geopolitical and economic environment.

 

Cash Equivalents

All highly liquid investments with original maturities of three months or less, including money market funds, certificates of deposit, and U.S. Treasury bills purchased three months or less from maturity, are considered cash equivalents.

 

Receivables and Credit Policy

Trade receivables from customers are uncollateralized customer obligations due under normal trade terms. For direct-to-consumer sales, payment is required before product is shipped. Trade receivables are stated at the amount billed to the customer. Payments of trade receivables are allocated to the specific invoices identified on the customer’s remittance advice or, if unspecified, are applied to the earliest unpaid invoice. The Company, by policy, routinely assesses the financial strength of its customers. To comply with industry standards, we offer “net 30” payments on wholesale orders of $1,500 or more. For wholesale orders, to acquire an order on net 30 terms, the customer is provided a credit check application as well as a credit card authorization form. The authorization form explicitly states when and for much we will bill the customer via credit card.

 

Accounts receivable are reported net of the allowance for doubtful accounts. The allowance for doubtful accounts is determined based upon a variety of judgments and factors. Factors considered in determining the allowance include historical collection, write-off experience, and management’s assessment of collectibility from customers, including current conditions, reasonable forecasts, and expectations of future collectibility and collection efforts. Management continuously assesses the collectibility of receivables and adjusts estimates based on actual experience and future expectations based on economic indicators. Receivable balances are written-off against the allowance when such balances are deemed to be uncollectible. The Company recognized bad debt expense of $30,275 and $116,230 for the years ended December 31, 2023 and 2022, respectively.

 

A roll forward of the allowance for doubtful accounts for the year ended December 31, 2023 is as follows:

 

         
Balance at December 31, 2022   $ 92,646  
Bad debt expense     30,275  
Write-offs(1)     (52,149 )
Recoveries(1)     (45,000 )
Balance at December 31, 2023   $ 25,772  

 

 
(1) During the year ended December 31, 2023, the Company entered into a settlement agreement with a former wholesale customer. As a result of this settlement, $47,646 of accounts receivable were written-off as uncollectible, while the $45,000 collected under the settlement agreement was reflected as a gain within general and administrative expenses in the statement of operations.

 

Inventory

Our inventory includes purchased eyewear and is stated at the lower of cost or net realizable value, with cost determined on a specific identification method of inventory costing which attaches the actual cost to an identifiable unit of product. Provisions for excess, obsolete, or slow-moving inventory are recorded after periodic evaluation of historical sales, current economic trends, forecasted sales, estimated product life cycles, and estimated inventory levels. No provisions were determined as needed as of December 31, 2023 and 2022.

 

As of December 31, 2023 and 2022, the Company recorded an inventory prepayment in the amount of $323,520 and $197,750, respectively, related to down payment on eyewear purchased from the manufacturer, prior to shipment of the product that occurred after the respective balance sheet dates.

 

Intangible Assets

Intangible assets relate to patent costs received in conjunction with the initial capitalization of the Company and internally developed utility and design patents. The Company amortizes these assets over the estimated useful life of the patents. The Company reviews its intangible assets for impairment whenever changes in circumstances indicate that the carrying amount of the assets may not be recoverable.

 

Capitalized Software

The Company has incurred software development costs related to development of the Vyrb app, and has capitalized these costs in accordance with Accounting Standards Codification (“ASC”) 985-20, “Software – Costs of Software to be Sold, Leased, or Marketed,” considering it is the Company’s intention to market and sell the software externally. Planning, designing, coding, and testing occurred necessary to meet Vyrb’s design specifications; as such, all coding, development, and testing costs incurred subsequent to establishing technical feasibility were capitalized.

 

We launched an open beta version of the Vyrb application (for both iOS and Android) in December 2021 as the Company’s first social media platform, demonstrating the functionality of the software. The app has had several new features introduced in 2023, including live audio chatrooms for users of the Company’s smart eyewear, and offers market-leading audio accessibility features for social media, including the ability to create and listen to a feed of audio content completely hands-free, using unique voice assistant commands created for the app. The Company plans to continue to develop the expansive Vyrb platform into a feature-rich social toolbox for its customers. This includes the introduction of revenue-generating features such as native ads and in-app upgrades, as well as gamification features such as a points and rewards system.

 

However, as the Company diverted most of its software development resources in 2023 to the development and launch of the Lucyd app (which provides groundbreaking Generative AI features to our smart eyewear), the revenue-generating features for the Vyrb app were delayed, and are now planned to launch in 2024. Amortization of the capitalized software costs related to the Vyrb app will begin once revenue-generating operations associated with the software have commenced. No software development costs have been capitalized with respect to the Lucyd app.

 

Property and Equipment

Property and equipment are depreciated using the straight-line method over the estimated useful lives or lease terms if shorter. Depreciation expense for the years ended December 31, 2023 and 2022 was $61,093 and $22,101, respectively. For income tax purposes, accelerated depreciation methods are generally used. Repair and maintenance costs are expensed as incurred.

 

                     
    December 31,     December 31,     Estimated
Useful Lives
 
Property & Equipment   2023     2022     (in Years)  
Mobile Kiosk Display   $ 127,333     $ 63,395     3 years  
Computer Equipment     44,901       44,901     3 Years  
Office Equipment     10,291       17,273     3 Years  
Internal-Use Software     31,300       16,775     3 to 5 Years  
Property and equipment, gross     213,825       142,343        
Less: Accumulated depreciation     (80,977 )     (22,599 )      
Property and equipment, net   $ 132,848     $ 119,744        

 

Income Taxes

The Company accounts for income taxes under an asset and liability approach that recognizes deferred tax assets and liabilities based on the difference between the financial statement carrying amounts and the tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.

 

The Company follows a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken, or expected to be taken, in a tax return. Any interest and penalties accrued related to uncertain tax positions are recorded in tax expense.

 

The Company assesses the realizability of its net deferred tax assets on an annual basis. If, after considering all relevant positive and negative evidence, it is more likely than not that some portion or all of the net deferred tax assets will not be realized, the Company will reduce the net deferred tax assets by a valuation allowance. The realization of net deferred tax assets is dependent on several factors, including the generation of sufficient taxable income prior to the expiration of net operating loss carryforwards.

 

Fair Value of Financial Instruments

For certain of the Company’s financial instruments, including cash, cash equivalents, accounts receivable, accounts payable, and cash advances provided by Tekcapital and Affiliates, the carrying amounts approximate fair value due to the short-term maturities of these instruments.

 

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents, and accounts receivable. The Company limits its credit risk with respect to cash by maintaining cash and cash equivalent balances with high quality financial institutions. At times, the Company’s cash balances may exceed federally insured limits. Concentrations of credit risk with respect to accounts receivable are generally considered minimal due to collection history. However, as of December 31, 2023, $77,950 or approximately 50% of the Company’s gross accounts receivable balance was related to a single customer under a long-term instalment arrangement; the Company manages its risk related to this counterparty via other contractual arrangements with such counterparty, and incentivization through stock-based compensation.

 

Stock-Based Compensation

The Company accounts for stock-based compensation to employees and directors and others in accordance with FASB ASC Topic 718, which requires that compensation expense be recognized in the financial statements for stock-based awards based on the grant date fair value. Forfeitures are accounted for as a reduction of compensation expense in the period when such forfeitures occur.

 

For stock option awards, the Black-Scholes-Merton option pricing model was used to estimate the fair value of share-based awards. The Black-Scholes-Merton option pricing model incorporates various and highly subjective assumptions, including expected term and share price volatility.

 

The expected term of the stock options was estimated based on the simplified method as allowed by Staff Accounting Bulletin 107 (SAB 107).

 

The share price volatility at the grant date is estimated using historical stock prices based upon the expected term of the options granted, using stock prices of comparably profiled public companies.

 

The risk-free interest rate assumption is determined using the rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued.

 

For restricted stock units, the fair value of the share-based award is based on the quoted market price of our common shares on the NASDAQ stock exchange.

 

Revenue Recognition

Our revenue is generated from the sales of prescription and non-prescription optical glasses, sunglasses, and shipping charges, which are charged to the customer, associated with these purchases. We sell products through our retail store resellers, distributors, on our own website Lucyd.co, and on Amazon.com.

 

To determine revenue recognition, we perform the following steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. At contract inception, we assess the goods or services promised within each contract and determine those that are performance obligations, and also assess whether each promised good or service is distinct. We then recognize as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. In instances where the collectibility of contractual consideration is not probable at the time of sale, the revenue is deferred on our balance sheet as a contract liability, and the associated cost of goods sold is deferred on our balance sheet as a contract asset; subsequently, we recognize such revenue and cost of goods sold as payments are received. During the year ended December 31, 2023, we recognized $17,500 of revenue that was included in the contract liability balance as of January 1, 2023.

 

All revenue, including sales processed online and through our retail store resellers and distributors, is reported net of sales taxes collected from customers on behalf of taxing authorities, returns, and discounts.

 

For sales generated through our e-commerce channels, we identify the contract with a customer upon online purchase of our eyewear and transaction price at the manufacturer suggested retail price (“MSRP”) for non-prescription, polarized sunglass and blue light blocking glasses across all of our online channels. Our e-commerce revenue is recognized upon meeting of the performance obligation when the eyewear is shipped to end customers. Only U.S. consumers enjoy free USPS first class postage, with faster delivery options available for extra cost, for sales processed through our website and on Amazon. For Amazon sales, shipping is free for U.S consumers while international customers pay shipping charges on top of MSRP. Any costs associated with fees charged by the online platforms (Shopify for Lucyd.co website and Amazon) are not recharged to customers and are recorded as a component of cost of goods sold as incurred. The Company charges applicable state sales taxes in addition to the MSRP for both online channels and all other marketplaces on which the company sells products.

 

For sales to our retail store partners, we identify the contract with a customer upon receipt of an order of our eyewear through our Shopify wholesale portal or direct purchase order. Our revenue is recognized upon meeting the performance obligation, which is delivery of the Company’s eyewear products to the retail store and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to the retail store partners includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale retail orders, no e-commerce fees are applicable.

 

For sales to distributors, we identify the contract with a customer upon receipt of an order of our eyewear through a direct purchase order. If collectability of substantially all of the contract consideration is probable, our revenue is recognized upon meeting the performance obligation, which is delivery of our eyewear products to the distributor, and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to distributors includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale distributor orders, no e-commerce fees are applicable.

 

The Company’s sales do not contain any variable consideration.

 

We allow our customers to return our products, subject to our refund policy, which allows any customer to return our products for any reason within the first:

 

  7 days for sales made through our website (Lucyd.co)

 

  30 days for sales made through Amazon

 

  30 days for sales to most wholesale retailers and distributors (although certain sales to independent distributors are ineligible for returns)

 

For all of our sales, at the time of sale, we establish a reserve for returns, based on historical experience and expected future returns, which is recorded as a reduction of sales. Additionally, we review all individual returns received in the month following the balance sheet date pertaining to orders processed prior to the balance sheet date in order to determine whether an allowance for sales returns is necessary. The Company recorded an allowance for sales returns of $25,933 and $24,897 as of December 31, 2023 and 2022, respectively.

 

Shipping and Handling

Costs incurred for shipping and handling are included in cost of revenue at the time the related revenue is recognized. Amounts billed to a customer for shipping and handling are reported as revenues.

 

Recently Adopted Accounting Pronouncements

Effective January 1, 2023, the Company adopted the provisions of Accounting Standards Update (“ASU”) 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (as amended by ASU 2018-19 in November 2018, ASU 2019-05 in May 2019, ASU 2019-10 and 2019-11 in November 2019, ASU 2020-02 in February 2020, and ASU 2022-02 in March 2022). This standard requires entities to estimate lifetime expected credit losses for financial instruments, including trade and other receivables, which will generally result in earlier recognition of credit losses. The adoption of this new guidance did not have a significant impact on our results of operations, cash flows, or financial condition.

 

Recently Issued Accounting Pronouncements

In October 2023, the FASB issued ASU 2023-06, Disclosure Improvements. This ASU amends the presentation and disclosure of a variety of topics in the ASC, including derivatives, diluted earnings per share, changes in reporting entity, preferred stock, certain industry-specific items, and various other topics, in order to align them with SEC regulations. The amendments to the various topics should be applied prospectively, and the effective date will be determined for each individual disclosure based on the effective date of the SEC’s removal of the related disclosure requirement from Regulation S-X or Regulation S-K. We do not anticipate that the adoption of this ASU will have a significant impact on our financial statements.

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. ASU 2023-07 improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. In addition, the ASU enhances interim disclosure requirements, clarifies circumstances in which an entity can disclose multiple segment measures of profit or loss, and contains other disclosure requirements. The ASU does not change how an entity identifies its operating segments, aggregates those operating segments, or applies the quantitative thresholds to determine its reportable segments. ASU 2023-07 is required to be applied retrospectively to all periods presented in the financial statements, and is effective for Innovative Eyewear, Inc. for fiscal years beginning after December 15, 2023 (i.e., January 1, 2024) and interim periods within fiscal years beginning after December 15, 2024 (i.e., January 1, 2025). We do not anticipate that the adoption of this ASU will have a significant impact on our financial statements.

 

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. ASU 2023-09 requires disclosure of additional categories of information about federal, state, and foreign income taxes in the rate reconciliation table and requires entities to provide more details about the reconciling items in some categories if items meet a quantitative threshold. The ASU also requires entities to disclose income taxes paid, net of refunds, disaggregated by federal (national), state, and foreign taxes for annual periods and to disaggregate the information by jurisdiction based on a quantitative threshold. The guidance makes several other changes to the disclosure requirements. The ASU is required to be applied prospectively, with the option to apply it retrospectively. The ASU is effective for Innovative Eyewear, Inc. for fiscal years beginning after December 15, 2024. We do not anticipate that the adoption of this ASU will have a significant impact on our financial statements.

 

Subsequent Events

In connection with the preparation of these financial statements, the Company has evaluated subsequent events through March 24, 2024, which is the date the financial statements were available to be issued. See Note 11 for additional information.

 

XML 32 R11.htm IDEA: XBRL DOCUMENT v3.24.1
GOING CONCERN
12 Months Ended
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
GOING CONCERN

NOTE 3 – GOING CONCERN

 

The Company has a limited operating history. The Company’s business and operations are sensitive to general business and economic conditions in the United States. A host of factors beyond the Company’s control could cause fluctuations in these conditions. Adverse conditions may include recession, downturn, or otherwise, changes in regulations or restrictions in imports, competition, or changes in consumer taste. These adverse conditions could affect the Company’s financial condition and the results of its operations.

 

The Company meets its day-to-day working capital requirements using monies raised through sales of eyewear and issuances of equity, including our initial public offering completed in August 2022, a secondary public offering completed in June 2023, and exercises of warrants by stockholders (see Note 8 for additional details). The Company also previously issued a convertible note held by Tekcapital and Affiliates, which was repaid in full during the year ended December 31, 2023 (see Note 6). Effective March 1, 2024, the Company issued a new 18-month convertible note to Tekcapital and Affiliates (see Note 11 for details).

 

Management expects that operating losses could continue in the foreseeable future as we continue to invest in the expansion and development of our business. Management’s forecasts and projections indicate that the Company’s existing cash and cash equivalents (including the proceeds from the aforementioned second public offering and proceeds received from investors’ exercises of warrants), plus planned capital-raising activities in 2024, will be sufficient to fund operations through at least end of March 2025.

 

XML 33 R12.htm IDEA: XBRL DOCUMENT v3.24.1
INCOME TAX PROVISION
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
INCOME TAX PROVISION

NOTE 4 – INCOME TAX PROVISION

 

The following is a reconciliation of tax computed at the statutory federal rate to the income tax benefit in the statements of operations:

 

               
    2023     2022  
Income tax benefit at the statutory federal rate   $ 1,389,526     $ 1,193,185  
State income tax benefits, net of federal benefit     50,907       35,149  
Change in valuation allowance     (1,440,433 )     (1,228,334 )
Total   $ -     $ -  

 

The components of the Company’s deferred tax assets are as follows:

 

               
    2023     2022  
Deferred tax assets:                
Stock-based compensation   $ 877,645     $ 610,530  
Other – net     219,723       122,133  
Net operating losses – federal     2,483,530       1,346,823  
Net operating losses – state     148,177       81,911  
 Deferred tax assets Gross     3,729,075       2,161,397  
Less Valuation Allowance     (3,729,075 )     (2,161,397 )
Net deferred tax assets   $ -     $ -  

 

Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities. Deferred tax assets or liabilities at the end of each period are determined using the tax rate expected to be in effect when taxes are actually paid or recovered.

 

A valuation allowance is established when it is more likely than not that all or a portion of a deferred tax asset will not be realized. A review of all available positive and negative evidence is considered, including the Company’s current and past performance, the market environment in which the Company operates, length of carryback and carryforward periods, and existing contracts that will result in future profits. After reviewing all the evidence, the Company has recorded a full valuation allowance against its deferred tax assets.

 

At December 31, 2023, the Company had federal net operating loss carryforwards of $11,826,332 and state net operating loss carryforwards of $6,515,176, both of which do not expire.

 

The Company files Federal and Florida tax returns. The years that remain subject to examination are the years ended December 31, 2020, 2021, 2022, and 2023. As of December 31, 2023 and 2022, the Company does not believe that is has any liabilities for uncertain tax positions.

 

XML 34 R13.htm IDEA: XBRL DOCUMENT v3.24.1
INTANGIBLE ASSETS
12 Months Ended
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
INTANGIBLE ASSETS

NOTE 5 – INTANGIBLE ASSETS

 

               
Finite-lived intangible assets   December 31,
2023
    December 31,
2022
 
Patent Costs   $ 329,232     $ 156,196  
Intangible assets, gross     329,232       156,196  
Less: Accumulated amortization     (42,803 )     (18,639 )
Intangible assets, net   $ 286,429     $ 137,557  

 

These costs are amortized using the straight-line method over a period of 10 years. Amortization expense totalled $24,164 and $10,466 for the years ended December 31, 2023 and 2022, respectively. Future amortization is expected to approximate $30,000 per year.

 

XML 35 R14.htm IDEA: XBRL DOCUMENT v3.24.1
RELATED PARTY TRANSACTIONS
12 Months Ended
Dec. 31, 2023
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 6 – RELATED PARTY TRANSACTIONS

 

Convertible Note and Due to Tekcapital and Affiliates

During the year ended December 31, 2022 and through December 1, 2023, the Company had the availability of, but not the contractual right to, intercompany financing from Tekcapital and Affiliates in the form of either cash advances or borrowings under a convertible note (as discussed below).

 

On December 1, 2020, the Company issued a convertible note to Tekcapital and Affiliates for up to $2,000,000 that bears interest at 10% per annum, which includes the option to convert the debt into the Company’s common stock at market price. The note can be converted into shares of common stock of the Company upon occurrence of certain conversion events, as defined. On November 1, 2021, the Company amended and restated the convertible note agreement with Tekcapital and Affiliates, increasing the amount of available financing from $2,000,000 to $3,000,000.

 

On August 15, 2022, in connection with the Company’s initial public offering (see Note 8), the Company converted related party borrowings totalling $2,002,280 into 266,970 shares of common stock at $7.50 per share.

 

The convertible notes balances were $61,356 at December 31, 2022. In January 2023, the Company borrowed an additional $48,143 under such convertible notes, and subsequently repaid the outstanding balances of the convertible notes in full in February 2023. No further amounts were borrowed under the convertible notes, and the convertible notes matured on December 1, 2023 with no amounts outstanding.

 

Subsequent to the year ended December 31, 2023 (effective March 1, 2024), the Company issued a new 18-month convertible note to Tekcapital and Affiliates; see Note 11 for details.

 

Management Service Agreement

In 2020, the Company entered into a management services agreement with Tekcapital Europe Ltd. (an affiliate of our largest stockholder, Lucyd Ltd., whose Chief Executive Officer is the father of our Chief Executive Officer), for which the Company was billed $25,000 quarterly. Effective February 1, 2022, the original management services agreement was amended to have the Company billed at $35,000 quarterly. While the agreement does not stipulate a specific maturity date, it can be terminated with 30 calendar days written notice by any party.

 

The related party provides the following services:

 

  Support and advice to the Company in accordance with their area of expertise;

 

  Research, technical review, legal review, recruitment, software development, marketing, public relations, and advertisement; and

 

  Advice, assistance, and consultation services to support the Company or in relation to any other related matter.

 

The Company incurred $140,000 during each of the years ended December 31, 2023 and 2022 under this management services agreement.

 

Rent of Office Space

Prior to the February 1, 2022 amendment of the aforementioned management services agreement, the Company was provided with rent-free office space by Tekcapital and Affiliates. Effective February 1, 2022, Tekcapital began to bill the Company for an allocation of rent paid by Tekcapital on the Company’s behalf; the underlying lease between Tekcapital and its landlord has an end date of January 31, 2025. The Company recognized expense related to this arrangement of $91,672 and $74,442 of for the years ended December 31, 2023 and 2022, respectively.

 

XML 36 R15.htm IDEA: XBRL DOCUMENT v3.24.1
COMMITMENTS AND CONTINGENCIES
12 Months Ended
Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 7 – COMMITMENTS AND CONTINGENCIES

 

Legal Matters

In August 2023, the Company entered into a settlement agreement with a former wholesale customer who owed the Company $92,646. As a result of this settlement, $47,646 of accounts receivable were written-off as uncollectible, while the $45,000 collected under the settlement agreement was reflected as a gain within general and administrative expenses in the statement of operations.

 

In November 2023, a third party filed a complaint before the International Trade Commission, alleging that certain of our products (as well as certain products of our competitors) infringed on patents held by the third party. In December 2023, the International Trade Commission instituted an investigation against the Company. As of December 31, 2023, the Company recorded a liability of approximately $103,000 related to this matter. This matter was subsequently settled and resolved in January 2024; refer to Note 11 for details.

 

Additionally, the Company is currently pursuing collection of $41,452 from an individual who was both a former member of management and a former member of our board of directors. The amount owed to us represents the remaining balance of an advance against future commissions that was previously paid to such individual under a contractual agreement. We desire to resolve this matter amicably and expeditiously; accordingly, we have presented this individual with a demand for repayment, and are exploring all options available to us with the assistance of legal counsel. No amounts related to this matter have been recorded on the balance sheet and statement of operations as of and for the year ended December 31, 2023.

 

Leases

Our executive offices are located at 11900 Biscayne Blvd., Suite 630 Miami, Florida 33181. Our executive offices are provided to us by the Tekcapital and Affiliates (see Note 6). We consider our current office space adequate for our current operations.

 

License Agreements

During the years ended December 31, 2023 and 2022, we entered into several multi-year license agreements which grant us the right to sell certain branded smart eyewear, including the Nautica, Eddie Bauer, and Reebok brands worldwide. These agreements require us to pay royalties based on a percentage of net retail and wholesale sales during the period of the license, and also require guaranteed minimum royalty payments. The agreements have base terms of 10 years but are cancellable at the option of the Company during the fifth year.

 

The aggregate future minimum payments due under these license agreements are as follows:

 

       
2024   $ 161,210  
2025     436,000  
2026     834,000  
2027     1,290,000  
2028     1,543,000  
Thereafter (through 2032)     9,907,000  
Total   $ 14,171,210  

 

Other Commitments

See related party management services agreement discussed in Note 6.

 

XML 37 R16.htm IDEA: XBRL DOCUMENT v3.24.1
STOCKHOLDERS’ EQUITY
12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 8 – STOCKHOLDERS’ EQUITY

 

Pursuant to a corporate resolution on July 1, 2021, the Company has authority to issue up to 15,000,000 shares of preferred stock and 50,000,000 shares of common stock. There were no shares of preferred stock issued or outstanding as of December 31, 2023 and 2022.

 

Initial Public Offering

On August 17, 2022, the Company closed on its initial public offering of 980,000 units consisting of 980,000 shares of its common stock and 1,960,000 warrants to purchase 1,960,000 shares of common stock at a combined offering price of $7.50 per unit in exchange for gross proceeds of approximately $7.35 million, before deducting underwriting discounts and offering expenses. Each share of common stock was sold together with two warrants. Each warrant is exercisable to purchase one share of common stock at an initial exercise price of $7.50 per share, subject to certain adjustments as set forth in the warrant agreement. In addition, the Company granted the underwriters a 45-day option to purchase up to an additional 147,000 shares of common stock and/or warrants to purchase up to an additional 294,000 shares of common stock to cover over-allotments, of which the Underwriter exercised its option to purchase additional warrants to purchase 294,000 shares of common stock concurrently with the closing.

 

The shares of common stock and warrants began trading on The Nasdaq Capital Market on August 15, 2022, under the symbols “LUCY” and “LUCYW,” respectively.

 

Also, pursuant to the terms of the underwriting agreement for the offering, the Company issued by the Underwriter certain other warrants to purchase up to 58,800 shares of the Company’s common stock at an exercise price of $8.228 per share.

 

The net proceeds received by the Company from this offering amounted to $6,015,918.

 

Second Public Offering

On June 26, 2023, the Company closed on a public offering of 4,500,000 units consisting of 4,500,000 shares of its common stock and 4,500,000 warrants to purchase 4,500,000 shares of common stock (the “Common Warrants”) at a combined offering price of $1.05 per unit in exchange for gross proceeds of approximately $4.73 million, before deducting underwriting discounts and offering expenses. Each share of common stock was sold together with one warrant. Each Common Warrant is exercisable to purchase one share of common stock at an initial exercise price of $1.05 per share, subject to certain adjustments as set forth in the warrant agreement. In addition, pursuant to the terms of the placement agency agreement for the offering, the Company issued to the placement agent certain other warrants to purchase up to 180,000 shares of the Company’s common stock at an exercise price of $1.31 per share. The net proceeds received by the Company from this offering amounted to $4,115,688.

 

Warrants

On August 17, 2022, as part of the Company’s initial public offering described above, the Company issued a total of 2,254,000 warrants to purchase 2,254,000 shares of common stock, which began trading and are currently trading on the Nasdaq Capital Market, under the symbol “LUCYW” (which we refer to as the “Listed Warrants”).

 

In February 2023, holders of the Company’s Listed Warrants exercised such warrants to purchase an aggregate of 408,600 shares of the Company’s common stock, at an adjusted exercise price of $3.75 per share, resulting in cash proceeds to the Company of $1,532,250.

 

Between April 1, 2023 and April 16, 2023, holders of the Company’s Listed Warrants exercised such warrants to purchase an aggregate of 321,120 shares of the Company’s common stock, at an adjusted exercise price of $3.75 per share, resulting in cash proceeds to the Company of $1,204,200.

 

On April 17, 2023, the Company entered into a warrant exercise inducement letter agreement (“Inducement Letter”) with certain accredited investors that were existing holders of the Company’s Listed Warrants to purchase an aggregate of 150,000 shares of the Company’s common stock for cash, wherein the investors agreed to exercise all of their existing Listed Warrants at an exercise price of $3.75 per share. The gross proceeds to the Company from this transaction, before deducting estimated expenses and fees, was $562,000; the net proceeds received by the Company amounted to $391,268. In consideration for the immediate exercise of the existing Listed Warrants for cash, the exercising holders received new warrants to purchase up to an aggregate of 300,000 shares of common stock (the “Private Warrants”) in a private placement pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended. The Private Warrants are immediately exercisable upon issuance at an exercise price of $3.75 per common share and will expire on April 19, 2028. Although the Private Warrants were offered in a private placement pursuant to an applicable exemption from the registration requirements of the Securities Act and, along with the shares of common stock issuable upon their exercise, were not registered under the Securities Act, subsequently in May 2023 the shares of common stock issuable upon exercise of these warrants were registered with the SEC through a Form S-1 filing.

 

The only exercises of warrants to date have been those exercises of Listed Warrants in February and April of 2023 as described above. As of December 31, 2023, none of the Common Warrants, Private Warrants, nor any of the warrants issued to underwriters and placement agents have been exercised.

 

As of December 31, 2023, the Company’s outstanding warrants are as follows:

 

                     
Warrant Type   Warrants
Outstanding
    Exercise
Price
    Expiration
Date
 
Listed Warrants     1,374,280     $ 3.75     8/17/2027  
Common Warrants     4,500,000     $ 1.05     6/26/2028  
Private Warrants     300,000     $ 3.75     4/19/2028  
Underwriter warrants     58,800     $ 8.23     8/12/2027  
Placement agent warrants     180,000     $ 1.05     6/26/2028  
Total     6,413,080                

 

XML 38 R17.htm IDEA: XBRL DOCUMENT v3.24.1
STOCK-BASED COMPENSATION
12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
STOCK-BASED COMPENSATION

NOTE 9 – STOCK-BASED COMPENSATION

 

On July 1, 2021, an Equity Incentive Plan was approved, allowing for total of 20% of our issued and outstanding common stock, less the number of outstanding option grants, to be available for the grant of awards under the Plan. There were 1,685,000 option awards granted by the Company prior to the approval of the Plan, while 1,800,500 option awards have been granted under the Plan from July 1, 2021 through December 31, 2023.

 

Summary information regarding the number of options, exercise price, and remaining contractual life as of and during the years ended December 31, 2023 and 2022 is as follows:

 

                       
    Weighted Average
Exercise Price
per share
$
    Options
(Number)
    Weighted Average
Remaining
Contractual Life
(Years)
 
As at January 1, 2022     2.61       2,332,500          
Granted     -       -          
Exercised     -       -          
Forfeited     -       -          
As at December 31, 2022     2.61       2,332,500       1.68  
                         
As at January 1, 2023     2.61       2,332,500          
Granted     0.92       1,153,000          
Exercised     1.01       (316,000 )        
Forfeited / Expired     2.94       (275,000 )        
As at December 31, 2023     2.08       2,894,500       2.22  
Exercisable as at December 31, 2023     2.39       1,795,219       1.40  

 

As of December 31, 2023, the aggregate intrinsic value for all options outstanding as well as all options exercisable was zero.

 

During the year ended December 31, 2023, we granted the following option awards:

 

Options to purchase an aggregate of 330,000 shares of common stock at $1.275 per share were issued to the Company’s officers and management, of which 1/3 vested immediately, 1/3 shall vest on January 13, 2024, and the remaining 1/3 shall vest on January 13, 2025. The options expire on January 13, 2028.

 

Options to purchase an aggregate of 75,000 shares of common stock at $1.275 per share were issued to non-management directors, which vest evenly over three years, whereby 1/3 shall vest on each of January 13, 2024, January 13, 2025, and January 13, 2026. The options expire on January 13, 2028.

 

Options to purchase an aggregate of 162,000 shares of common stock at $1.275 per share were issued to certain employees and consultants, which vest evenly over three years, whereby 1/3 shall vest on each of January 13, 2024, January 13, 2025, and January 13, 2026. The options expire on January 13, 2028.

 

Options to purchase an aggregate of 75,000 shares of common stock at $1.275 per share were issued to an employee, which would have vested evenly over three years (whereby 1/6 of the options would have vested every six months). During the year ended December 31, 2023, however, all of these options were forfeited.

 

Options to purchase an aggregate of 6,000 shares of common stock at $1.275 per share were issued to a consultant, which vested immediately. These options were all exercised during the year ended December 31, 2023.

 

Options to purchase an aggregate of 15,000 shares of common stock at $0.66 per share were issued to certain employees and consultants, which vest evenly over two years, whereby 1/4 of the options shall vest every six months. The options expire on September 5, 2028.

 

Options to purchase an aggregate of 490,000 shares of common stock at $0.45 per share were issued to the Company’s officers and management, of which 1/3 vested immediately, 1/3 shall vest on December 18, 2024, and the remaining 1/3 shall vest on December 18, 2025. The options expire on December 18, 2028.

 

There were no option awards granted during the year ended December 31, 2022.

 

The fair value of options granted is calculated using the Black-Scholes-Merton option pricing model. The underlying assumptions used in the option pricing model for stock option awards granted in 2023 were as follows:

 

     
Attribute      
Share price at date of grant   $0.43 - $1.28  
Expected term (in years)   3 - 4  
Risk free rate   3.74% - 4.65 %
Expected volatility   106% - 133 %
Expected dividend yield   0  
Grant date fair value of options   $0.28 - $1.02  

 

The weighted average grant date fair value of options outstanding was $1.49 and $1.84 as of December 31, 2023 and 2022, respectively.

 

As of December 31, 2023, unrecognized stock option expense of approximately $721,000 remains to be recognized over next 1.12 years.

 

Award Modifications

On June 1, 2023, we modified the terms of certain options previously awarded in 2021 to purchase an aggregate of 140,000 shares of common stock, in order to extend their expiration dates from July 21, 2023 to July 21, 2024. There were no changes to the exercise price or other terms of these stock options, and these options were already fully vested prior to the modification. As a result of this modification, we recognized incremental stock option expense of $9,188 for the year ended December 31, 2023.

 

Restricted Stock Unit Awards

On December 3, 2023, we entered into an endorsement agreement with an influencer for a one-year term, which included the award of an aggregate of 65,220 restricted stock units. These restricted stock units vest according to the following schedule: 16,305 shares on December 3, 2023 (which will be issued on or before March 31, 2024), 16,305 shares on March 2, 2024 (which will be issued on or before March 31, 2024), 16,305 shares on May 31, 2024, and 16,305 shares on August 29, 2024. Total stock-based compensation related to this award, based on the market price of the Company’s common stock on the date of grant, amounts to $27,066. We recognized $8,458 of expense related to this award during the year ended December 31, 2023, and will recognize the remaining expense of $18,608 on a straight-line basis over the remaining term of the agreement in 2024.

 

XML 39 R18.htm IDEA: XBRL DOCUMENT v3.24.1
EARNINGS PER SHARE
12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
EARNINGS PER SHARE

NOTE 10 – EARNINGS PER SHARE

 

The Company calculates earnings/(loss) per share data by calculating the quotient of earnings/(loss) divided by the weighted average number of common shares outstanding during the respective period as required by ASC 260-10-50. Due to the net losses for the years ended December 31, 2023 and 2022, all shares underlying the related party convertible debt, common stock warrants, and common stock options were excluded from the earnings per share calculation due to their anti-dilutive effect.

 

Calculation of net earnings per common share — basic and diluted:

 

           
    For the
year ended
 
    December 31,     December 31,  
    2023     2022  
Basic and diluted:                
Net loss   $ (6,663,428 )   $ (5,681,833 )
Weighted-average number of common shares     10,515,995       6,528,959  
Basic and diluted net loss per common share   $ (0.63 )   $ (0.87 )

 

XML 40 R19.htm IDEA: XBRL DOCUMENT v3.24.1
SUBSEQUENT EVENTS
12 Months Ended
Dec. 31, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 11 – SUBSEQUENT EVENTS

 

Settlement and License Agreement

On January 3, 2024, we settled and resolved certain matters with a third party, including a complaint that had been brought before the International Trade Commission and an investigation instituted by the International Trade Commission in 2023, and entered into a multi-year non-exclusive license agreement covering multiple smart eyewear patents. Pursuant to this license agreement, the Company added licenses for 46 new patents to its portfolio of owned and licensed patents and applications.

 

Loan to Tekcapital Europe, Ltd.

On January 11, 2024, we entered into an intercompany loan agreement (as lender) with Tekcapital Europe, Ltd. (as borrower), an affiliate of our largest stockholder, Lucyd Ltd., whose Chief Executive Officer is the father of our Chief Executive Officer, and Tekcapital Plc, the parent of Tekcapital Europe Ltd. Pursuant to this agreement, the Company loaned 600,000 British pounds sterling (equivalent to approximately $765,000) to Tekcapital Europe Ltd. The loan bears simple interest at a rate of 10% per annum and is required to be repaid on or before April 11, 2024. Tekcapital Plc executed the agreement as guarantor for Tekcapital Europe Ltd. on the full amount of the loan. Tekcapital Europe Ltd. repaid the loan in full in March 2024.

 

New Convertible Note

Effective March 1, 2024, the Company issued a convertible note to Lucyd Ltd., the largest stockholder of the Company, for up to $1,250,000 that bears interest at 10% per annum, which includes the option to convert the debt into the Company’s common stock at market price. The note can be converted into shares of common stock of the Company upon the occurrence of certain events, as defined in the note, or for any reason at the sole discretion of Lucyd Ltd. The note has a maturity date of September 1, 2025, at which time all outstanding principal and accrued interest is payable in full. As of the date these financial statements were available to be issued, the Company has not borrowed any amounts under this convertible note.

XML 41 R20.htm IDEA: XBRL DOCUMENT v3.24.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and in accordance with the accounting rules under Regulation S-X, as promulgated by the Securities and Exchange Commission (“SEC”). In the opinion of management, all adjustments considered necessary for the fair presentation of the financial statements for the years presented have been included. The results of operations for the years ended December 31, 2023 and 2022 are not necessarily indicative of the results to be expected for future periods.

 

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates, particularly given the significant uncertainties associated with the current geopolitical and economic environment.

 

Cash Equivalents

Cash Equivalents

All highly liquid investments with original maturities of three months or less, including money market funds, certificates of deposit, and U.S. Treasury bills purchased three months or less from maturity, are considered cash equivalents.

 

Receivables and Credit Policy

Receivables and Credit Policy

Trade receivables from customers are uncollateralized customer obligations due under normal trade terms. For direct-to-consumer sales, payment is required before product is shipped. Trade receivables are stated at the amount billed to the customer. Payments of trade receivables are allocated to the specific invoices identified on the customer’s remittance advice or, if unspecified, are applied to the earliest unpaid invoice. The Company, by policy, routinely assesses the financial strength of its customers. To comply with industry standards, we offer “net 30” payments on wholesale orders of $1,500 or more. For wholesale orders, to acquire an order on net 30 terms, the customer is provided a credit check application as well as a credit card authorization form. The authorization form explicitly states when and for much we will bill the customer via credit card.

 

Accounts receivable are reported net of the allowance for doubtful accounts. The allowance for doubtful accounts is determined based upon a variety of judgments and factors. Factors considered in determining the allowance include historical collection, write-off experience, and management’s assessment of collectibility from customers, including current conditions, reasonable forecasts, and expectations of future collectibility and collection efforts. Management continuously assesses the collectibility of receivables and adjusts estimates based on actual experience and future expectations based on economic indicators. Receivable balances are written-off against the allowance when such balances are deemed to be uncollectible. The Company recognized bad debt expense of $30,275 and $116,230 for the years ended December 31, 2023 and 2022, respectively.

 

A roll forward of the allowance for doubtful accounts for the year ended December 31, 2023 is as follows:

 

         
Balance at December 31, 2022   $ 92,646  
Bad debt expense     30,275  
Write-offs(1)     (52,149 )
Recoveries(1)     (45,000 )
Balance at December 31, 2023   $ 25,772  

 

 
(1) During the year ended December 31, 2023, the Company entered into a settlement agreement with a former wholesale customer. As a result of this settlement, $47,646 of accounts receivable were written-off as uncollectible, while the $45,000 collected under the settlement agreement was reflected as a gain within general and administrative expenses in the statement of operations.

 

Inventory

Inventory

Our inventory includes purchased eyewear and is stated at the lower of cost or net realizable value, with cost determined on a specific identification method of inventory costing which attaches the actual cost to an identifiable unit of product. Provisions for excess, obsolete, or slow-moving inventory are recorded after periodic evaluation of historical sales, current economic trends, forecasted sales, estimated product life cycles, and estimated inventory levels. No provisions were determined as needed as of December 31, 2023 and 2022.

 

As of December 31, 2023 and 2022, the Company recorded an inventory prepayment in the amount of $323,520 and $197,750, respectively, related to down payment on eyewear purchased from the manufacturer, prior to shipment of the product that occurred after the respective balance sheet dates.

 

Intangible Assets

Intangible Assets

Intangible assets relate to patent costs received in conjunction with the initial capitalization of the Company and internally developed utility and design patents. The Company amortizes these assets over the estimated useful life of the patents. The Company reviews its intangible assets for impairment whenever changes in circumstances indicate that the carrying amount of the assets may not be recoverable.

 

Capitalized Software

Capitalized Software

The Company has incurred software development costs related to development of the Vyrb app, and has capitalized these costs in accordance with Accounting Standards Codification (“ASC”) 985-20, “Software – Costs of Software to be Sold, Leased, or Marketed,” considering it is the Company’s intention to market and sell the software externally. Planning, designing, coding, and testing occurred necessary to meet Vyrb’s design specifications; as such, all coding, development, and testing costs incurred subsequent to establishing technical feasibility were capitalized.

 

We launched an open beta version of the Vyrb application (for both iOS and Android) in December 2021 as the Company’s first social media platform, demonstrating the functionality of the software. The app has had several new features introduced in 2023, including live audio chatrooms for users of the Company’s smart eyewear, and offers market-leading audio accessibility features for social media, including the ability to create and listen to a feed of audio content completely hands-free, using unique voice assistant commands created for the app. The Company plans to continue to develop the expansive Vyrb platform into a feature-rich social toolbox for its customers. This includes the introduction of revenue-generating features such as native ads and in-app upgrades, as well as gamification features such as a points and rewards system.

 

However, as the Company diverted most of its software development resources in 2023 to the development and launch of the Lucyd app (which provides groundbreaking Generative AI features to our smart eyewear), the revenue-generating features for the Vyrb app were delayed, and are now planned to launch in 2024. Amortization of the capitalized software costs related to the Vyrb app will begin once revenue-generating operations associated with the software have commenced. No software development costs have been capitalized with respect to the Lucyd app.

 

Property and Equipment

Property and Equipment

Property and equipment are depreciated using the straight-line method over the estimated useful lives or lease terms if shorter. Depreciation expense for the years ended December 31, 2023 and 2022 was $61,093 and $22,101, respectively. For income tax purposes, accelerated depreciation methods are generally used. Repair and maintenance costs are expensed as incurred.

 

                     
    December 31,     December 31,     Estimated
Useful Lives
 
Property & Equipment   2023     2022     (in Years)  
Mobile Kiosk Display   $ 127,333     $ 63,395     3 years  
Computer Equipment     44,901       44,901     3 Years  
Office Equipment     10,291       17,273     3 Years  
Internal-Use Software     31,300       16,775     3 to 5 Years  
Property and equipment, gross     213,825       142,343        
Less: Accumulated depreciation     (80,977 )     (22,599 )      
Property and equipment, net   $ 132,848     $ 119,744        

 

Income Taxes

Income Taxes

The Company accounts for income taxes under an asset and liability approach that recognizes deferred tax assets and liabilities based on the difference between the financial statement carrying amounts and the tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.

 

The Company follows a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken, or expected to be taken, in a tax return. Any interest and penalties accrued related to uncertain tax positions are recorded in tax expense.

 

The Company assesses the realizability of its net deferred tax assets on an annual basis. If, after considering all relevant positive and negative evidence, it is more likely than not that some portion or all of the net deferred tax assets will not be realized, the Company will reduce the net deferred tax assets by a valuation allowance. The realization of net deferred tax assets is dependent on several factors, including the generation of sufficient taxable income prior to the expiration of net operating loss carryforwards.

 

Fair Value of Financial Instruments

Fair Value of Financial Instruments

For certain of the Company’s financial instruments, including cash, cash equivalents, accounts receivable, accounts payable, and cash advances provided by Tekcapital and Affiliates, the carrying amounts approximate fair value due to the short-term maturities of these instruments.

 

Concentrations of Credit Risk

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents, and accounts receivable. The Company limits its credit risk with respect to cash by maintaining cash and cash equivalent balances with high quality financial institutions. At times, the Company’s cash balances may exceed federally insured limits. Concentrations of credit risk with respect to accounts receivable are generally considered minimal due to collection history. However, as of December 31, 2023, $77,950 or approximately 50% of the Company’s gross accounts receivable balance was related to a single customer under a long-term instalment arrangement; the Company manages its risk related to this counterparty via other contractual arrangements with such counterparty, and incentivization through stock-based compensation.

 

Stock-Based Compensation

Stock-Based Compensation

The Company accounts for stock-based compensation to employees and directors and others in accordance with FASB ASC Topic 718, which requires that compensation expense be recognized in the financial statements for stock-based awards based on the grant date fair value. Forfeitures are accounted for as a reduction of compensation expense in the period when such forfeitures occur.

 

For stock option awards, the Black-Scholes-Merton option pricing model was used to estimate the fair value of share-based awards. The Black-Scholes-Merton option pricing model incorporates various and highly subjective assumptions, including expected term and share price volatility.

 

The expected term of the stock options was estimated based on the simplified method as allowed by Staff Accounting Bulletin 107 (SAB 107).

 

The share price volatility at the grant date is estimated using historical stock prices based upon the expected term of the options granted, using stock prices of comparably profiled public companies.

 

The risk-free interest rate assumption is determined using the rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued.

 

For restricted stock units, the fair value of the share-based award is based on the quoted market price of our common shares on the NASDAQ stock exchange.

 

Revenue Recognition

Revenue Recognition

Our revenue is generated from the sales of prescription and non-prescription optical glasses, sunglasses, and shipping charges, which are charged to the customer, associated with these purchases. We sell products through our retail store resellers, distributors, on our own website Lucyd.co, and on Amazon.com.

 

To determine revenue recognition, we perform the following steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. At contract inception, we assess the goods or services promised within each contract and determine those that are performance obligations, and also assess whether each promised good or service is distinct. We then recognize as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. In instances where the collectibility of contractual consideration is not probable at the time of sale, the revenue is deferred on our balance sheet as a contract liability, and the associated cost of goods sold is deferred on our balance sheet as a contract asset; subsequently, we recognize such revenue and cost of goods sold as payments are received. During the year ended December 31, 2023, we recognized $17,500 of revenue that was included in the contract liability balance as of January 1, 2023.

 

All revenue, including sales processed online and through our retail store resellers and distributors, is reported net of sales taxes collected from customers on behalf of taxing authorities, returns, and discounts.

 

For sales generated through our e-commerce channels, we identify the contract with a customer upon online purchase of our eyewear and transaction price at the manufacturer suggested retail price (“MSRP”) for non-prescription, polarized sunglass and blue light blocking glasses across all of our online channels. Our e-commerce revenue is recognized upon meeting of the performance obligation when the eyewear is shipped to end customers. Only U.S. consumers enjoy free USPS first class postage, with faster delivery options available for extra cost, for sales processed through our website and on Amazon. For Amazon sales, shipping is free for U.S consumers while international customers pay shipping charges on top of MSRP. Any costs associated with fees charged by the online platforms (Shopify for Lucyd.co website and Amazon) are not recharged to customers and are recorded as a component of cost of goods sold as incurred. The Company charges applicable state sales taxes in addition to the MSRP for both online channels and all other marketplaces on which the company sells products.

 

For sales to our retail store partners, we identify the contract with a customer upon receipt of an order of our eyewear through our Shopify wholesale portal or direct purchase order. Our revenue is recognized upon meeting the performance obligation, which is delivery of the Company’s eyewear products to the retail store and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to the retail store partners includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale retail orders, no e-commerce fees are applicable.

 

For sales to distributors, we identify the contract with a customer upon receipt of an order of our eyewear through a direct purchase order. If collectability of substantially all of the contract consideration is probable, our revenue is recognized upon meeting the performance obligation, which is delivery of our eyewear products to the distributor, and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to distributors includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale distributor orders, no e-commerce fees are applicable.

 

The Company’s sales do not contain any variable consideration.

 

We allow our customers to return our products, subject to our refund policy, which allows any customer to return our products for any reason within the first:

 

  7 days for sales made through our website (Lucyd.co)

 

  30 days for sales made through Amazon

 

  30 days for sales to most wholesale retailers and distributors (although certain sales to independent distributors are ineligible for returns)

 

For all of our sales, at the time of sale, we establish a reserve for returns, based on historical experience and expected future returns, which is recorded as a reduction of sales. Additionally, we review all individual returns received in the month following the balance sheet date pertaining to orders processed prior to the balance sheet date in order to determine whether an allowance for sales returns is necessary. The Company recorded an allowance for sales returns of $25,933 and $24,897 as of December 31, 2023 and 2022, respectively.

 

Shipping and Handling

Shipping and Handling

Costs incurred for shipping and handling are included in cost of revenue at the time the related revenue is recognized. Amounts billed to a customer for shipping and handling are reported as revenues.

 

Recently Adopted Accounting Pronouncements

Recently Adopted Accounting Pronouncements

Effective January 1, 2023, the Company adopted the provisions of Accounting Standards Update (“ASU”) 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (as amended by ASU 2018-19 in November 2018, ASU 2019-05 in May 2019, ASU 2019-10 and 2019-11 in November 2019, ASU 2020-02 in February 2020, and ASU 2022-02 in March 2022). This standard requires entities to estimate lifetime expected credit losses for financial instruments, including trade and other receivables, which will generally result in earlier recognition of credit losses. The adoption of this new guidance did not have a significant impact on our results of operations, cash flows, or financial condition.

 

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

In October 2023, the FASB issued ASU 2023-06, Disclosure Improvements. This ASU amends the presentation and disclosure of a variety of topics in the ASC, including derivatives, diluted earnings per share, changes in reporting entity, preferred stock, certain industry-specific items, and various other topics, in order to align them with SEC regulations. The amendments to the various topics should be applied prospectively, and the effective date will be determined for each individual disclosure based on the effective date of the SEC’s removal of the related disclosure requirement from Regulation S-X or Regulation S-K. We do not anticipate that the adoption of this ASU will have a significant impact on our financial statements.

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. ASU 2023-07 improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. In addition, the ASU enhances interim disclosure requirements, clarifies circumstances in which an entity can disclose multiple segment measures of profit or loss, and contains other disclosure requirements. The ASU does not change how an entity identifies its operating segments, aggregates those operating segments, or applies the quantitative thresholds to determine its reportable segments. ASU 2023-07 is required to be applied retrospectively to all periods presented in the financial statements, and is effective for Innovative Eyewear, Inc. for fiscal years beginning after December 15, 2023 (i.e., January 1, 2024) and interim periods within fiscal years beginning after December 15, 2024 (i.e., January 1, 2025). We do not anticipate that the adoption of this ASU will have a significant impact on our financial statements.

 

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. ASU 2023-09 requires disclosure of additional categories of information about federal, state, and foreign income taxes in the rate reconciliation table and requires entities to provide more details about the reconciling items in some categories if items meet a quantitative threshold. The ASU also requires entities to disclose income taxes paid, net of refunds, disaggregated by federal (national), state, and foreign taxes for annual periods and to disaggregate the information by jurisdiction based on a quantitative threshold. The guidance makes several other changes to the disclosure requirements. The ASU is required to be applied prospectively, with the option to apply it retrospectively. The ASU is effective for Innovative Eyewear, Inc. for fiscal years beginning after December 15, 2024. We do not anticipate that the adoption of this ASU will have a significant impact on our financial statements.

 

Subsequent Events

Subsequent Events

In connection with the preparation of these financial statements, the Company has evaluated subsequent events through March 24, 2024, which is the date the financial statements were available to be issued. See Note 11 for additional information.

 

XML 42 R21.htm IDEA: XBRL DOCUMENT v3.24.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Schedule of allowance for doubtful account
         
Balance at December 31, 2022   $ 92,646  
Bad debt expense     30,275  
Write-offs(1)     (52,149 )
Recoveries(1)     (45,000 )
Balance at December 31, 2023   $ 25,772  

 

 
(1) During the year ended December 31, 2023, the Company entered into a settlement agreement with a former wholesale customer. As a result of this settlement, $47,646 of accounts receivable were written-off as uncollectible, while the $45,000 collected under the settlement agreement was reflected as a gain within general and administrative expenses in the statement of operations.
Schedule of estimated useful lives of property and equipment
                     
    December 31,     December 31,     Estimated
Useful Lives
 
Property & Equipment   2023     2022     (in Years)  
Mobile Kiosk Display   $ 127,333     $ 63,395     3 years  
Computer Equipment     44,901       44,901     3 Years  
Office Equipment     10,291       17,273     3 Years  
Internal-Use Software     31,300       16,775     3 to 5 Years  
Property and equipment, gross     213,825       142,343        
Less: Accumulated depreciation     (80,977 )     (22,599 )      
Property and equipment, net   $ 132,848     $ 119,744        
XML 43 R22.htm IDEA: XBRL DOCUMENT v3.24.1
INCOME TAX PROVISION (Tables)
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of reconciliation of federal statutory tax rate
               
    2023     2022  
Income tax benefit at the statutory federal rate   $ 1,389,526     $ 1,193,185  
State income tax benefits, net of federal benefit     50,907       35,149  
Change in valuation allowance     (1,440,433 )     (1,228,334 )
Total   $ -     $ -  
Schedule of deferred tax assets
               
    2023     2022  
Deferred tax assets:                
Stock-based compensation   $ 877,645     $ 610,530  
Other – net     219,723       122,133  
Net operating losses – federal     2,483,530       1,346,823  
Net operating losses – state     148,177       81,911  
 Deferred tax assets Gross     3,729,075       2,161,397  
Less Valuation Allowance     (3,729,075 )     (2,161,397 )
Net deferred tax assets   $ -     $ -  
XML 44 R23.htm IDEA: XBRL DOCUMENT v3.24.1
INTANGIBLE ASSETS (Tables)
12 Months Ended
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of intangible assets
               
Finite-lived intangible assets   December 31,
2023
    December 31,
2022
 
Patent Costs   $ 329,232     $ 156,196  
Intangible assets, gross     329,232       156,196  
Less: Accumulated amortization     (42,803 )     (18,639 )
Intangible assets, net   $ 286,429     $ 137,557  
XML 45 R24.htm IDEA: XBRL DOCUMENT v3.24.1
COMMITMENTS AND CONTINGENCIES (Tables)
12 Months Ended
Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
Schedule of future minimum payments due
       
2024   $ 161,210  
2025     436,000  
2026     834,000  
2027     1,290,000  
2028     1,543,000  
Thereafter (through 2032)     9,907,000  
Total   $ 14,171,210  
XML 46 R25.htm IDEA: XBRL DOCUMENT v3.24.1
STOCKHOLDERS’ EQUITY (Tables)
12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Schedule of stockholder’s equity
                     
Warrant Type   Warrants
Outstanding
    Exercise
Price
    Expiration
Date
 
Listed Warrants     1,374,280     $ 3.75     8/17/2027  
Common Warrants     4,500,000     $ 1.05     6/26/2028  
Private Warrants     300,000     $ 3.75     4/19/2028  
Underwriter warrants     58,800     $ 8.23     8/12/2027  
Placement agent warrants     180,000     $ 1.05     6/26/2028  
Total     6,413,080                
XML 47 R26.htm IDEA: XBRL DOCUMENT v3.24.1
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Schedule fair value of options granted
                       
    Weighted Average
Exercise Price
per share
$
    Options
(Number)
    Weighted Average
Remaining
Contractual Life
(Years)
 
As at January 1, 2022     2.61       2,332,500          
Granted     -       -          
Exercised     -       -          
Forfeited     -       -          
As at December 31, 2022     2.61       2,332,500       1.68  
                         
As at January 1, 2023     2.61       2,332,500          
Granted     0.92       1,153,000          
Exercised     1.01       (316,000 )        
Forfeited / Expired     2.94       (275,000 )        
As at December 31, 2023     2.08       2,894,500       2.22  
Exercisable as at December 31, 2023     2.39       1,795,219       1.40  
Schedule of number of share options and the weighted average exercise price outstanding
     
Attribute      
Share price at date of grant   $0.43 - $1.28  
Expected term (in years)   3 - 4  
Risk free rate   3.74% - 4.65 %
Expected volatility   106% - 133 %
Expected dividend yield   0  
Grant date fair value of options   $0.28 - $1.02  
XML 48 R27.htm IDEA: XBRL DOCUMENT v3.24.1
EARNINGS PER SHARE (Tables)
12 Months Ended
Dec. 31, 2023
Earnings Per Share [Abstract]  
Calculation of net earnings per common share - basic and diluted
           
    For the
year ended
 
    December 31,     December 31,  
    2023     2022  
Basic and diluted:                
Net loss   $ (6,663,428 )   $ (5,681,833 )
Weighted-average number of common shares     10,515,995       6,528,959  
Basic and diluted net loss per common share   $ (0.63 )   $ (0.87 )
XML 49 R28.htm IDEA: XBRL DOCUMENT v3.24.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)
12 Months Ended
Dec. 31, 2023
USD ($)
Accounting Policies [Abstract]  
Balance at beginning $ 92,646
Bad debt expense 30,275
Write-offs (52,149) [1]
Recoveries (45,000) [1]
Balance at ending $ 25,772
[1] During the year ended December 31, 2023, the Company entered into a settlement agreement with a former wholesale customer. As a result of this settlement, $47,646 of accounts receivable were written-off as uncollectible, while the $45,000 collected under the settlement agreement was reflected as a gain within general and administrative expenses in the statement of operations.
XML 50 R29.htm IDEA: XBRL DOCUMENT v3.24.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 213,825 $ 142,343
Less: Accumulated depreciation (80,977) (22,599)
Property and equipment, net 132,848 119,744
Mobile Kiosk Display [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 127,333 63,395
Property, Plant and Equipment, Useful Life 3 years  
Computer Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 44,901 44,901
Property, Plant and Equipment, Useful Life 3 years  
Office Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 10,291 17,273
Property, Plant and Equipment, Useful Life 3 years  
Internal Use Software [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 31,300 $ 16,775
Internal Use Software [Member] | Minimum [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Useful Life 3 years  
Internal Use Software [Member] | Maximum [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Useful Life 5 years  
XML 51 R30.htm IDEA: XBRL DOCUMENT v3.24.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Product Information [Line Items]    
Bad debt expenses $ 30,275 $ 116,230
Inventory prepayment 323,520 197,750
Depreciation expense 61,093 22,101
Accounts receivable 93,211 110,258
Revenue recognized 17,500  
Allowance for sales returns 25,933 $ 24,897
Accounts Receivable [Member]    
Product Information [Line Items]    
Accounts receivable $ 77,950  
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Single Customer [Member]    
Product Information [Line Items]    
Concentrations of Credit Risk 50.00%  
XML 52 R31.htm IDEA: XBRL DOCUMENT v3.24.1
INCOME TAX PROVISION (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Tax Disclosure [Abstract]    
Income tax benefit at the statutory federal rate $ 1,389,526 $ 1,193,185
State income tax benefits, net of federal benefit 50,907 35,149
Change in valuation allowance 1,440,433 1,228,334
Total
XML 53 R32.htm IDEA: XBRL DOCUMENT v3.24.1
INCOME TAX PROVISION (Details 1) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Deferred tax assets:    
Stock-based compensation $ 877,645 $ 610,530
Other – net 219,723 122,133
Net operating losses – federal 2,483,530 1,346,823
Net operating losses – state 148,177 81,911
 Deferred tax assets Gross 3,729,075 2,161,397
Less Valuation Allowance (3,729,075) (2,161,397)
Net deferred tax assets
XML 54 R33.htm IDEA: XBRL DOCUMENT v3.24.1
INCOME TAX PROVISION (Details Narrative) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Income Tax Disclosure [Abstract]    
Federal net operating loss carryforwards $ 11,826,332  
State net operating loss carryforwards 6,515,176  
Liabilities for uncertain tax positions $ 0 $ 0
XML 55 R34.htm IDEA: XBRL DOCUMENT v3.24.1
INTANGIBLE ASSETS (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]    
Intangible assets, gross $ 329,232 $ 156,196
Less: Accumulated amortization (42,803) (18,639)
Intangible assets, net 286,429 137,557
Patents [Member]    
Finite-Lived Intangible Assets [Line Items]    
Intangible assets, gross $ 329,232 $ 156,196
XML 56 R35.htm IDEA: XBRL DOCUMENT v3.24.1
INTANGIBLE ASSETS (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]    
Amortization expense $ 24,164 $ 10,466
Future amortization $ 30,000  
XML 57 R36.htm IDEA: XBRL DOCUMENT v3.24.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Aug. 15, 2022
Nov. 01, 2021
Dec. 01, 2020
Jan. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Related Party Transaction [Line Items]            
Convertible debt issued       $ 48,143 $ 1,475,000
Convertible notes balances           61,356
Management fee         140,000 140,000
Tekcapital And Affiliates [Member]            
Related Party Transaction [Line Items]            
Interest rate     10.00%      
Convertible debt issued   $ 3,000,000 $ 2,000,000      
Lucyd [Member] | IPO [Member]            
Related Party Transaction [Line Items]            
Conversion of stock, amount $ 2,002,280          
Number of shares converted 266,970          
Conversion Price $ 7.50          
Tekcapital Europe Ltd [Member]            
Related Party Transaction [Line Items]            
Management fee         140,000 140,000
Rent expenses         $ 91,672 $ 74,442
XML 58 R37.htm IDEA: XBRL DOCUMENT v3.24.1
COMMITMENTS AND CONTINGENCIES (Details)
Dec. 31, 2023
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
2024 $ 161,210
2025 436,000
2026 834,000
2027 1,290,000
2028 1,543,000
Thereafter (through 2032) 9,907,000
Total $ 14,171,210
XML 59 R38.htm IDEA: XBRL DOCUMENT v3.24.1
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2023
Aug. 31, 2023
Offsetting Assets [Line Items]    
Legal matters liability $ 103,000  
Base term 10 years  
Settlement Agreement [Member]    
Offsetting Assets [Line Items]    
Settlement amount   $ 92,646
Accounts receivable written-off   47,646
Net account receivable   $ 45,000
XML 60 R39.htm IDEA: XBRL DOCUMENT v3.24.1
STOCKHOLDERS' EQUITY (Details) - $ / shares
Dec. 31, 2023
Feb. 28, 2023
Class of Warrant or Right [Line Items]    
Warrants outstanding 6,413,080  
Exercise price   $ 3.75
Listed Warrants [Member]    
Class of Warrant or Right [Line Items]    
Warrants outstanding 1,374,280  
Exercise price $ 3.75  
Expiration Date Aug. 17, 2027  
Common Warrants [Member]    
Class of Warrant or Right [Line Items]    
Warrants outstanding 4,500,000  
Exercise price $ 1.05  
Expiration Date Jun. 26, 2028  
Private Warrants [Member]    
Class of Warrant or Right [Line Items]    
Warrants outstanding 300,000  
Exercise price $ 3.75  
Expiration Date Apr. 19, 2028  
Underwriter Warrants [Member]    
Class of Warrant or Right [Line Items]    
Warrants outstanding 58,800  
Exercise price $ 8.23  
Expiration Date Aug. 12, 2027  
Placemen Agent Warrants [Member]    
Class of Warrant or Right [Line Items]    
Warrants outstanding 180,000  
Exercise price $ 1.05  
Expiration Date Jun. 26, 2028  
XML 61 R40.htm IDEA: XBRL DOCUMENT v3.24.1
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Aug. 17, 2022
Aug. 15, 2022
Jun. 26, 2023
Apr. 17, 2023
Apr. 16, 2023
Feb. 28, 2023
Aug. 17, 2022
Dec. 31, 2023
Dec. 31, 2022
Subsidiary, Sale of Stock [Line Items]                  
Preferred stock , shares authorized               15,000,000 15,000,000
Common stock, shares authorized               50,000,000 50,000,000
Preferred stock , shares issued               0 0
Preferred stock, shares Outstanding               0 0
Proceeds from offering               $ 6,127,067
Exercise price           $ 3.75      
Cash proceeds           $ 1,532,250   $ 3,127,718
Number of warrant exercised           408,600      
Inducement Letter [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Exercise price       $ 3.75          
Number of warrant exercised       150,000          
Sale of transaction       $ 562,000          
Warrant [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Number of warrants purchased     180,000            
Exercise price     $ 1.31   $ 3.75        
Cash proceeds     $ 4,115,688   $ 1,204,200        
Number of warrant exercised         321,120        
New Warrants [Member] | Inducement Letter [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Exercise price       $ 3.75          
Number of warrant exercised       300,000          
Sale of transaction       $ 391,268          
Common Stock [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Issauance of common stock 2,254,000   4,500,000       980,000    
IPO [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Issauance of common stock             980,000    
Share Price $ 7.50           $ 7.50    
Proceeds from offering   $ 6,015,918         $ 7,350,000    
Underwriters description             Company granted the underwriters a 45-day option to purchase up to an additional 147,000 shares of common stock and/or warrants to purchase up to an additional 294,000 shares of common stock to cover over-allotments, of which the Underwriter exercised its option to purchase additional warrants to purchase 294,000 shares of common stock concurrently with the closing.    
Number of warrants purchased 2,254,000   4,500,000            
Exercise price     $ 1.05            
Cash proceeds     $ 4,730,000            
IPO [Member] | Maxim [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Number of warrants purchased   58,800              
Exercise price   $ 8.228              
XML 62 R41.htm IDEA: XBRL DOCUMENT v3.24.1
STOCK BASED COMPENSATION (Details) - $ / shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Equity [Abstract]    
Weighted avaerage exercise price per share, Option Outstanding at beginnig $ 2.61 $ 2.61
Option Outstanding at beginnig 2,332,500 2,332,500
Weighted avaerage exercise price per share, Option Granted $ 0.92
Option Granted 1,153,000
Weighted avaerage exercise price per share, Option Exercised $ 1.01
Option Exercised 316,000
Weighted avaerage exercise price per share, Option Forfeited $ 2.94
Option Forfeited 275,000
Weighted avaerage exercise price per share, Option Outstanding at ending $ 2.08 $ 2.61
Option Outstanding at ending 2,894,500 2,332,500
Weighted avaerage remaining contractual life (Years) 2 years 2 months 19 days 1 year 8 months 4 days
Option Exercised (316,000)
Option Forfeited (275,000)
Weighted avaerage exercise price per share, Option Exercisable $ 2.39  
Option Exercisable 1,795,219  
Weighted avaerage remaining contractual life (Years), Option Exercisable 1 year 4 months 24 days  
XML 63 R42.htm IDEA: XBRL DOCUMENT v3.24.1
STOCK BASED COMPENSATION (Details 1) - $ / shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Expected dividend yield 0.00%  
Grant date fair value of options $ 1.49 $ 1.84
Minimum [Member]    
Share price at date of grant $ 0.43  
Options life in years 3 years  
Risk free rate 3.74%  
Expected volatility 106.00%  
Grant date fair value of options $ 0.28  
Maximum [Member]    
Share price at date of grant $ 1.28  
Options life in years 4 years  
Risk free rate 4.65%  
Expected volatility 133.00%  
Grant date fair value of options $ 1.02  
XML 64 R43.htm IDEA: XBRL DOCUMENT v3.24.1
STOCK-BASED COMPENSATION (Details Narrative) - USD ($)
12 Months Ended
Dec. 03, 2023
Jun. 01, 2023
Dec. 31, 2023
Dec. 31, 2022
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]        
Stock granted     1,800,500  
Weighted average grant date fair value of options outstanding     $ 1.49 $ 1.84
Unrecognized stock compensation expense     $ 721,000  
Unrecognized stock compensation expense, term     1 year 1 month 13 days  
Number of common stock purchased   140,000 9,188  
Options outstanding intrinsic value     $ 0  
Options exercisable intrinsic value     0  
Stock-based compensation     936,769 $ 1,473,864
Restricted Stock Units (RSUs) [Member]        
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]        
Number of restricted stock units granted 65,220      
Restricted stock units vested description These restricted stock units vest according to the following schedule: 16,305 shares on December 3, 2023 (which will be issued on or before March 31, 2024), 16,305 shares on March 2, 2024 (which will be issued on or before March 31, 2024), 16,305 shares on May 31, 2024, and 16,305 shares on August 29, 2024.      
Stock-based compensation     8,458  
Straight line basis     $ 18,608  
Officers And Management [Member]        
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]        
Number of options purchased     330,000  
Exercise price     $ 1.275  
Non Management Directors [Member]        
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]        
Number of options purchased     75,000  
Exercise price     $ 1.275  
Employees And Consultants [Member]        
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]        
Number of options purchased     162,000  
Exercise price     $ 1.275  
Employee [Member]        
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]        
Number of options purchased     75,000  
Exercise price     $ 1.275  
Warrants to purchase Common Stock        
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]        
Number of options purchased     6,000  
Exercise price     $ 1.275  
Employees And Consultants 1 [Member]        
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]        
Number of options purchased     15,000  
Exercise price     $ 0.66  
Officers And Management 1 [Member]        
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]        
Number of options purchased     490,000  
Exercise price     $ 0.45  
XML 65 R44.htm IDEA: XBRL DOCUMENT v3.24.1
EARNINGS PER SHARE (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Basic and diluted:    
Net loss $ (6,663,428) $ (5,681,833)
Weighted-average number of common shares 10,515,995 6,528,959
Basic and diluted net loss per common share $ (0.63) $ (0.87)
XML 66 R45.htm IDEA: XBRL DOCUMENT v3.24.1
SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member] - USD ($)
Mar. 01, 2024
Jan. 11, 2024
Tekcapital Europe Ltd [Member]    
Subsequent Event [Line Items]    
Loans payable   $ 765,000
Interest rate   10.00%
Maturity date   Apr. 11, 2024
Lucyd [Member]    
Subsequent Event [Line Items]    
Interest rate 10.00%  
Maturity date Sep. 01, 2025  
Number of stock issued $ 1,250,000  
EXCEL 67 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 76 innovative_10k_htm.xml IDEA: XBRL DOCUMENT 0001808377 2023-01-01 2023-12-31 0001808377 LUCY:CommonStock0.00001ParValueMember 2023-01-01 2023-12-31 0001808377 LUCY:WarrantsToPurchaseCommonStockMember 2023-01-01 2023-12-31 0001808377 2023-06-30 0001808377 2024-03-22 0001808377 2023-10-01 2023-12-31 0001808377 2023-12-31 0001808377 2022-12-31 0001808377 2022-01-01 2022-12-31 0001808377 us-gaap:CommonStockMember 2022-12-31 0001808377 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001808377 LUCY:StockSubscriptionReceivableMember 2022-12-31 0001808377 us-gaap:RetainedEarningsMember 2022-12-31 0001808377 us-gaap:CommonStockMember 2021-12-31 0001808377 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001808377 LUCY:StockSubscriptionReceivableMember 2021-12-31 0001808377 us-gaap:RetainedEarningsMember 2021-12-31 0001808377 2021-12-31 0001808377 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001808377 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-12-31 0001808377 LUCY:StockSubscriptionReceivableMember 2023-01-01 2023-12-31 0001808377 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0001808377 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001808377 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001808377 LUCY:StockSubscriptionReceivableMember 2022-01-01 2022-12-31 0001808377 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001808377 us-gaap:CommonStockMember 2023-12-31 0001808377 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001808377 LUCY:StockSubscriptionReceivableMember 2023-12-31 0001808377 us-gaap:RetainedEarningsMember 2023-12-31 0001808377 us-gaap:AccountsReceivableMember 2023-12-31 0001808377 LUCY:SingleCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001808377 LUCY:MobileKioskDisplayMember 2023-12-31 0001808377 LUCY:MobileKioskDisplayMember 2022-12-31 0001808377 us-gaap:ComputerEquipmentMember 2023-12-31 0001808377 us-gaap:ComputerEquipmentMember 2022-12-31 0001808377 us-gaap:OfficeEquipmentMember 2023-12-31 0001808377 us-gaap:OfficeEquipmentMember 2022-12-31 0001808377 LUCY:InternalUseSoftwareMember 2023-12-31 0001808377 LUCY:InternalUseSoftwareMember 2022-12-31 0001808377 srt:MinimumMember LUCY:InternalUseSoftwareMember 2023-12-31 0001808377 srt:MaximumMember LUCY:InternalUseSoftwareMember 2023-12-31 0001808377 us-gaap:PatentsMember 2023-12-31 0001808377 us-gaap:PatentsMember 2022-12-31 0001808377 LUCY:TekcapitalAndAffiliatesMember 2020-11-29 2020-12-01 0001808377 LUCY:TekcapitalAndAffiliatesMember 2021-10-29 2021-11-01 0001808377 LUCY:LucydMember us-gaap:IPOMember 2022-08-01 2022-08-15 0001808377 LUCY:LucydMember us-gaap:IPOMember 2022-08-15 0001808377 2023-01-02 2023-01-31 0001808377 LUCY:TekcapitalEuropeLtdMember 2023-01-01 2023-12-31 0001808377 LUCY:TekcapitalEuropeLtdMember 2022-01-01 2022-12-31 0001808377 LUCY:SettlementAgreementMember 2023-08-31 0001808377 us-gaap:IPOMember 2022-08-01 2022-08-17 0001808377 us-gaap:CommonStockMember 2022-08-01 2022-08-17 0001808377 us-gaap:IPOMember 2022-08-17 0001808377 LUCY:MaximMember us-gaap:IPOMember 2022-08-01 2022-08-15 0001808377 LUCY:MaximMember us-gaap:IPOMember 2022-08-15 0001808377 us-gaap:IPOMember 2022-08-01 2022-08-15 0001808377 us-gaap:IPOMember 2023-06-02 2023-06-26 0001808377 us-gaap:CommonStockMember 2023-06-02 2023-06-26 0001808377 us-gaap:IPOMember 2023-06-26 0001808377 us-gaap:WarrantMember 2023-06-02 2023-06-26 0001808377 us-gaap:WarrantMember 2023-06-26 0001808377 us-gaap:IPOMember 2022-08-16 2022-08-17 0001808377 us-gaap:CommonStockMember 2022-08-16 2022-08-17 0001808377 2023-02-01 2023-02-28 0001808377 2023-02-28 0001808377 us-gaap:WarrantMember 2023-04-01 2023-04-16 0001808377 us-gaap:WarrantMember 2023-04-16 0001808377 LUCY:InducementLetterMember 2023-04-01 2023-04-17 0001808377 LUCY:InducementLetterMember 2023-04-17 0001808377 LUCY:NewWarrantsMember LUCY:InducementLetterMember 2023-04-01 2023-04-17 0001808377 LUCY:NewWarrantsMember LUCY:InducementLetterMember 2023-04-17 0001808377 LUCY:ListedWarrantsMember 2023-12-31 0001808377 LUCY:CommonWarrantsMember 2023-12-31 0001808377 LUCY:PrivateWarrantsMember 2023-12-31 0001808377 LUCY:UnderwriterWarrantsMember 2023-12-31 0001808377 LUCY:PlacemenAgentWarrantsMember 2023-12-31 0001808377 LUCY:OfficersAndManagementMember 2023-01-01 2023-12-31 0001808377 LUCY:NonManagementDirectorsMember 2023-01-01 2023-12-31 0001808377 LUCY:EmployeesAndConsultantsMember 2023-01-01 2023-12-31 0001808377 LUCY:EmployeeMember 2023-01-01 2023-12-31 0001808377 LUCY:AConsultantMember 2023-01-01 2023-12-31 0001808377 LUCY:EmployeesAndConsultants1Member 2023-01-01 2023-12-31 0001808377 LUCY:OfficersAndManagement1Member 2023-01-01 2023-12-31 0001808377 2023-05-30 2023-06-01 0001808377 us-gaap:RestrictedStockUnitsRSUMember 2023-12-01 2023-12-03 0001808377 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-12-31 0001808377 srt:MinimumMember 2023-12-31 0001808377 srt:MaximumMember 2023-12-31 0001808377 srt:MinimumMember 2023-01-01 2023-12-31 0001808377 srt:MaximumMember 2023-01-01 2023-12-31 0001808377 LUCY:TekcapitalEuropeLtdMember us-gaap:SubsequentEventMember 2024-01-11 0001808377 LUCY:TekcapitalEuropeLtdMember us-gaap:SubsequentEventMember 2024-01-01 2024-01-11 0001808377 LUCY:LucydMember us-gaap:SubsequentEventMember 2024-02-27 2024-03-01 iso4217:USD shares iso4217:USD shares pure false 2023 FY 0001808377 10-K true 2023-12-31 --12-31 false 001-41392 INNOVATIVE EYEWEAR, INC. FL 85-0734861 11900 Biscayne Blvd. Suite 630 North Miami FL 33181 954 826-0329 Common Stock, $0.00001 par value LUCY NASDAQ Warrants to purchase Common Stock LUCYW NASDAQ No No Yes Yes Non-accelerated Filer true true false false false false 6916698 12933544 false false false false Cherry Bekaert LLP 677 Tampa, Florida 4287447 3591109 25772 92646 93211 110258 313648 210673 323520 197750 533239 94701 6256 59447 36240 5616768 4240731 286429 137557 110073 110073 132848 119744 72644 81779 6218762 4689884 581986 275660 42500 30000 232989 61356 624486 600005 35450 65450 659936 665455 0.00001 0.00001 50000000 50000000 12917239 12917239 7307157 7307157 129 73 22528112 14330343 -16969415 -10305987 5558826 4024429 6218762 4689884 1152479 659788 1271808 716077 -119329 -56289 3886960 2796669 2047069 2059012 662184 524692 140000 140000 6736213 5520373 195150 3036 105171 192114 -105171 -6663428 -5681833 10515995 6528959 -0.63 -0.63 -0.87 -0.87 7307157 73 14330343 -10305987 4024429 230362 2 17648 17650 729720 7 2736443 2736450 4500000 45 4115643 4115688 150000 2 391266 391268 936769 936769 -6663428 -6663428 12917239 129 22528112 -16969415 5558826 6060187 60 4842836 -11226 -4624154 207516 6684 6684 -4542 4542 980000 10 6015908 6015918 266970 3 2002277 2002280 1473864 1473864 -5681833 -5681833 7307157 73 14330343 -10305987 4024429 -6663428 -5681833 61093 22101 24164 10466 3036 105171 936769 1473864 299061 960362 -14725 116230 50796 -2316 3678 183094 303290 67951 102975 142292 564308 -47765 -1460 -3878 22569 -5766303 -3224418 1949204 -2000000 173036 60717 78463 121561 1950 37673 -198753 -219951 6127067 4115688 3127718 17650 6684 1475000 109499 653000 490163 6661394 6955751 696338 3511382 3591109 79727 4287447 3591109 299061 960362 -4542 2002280 <p id="xdx_801_eus-gaap--NatureOfOperations_z0I8L62kMlz1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 1 – <span id="xdx_82C_zlkT44dPoEj2">GENERAL INFORMATION</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Innovative Eyewear, Inc. (the “Company,” “us,” “we,” or “our”) is a corporation organized under the laws of the State of Florida that develops and sells cutting-edge eyeglasses and sunglasses, which are designed to allow our customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. The Company was founded by Lucyd Ltd., a portfolio company of Tekcapital Plc through Tekcapital Europe, Ltd. (collectively, together with Lucyd Ltd., “Tekcapital and Affiliates”), which owned approximately 40% of our issued and outstanding shares of common stock and was our largest stockholder as of December 31, 2023. Innovative Eyewear licensed the exclusive rights to the Lucyd® brand from Lucyd Ltd., which includes the exclusive use of all of Lucyd’s intellectual property, including our main product, Lucyd Lyte® glasses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_804_eus-gaap--SignificantAccountingPoliciesTextBlock_zMawHjYa8z3d" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 2 – <span id="xdx_82B_zMU4GVOIRdRk">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_843_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_zdwHuJXlj2Ac" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_867_zv4k2N8CKdcd">Basis of Presentation</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and in accordance with the accounting rules under Regulation S-X, as promulgated by the Securities and Exchange Commission (“SEC”). In the opinion of management, all adjustments considered necessary for the fair presentation of the financial statements for the years presented have been included. The results of operations for the years ended December 31, 2023 and 2022 are not necessarily indicative of the results to be expected for future periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_842_eus-gaap--UseOfEstimates_zH5jdsro4XT9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86F_zlUvNusBbyXj">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates, particularly given the significant uncertainties associated with the current geopolitical and economic environment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_84F_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zCVIeJuxwKz" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_864_zMST1MQWHao5">Cash Equivalents</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All highly liquid investments with original maturities of three months or less, including money market funds, certificates of deposit, and U.S. Treasury bills purchased three months or less from maturity, are considered cash equivalents.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_84B_eus-gaap--ReceivablesPolicyTextBlock_zSt815GSuQ43" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86B_znsm44nyGWnc">Receivables and Credit Policy</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Trade receivables from customers are uncollateralized customer obligations due under normal trade terms. For direct-to-consumer sales, payment is required before product is shipped. Trade receivables are stated at the amount billed to the customer. Payments of trade receivables are allocated to the specific invoices identified on the customer’s remittance advice or, if unspecified, are applied to the earliest unpaid invoice. The Company, by policy, routinely assesses the financial strength of its customers. To comply with industry standards, we offer “net 30” payments on wholesale orders of $1,500 or more. For wholesale orders, to acquire an order on net 30 terms, the customer is provided a credit check application as well as a credit card authorization form. The authorization form explicitly states when and for much we will bill the customer via credit card.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable are reported net of the allowance for doubtful accounts. The allowance for doubtful accounts is determined based upon a variety of judgments and factors. Factors considered in determining the allowance include historical collection, write-off experience, and management’s assessment of collectibility from customers, including current conditions, reasonable forecasts, and expectations of future collectibility and collection efforts. Management continuously assesses the collectibility of receivables and adjusts estimates based on actual experience and future expectations based on economic indicators. Receivable balances are written-off against the allowance when such balances are deemed to be uncollectible. The Company recognized bad debt expense of $<span id="xdx_906_ecustom--BadDebtExpenses_pp0p0_c20230101__20231231_z8ED0deGm5Wc" title="Bad debt expenses">30,275</span> and $<span id="xdx_902_ecustom--BadDebtExpenses_pp0p0_c20220101__20221231_za2irhInwwXe" title="Bad debt expenses">116,230</span> for the years ended December 31, 2023 and 2022, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A roll forward of the allowance for doubtful accounts for the year ended December 31, 2023 is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--AllowanceForDoubtfulAccountsTableTextBlock_zt2WvBmK31D1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> <span id="xdx_8BF_z7Hxrlx7qHW4" style="display: none">Schedule of allowance for doubtful account</span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; width: 88%; vertical-align: top">Balance at December 31, 2022</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230101__20231231_zMca1li2avIb" style="width: 9%; text-align: right" title="Balance at beginning">92,646</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Bad debt expense</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_986_ecustom--BadDebtExpense_pp0p0_c20230101__20231231_zZkUzYQiesY4" style="text-align: right" title="Bad debt expense">30,275</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; font-weight: 400; font-style: normal; vertical-align: top">Write-offs<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)</sup></span></td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98C_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_iN_pp0p0_di_c20230101__20231231_fKDEp_z3DSBxEwNkEi" style="text-align: right" title="Write-offs">(52,149</td> <td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; font-weight: 400; font-style: normal; padding-bottom: 1pt; vertical-align: top">Recoveries<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)</sup></span></td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_98C_eus-gaap--AllowanceForDoubtfulAccountsReceivableRecoveries_iN_pp0p0_di_c20230101__20231231_fKDEp_ze8iGFGWYQ9b" style="border-bottom: Black 1pt solid; text-align: right" title="Recoveries">(45,000</td> <td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt; vertical-align: top">Balance at December 31, 2023</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_980_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230101__20231231_zpRl5GI49Lrl" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at ending">25,772</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt"> </div></div> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0"></td> <td id="xdx_F0A_zp8J9UwWTNdj" style="width: 0.25in; text-align: left">(1)</td> <td id="xdx_F10_z2LAeLyEv0vi" style="text-align: justify">During the year ended December 31, 2023, the Company entered into a settlement agreement with a former wholesale customer. As a result of this settlement, $47,646 of accounts receivable were written-off as uncollectible, while the $45,000 collected under the settlement agreement was reflected as a gain within general and administrative expenses in the statement of operations.</td> </tr> </table> <p id="xdx_8AF_zdfz9UtnWUhh" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_841_eus-gaap--InventoryPolicyTextBlock_zCjLby0IYoRb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86E_za7Fmc4gL589">Inventory</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our inventory includes purchased eyewear and is stated at the lower of cost or net realizable value, with cost determined on a specific identification method of inventory costing which attaches the actual cost to an identifiable unit of product. Provisions for excess, obsolete, or slow-moving inventory are recorded after periodic evaluation of historical sales, current economic trends, forecasted sales, estimated product life cycles, and estimated inventory levels. No provisions were determined as needed as of December 31, 2023 and 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2023 and 2022, the Company recorded an inventory prepayment in the amount of $<span id="xdx_90C_ecustom--InventoryPrepayment_c20231231_pp0p0" title="Inventory prepayment">323,520</span> and $<span id="xdx_90D_ecustom--InventoryPrepayment_c20221231_pp0p0" title="Inventory prepayment">197,750</span>, respectively, related to down payment on eyewear purchased from the manufacturer, prior to shipment of the product that occurred after the respective balance sheet dates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_849_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zGekyyVbxyrh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86A_z0wTW3dYU9Fe">Intangible Assets</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Intangible assets relate to patent costs received in conjunction with the initial capitalization of the Company and internally developed utility and design patents. The Company amortizes these assets over the estimated useful life of the patents. The Company reviews its intangible assets for impairment whenever changes in circumstances indicate that the carrying amount of the assets may not be recoverable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_84D_ecustom--CapitalizedSoftwarePolicyTextBlock_z12qIlg88vMl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_861_zKGvIGRXnRPk">Capitalized Software</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has incurred software development costs related to development of the Vyrb app, and has capitalized these costs in accordance with Accounting Standards Codification (“ASC”) 985-20, “Software – Costs of Software to be Sold, Leased, or Marketed,” considering it is the Company’s intention to market and sell the software externally. Planning, designing, coding, and testing occurred necessary to meet Vyrb’s design specifications; as such, all coding, development, and testing costs incurred subsequent to establishing technical feasibility were capitalized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We launched an open beta version of the Vyrb application (for both iOS and Android) in December 2021 as the Company’s first social media platform, demonstrating the functionality of the software. The app has had several new features introduced in 2023, including live audio chatrooms for users of the Company’s smart eyewear, and offers market-leading audio accessibility features for social media, including the ability to create and listen to a feed of audio content completely hands-free, using unique voice assistant commands created for the app. The Company plans to continue to develop the expansive Vyrb platform into a feature-rich social toolbox for its customers. This includes the introduction of revenue-generating features such as native ads and in-app upgrades, as well as gamification features such as a points and rewards system.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">However, as the Company diverted most of its software development resources in 2023 to the development and launch of the Lucyd app (which provides groundbreaking Generative AI features to our smart eyewear), the revenue-generating features for the Vyrb app were delayed, and are now planned to launch in 2024. Amortization of the capitalized software costs related to the Vyrb app will begin once revenue-generating operations associated with the software have commenced. No software development costs have been capitalized with respect to the Lucyd app.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_846_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_ztVBGcdKKiq3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86E_z1IeMRmhmO97">Property and Equipment</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment are depreciated using the straight-line method over the estimated useful lives or lease terms if shorter. Depreciation expense for the years ended December 31, 2023 and 2022 was $<span id="xdx_90D_eus-gaap--Depreciation_c20230101__20231231_pp0p0" title="Depreciation expense">61,093</span> and $<span id="xdx_90F_eus-gaap--Depreciation_c20220101__20221231_pp0p0" title="Depreciation expense">22,101</span>, respectively. For income tax purposes, accelerated depreciation methods are generally used. Repair and maintenance costs are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentNetTableTextBlock_zUsWsqeWvLL9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 1pt"><span id="xdx_8BB_z7ObN868h0vb" style="display: none">Schedule of estimated useful lives of property and equipment</span></td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td> <td style="text-align: right" title="Property and equipment, gross"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td> <td style="text-align: right" title="Property and equipment, gross"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td> <td style="vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td> <td style="vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td style="vertical-align: bottom; font-weight: bold; text-align: center">Estimated<br/> Useful Lives</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Property &amp; Equipment</td> <td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2023</td> <td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td> <td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">(in Years)</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 62%; text-align: left">Mobile Kiosk Display</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MobileKioskDisplayMember_pp0p0" style="width: 9%; text-align: right" title="Property and equipment, gross">127,333</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MobileKioskDisplayMember_pp0p0" style="width: 9%; text-align: right" title="Property and equipment, gross">63,395</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: center"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MobileKioskDisplayMember_z3foqvidYrXf" title="Property, Plant and Equipment, Useful Life">3 </span>years</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Computer Equipment</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross">44,901</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross">44,901</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zhTb6JOJNrAg" title="Property, Plant and Equipment, Useful Life">3</span> Years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Office Equipment</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross">10,291</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross">17,273</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zBAA2efd1n24" title="Property, Plant and Equipment, Useful Life">3</span> Years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 1pt">Internal-Use Software</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--InternalUseSoftwareMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross">31,300</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--InternalUseSoftwareMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross">16,775</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--InternalUseSoftwareMember__srt--RangeAxis__srt--MinimumMember_zYyRqXKJXod2" title="Property, Plant and Equipment, Useful Life">3</span> to <span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--InternalUseSoftwareMember__srt--RangeAxis__srt--MaximumMember_zdEMkTd22w6k" title="Property, Plant and Equipment, Useful Life">5</span> Years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left">Property and equipment, gross</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20231231_pp0p0" style="text-align: right" title="Property and equipment, gross">213,825</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20221231_pp0p0" style="text-align: right" title="Property and equipment, gross">142,343</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 1pt">Less: Accumulated depreciation</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20231231_zQkSobE3NVNf" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation">(80,977</td> <td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20221231_zzGsLxGhyHS4" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation">(22,599</td> <td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left; padding-bottom: 2.5pt">Property and equipment, net</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20231231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net">132,848</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net">119,744</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"> </td> <td> </td></tr> </table> <p id="xdx_8A3_zaN8DTooUj6b" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_845_eus-gaap--IncomeTaxPolicyTextBlock_zpMn8Y0ux7Ze" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86B_zHs5eE2BDeG1">Income Taxes</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for income taxes under an asset and liability approach that recognizes deferred tax assets and liabilities based on the difference between the financial statement carrying amounts and the tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company follows a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken, or expected to be taken, in a tax return. Any interest and penalties accrued related to uncertain tax positions are recorded in tax expense.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company assesses the realizability of its net deferred tax assets on an annual basis. If, after considering all relevant positive and negative evidence, it is more likely than not that some portion or all of the net deferred tax assets will not be realized, the Company will reduce the net deferred tax assets by a valuation allowance. The realization of net deferred tax assets is dependent on several factors, including the generation of sufficient taxable income prior to the expiration of net operating loss carryforwards.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_ziFq8td1THLf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86C_zYw4hAZbxSoh">Fair Value of Financial Instruments</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For certain of the Company’s financial instruments, including cash, cash equivalents, accounts receivable, accounts payable, and cash advances provided by Tekcapital and Affiliates, the carrying amounts approximate fair value due to the short-term maturities of these instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_84A_eus-gaap--ConcentrationRiskCreditRisk_z8D9jot0M2Gh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86A_zSOaHs6U9LBk">Concentrations of Credit Risk</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents, and accounts receivable. The Company limits its credit risk with respect to cash by maintaining cash and cash equivalent balances with high quality financial institutions. At times, the Company’s cash balances may exceed federally insured limits. Concentrations of credit risk with respect to accounts receivable are generally considered minimal due to collection history. However, as of December 31, 2023, $<span id="xdx_90C_eus-gaap--AccountsReceivableNetCurrent_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_pp0p0" title="Accounts receivable">77,950</span> or approximately <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SingleCustomerMember_pdd" title="Concentrations of Credit Risk">50%</span> of the Company’s gross accounts receivable balance was related to a single customer under a long-term instalment arrangement; the Company manages its risk related to this counterparty via other contractual arrangements with such counterparty, and incentivization through stock-based compensation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_84A_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zdBJNPmMaMo4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86B_zWimvPp4CyW7">Stock-Based Compensation</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for stock-based compensation to employees and directors and others in accordance with FASB ASC Topic 718, which requires that compensation expense be recognized in the financial statements for stock-based awards based on the grant date fair value. Forfeitures are accounted for as a reduction of compensation expense in the period when such forfeitures occur.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For stock option awards, the Black-Scholes-Merton option pricing model was used to estimate the fair value of share-based awards. The Black-Scholes-Merton option pricing model incorporates various and highly subjective assumptions, including expected term and share price volatility.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify; vertical-align: top"></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify; vertical-align: top">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">The expected term of the stock options was estimated based on the simplified method as allowed by Staff Accounting Bulletin 107 (SAB 107).</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify; vertical-align: top"></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify; vertical-align: top">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">The share price volatility at the grant date is estimated using historical stock prices based upon the expected term of the options granted, using stock prices of comparably profiled public companies.</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify; vertical-align: top"></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify; vertical-align: top">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">The risk-free interest rate assumption is determined using the rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued.</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For restricted stock units, the fair value of the share-based award is based on the quoted market price of our common shares on the NASDAQ stock exchange.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_841_eus-gaap--RevenueRecognitionPolicyTextBlock_zJsphwhK3mbf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_860_z5rBj82w71pd">Revenue Recognition</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our revenue is generated from the sales of prescription and non-prescription optical glasses, sunglasses, and shipping charges, which are charged to the customer, associated with these purchases. We sell products through our retail store resellers, distributors, on our own website Lucyd.co, and on Amazon.com.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">To determine revenue recognition, we perform the following steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. At contract inception, we assess the goods or services promised within each contract and determine those that are performance obligations, and also assess whether each promised good or service is distinct. We then recognize as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. In instances where the collectibility of contractual consideration is not probable at the time of sale, the revenue is deferred on our balance sheet as a contract liability, and the associated cost of goods sold is deferred on our balance sheet as a contract asset; subsequently, we recognize such revenue and cost of goods sold as payments are received. During the year ended December 31, 2023, we recognized $<span id="xdx_902_ecustom--RevenueRecognized_c20230101__20231231_pp0p0" title="Revenue recognized">17,500</span> of revenue that was included in the contract liability balance as of January 1, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All revenue, including sales processed online and through our retail store resellers and distributors, is reported net of sales taxes collected from customers on behalf of taxing authorities, returns, and discounts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For sales generated through our e-commerce channels, we identify the contract with a customer upon online purchase of our eyewear and transaction price at the manufacturer suggested retail price (“MSRP”) for non-prescription, polarized sunglass and blue light blocking glasses across all of our online channels. Our e-commerce revenue is recognized upon meeting of the performance obligation when the eyewear is shipped to end customers. Only U.S. consumers enjoy free USPS first class postage, with faster delivery options available for extra cost, for sales processed through our website and on Amazon. For Amazon sales, shipping is free for U.S consumers while international customers pay shipping charges on top of MSRP. Any costs associated with fees charged by the online platforms (Shopify for Lucyd.co website and Amazon) are not recharged to customers and are recorded as a component of cost of goods sold as incurred. The Company charges applicable state sales taxes in addition to the MSRP for both online channels and all other marketplaces on which the company sells products.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For sales to our retail store partners, we identify the contract with a customer upon receipt of an order of our eyewear through our Shopify wholesale portal or direct purchase order. Our revenue is recognized upon meeting the performance obligation, which is delivery of the Company’s eyewear products to the retail store and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to the retail store partners includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale retail orders, no e-commerce fees are applicable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For sales to distributors, we identify the contract with a customer upon receipt of an order of our eyewear through a direct purchase order. If collectability of substantially all of the contract consideration is probable, our revenue is recognized upon meeting the performance obligation, which is delivery of our eyewear products to the distributor, and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to distributors includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale distributor orders, no e-commerce fees are applicable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s sales do not contain any variable consideration.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We allow our customers to return our products, subject to our refund policy, which allows any customer to return our products for any reason within the first:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">7 days for sales made through our website (Lucyd.co)</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">30 days for sales made through Amazon</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">30 days for sales to most wholesale retailers and distributors (although certain sales to independent distributors are ineligible for returns)</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For all of our sales, at the time of sale, we establish a reserve for returns, based on historical experience and expected future returns, which is recorded as a reduction of sales. Additionally, we review all individual returns received in the month following the balance sheet date pertaining to orders processed prior to the balance sheet date in order to determine whether an allowance for sales returns is necessary. The Company recorded an allowance for sales returns of $<span id="xdx_90A_ecustom--AllowanceForSalesReturns_c20231231_pp0p0" title="Allowance for sales returns">25,933</span> and $<span id="xdx_909_ecustom--AllowanceForSalesReturns_c20221231_pp0p0" title="Allowance for sales returns">24,897</span> as of December 31, 2023 and 2022, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_84A_ecustom--ShippingAndHandlingsPolicyTextBlock_z7Gcd0JijCx1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86A_zkFBjFQhZR9c">Shipping and Handling</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Costs incurred for shipping and handling are included in cost of revenue at the time the related revenue is recognized. Amounts billed to a customer for shipping and handling are reported as revenues.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_846_ecustom--RecentlyAdoptedAccountingPronouncementsPolicyTextBlock_zTJBzrW0WpCl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_864_zCUS8TyBAI9a">Recently Adopted Accounting Pronouncements</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective January 1, 2023, the Company adopted the provisions of Accounting Standards Update (“ASU”) 2016-13, <i>Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</i> (as amended by ASU 2018-19 in November 2018, ASU 2019-05 in May 2019, ASU 2019-10 and 2019-11 in November 2019, ASU 2020-02 in February 2020, and ASU 2022-02 in March 2022). This standard requires entities to estimate lifetime expected credit losses for financial instruments, including trade and other receivables, which will generally result in earlier recognition of credit losses. The adoption of this new guidance did not have a significant impact on our results of operations, cash flows, or financial condition.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_ze4hGjvrggR1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_867_z0NovlSFZHY6">Recently Issued Accounting Pronouncements</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In October 2023, the FASB issued ASU 2023-06, <i>Disclosure Improvements</i>. This ASU amends the presentation and disclosure of a variety of topics in the ASC, including derivatives, diluted earnings per share, changes in reporting entity, preferred stock, certain industry-specific items, and various other topics, in order to align them with SEC regulations. The amendments to the various topics should be applied prospectively, and the effective date will be determined for each individual disclosure based on the effective date of the SEC’s removal of the related disclosure requirement from Regulation S-X or Regulation S-K. We do not anticipate that the adoption of this ASU will have a significant impact on our financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In November 2023, the FASB issued ASU 2023-07, <i>Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</i>. ASU 2023-07 improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. In addition, the ASU enhances interim disclosure requirements, clarifies circumstances in which an entity can disclose multiple segment measures of profit or loss, and contains other disclosure requirements. The ASU does not change how an entity identifies its operating segments, aggregates those operating segments, or applies the quantitative thresholds to determine its reportable segments. ASU 2023-07 is required to be applied retrospectively to all periods presented in the financial statements, and is effective for Innovative Eyewear, Inc. for fiscal years beginning after December 15, 2023 (i.e., January 1, 2024) and interim periods within fiscal years beginning after December 15, 2024 (i.e., January 1, 2025). We do not anticipate that the adoption of this ASU will have a significant impact on our financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2023, the FASB issued ASU 2023-09, <i>Income Taxes (Topic 740): Improvements to Income Tax Disclosures</i>. ASU 2023-09 requires disclosure of additional categories of information about federal, state, and foreign income taxes in the rate reconciliation table and requires entities to provide more details about the reconciling items in some categories if items meet a quantitative threshold. The ASU also requires entities to disclose income taxes paid, net of refunds, disaggregated by federal (national), state, and foreign taxes for annual periods and to disaggregate the information by jurisdiction based on a quantitative threshold. The guidance makes several other changes to the disclosure requirements. The ASU is required to be applied prospectively, with the option to apply it retrospectively. The ASU is effective for Innovative Eyewear, Inc. for fiscal years beginning after December 15, 2024. We do not anticipate that the adoption of this ASU will have a significant impact on our financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_848_eus-gaap--SubsequentEventsPolicyPolicyTextBlock_zjx4QaIdiVq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_868_zGDSZNdPKUhd">Subsequent Events</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection with the preparation of these financial statements, the Company has evaluated subsequent events through March 24, 2024, which is the date the financial statements were available to be issued. See Note 11 for additional information.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_843_eus-gaap--BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_zdwHuJXlj2Ac" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_867_zv4k2N8CKdcd">Basis of Presentation</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and in accordance with the accounting rules under Regulation S-X, as promulgated by the Securities and Exchange Commission (“SEC”). In the opinion of management, all adjustments considered necessary for the fair presentation of the financial statements for the years presented have been included. The results of operations for the years ended December 31, 2023 and 2022 are not necessarily indicative of the results to be expected for future periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_842_eus-gaap--UseOfEstimates_zH5jdsro4XT9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86F_zlUvNusBbyXj">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates, particularly given the significant uncertainties associated with the current geopolitical and economic environment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_84F_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zCVIeJuxwKz" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_864_zMST1MQWHao5">Cash Equivalents</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All highly liquid investments with original maturities of three months or less, including money market funds, certificates of deposit, and U.S. Treasury bills purchased three months or less from maturity, are considered cash equivalents.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_84B_eus-gaap--ReceivablesPolicyTextBlock_zSt815GSuQ43" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86B_znsm44nyGWnc">Receivables and Credit Policy</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Trade receivables from customers are uncollateralized customer obligations due under normal trade terms. For direct-to-consumer sales, payment is required before product is shipped. Trade receivables are stated at the amount billed to the customer. Payments of trade receivables are allocated to the specific invoices identified on the customer’s remittance advice or, if unspecified, are applied to the earliest unpaid invoice. The Company, by policy, routinely assesses the financial strength of its customers. To comply with industry standards, we offer “net 30” payments on wholesale orders of $1,500 or more. For wholesale orders, to acquire an order on net 30 terms, the customer is provided a credit check application as well as a credit card authorization form. The authorization form explicitly states when and for much we will bill the customer via credit card.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable are reported net of the allowance for doubtful accounts. The allowance for doubtful accounts is determined based upon a variety of judgments and factors. Factors considered in determining the allowance include historical collection, write-off experience, and management’s assessment of collectibility from customers, including current conditions, reasonable forecasts, and expectations of future collectibility and collection efforts. Management continuously assesses the collectibility of receivables and adjusts estimates based on actual experience and future expectations based on economic indicators. Receivable balances are written-off against the allowance when such balances are deemed to be uncollectible. The Company recognized bad debt expense of $<span id="xdx_906_ecustom--BadDebtExpenses_pp0p0_c20230101__20231231_z8ED0deGm5Wc" title="Bad debt expenses">30,275</span> and $<span id="xdx_902_ecustom--BadDebtExpenses_pp0p0_c20220101__20221231_za2irhInwwXe" title="Bad debt expenses">116,230</span> for the years ended December 31, 2023 and 2022, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A roll forward of the allowance for doubtful accounts for the year ended December 31, 2023 is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--AllowanceForDoubtfulAccountsTableTextBlock_zt2WvBmK31D1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> <span id="xdx_8BF_z7Hxrlx7qHW4" style="display: none">Schedule of allowance for doubtful account</span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; width: 88%; vertical-align: top">Balance at December 31, 2022</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230101__20231231_zMca1li2avIb" style="width: 9%; text-align: right" title="Balance at beginning">92,646</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Bad debt expense</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_986_ecustom--BadDebtExpense_pp0p0_c20230101__20231231_zZkUzYQiesY4" style="text-align: right" title="Bad debt expense">30,275</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; font-weight: 400; font-style: normal; vertical-align: top">Write-offs<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)</sup></span></td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98C_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_iN_pp0p0_di_c20230101__20231231_fKDEp_z3DSBxEwNkEi" style="text-align: right" title="Write-offs">(52,149</td> <td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; font-weight: 400; font-style: normal; padding-bottom: 1pt; vertical-align: top">Recoveries<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)</sup></span></td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_98C_eus-gaap--AllowanceForDoubtfulAccountsReceivableRecoveries_iN_pp0p0_di_c20230101__20231231_fKDEp_ze8iGFGWYQ9b" style="border-bottom: Black 1pt solid; text-align: right" title="Recoveries">(45,000</td> <td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt; vertical-align: top">Balance at December 31, 2023</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_980_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230101__20231231_zpRl5GI49Lrl" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at ending">25,772</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt"> </div></div> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0"></td> <td id="xdx_F0A_zp8J9UwWTNdj" style="width: 0.25in; text-align: left">(1)</td> <td id="xdx_F10_z2LAeLyEv0vi" style="text-align: justify">During the year ended December 31, 2023, the Company entered into a settlement agreement with a former wholesale customer. As a result of this settlement, $47,646 of accounts receivable were written-off as uncollectible, while the $45,000 collected under the settlement agreement was reflected as a gain within general and administrative expenses in the statement of operations.</td> </tr> </table> <p id="xdx_8AF_zdfz9UtnWUhh" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> 30275 116230 <table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--AllowanceForDoubtfulAccountsTableTextBlock_zt2WvBmK31D1" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> <span id="xdx_8BF_z7Hxrlx7qHW4" style="display: none">Schedule of allowance for doubtful account</span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; width: 88%; vertical-align: top">Balance at December 31, 2022</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iS_pp0p0_c20230101__20231231_zMca1li2avIb" style="width: 9%; text-align: right" title="Balance at beginning">92,646</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Bad debt expense</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_986_ecustom--BadDebtExpense_pp0p0_c20230101__20231231_zZkUzYQiesY4" style="text-align: right" title="Bad debt expense">30,275</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; font-weight: 400; font-style: normal; vertical-align: top">Write-offs<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)</sup></span></td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98C_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_iN_pp0p0_di_c20230101__20231231_fKDEp_z3DSBxEwNkEi" style="text-align: right" title="Write-offs">(52,149</td> <td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; font-weight: 400; font-style: normal; padding-bottom: 1pt; vertical-align: top">Recoveries<span style="font: normal 400 10pt Times New Roman, Times, Serif"><sup>(1)</sup></span></td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_98C_eus-gaap--AllowanceForDoubtfulAccountsReceivableRecoveries_iN_pp0p0_di_c20230101__20231231_fKDEp_ze8iGFGWYQ9b" style="border-bottom: Black 1pt solid; text-align: right" title="Recoveries">(45,000</td> <td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 2.5pt; vertical-align: top">Balance at December 31, 2023</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_980_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iE_pp0p0_c20230101__20231231_zpRl5GI49Lrl" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance at ending">25,772</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <div style="width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt"> </div></div> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0"></td> <td id="xdx_F0A_zp8J9UwWTNdj" style="width: 0.25in; text-align: left">(1)</td> <td id="xdx_F10_z2LAeLyEv0vi" style="text-align: justify">During the year ended December 31, 2023, the Company entered into a settlement agreement with a former wholesale customer. As a result of this settlement, $47,646 of accounts receivable were written-off as uncollectible, while the $45,000 collected under the settlement agreement was reflected as a gain within general and administrative expenses in the statement of operations.</td> </tr> </table> 92646 30275 52149 45000 25772 <p id="xdx_841_eus-gaap--InventoryPolicyTextBlock_zCjLby0IYoRb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86E_za7Fmc4gL589">Inventory</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our inventory includes purchased eyewear and is stated at the lower of cost or net realizable value, with cost determined on a specific identification method of inventory costing which attaches the actual cost to an identifiable unit of product. Provisions for excess, obsolete, or slow-moving inventory are recorded after periodic evaluation of historical sales, current economic trends, forecasted sales, estimated product life cycles, and estimated inventory levels. No provisions were determined as needed as of December 31, 2023 and 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2023 and 2022, the Company recorded an inventory prepayment in the amount of $<span id="xdx_90C_ecustom--InventoryPrepayment_c20231231_pp0p0" title="Inventory prepayment">323,520</span> and $<span id="xdx_90D_ecustom--InventoryPrepayment_c20221231_pp0p0" title="Inventory prepayment">197,750</span>, respectively, related to down payment on eyewear purchased from the manufacturer, prior to shipment of the product that occurred after the respective balance sheet dates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> 323520 197750 <p id="xdx_849_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zGekyyVbxyrh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86A_z0wTW3dYU9Fe">Intangible Assets</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Intangible assets relate to patent costs received in conjunction with the initial capitalization of the Company and internally developed utility and design patents. The Company amortizes these assets over the estimated useful life of the patents. The Company reviews its intangible assets for impairment whenever changes in circumstances indicate that the carrying amount of the assets may not be recoverable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_84D_ecustom--CapitalizedSoftwarePolicyTextBlock_z12qIlg88vMl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_861_zKGvIGRXnRPk">Capitalized Software</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has incurred software development costs related to development of the Vyrb app, and has capitalized these costs in accordance with Accounting Standards Codification (“ASC”) 985-20, “Software – Costs of Software to be Sold, Leased, or Marketed,” considering it is the Company’s intention to market and sell the software externally. Planning, designing, coding, and testing occurred necessary to meet Vyrb’s design specifications; as such, all coding, development, and testing costs incurred subsequent to establishing technical feasibility were capitalized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We launched an open beta version of the Vyrb application (for both iOS and Android) in December 2021 as the Company’s first social media platform, demonstrating the functionality of the software. The app has had several new features introduced in 2023, including live audio chatrooms for users of the Company’s smart eyewear, and offers market-leading audio accessibility features for social media, including the ability to create and listen to a feed of audio content completely hands-free, using unique voice assistant commands created for the app. The Company plans to continue to develop the expansive Vyrb platform into a feature-rich social toolbox for its customers. This includes the introduction of revenue-generating features such as native ads and in-app upgrades, as well as gamification features such as a points and rewards system.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">However, as the Company diverted most of its software development resources in 2023 to the development and launch of the Lucyd app (which provides groundbreaking Generative AI features to our smart eyewear), the revenue-generating features for the Vyrb app were delayed, and are now planned to launch in 2024. Amortization of the capitalized software costs related to the Vyrb app will begin once revenue-generating operations associated with the software have commenced. No software development costs have been capitalized with respect to the Lucyd app.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_846_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_ztVBGcdKKiq3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86E_z1IeMRmhmO97">Property and Equipment</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment are depreciated using the straight-line method over the estimated useful lives or lease terms if shorter. Depreciation expense for the years ended December 31, 2023 and 2022 was $<span id="xdx_90D_eus-gaap--Depreciation_c20230101__20231231_pp0p0" title="Depreciation expense">61,093</span> and $<span id="xdx_90F_eus-gaap--Depreciation_c20220101__20221231_pp0p0" title="Depreciation expense">22,101</span>, respectively. For income tax purposes, accelerated depreciation methods are generally used. Repair and maintenance costs are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentNetTableTextBlock_zUsWsqeWvLL9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 1pt"><span id="xdx_8BB_z7ObN868h0vb" style="display: none">Schedule of estimated useful lives of property and equipment</span></td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td> <td style="text-align: right" title="Property and equipment, gross"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td> <td style="text-align: right" title="Property and equipment, gross"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td> <td style="vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td> <td style="vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td style="vertical-align: bottom; font-weight: bold; text-align: center">Estimated<br/> Useful Lives</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Property &amp; Equipment</td> <td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2023</td> <td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td> <td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">(in Years)</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 62%; text-align: left">Mobile Kiosk Display</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MobileKioskDisplayMember_pp0p0" style="width: 9%; text-align: right" title="Property and equipment, gross">127,333</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MobileKioskDisplayMember_pp0p0" style="width: 9%; text-align: right" title="Property and equipment, gross">63,395</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: center"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MobileKioskDisplayMember_z3foqvidYrXf" title="Property, Plant and Equipment, Useful Life">3 </span>years</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Computer Equipment</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross">44,901</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross">44,901</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zhTb6JOJNrAg" title="Property, Plant and Equipment, Useful Life">3</span> Years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Office Equipment</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross">10,291</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross">17,273</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zBAA2efd1n24" title="Property, Plant and Equipment, Useful Life">3</span> Years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 1pt">Internal-Use Software</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--InternalUseSoftwareMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross">31,300</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--InternalUseSoftwareMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross">16,775</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--InternalUseSoftwareMember__srt--RangeAxis__srt--MinimumMember_zYyRqXKJXod2" title="Property, Plant and Equipment, Useful Life">3</span> to <span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--InternalUseSoftwareMember__srt--RangeAxis__srt--MaximumMember_zdEMkTd22w6k" title="Property, Plant and Equipment, Useful Life">5</span> Years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left">Property and equipment, gross</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20231231_pp0p0" style="text-align: right" title="Property and equipment, gross">213,825</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20221231_pp0p0" style="text-align: right" title="Property and equipment, gross">142,343</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 1pt">Less: Accumulated depreciation</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20231231_zQkSobE3NVNf" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation">(80,977</td> <td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20221231_zzGsLxGhyHS4" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation">(22,599</td> <td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left; padding-bottom: 2.5pt">Property and equipment, net</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20231231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net">132,848</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net">119,744</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"> </td> <td> </td></tr> </table> <p id="xdx_8A3_zaN8DTooUj6b" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> 61093 22101 <table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentNetTableTextBlock_zUsWsqeWvLL9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 1pt"><span id="xdx_8BB_z7ObN868h0vb" style="display: none">Schedule of estimated useful lives of property and equipment</span></td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td> <td style="text-align: right" title="Property and equipment, gross"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td> <td style="text-align: right" title="Property and equipment, gross"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td> <td style="vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td> <td style="vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td style="vertical-align: bottom; font-weight: bold; text-align: center">Estimated<br/> Useful Lives</td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Property &amp; Equipment</td> <td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2023</td> <td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td> <td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">(in Years)</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 62%; text-align: left">Mobile Kiosk Display</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MobileKioskDisplayMember_pp0p0" style="width: 9%; text-align: right" title="Property and equipment, gross">127,333</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MobileKioskDisplayMember_pp0p0" style="width: 9%; text-align: right" title="Property and equipment, gross">63,395</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: center"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--MobileKioskDisplayMember_z3foqvidYrXf" title="Property, Plant and Equipment, Useful Life">3 </span>years</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Computer Equipment</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross">44,901</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross">44,901</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zhTb6JOJNrAg" title="Property, Plant and Equipment, Useful Life">3</span> Years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Office Equipment</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross">10,291</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_pp0p0" style="text-align: right" title="Property and equipment, gross">17,273</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zBAA2efd1n24" title="Property, Plant and Equipment, Useful Life">3</span> Years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 1pt">Internal-Use Software</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--InternalUseSoftwareMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross">31,300</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--InternalUseSoftwareMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross">16,775</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--InternalUseSoftwareMember__srt--RangeAxis__srt--MinimumMember_zYyRqXKJXod2" title="Property, Plant and Equipment, Useful Life">3</span> to <span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20231231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--InternalUseSoftwareMember__srt--RangeAxis__srt--MaximumMember_zdEMkTd22w6k" title="Property, Plant and Equipment, Useful Life">5</span> Years</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left">Property and equipment, gross</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_c20231231_pp0p0" style="text-align: right" title="Property and equipment, gross">213,825</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_c20221231_pp0p0" style="text-align: right" title="Property and equipment, gross">142,343</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 1pt">Less: Accumulated depreciation</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20231231_zQkSobE3NVNf" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation">(80,977</td> <td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_98C_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20221231_zzGsLxGhyHS4" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated depreciation">(22,599</td> <td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: center; padding-bottom: 1pt"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left; padding-bottom: 2.5pt">Property and equipment, net</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_c20231231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net">132,848</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net">119,744</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"> </td> <td> </td></tr> </table> 127333 63395 P3Y 44901 44901 P3Y 10291 17273 P3Y 31300 16775 P3Y P5Y 213825 142343 80977 22599 132848 119744 <p id="xdx_845_eus-gaap--IncomeTaxPolicyTextBlock_zpMn8Y0ux7Ze" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86B_zHs5eE2BDeG1">Income Taxes</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for income taxes under an asset and liability approach that recognizes deferred tax assets and liabilities based on the difference between the financial statement carrying amounts and the tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company follows a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken, or expected to be taken, in a tax return. Any interest and penalties accrued related to uncertain tax positions are recorded in tax expense.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company assesses the realizability of its net deferred tax assets on an annual basis. If, after considering all relevant positive and negative evidence, it is more likely than not that some portion or all of the net deferred tax assets will not be realized, the Company will reduce the net deferred tax assets by a valuation allowance. The realization of net deferred tax assets is dependent on several factors, including the generation of sufficient taxable income prior to the expiration of net operating loss carryforwards.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_842_eus-gaap--FairValueOfFinancialInstrumentsPolicy_ziFq8td1THLf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86C_zYw4hAZbxSoh">Fair Value of Financial Instruments</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For certain of the Company’s financial instruments, including cash, cash equivalents, accounts receivable, accounts payable, and cash advances provided by Tekcapital and Affiliates, the carrying amounts approximate fair value due to the short-term maturities of these instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_84A_eus-gaap--ConcentrationRiskCreditRisk_z8D9jot0M2Gh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86A_zSOaHs6U9LBk">Concentrations of Credit Risk</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash, cash equivalents, and accounts receivable. The Company limits its credit risk with respect to cash by maintaining cash and cash equivalent balances with high quality financial institutions. At times, the Company’s cash balances may exceed federally insured limits. Concentrations of credit risk with respect to accounts receivable are generally considered minimal due to collection history. However, as of December 31, 2023, $<span id="xdx_90C_eus-gaap--AccountsReceivableNetCurrent_c20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_pp0p0" title="Accounts receivable">77,950</span> or approximately <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SingleCustomerMember_pdd" title="Concentrations of Credit Risk">50%</span> of the Company’s gross accounts receivable balance was related to a single customer under a long-term instalment arrangement; the Company manages its risk related to this counterparty via other contractual arrangements with such counterparty, and incentivization through stock-based compensation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> 77950 0.50 <p id="xdx_84A_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zdBJNPmMaMo4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86B_zWimvPp4CyW7">Stock-Based Compensation</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for stock-based compensation to employees and directors and others in accordance with FASB ASC Topic 718, which requires that compensation expense be recognized in the financial statements for stock-based awards based on the grant date fair value. Forfeitures are accounted for as a reduction of compensation expense in the period when such forfeitures occur.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For stock option awards, the Black-Scholes-Merton option pricing model was used to estimate the fair value of share-based awards. The Black-Scholes-Merton option pricing model incorporates various and highly subjective assumptions, including expected term and share price volatility.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify; vertical-align: top"></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify; vertical-align: top">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">The expected term of the stock options was estimated based on the simplified method as allowed by Staff Accounting Bulletin 107 (SAB 107).</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify; vertical-align: top"></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify; vertical-align: top">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">The share price volatility at the grant date is estimated using historical stock prices based upon the expected term of the options granted, using stock prices of comparably profiled public companies.</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify; vertical-align: top"></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify; vertical-align: top">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">The risk-free interest rate assumption is determined using the rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued.</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For restricted stock units, the fair value of the share-based award is based on the quoted market price of our common shares on the NASDAQ stock exchange.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_841_eus-gaap--RevenueRecognitionPolicyTextBlock_zJsphwhK3mbf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_860_z5rBj82w71pd">Revenue Recognition</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our revenue is generated from the sales of prescription and non-prescription optical glasses, sunglasses, and shipping charges, which are charged to the customer, associated with these purchases. We sell products through our retail store resellers, distributors, on our own website Lucyd.co, and on Amazon.com.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">To determine revenue recognition, we perform the following steps: (i) identify the contract(s) with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) we satisfy a performance obligation. At contract inception, we assess the goods or services promised within each contract and determine those that are performance obligations, and also assess whether each promised good or service is distinct. We then recognize as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. In instances where the collectibility of contractual consideration is not probable at the time of sale, the revenue is deferred on our balance sheet as a contract liability, and the associated cost of goods sold is deferred on our balance sheet as a contract asset; subsequently, we recognize such revenue and cost of goods sold as payments are received. During the year ended December 31, 2023, we recognized $<span id="xdx_902_ecustom--RevenueRecognized_c20230101__20231231_pp0p0" title="Revenue recognized">17,500</span> of revenue that was included in the contract liability balance as of January 1, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All revenue, including sales processed online and through our retail store resellers and distributors, is reported net of sales taxes collected from customers on behalf of taxing authorities, returns, and discounts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For sales generated through our e-commerce channels, we identify the contract with a customer upon online purchase of our eyewear and transaction price at the manufacturer suggested retail price (“MSRP”) for non-prescription, polarized sunglass and blue light blocking glasses across all of our online channels. Our e-commerce revenue is recognized upon meeting of the performance obligation when the eyewear is shipped to end customers. Only U.S. consumers enjoy free USPS first class postage, with faster delivery options available for extra cost, for sales processed through our website and on Amazon. For Amazon sales, shipping is free for U.S consumers while international customers pay shipping charges on top of MSRP. Any costs associated with fees charged by the online platforms (Shopify for Lucyd.co website and Amazon) are not recharged to customers and are recorded as a component of cost of goods sold as incurred. The Company charges applicable state sales taxes in addition to the MSRP for both online channels and all other marketplaces on which the company sells products.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For sales to our retail store partners, we identify the contract with a customer upon receipt of an order of our eyewear through our Shopify wholesale portal or direct purchase order. Our revenue is recognized upon meeting the performance obligation, which is delivery of the Company’s eyewear products to the retail store and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to the retail store partners includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale retail orders, no e-commerce fees are applicable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For sales to distributors, we identify the contract with a customer upon receipt of an order of our eyewear through a direct purchase order. If collectability of substantially all of the contract consideration is probable, our revenue is recognized upon meeting the performance obligation, which is delivery of our eyewear products to the distributor, and is also recorded net of returns and discounts. Our wholesale pricing for eyewear sold to distributors includes volume discounts, due to the nature of large quantity orders. The pricing includes shipping charges, while excluding any state sales tax charges applicable. Due to the nature of wholesale distributor orders, no e-commerce fees are applicable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s sales do not contain any variable consideration.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We allow our customers to return our products, subject to our refund policy, which allows any customer to return our products for any reason within the first:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">7 days for sales made through our website (Lucyd.co)</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">30 days for sales made through Amazon</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">30 days for sales to most wholesale retailers and distributors (although certain sales to independent distributors are ineligible for returns)</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For all of our sales, at the time of sale, we establish a reserve for returns, based on historical experience and expected future returns, which is recorded as a reduction of sales. Additionally, we review all individual returns received in the month following the balance sheet date pertaining to orders processed prior to the balance sheet date in order to determine whether an allowance for sales returns is necessary. The Company recorded an allowance for sales returns of $<span id="xdx_90A_ecustom--AllowanceForSalesReturns_c20231231_pp0p0" title="Allowance for sales returns">25,933</span> and $<span id="xdx_909_ecustom--AllowanceForSalesReturns_c20221231_pp0p0" title="Allowance for sales returns">24,897</span> as of December 31, 2023 and 2022, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> 17500 25933 24897 <p id="xdx_84A_ecustom--ShippingAndHandlingsPolicyTextBlock_z7Gcd0JijCx1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86A_zkFBjFQhZR9c">Shipping and Handling</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Costs incurred for shipping and handling are included in cost of revenue at the time the related revenue is recognized. Amounts billed to a customer for shipping and handling are reported as revenues.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_846_ecustom--RecentlyAdoptedAccountingPronouncementsPolicyTextBlock_zTJBzrW0WpCl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_864_zCUS8TyBAI9a">Recently Adopted Accounting Pronouncements</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective January 1, 2023, the Company adopted the provisions of Accounting Standards Update (“ASU”) 2016-13, <i>Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</i> (as amended by ASU 2018-19 in November 2018, ASU 2019-05 in May 2019, ASU 2019-10 and 2019-11 in November 2019, ASU 2020-02 in February 2020, and ASU 2022-02 in March 2022). This standard requires entities to estimate lifetime expected credit losses for financial instruments, including trade and other receivables, which will generally result in earlier recognition of credit losses. The adoption of this new guidance did not have a significant impact on our results of operations, cash flows, or financial condition.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_ze4hGjvrggR1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_867_z0NovlSFZHY6">Recently Issued Accounting Pronouncements</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In October 2023, the FASB issued ASU 2023-06, <i>Disclosure Improvements</i>. This ASU amends the presentation and disclosure of a variety of topics in the ASC, including derivatives, diluted earnings per share, changes in reporting entity, preferred stock, certain industry-specific items, and various other topics, in order to align them with SEC regulations. The amendments to the various topics should be applied prospectively, and the effective date will be determined for each individual disclosure based on the effective date of the SEC’s removal of the related disclosure requirement from Regulation S-X or Regulation S-K. We do not anticipate that the adoption of this ASU will have a significant impact on our financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In November 2023, the FASB issued ASU 2023-07, <i>Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</i>. ASU 2023-07 improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. In addition, the ASU enhances interim disclosure requirements, clarifies circumstances in which an entity can disclose multiple segment measures of profit or loss, and contains other disclosure requirements. The ASU does not change how an entity identifies its operating segments, aggregates those operating segments, or applies the quantitative thresholds to determine its reportable segments. ASU 2023-07 is required to be applied retrospectively to all periods presented in the financial statements, and is effective for Innovative Eyewear, Inc. for fiscal years beginning after December 15, 2023 (i.e., January 1, 2024) and interim periods within fiscal years beginning after December 15, 2024 (i.e., January 1, 2025). We do not anticipate that the adoption of this ASU will have a significant impact on our financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2023, the FASB issued ASU 2023-09, <i>Income Taxes (Topic 740): Improvements to Income Tax Disclosures</i>. ASU 2023-09 requires disclosure of additional categories of information about federal, state, and foreign income taxes in the rate reconciliation table and requires entities to provide more details about the reconciling items in some categories if items meet a quantitative threshold. The ASU also requires entities to disclose income taxes paid, net of refunds, disaggregated by federal (national), state, and foreign taxes for annual periods and to disaggregate the information by jurisdiction based on a quantitative threshold. The guidance makes several other changes to the disclosure requirements. The ASU is required to be applied prospectively, with the option to apply it retrospectively. The ASU is effective for Innovative Eyewear, Inc. for fiscal years beginning after December 15, 2024. We do not anticipate that the adoption of this ASU will have a significant impact on our financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_848_eus-gaap--SubsequentEventsPolicyPolicyTextBlock_zjx4QaIdiVq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_868_zGDSZNdPKUhd">Subsequent Events</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection with the preparation of these financial statements, the Company has evaluated subsequent events through March 24, 2024, which is the date the financial statements were available to be issued. See Note 11 for additional information.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_80C_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zWi2oSefSAL3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 3 – <span id="xdx_82E_zGdMhNyz6Lad">GOING CONCERN</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has a limited operating history. The Company’s business and operations are sensitive to general business and economic conditions in the United States. A host of factors beyond the Company’s control could cause fluctuations in these conditions. Adverse conditions may include recession, downturn, or otherwise, changes in regulations or restrictions in imports, competition, or changes in consumer taste. These adverse conditions could affect the Company’s financial condition and the results of its operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company meets its day-to-day working capital requirements using monies raised through sales of eyewear and issuances of equity, including our initial public offering completed in August 2022, a secondary public offering completed in June 2023, and exercises of warrants by stockholders (see Note 8 for additional details). The Company also previously issued a convertible note held by Tekcapital and Affiliates, which was repaid in full during the year ended December 31, 2023 (see Note 6). Effective March 1, 2024, the Company issued a new 18-month convertible note to Tekcapital and Affiliates (see Note 11 for details).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management expects that operating losses could continue in the foreseeable future as we continue to invest in the expansion and development of our business. Management’s forecasts and projections indicate that the Company’s existing cash and cash equivalents (including the proceeds from the aforementioned second public offering and proceeds received from investors’ exercises of warrants), plus planned capital-raising activities in 2024, will be sufficient to fund operations through at least end of March 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_803_eus-gaap--IncomeTaxDisclosureTextBlock_zjDOk3TCCRai" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 4 – <span id="xdx_822_z8lCarUAytzb">INCOME TAX PROVISION</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following is a reconciliation of tax computed at the statutory federal rate to the income tax benefit in the statements of operations:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zWtToRu7S7Kl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAX PROVISION (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span id="xdx_8BE_zDHg3ohlIFZ3" style="display: none">Schedule of reconciliation of federal statutory tax rate</span></td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_490_20230101__20231231_z5i31OuyDXwa" style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_49D_20220101__20221231_zwwA7UbupyE6" style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: left"> </td> <td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td> <td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td> <td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td> <td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_407_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzabV_z8y8SzuW2I76" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 76%; text-align: left">Income tax benefit at the statutory federal rate</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">1,389,526</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">1,193,185</td> <td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_maITEBzabV_z31vZzIYOVMe" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">State income tax benefits, net of federal benefit</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">50,907</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">35,149</td> <td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_iN_pp0p0_maITEBzabV_z0zVJlGuKHC8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 1pt">Change in valuation allowance</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">(1,440,433</td> <td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">(1,228,334</td> <td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzabV_zpaX5ROZdpcd" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left">Total</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0609">-</span></td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0610">-</span></td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AB_zo5lnas0g8tc" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The components of the Company’s deferred tax assets are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zmqXX3ua2ON9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAX PROVISION (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left"><span id="xdx_8B5_zWntaikiOcuj" style="display: none">Schedule of deferred tax assets</span></td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_494_20231231_zgz34cDFON3h" style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_49B_20221231_zB1c8Nwgqgob" style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: left"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2023</td> <td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td> <td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsGrossAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Deferred tax assets:</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_i01I_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; width: 76%; text-align: left">Stock-based compensation</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">877,645</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">610,530</td> <td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsOther_i01I_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left">Other – net</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">219,723</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">122,133</td> <td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_i01I_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left">Net operating losses – federal</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">2,483,530</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,346,823</td> <td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_i01I_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left; padding-bottom: 1pt">Net operating losses – state</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">148,177</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">81,911</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsGross_i01I_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="color: White; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> Deferred tax assets Gross</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">3,729,075</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">2,161,397</td> <td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsValuationAllowance_i01NI_pp0p0_di_zNs5NWULIY7d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 1pt">Less Valuation Allowance</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">(3,729,075</td> <td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">(2,161,397</td> <td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsNet_i01I_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 2.5pt">Net deferred tax assets</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0635">-</span></td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0636">-</span></td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zMPx8OBS6ged" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities. Deferred tax assets or liabilities at the end of each period are determined using the tax rate expected to be in effect when taxes are actually paid or recovered.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A valuation allowance is established when it is more likely than not that all or a portion of a deferred tax asset will not be realized. A review of all available positive and negative evidence is considered, including the Company’s current and past performance, the market environment in which the Company operates, length of carryback and carryforward periods, and existing contracts that will result in future profits. After reviewing all the evidence, the Company has recorded a full valuation allowance against its deferred tax assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At December 31, 2023, the Company had federal net operating loss carryforwards of $<span id="xdx_90B_eus-gaap--OperatingLossCarryforwards_c20231231_pp0p0" title="Federal net operating loss carryforwards">11,826,332</span> and state net operating loss carryforwards of $<span id="xdx_90C_ecustom--StateNetOperatingLossCarryforwards_c20231231_pp0p0" title="State net operating loss carryforwards">6,515,176</span>, both of which do not expire.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company files Federal and Florida tax returns. The years that remain subject to examination are the years ended December 31, 2020, 2021, 2022, and 2023. As of December 31, 2023 and 2022, the Company does <span id="xdx_907_eus-gaap--LiabilityForUncertainTaxPositionsCurrent_iI_pp0p0_do_c20231231_zxjaDsdBUiy1" title="Liabilities for uncertain tax positions"><span id="xdx_90A_eus-gaap--LiabilityForUncertainTaxPositionsCurrent_iI_pp0p0_do_c20221231_zdngpz3ly08k" title="Liabilities for uncertain tax positions">no</span></span>t believe that is has any liabilities for uncertain tax positions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89A_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zWtToRu7S7Kl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAX PROVISION (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span id="xdx_8BE_zDHg3ohlIFZ3" style="display: none">Schedule of reconciliation of federal statutory tax rate</span></td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_490_20230101__20231231_z5i31OuyDXwa" style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_49D_20220101__20221231_zwwA7UbupyE6" style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: bottom; text-align: left"> </td> <td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td> <td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td> <td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2022</td> <td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_407_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzabV_z8y8SzuW2I76" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 76%; text-align: left">Income tax benefit at the statutory federal rate</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">1,389,526</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">1,193,185</td> <td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--IncomeTaxReconciliationStateAndLocalIncomeTaxes_maITEBzabV_z31vZzIYOVMe" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">State income tax benefits, net of federal benefit</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">50,907</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">35,149</td> <td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_iN_pp0p0_maITEBzabV_z0zVJlGuKHC8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 1pt">Change in valuation allowance</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">(1,440,433</td> <td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">(1,228,334</td> <td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzabV_zpaX5ROZdpcd" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left">Total</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0609">-</span></td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0610">-</span></td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1389526 1193185 50907 35149 -1440433 -1228334 <table cellpadding="0" cellspacing="0" id="xdx_89B_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zmqXX3ua2ON9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAX PROVISION (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left"><span id="xdx_8B5_zWntaikiOcuj" style="display: none">Schedule of deferred tax assets</span></td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_494_20231231_zgz34cDFON3h" style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_49B_20221231_zB1c8Nwgqgob" style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: left"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2023</td> <td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td> <td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsGrossAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Deferred tax assets:</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_i01I_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; width: 76%; text-align: left">Stock-based compensation</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">877,645</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">610,530</td> <td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsOther_i01I_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left">Other – net</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">219,723</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">122,133</td> <td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsForeign_i01I_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left">Net operating losses – federal</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">2,483,530</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,346,823</td> <td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_i01I_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; vertical-align: top; text-align: left; padding-bottom: 1pt">Net operating losses – state</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">148,177</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">81,911</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsGross_i01I_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="color: White; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> Deferred tax assets Gross</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">3,729,075</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">2,161,397</td> <td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsValuationAllowance_i01NI_pp0p0_di_zNs5NWULIY7d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 1pt">Less Valuation Allowance</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">(3,729,075</td> <td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">(2,161,397</td> <td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsNet_i01I_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 2.5pt">Net deferred tax assets</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0635">-</span></td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0636">-</span></td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 877645 610530 219723 122133 2483530 1346823 148177 81911 3729075 2161397 3729075 2161397 11826332 6515176 0 0 <p id="xdx_80A_eus-gaap--IntangibleAssetsDisclosureTextBlock_zZRh6JI7yYV8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 5 –<span id="xdx_821_zPXpnfCdCoD8"> INTANGIBLE ASSETS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_znSekKoaHt68" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INTANGIBLE ASSETS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span id="xdx_8BB_z3odOk7GrN4g" style="display: none">Schedule of intangible assets</span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><b>Finite-lived intangible assets</b></td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,<br/> 2023</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,<br/> 2022</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Patent Costs</td> <td style="padding-bottom: 1pt; width: 1%"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td> <td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Intangible assets, gross">329,232</td> <td style="padding-bottom: 1pt; width: 1%; text-align: left"> </td> <td style="padding-bottom: 1pt; width: 1%"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td> <td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Intangible assets, gross">156,196</td> <td style="padding-bottom: 1pt; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Intangible assets, gross</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20231231_pp0p0" style="text-align: right" title="Intangible assets, gross">329,232</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231_pp0p0" style="text-align: right" title="Intangible assets, gross">156,196</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Less: Accumulated amortization</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20231231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization">(42,803</td> <td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization">(18,639</td> <td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Intangible assets, net</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_c20231231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, net">286,429</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, net">137,557</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These costs are amortized using the straight-line method over a period of 10 years. Amortization expense totalled $<span id="xdx_900_eus-gaap--AdjustmentForAmortization_c20230101__20231231_pp0p0" title="Amortization expense">24,164</span> and $<span id="xdx_902_eus-gaap--AdjustmentForAmortization_c20220101__20221231_pp0p0" title="Amortization expense">10,466</span> for the years ended December 31, 2023 and 2022, respectively. Future amortization is expected to approximate $<span id="xdx_90E_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c20231231_pp0p0" title="Future amortization">30,000</span> per year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_znSekKoaHt68" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INTANGIBLE ASSETS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left"><span id="xdx_8BB_z3odOk7GrN4g" style="display: none">Schedule of intangible assets</span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><b>Finite-lived intangible assets</b></td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,<br/> 2023</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,<br/> 2022</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in; width: 76%; text-align: left">Patent Costs</td> <td style="padding-bottom: 1pt; width: 1%"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td> <td id="xdx_983_eus-gaap--FiniteLivedIntangibleAssetsGross_c20231231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Intangible assets, gross">329,232</td> <td style="padding-bottom: 1pt; width: 1%; text-align: left"> </td> <td style="padding-bottom: 1pt; width: 1%"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td> <td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_pp0p0" style="border-bottom: Black 1pt solid; width: 9%; text-align: right" title="Intangible assets, gross">156,196</td> <td style="padding-bottom: 1pt; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Intangible assets, gross</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20231231_pp0p0" style="text-align: right" title="Intangible assets, gross">329,232</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20221231_pp0p0" style="text-align: right" title="Intangible assets, gross">156,196</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Less: Accumulated amortization</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20231231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization">(42,803</td> <td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20221231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated amortization">(18,639</td> <td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Intangible assets, net</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_c20231231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, net">286,429</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_c20221231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Intangible assets, net">137,557</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 329232 156196 329232 156196 -42803 -18639 286429 137557 24164 10466 30000 <p id="xdx_80B_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zul8OmwNrlvd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 6 – <span id="xdx_82F_z0OjIufDoixk">RELATED PARTY TRANSACTIONS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Convertible Note and Due to Tekcapital and Affiliates</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended December 31, 2022 and through December 1, 2023, the Company had the availability of, but not the contractual right to, intercompany financing from Tekcapital and Affiliates in the form of either cash advances or borrowings under a convertible note (as discussed below).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 1, 2020, the Company issued a convertible note to Tekcapital and Affiliates for up to $2,000,000 that bears interest at <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20201129__20201201__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TekcapitalAndAffiliatesMember_pdd" title="Interest rate">10%</span> per annum, which includes the option to convert the debt into the Company’s common stock at market price. The note can be converted into shares of common stock of the Company upon occurrence of certain conversion events, as defined. On November 1, 2021, the Company amended and restated the convertible note agreement with Tekcapital and Affiliates, increasing the amount of available financing from $<span id="xdx_90D_eus-gaap--ProceedsFromConvertibleDebt_c20201129__20201201__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TekcapitalAndAffiliatesMember_pp0p0" title="Convertible debt issued">2,000,000</span> to $<span id="xdx_90D_eus-gaap--ProceedsFromConvertibleDebt_c20211029__20211101__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TekcapitalAndAffiliatesMember_pp0p0" title="Convertible debt issued">3,000,000</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 15, 2022, in connection with the Company’s initial public offering (see Note 8), the Company converted related party borrowings totalling $<span id="xdx_902_eus-gaap--ConversionOfStockAmountConverted1_c20220801__20220815__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LucydMember_pp0p0" title="Conversion of stock, amount">2,002,280</span> into <span id="xdx_907_eus-gaap--ConversionOfStockSharesConverted1_c20220801__20220815__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LucydMember_pdd" title="Number of shares converted">266,970</span> shares of common stock at $<span id="xdx_901_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20220815__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LucydMember_pdd" title="Conversion Price">7.50</span> per share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The convertible notes balances were $<span id="xdx_90D_eus-gaap--ConvertibleDebt_c20221231_pp0p0" title="Convertible notes balances">61,356</span> at December 31, 2022. In January 2023, the Company borrowed an additional $<span id="xdx_90B_eus-gaap--ProceedsFromConvertibleDebt_c20230102__20230131_pp0p0" title="Convertible debt issued">48,143</span> under such convertible notes, and subsequently repaid the outstanding balances of the convertible notes in full in February 2023. No further amounts were borrowed under the convertible notes, and the convertible notes matured on December 1, 2023 with no amounts outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Subsequent to the year ended December 31, 2023 (effective March 1, 2024), the Company issued a new 18-month convertible note to Tekcapital and Affiliates; see Note 11 for details.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Management Service Agreement</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In 2020, the Company entered into a management services agreement with Tekcapital Europe Ltd. (an affiliate of our largest stockholder, Lucyd Ltd., whose Chief Executive Officer is the father of our Chief Executive Officer), for which the Company was billed $25,000 quarterly. Effective February 1, 2022, the original management services agreement was amended to have the Company billed at $35,000 quarterly. While the agreement does not stipulate a specific maturity date, it can be terminated with 30 calendar days written notice by any party.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The related party provides the following services:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">Support and advice to the Company in accordance with their area of expertise; </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">Research, technical review, legal review, recruitment, software development, marketing, public relations, and advertisement; and</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">Advice, assistance, and consultation services to support the Company or in relation to any other related matter.</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company incurred $<span id="xdx_903_eus-gaap--ManagementFeeExpense_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TekcapitalEuropeLtdMember_pp0p0" title="Management fee"><span id="xdx_901_eus-gaap--ManagementFeeExpense_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TekcapitalEuropeLtdMember_pp0p0" title="Management fee">140,000</span></span> during each of the years ended December 31, 2023 and 2022 under this management services agreement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Rent of Office Space</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Prior to the February 1, 2022 amendment of the aforementioned management services agreement, the Company was provided with rent-free office space by Tekcapital and Affiliates. Effective February 1, 2022, Tekcapital began to bill the Company for an allocation of rent paid by Tekcapital on the Company’s behalf; the underlying lease between Tekcapital and its landlord has an end date of January 31, 2025. The Company recognized expense related to this arrangement of $<span id="xdx_90A_ecustom--RentExpenses_c20230101__20231231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TekcapitalEuropeLtdMember_pp0p0" title="Rent expenses">91,672</span> and $<span id="xdx_908_ecustom--RentExpenses_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TekcapitalEuropeLtdMember_pp0p0" title="Rent expenses">74,442</span> of for the years ended December 31, 2023 and 2022, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> 0.10 2000000 3000000 2002280 266970 7.50 61356 48143 140000 140000 91672 74442 <p id="xdx_804_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zLWOlR3knIO2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 7 – <span id="xdx_824_zyTJTDUZGMN8">COMMITMENTS AND CONTINGENCIES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Legal Matters</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In August 2023, the Company entered into a settlement agreement with a former wholesale customer who owed the Company $<span id="xdx_90A_ecustom--SettlementAmount_c20230831__us-gaap--TransactionTypeAxis__custom--SettlementAgreementMember_pp0p0" title="Settlement amount">92,646</span>. As a result of this settlement, $<span id="xdx_904_ecustom--AccountsReceivableWrittenoff_c20230831__us-gaap--TransactionTypeAxis__custom--SettlementAgreementMember_pp0p0" title="Accounts receivable written-off">47,646</span> of accounts receivable were written-off as uncollectible, while the $<span id="xdx_90F_eus-gaap--AccountsAndNotesReceivableNet_c20230831__us-gaap--TransactionTypeAxis__custom--SettlementAgreementMember_pp0p0" title="Net account receivable">45,000</span> collected under the settlement agreement was reflected as a gain within general and administrative expenses in the statement of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In November 2023, a third party filed a complaint before the International Trade Commission, alleging that certain of our products (as well as certain products of our competitors) infringed on patents held by the third party. In December 2023, the International Trade Commission instituted an investigation against the Company. As of December 31, 2023, the Company recorded a liability of approximately $<span id="xdx_909_ecustom--LegalMattersLiability_c20231231_pp0p0" title="Legal matters liability">103,000</span> related to this matter. This matter was subsequently settled and resolved in January 2024; refer to Note 11 for details.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Additionally, the Company is currently pursuing collection of $41,452 from an individual who was both a former member of management and a former member of our board of directors. The amount owed to us represents the remaining balance of an advance against future commissions that was previously paid to such individual under a contractual agreement. We desire to resolve this matter amicably and expeditiously; accordingly, we have presented this individual with a demand for repayment, and are exploring all options available to us with the assistance of legal counsel. No amounts related to this matter have been recorded on the balance sheet and statement of operations as of and for the year ended December 31, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Leases</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our executive offices are located at 11900 Biscayne Blvd., Suite 630 Miami, Florida 33181. Our executive offices are provided to us by the Tekcapital and Affiliates (see Note 6). We consider our current office space adequate for our current operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>License Agreements</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the years ended December 31, 2023 and 2022, we entered into several multi-year license agreements which grant us the right to sell certain branded smart eyewear, including the Nautica, Eddie Bauer, and Reebok brands worldwide. These agreements require us to pay royalties based on a percentage of net retail and wholesale sales during the period of the license, and also require guaranteed minimum royalty payments. The agreements have base terms of <span id="xdx_902_ecustom--BaseTerm_dtY_c20230101__20231231_z1iBFuiMbNe7" title="Base term">10</span> years but are cancellable at the option of the Company during the fifth year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The aggregate future minimum payments due under these license agreements are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zHlCDDkTloaa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - COMMITMENTS AND CONTINGENCIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span id="xdx_8B5_zkADQF8phqvb" style="display: none">Schedule of future minimum payments due</span></td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_494_20231231_z4erEgcBe90e" style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPz0i5_zc5hQU96RiIj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 88%; text-align: left">2024</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">161,210</td> <td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPz0i5_zHoy8KylEF79" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">2025</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">436,000</td> <td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maLOLLPz0i5_z8CavdlaxD93" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">2026</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">834,000</td> <td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_maLOLLPz0i5_zLDrTAs1wcwe" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">2027</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,290,000</td> <td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_maLOLLPz0i5_z7qxhXzVw7m8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">2028</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,543,000</td> <td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pp0p0_maLOLLPz0i5_zRTebe3aIsOh" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; padding-bottom: 1pt; text-align: left">Thereafter (through 2032)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">9,907,000</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPz0i5_zJiTPd1yzJel" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; padding-bottom: 2.5pt; text-align: left">Total</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">14,171,210</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Other Commitments</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">See related party management services agreement discussed in Note 6.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> 92646 47646 45000 103000 P10Y <table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zHlCDDkTloaa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - COMMITMENTS AND CONTINGENCIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span id="xdx_8B5_zkADQF8phqvb" style="display: none">Schedule of future minimum payments due</span></td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_494_20231231_z4erEgcBe90e" style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPz0i5_zc5hQU96RiIj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 88%; text-align: left">2024</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">161,210</td> <td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPz0i5_zHoy8KylEF79" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">2025</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">436,000</td> <td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0_maLOLLPz0i5_z8CavdlaxD93" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">2026</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">834,000</td> <td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pp0p0_maLOLLPz0i5_zLDrTAs1wcwe" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">2027</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,290,000</td> <td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pp0p0_maLOLLPz0i5_z7qxhXzVw7m8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">2028</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,543,000</td> <td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pp0p0_maLOLLPz0i5_zRTebe3aIsOh" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; padding-bottom: 1pt; text-align: left">Thereafter (through 2032)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">9,907,000</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPz0i5_zJiTPd1yzJel" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; padding-bottom: 2.5pt; text-align: left">Total</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">14,171,210</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 161210 436000 834000 1290000 1543000 9907000 14171210 <p id="xdx_80A_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zICl5L5xw8eh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 8 – <span id="xdx_820_ziHQ6XnvHvRi">STOCKHOLDERS’ EQUITY</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to a corporate resolution on July 1, 2021, the Company has authority to issue up to <span id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_c20231231_pdd" title="Preferred stock , shares authorized"><span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_c20221231_pdd" title="Preferred stock , shares authorized">15,000,000</span></span> shares of preferred stock and <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20231231_zZom56NsPa6k" title="Common stock, shares authorized"><span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_c20221231_z3fkzjb39hTe" title="Common stock, shares authorized">50,000,000</span></span> shares of common stock. There were <span id="xdx_902_eus-gaap--PreferredStockSharesIssued_iI_do_c20231231_ziETZcheufhj" title="Preferred stock , shares issued"><span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20231231_zf3BKVgjkuHl" title="Preferred stock, shares Outstanding"><span id="xdx_90A_eus-gaap--PreferredStockSharesIssued_iI_do_c20221231_zHeO2DGsYbLe" title="Preferred stock , shares issued"><span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20221231_zrYCCMFsqXn5" title="Preferred stock, shares Outstanding">no</span></span></span></span> shares of preferred stock issued or outstanding as of December 31, 2023 and 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Initial Public Offering</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 17, 2022, the Company closed on its initial public offering of <span id="xdx_901_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220801__20220817__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Issauance of common stock">980,000</span> units consisting of <span id="xdx_90E_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220801__20220817__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pdd" title="Issauance of common stock">980,000</span> shares of its common stock and 1,960,000 warrants to purchase 1,960,000 shares of common stock at a combined offering price of $<span id="xdx_906_eus-gaap--SharePrice_c20220817__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Share Price">7.50</span> per unit in exchange for gross proceeds of approximately $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pn3n3_dm_c20220801__20220817__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zWpgp82yuzG" title="Proceeds from offering">7.35</span> million, before deducting underwriting discounts and offering expenses. Each share of common stock was sold together with two warrants. Each warrant is exercisable to purchase one share of common stock at an initial exercise price of $7.50 per share, subject to certain adjustments as set forth in the warrant agreement. In addition, the <span id="xdx_907_ecustom--UnderwritersDescription_c20220801__20220817__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember" title="Underwriters description">Company granted the underwriters a 45-day option to purchase up to an additional 147,000 shares of common stock and/or warrants to purchase up to an additional 294,000 shares of common stock to cover over-allotments, of which the Underwriter exercised its option to purchase additional warrants to purchase 294,000 shares of common stock concurrently with the closing.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The shares of common stock and warrants began trading on The Nasdaq Capital Market on August 15, 2022, under the symbols “LUCY” and “LUCYW,” respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Also, pursuant to the terms of the underwriting agreement for the offering, the Company issued by the Underwriter certain other warrants to purchase up to <span id="xdx_90F_ecustom--NumberOfWarrantsPurchased_c20220801__20220815__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MaximMember_pdd" title="Number of warrants purchased">58,800</span> shares of the Company’s common stock at an exercise price of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20220815__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MaximMember_pdd" title="Exercise price">8.228</span> per share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The net proceeds received by the Company from this offering amounted to $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20220801__20220815__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pp0p0" title="Proceeds from offering">6,015,918</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Second Public Offering</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 26, 2023, the Company closed on a public offering of <span id="xdx_907_ecustom--NumberOfWarrantsPurchased_c20230602__20230626__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Number of warrants purchased">4,500,000</span> units consisting of <span id="xdx_900_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230602__20230626__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pdd" title="Issauance of common stock">4,500,000</span> shares of its common stock and 4,500,000 warrants to purchase 4,500,000 shares of common stock (the “Common Warrants”) at a combined offering price of $<span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20230626__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Exercise price">1.05</span> per unit in exchange for gross proceeds of approximately $<span id="xdx_90C_eus-gaap--ProceedsFromWarrantExercises_pn3n3_dm_c20230602__20230626__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zbnd7Az7K6a3" title="Cash proceeds">4.73</span> million, before deducting underwriting discounts and offering expenses. Each share of common stock was sold together with one warrant. Each Common Warrant is exercisable to purchase one share of common stock at an initial exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20230626__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zESJUkAWneka" title="Exercise price">1.05</span> per share, subject to certain adjustments as set forth in the warrant agreement. In addition, pursuant to the terms of the placement agency agreement for the offering, the Company issued to the placement agent certain other warrants to purchase up to <span id="xdx_902_ecustom--NumberOfWarrantsPurchased_c20230602__20230626__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_pdd" title="Number of warrants purchased">180,000</span> shares of the Company’s common stock at an exercise price of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20230626__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_pdd" title="Exercise price">1.31</span> per share. The net proceeds received by the Company from this offering amounted to $<span id="xdx_900_eus-gaap--ProceedsFromWarrantExercises_c20230602__20230626__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_pp0p0" title="Cash proceeds">4,115,688</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Warrants</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 17, 2022, as part of the Company’s initial public offering described above, the Company issued a total of <span id="xdx_90D_ecustom--NumberOfWarrantsPurchased_c20220816__20220817__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_pdd" title="Number of warrants purchased">2,254,000</span> warrants to purchase <span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220816__20220817__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pdd" title="Issauance of common stock">2,254,000</span> shares of common stock, which began trading and are currently trading on the Nasdaq Capital Market, under the symbol “LUCYW” (which we refer to as the “Listed Warrants”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2023, holders of the Company’s Listed Warrants exercised such warrants to purchase an aggregate of <span id="xdx_905_ecustom--NumberOfWarrantExercised_c20230201__20230228_pdd" title="Number of warrant exercised">408,600</span> shares of the Company’s common stock, at an adjusted exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20230228_pdd" title="Exercise price">3.75</span> per share, resulting in cash proceeds to the Company of $<span id="xdx_90A_eus-gaap--ProceedsFromWarrantExercises_c20230201__20230228_pp0p0" title="Cash proceeds">1,532,250</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Between April 1, 2023 and April 16, 2023, holders of the Company’s Listed Warrants exercised such warrants to purchase an aggregate of <span id="xdx_900_ecustom--NumberOfWarrantExercised_c20230401__20230416__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_pdd" title="Number of warrant exercised">321,120</span> shares of the Company’s common stock, at an adjusted exercise price of $<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20230416__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_pdd" title="Exercise price">3.75</span> per share, resulting in cash proceeds to the Company of $<span id="xdx_90A_eus-gaap--ProceedsFromWarrantExercises_c20230401__20230416__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_pp0p0" title="Cash proceeds">1,204,200</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 17, 2023, the Company entered into a warrant exercise inducement letter agreement (“Inducement Letter”) with certain accredited investors that were existing holders of the Company’s Listed Warrants to purchase an aggregate of <span id="xdx_90F_ecustom--NumberOfWarrantExercised_c20230401__20230417__us-gaap--TypeOfArrangementAxis__custom--InducementLetterMember_pdd" title="Number of warrant exercised">150,000</span> shares of the Company’s common stock for cash, wherein the investors agreed to exercise all of their existing Listed Warrants at an exercise price of $<span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20230417__us-gaap--TypeOfArrangementAxis__custom--InducementLetterMember_pdd" title="Exercise price">3.75</span> per share. The gross proceeds to the Company from this transaction, before deducting estimated expenses and fees, was $<span id="xdx_904_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20230401__20230417__us-gaap--TypeOfArrangementAxis__custom--InducementLetterMember_pp0p0" title="Sale of transaction">562,000</span>; the net proceeds received by the Company amounted to $<span id="xdx_903_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20230401__20230417__us-gaap--TypeOfArrangementAxis__custom--InducementLetterMember__us-gaap--ClassOfWarrantOrRightAxis__custom--NewWarrantsMember_pp0p0" title="Sale of transaction">391,268</span>. In consideration for the immediate exercise of the existing Listed Warrants for cash, the exercising holders received new warrants to purchase up to an aggregate of <span id="xdx_907_ecustom--NumberOfWarrantExercised_c20230401__20230417__us-gaap--TypeOfArrangementAxis__custom--InducementLetterMember__us-gaap--ClassOfWarrantOrRightAxis__custom--NewWarrantsMember_pdd" title="Number of warrant exercised">300,000</span> shares of common stock (the “Private Warrants”) in a private placement pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended. The Private Warrants are immediately exercisable upon issuance at an exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20230417__us-gaap--TypeOfArrangementAxis__custom--InducementLetterMember__us-gaap--ClassOfWarrantOrRightAxis__custom--NewWarrantsMember_pdd" title="Exercise price">3.75</span> per common share and will expire on April 19, 2028. Although the Private Warrants were offered in a private placement pursuant to an applicable exemption from the registration requirements of the Securities Act and, along with the shares of common stock issuable upon their exercise, were not registered under the Securities Act, subsequently in May 2023 the shares of common stock issuable upon exercise of these warrants were registered with the SEC through a Form S-1 filing.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The only exercises of warrants to date have been those exercises of Listed Warrants in February and April of 2023 as described above. As of December 31, 2023, none of the Common Warrants, Private Warrants, nor any of the warrants issued to underwriters and placement agents have been exercised.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2023, the Company’s outstanding warrants are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfStockholdersEquityTableTextBlock_z6k4vTfzoPC2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span id="xdx_8BC_zm7BT3mQPHxj" style="display: none">Schedule of stockholder’s equity</span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Warrant Type</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants<br/> Outstanding</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise<br/> Price</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Expiration<br/> Date</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 62%; text-align: left">Listed Warrants</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--ListedWarrantsMember_pdd" style="width: 9%; text-align: right" title="Warrants outstanding">1,374,280</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--ListedWarrantsMember_pdd" style="width: 9%; text-align: right" title="Exercise price">3.75</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: center"><span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--ListedWarrantsMember" title="Expiration Date">8/17/2027</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Common Warrants</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--CommonWarrantsMember_pdd" style="text-align: right" title="Warrants outstanding">4,500,000</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--CommonWarrantsMember_pdd" style="text-align: right" title="Exercise price">1.05</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"><span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--CommonWarrantsMember" title="Expiration Date">6/26/2028</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Private Warrants</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivateWarrantsMember_pdd" style="text-align: right" title="Warrants outstanding">300,000</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivateWarrantsMember_pdd" style="text-align: right" title="Exercise price">3.75</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"><span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivateWarrantsMember" title="Expiration Date">4/19/2028</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Underwriter warrants</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--UnderwriterWarrantsMember_pdd" style="text-align: right" title="Warrants outstanding">58,800</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--UnderwriterWarrantsMember_pdd" style="text-align: right" title="Exercise price">8.23</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"><span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--UnderwriterWarrantsMember" title="Expiration Date">8/12/2027</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Placement agent warrants</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PlacemenAgentWarrantsMember_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants outstanding">180,000</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: left">$</td> <td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PlacemenAgentWarrantsMember_pdd" style="text-align: right" title="Exercise price">1.05</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: center"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PlacemenAgentWarrantsMember" title="Expiration Date">6/26/2028</span></td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in; text-align: left; font-weight: bold; vertical-align: top">Total</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td> <td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightOutstanding_c20231231_pdd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Warrants outstanding">6,413,080</td> <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> 15000000 15000000 50000000 50000000 0 0 0 0 980000 980000 7.50 7350000 Company granted the underwriters a 45-day option to purchase up to an additional 147,000 shares of common stock and/or warrants to purchase up to an additional 294,000 shares of common stock to cover over-allotments, of which the Underwriter exercised its option to purchase additional warrants to purchase 294,000 shares of common stock concurrently with the closing. 58800 8.228 6015918 4500000 4500000 1.05 4730000 1.05 180000 1.31 4115688 2254000 2254000 408600 3.75 1532250 321120 3.75 1204200 150000 3.75 562000 391268 300000 3.75 <table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfStockholdersEquityTableTextBlock_z6k4vTfzoPC2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span id="xdx_8BC_zm7BT3mQPHxj" style="display: none">Schedule of stockholder’s equity</span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Warrant Type</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants<br/> Outstanding</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercise<br/> Price</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Expiration<br/> Date</td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 62%; text-align: left">Listed Warrants</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--ListedWarrantsMember_pdd" style="width: 9%; text-align: right" title="Warrants outstanding">1,374,280</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--ListedWarrantsMember_pdd" style="width: 9%; text-align: right" title="Exercise price">3.75</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: center"><span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--ListedWarrantsMember" title="Expiration Date">8/17/2027</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Common Warrants</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_982_eus-gaap--ClassOfWarrantOrRightOutstanding_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--CommonWarrantsMember_pdd" style="text-align: right" title="Warrants outstanding">4,500,000</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--CommonWarrantsMember_pdd" style="text-align: right" title="Exercise price">1.05</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"><span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--CommonWarrantsMember" title="Expiration Date">6/26/2028</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Private Warrants</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_988_eus-gaap--ClassOfWarrantOrRightOutstanding_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivateWarrantsMember_pdd" style="text-align: right" title="Warrants outstanding">300,000</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivateWarrantsMember_pdd" style="text-align: right" title="Exercise price">3.75</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"><span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PrivateWarrantsMember" title="Expiration Date">4/19/2028</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Underwriter warrants</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--UnderwriterWarrantsMember_pdd" style="text-align: right" title="Warrants outstanding">58,800</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--UnderwriterWarrantsMember_pdd" style="text-align: right" title="Exercise price">8.23</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center"><span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--UnderwriterWarrantsMember" title="Expiration Date">8/12/2027</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Placement agent warrants</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_987_eus-gaap--ClassOfWarrantOrRightOutstanding_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PlacemenAgentWarrantsMember_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants outstanding">180,000</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: left">$</td> <td id="xdx_984_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PlacemenAgentWarrantsMember_pdd" style="text-align: right" title="Exercise price">1.05</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: center"><span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_c20231231__us-gaap--ClassOfWarrantOrRightAxis__custom--PlacemenAgentWarrantsMember" title="Expiration Date">6/26/2028</span></td> <td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in; text-align: left; font-weight: bold; vertical-align: top">Total</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td> <td id="xdx_98A_eus-gaap--ClassOfWarrantOrRightOutstanding_c20231231_pdd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Warrants outstanding">6,413,080</td> <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt"> </td></tr> </table> 1374280 3.75 2027-08-17 4500000 1.05 2028-06-26 300000 3.75 2028-04-19 58800 8.23 2027-08-12 180000 1.05 2028-06-26 6413080 <p id="xdx_808_eus-gaap--ShareholdersEquityAndShareBasedPaymentsTextBlock_zBnqw3yNUIS9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 9 – <span id="xdx_82D_z5YInkw7Qsm6">STOCK-BASED COMPENSATION</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 1, 2021, an Equity Incentive Plan was approved, allowing for total of 20% of our issued and outstanding common stock, less the number of outstanding option grants, to be available for the grant of awards under the Plan. There were 1,685,000 option awards granted by the Company prior to the approval of the Plan, while <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20230101__20231231_pdd" title="Stock granted">1,800,500</span> option awards have been granted under the Plan from July 1, 2021 through December 31, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Summary information regarding the number of options, exercise price, and remaining contractual life as of and during the years ended December 31, 2023 and 2022 is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_z5tk2MyjVqUg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK BASED COMPENSATION (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span id="xdx_8B8_zM3fmWiEI3Va" style="display: none">Schedule fair value of options granted</span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average<br/> Exercise Price<br/> per share<br/> $</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options<br/> (Number)</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average<br/> Remaining<br/> Contractual Life<br/> (Years)</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; text-indent: -0.125in; padding-left: 0.125in">As at January 1, 2022</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231_zRPPnEr6XFM9" style="width: 9%; text-align: right" title="Weighted avaerage exercise price per share, Option Outstanding at beginnig">2.61</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231_zNO7U8iPMECc" style="width: 9%; text-align: right" title="Option Outstanding at beginnig">2,332,500</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right"> </td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Granted</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231_pdd" style="text-align: right" title="Weighted avaerage exercise price per share, Option Granted"><span style="-sec-ix-hidden: xdx2ixbrl0853">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20221231_pdd" style="text-align: right" title="Option Granted"><span style="-sec-ix-hidden: xdx2ixbrl0855">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Exercised</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20221231_pdd" style="text-align: right" title="Weighted avaerage exercise price per share, Option Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0857">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20220101__20221231_pdd" style="text-align: right" title="Option Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0859">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in">Forfeited</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20221231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted avaerage exercise price per share, Option Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0861">-</span></td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220101__20221231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Option Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0863">-</span></td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in">As at December 31, 2022</td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231_zcE6YUzJBitb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Weighted avaerage exercise price per share, Option Outstanding at ending">2.61</td> <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20221231_zEiVIlI9N8M3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Option Outstanding at ending">2,332,500</td> <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231_zkTw7ez4HA22" title="Weighted avaerage remaining contractual life (Years)">1.68</span></td> <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">As at January 1, 2023</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231_znoSZPxRkNK5" style="text-align: right" title="Weighted avaerage exercise price per share, Option Outstanding at beginnig">2.61</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20231231_z9v4qWwzoTXg" style="text-align: right" title="Option Outstanding at beginnig">2,332,500</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Granted</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20231231_pdd" style="text-align: right" title="Weighted avaerage exercise price per share, Option Granted">0.92</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20230101__20231231_pdd" style="text-align: right" title="Option Granted">1,153,000</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Exercised</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230101__20231231_pdd" style="text-align: right" title="Weighted avaerage exercise price per share, Option Exercised">1.01</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230101__20231231_zC0ttPxNKhXi" style="text-align: right" title="Option Exercised">(316,000</td> <td style="text-align: left">)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in">Forfeited / Expired</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20231231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted avaerage exercise price per share, Option Forfeited">2.94</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230101__20231231_z0ccRizRCMx4" style="border-bottom: Black 1pt solid; text-align: right" title="Option Forfeited">(275,000</td> <td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in">As at December 31, 2023</td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20231231_zjiVA4Xkowp4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Weighted avaerage exercise price per share, Option Outstanding at ending">2.08</td> <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20231231_zZ0OJ5GBdnag" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Option Outstanding at ending">2,894,500</td> <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231_zJuLbXZbMDIk" title="Weighted avaerage remaining contractual life (Years)">2.22</span></td> <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in">Exercisable as at December 31, 2023</td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20231231_pdd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Weighted avaerage exercise price per share, Option Exercisable">2.39</td> <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20231231_pdd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Option Exercisable">1,795,219</td> <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231_z4omUa58S3Fc" title="Weighted avaerage remaining contractual life (Years), Option Exercisable">1.40</span></td> <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> </table> <p id="xdx_8AA_z2gX4zC0RWZ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2023, the aggregate intrinsic value for all options outstanding as well as all options exercisable was zero.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended December 31, 2023, we granted the following option awards:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left; vertical-align: top">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">Options to purchase an aggregate of <span id="xdx_902_ecustom--NumberOfOptionsPurchased_c20230101__20231231__srt--TitleOfIndividualAxis__custom--OfficersAndManagementMember_pdd" title="Number of options purchased">330,000</span> shares of common stock at $<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_c20230101__20231231__srt--TitleOfIndividualAxis__custom--OfficersAndManagementMember_pdd" title="Exercise price">1.275</span> per share were issued to the Company’s officers and management, of which 1/3 vested immediately, 1/3 shall vest on January 13, 2024, and the remaining 1/3 shall vest on January 13, 2025. The options expire on January 13, 2028.</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify; vertical-align: top"></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify; vertical-align: top">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">Options to purchase an aggregate of <span id="xdx_902_ecustom--NumberOfOptionsPurchased_c20230101__20231231__srt--TitleOfIndividualAxis__custom--NonManagementDirectorsMember_pdd" title="Number of options purchased">75,000</span> shares of common stock at $<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_c20230101__20231231__srt--TitleOfIndividualAxis__custom--NonManagementDirectorsMember_pdd" title="Exercise price">1.275</span> per share were issued to non-management directors, which vest evenly over three years, whereby 1/3 shall vest on each of January 13, 2024, January 13, 2025, and January 13, 2026. The options expire on January 13, 2028.</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify; vertical-align: top"></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify; vertical-align: top">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">Options to purchase an aggregate of <span id="xdx_909_ecustom--NumberOfOptionsPurchased_c20230101__20231231__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_pdd" title="Number of options purchased">162,000</span> shares of common stock at $<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_c20230101__20231231__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultantsMember_pdd" title="Exercise price">1.275</span> per share were issued to certain employees and consultants, which vest evenly over three years, whereby 1/3 shall vest on each of January 13, 2024, January 13, 2025, and January 13, 2026. The options expire on January 13, 2028.</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify; vertical-align: top"></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify; vertical-align: top">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">Options to purchase an aggregate of <span id="xdx_900_ecustom--NumberOfOptionsPurchased_c20230101__20231231__srt--TitleOfIndividualAxis__custom--EmployeeMember_pdd" title="Number of options purchased">75,000</span> shares of common stock at $<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_c20230101__20231231__srt--TitleOfIndividualAxis__custom--EmployeeMember_pdd" title="Exercise price">1.275</span> per share were issued to an employee, which would have vested evenly over three years (whereby 1/6 of the options would have vested every six months). During the year ended December 31, 2023, however, all of these options were forfeited.</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify; vertical-align: top"></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify; vertical-align: top">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">Options to purchase an aggregate of <span id="xdx_908_ecustom--NumberOfOptionsPurchased_c20230101__20231231__srt--TitleOfIndividualAxis__custom--AConsultantMember_pdd" title="Number of options purchased">6,000</span> shares of common stock at $<span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_c20230101__20231231__srt--TitleOfIndividualAxis__custom--AConsultantMember_pdd" title="Exercise price">1.275</span> per share were issued to a consultant, which vested immediately. These options were all exercised during the year ended December 31, 2023.</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify; vertical-align: top"></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify; vertical-align: top">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">Options to purchase an aggregate of <span id="xdx_90A_ecustom--NumberOfOptionsPurchased_c20230101__20231231__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultants1Member_pdd" title="Number of options purchased">15,000</span> shares of common stock at $<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_c20230101__20231231__srt--TitleOfIndividualAxis__custom--EmployeesAndConsultants1Member_pdd" title="Exercise price">0.66</span> per share were issued to certain employees and consultants, which vest evenly over two years, whereby 1/4 of the options shall vest every six months. The options expire on September 5, 2028.</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify; vertical-align: top"></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify; vertical-align: top">●</td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">Options to purchase an aggregate of <span id="xdx_906_ecustom--NumberOfOptionsPurchased_c20230101__20231231__srt--TitleOfIndividualAxis__custom--OfficersAndManagement1Member_pdd" title="Number of options purchased">490,000</span> shares of common stock at $<span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice_c20230101__20231231__srt--TitleOfIndividualAxis__custom--OfficersAndManagement1Member_pdd" title="Exercise price">0.45</span> per share were issued to the Company’s officers and management, of which 1/3 vested immediately, 1/3 shall vest on December 18, 2024, and the remaining 1/3 shall vest on December 18, 2025. The options expire on December 18, 2028.</td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There were no option awards granted during the year ended December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of options granted is calculated using the Black-Scholes-Merton option pricing model. The underlying assumptions used in the option pricing model for stock option awards granted in 2023 were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_zt1okztdPE14" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK BASED COMPENSATION (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span id="xdx_8B2_zWqRL5F2xdk6" style="display: none">Schedule of number of share options and the weighted average exercise price outstanding</span></td> <td> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Attribute</td> <td> </td> <td style="border-bottom: Black 1pt solid; text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">Share price at date of grant</td> <td> </td> <td style="text-align: right">$<span id="xdx_90D_eus-gaap--SharePrice_c20231231__srt--RangeAxis__srt--MinimumMember_pdd" title="Share price at date of grant">0.43</span> - $<span id="xdx_90B_eus-gaap--SharePrice_c20231231__srt--RangeAxis__srt--MaximumMember_pdd" title="Share price at date of grant">1.28</span></td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Expected term (in years)</td> <td> </td> <td style="text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_zfWUa9wVedji" title="Options life in years">3</span> - <span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zdElvIGLFjgk" title="Options life in years">4</span></td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Risk free rate</td> <td> </td> <td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_pdd" title="Risk free rate">3.74%</span> - <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zqL0DdbQPbJ6" title="Risk free rate">4.65</span></td> <td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Expected volatility</td> <td> </td> <td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_pdd" title="Expected volatility">106%</span> - <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zhGP0Xhmp7Of" title="Expected volatility">133</span></td> <td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 86%; text-align: left">Expected dividend yield</td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20230101__20231231_zc8OIExNE4Dl" title="Expected dividend yield">0</span></td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Grant date fair value of options</td> <td> </td> <td style="text-align: right">$<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_pdd" title="Grant date fair value of options">0.28</span> - $<span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_pdd" title="Grant date fair value of options">1.02</span></td> <td style="text-align: left"> </td></tr> </table> <p id="xdx_8A0_zHhysXuNcEVf" style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The weighted average grant date fair value of options outstanding was $<span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20231231_pdd" title="Weighted average grant date fair value of options outstanding">1.49</span> and $<span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220101__20221231_pdd" title="Weighted average grant date fair value of options outstanding">1.84</span> as of December 31, 2023 and 2022, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2023, unrecognized stock option expense of approximately $<span id="xdx_90C_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c20231231_pp0p0" title="Unrecognized stock compensation expense">721,000</span> remains to be recognized over next <span id="xdx_901_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20230101__20231231_zqktPBZywm7l" title="Unrecognized stock compensation expense, term">1.12</span> years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Award Modifications</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 1, 2023, we modified the terms of certain options previously awarded in 2021 to purchase an aggregate of <span id="xdx_90C_ecustom--NumberOfCommonStockPurchased_c20230530__20230601_pdd" title="Number of common stock purchased">140,000</span> shares of common stock, in order to extend their expiration dates from July 21, 2023 to July 21, 2024. There were <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_pp0p0_do_c20231231_zfbLpA8Snkz8" title="Options outstanding intrinsic value"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iI_pp0p0_do_c20231231_zNITFJ2GK0H2" title="Options exercisable intrinsic value">no</span></span> changes to the exercise price or other terms of these stock options, and these options were already fully vested prior to the modification. As a result of this modification, we recognized incremental stock option expense of $<span id="xdx_907_ecustom--NumberOfCommonStockPurchased_c20230101__20231231_pdd" title="Number of common stock purchased">9,188</span> for the year ended December 31, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Restricted Stock Unit Awards</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 3, 2023, we entered into an endorsement agreement with an influencer for a one-year term, which included the award of an aggregate of <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20231201__20231203__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pdd" title="Number of restricted stock units granted">65,220</span> restricted stock units. <span id="xdx_90C_ecustom--RestrictedStockUnitsVestedDescription_c20231201__20231203__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember" title="Restricted stock units vested description">These restricted stock units vest according to the following schedule: 16,305 shares on December 3, 2023 (which will be issued on or before March 31, 2024), 16,305 shares on March 2, 2024 (which will be issued on or before March 31, 2024), 16,305 shares on May 31, 2024, and 16,305 shares on August 29, 2024.</span> Total stock-based compensation related to this award, based on the market price of the Company’s common stock on the date of grant, amounts to $27,066. We recognized $<span id="xdx_90E_eus-gaap--ShareBasedCompensation_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0" title="Stock-based compensation">8,458</span> of expense related to this award during the year ended December 31, 2023, and will recognize the remaining expense of $<span id="xdx_904_eus-gaap--StraightLineRent_c20230101__20231231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_pp0p0" title="Straight line basis">18,608</span> on a straight-line basis over the remaining term of the agreement in 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> 1800500 <table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_z5tk2MyjVqUg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK BASED COMPENSATION (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><span id="xdx_8B8_zM3fmWiEI3Va" style="display: none">Schedule fair value of options granted</span></td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average<br/> Exercise Price<br/> per share<br/> $</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options<br/> (Number)</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Weighted Average<br/> Remaining<br/> Contractual Life<br/> (Years)</td> <td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left; text-indent: -0.125in; padding-left: 0.125in">As at January 1, 2022</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20220101__20221231_zRPPnEr6XFM9" style="width: 9%; text-align: right" title="Weighted avaerage exercise price per share, Option Outstanding at beginnig">2.61</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20221231_zNO7U8iPMECc" style="width: 9%; text-align: right" title="Option Outstanding at beginnig">2,332,500</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right"> </td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Granted</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20220101__20221231_pdd" style="text-align: right" title="Weighted avaerage exercise price per share, Option Granted"><span style="-sec-ix-hidden: xdx2ixbrl0853">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20220101__20221231_pdd" style="text-align: right" title="Option Granted"><span style="-sec-ix-hidden: xdx2ixbrl0855">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Exercised</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20220101__20221231_pdd" style="text-align: right" title="Weighted avaerage exercise price per share, Option Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0857">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20220101__20221231_pdd" style="text-align: right" title="Option Exercised"><span style="-sec-ix-hidden: xdx2ixbrl0859">-</span></td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in">Forfeited</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20220101__20221231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted avaerage exercise price per share, Option Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0861">-</span></td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_c20220101__20221231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Option Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl0863">-</span></td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in">As at December 31, 2022</td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20220101__20221231_zcE6YUzJBitb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Weighted avaerage exercise price per share, Option Outstanding at ending">2.61</td> <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20221231_zEiVIlI9N8M3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Option Outstanding at ending">2,332,500</td> <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231_zkTw7ez4HA22" title="Weighted avaerage remaining contractual life (Years)">1.68</span></td> <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">As at January 1, 2023</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20230101__20231231_znoSZPxRkNK5" style="text-align: right" title="Weighted avaerage exercise price per share, Option Outstanding at beginnig">2.61</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20230101__20231231_z9v4qWwzoTXg" style="text-align: right" title="Option Outstanding at beginnig">2,332,500</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Granted</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20230101__20231231_pdd" style="text-align: right" title="Weighted avaerage exercise price per share, Option Granted">0.92</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20230101__20231231_pdd" style="text-align: right" title="Option Granted">1,153,000</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Exercised</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20230101__20231231_pdd" style="text-align: right" title="Weighted avaerage exercise price per share, Option Exercised">1.01</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20230101__20231231_zC0ttPxNKhXi" style="text-align: right" title="Option Exercised">(316,000</td> <td style="text-align: left">)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in">Forfeited / Expired</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c20230101__20231231_pdd" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted avaerage exercise price per share, Option Forfeited">2.94</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20230101__20231231_z0ccRizRCMx4" style="border-bottom: Black 1pt solid; text-align: right" title="Option Forfeited">(275,000</td> <td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in">As at December 31, 2023</td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20230101__20231231_zjiVA4Xkowp4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Weighted avaerage exercise price per share, Option Outstanding at ending">2.08</td> <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20230101__20231231_zZ0OJ5GBdnag" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Option Outstanding at ending">2,894,500</td> <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230101__20231231_zJuLbXZbMDIk" title="Weighted avaerage remaining contractual life (Years)">2.22</span></td> <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in">Exercisable as at December 31, 2023</td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20231231_pdd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Weighted avaerage exercise price per share, Option Exercisable">2.39</td> <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20231231_pdd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Option Exercisable">1,795,219</td> <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230101__20231231_z4omUa58S3Fc" title="Weighted avaerage remaining contractual life (Years), Option Exercisable">1.40</span></td> <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> </table> 2.61 2332500 2.61 2332500 P1Y8M4D 2.61 2332500 0.92 1153000 1.01 316000 2.94 275000 2.08 2894500 P2Y2M19D 2.39 1795219 P1Y4M24D 330000 1.275 75000 1.275 162000 1.275 75000 1.275 6000 1.275 15000 0.66 490000 0.45 <table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock_zt1okztdPE14" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - STOCK BASED COMPENSATION (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span id="xdx_8B2_zWqRL5F2xdk6" style="display: none">Schedule of number of share options and the weighted average exercise price outstanding</span></td> <td> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: left">Attribute</td> <td> </td> <td style="border-bottom: Black 1pt solid; text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; vertical-align: top">Share price at date of grant</td> <td> </td> <td style="text-align: right">$<span id="xdx_90D_eus-gaap--SharePrice_c20231231__srt--RangeAxis__srt--MinimumMember_pdd" title="Share price at date of grant">0.43</span> - $<span id="xdx_90B_eus-gaap--SharePrice_c20231231__srt--RangeAxis__srt--MaximumMember_pdd" title="Share price at date of grant">1.28</span></td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Expected term (in years)</td> <td> </td> <td style="text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_zfWUa9wVedji" title="Options life in years">3</span> - <span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zdElvIGLFjgk" title="Options life in years">4</span></td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Risk free rate</td> <td> </td> <td style="text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_pdd" title="Risk free rate">3.74%</span> - <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zqL0DdbQPbJ6" title="Risk free rate">4.65</span></td> <td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Expected volatility</td> <td> </td> <td style="text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_pdd" title="Expected volatility">106%</span> - <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_zhGP0Xhmp7Of" title="Expected volatility">133</span></td> <td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 86%; text-align: left">Expected dividend yield</td> <td style="width: 1%"> </td> <td style="width: 12%; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20230101__20231231_zc8OIExNE4Dl" title="Expected dividend yield">0</span></td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left">Grant date fair value of options</td> <td> </td> <td style="text-align: right">$<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20231231__srt--RangeAxis__srt--MinimumMember_pdd" title="Grant date fair value of options">0.28</span> - $<span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20230101__20231231__srt--RangeAxis__srt--MaximumMember_pdd" title="Grant date fair value of options">1.02</span></td> <td style="text-align: left"> </td></tr> </table> 0.43 1.28 P3Y P4Y 0.0374 0.0465 1.06 1.33 0 0.28 1.02 1.49 1.84 721000 P1Y1M13D 140000 0 0 9188 65220 These restricted stock units vest according to the following schedule: 16,305 shares on December 3, 2023 (which will be issued on or before March 31, 2024), 16,305 shares on March 2, 2024 (which will be issued on or before March 31, 2024), 16,305 shares on May 31, 2024, and 16,305 shares on August 29, 2024. 8458 18608 <p id="xdx_80B_eus-gaap--EarningsPerShareTextBlock_zpJ9L1Ic1DK1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 10 – <span id="xdx_82B_zJCT22uolPN">EARNINGS PER SHARE</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company calculates earnings/(loss) per share data by calculating the quotient of earnings/(loss) divided by the weighted average number of common shares outstanding during the respective period as required by ASC 260-10-50. Due to the net losses for the years ended December 31, 2023 and 2022, all shares underlying the related party convertible debt, common stock warrants, and common stock options were excluded from the earnings per share calculation due to their anti-dilutive effect.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Calculation of net earnings per common share — basic and diluted:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zqXrXvzgvELe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - EARNINGS PER SHARE (Details)"> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span id="xdx_8B9_z6RXXDElyeka" style="display: none">Calculation of net earnings per common share - basic and diluted</span></td> <td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20230101__20231231_z4ulayPxxhU9" style="vertical-align: bottom; font-weight: bold; text-align: center"> </td> <td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20220101__20221231_zlrzvTe8ibnk" style="vertical-align: bottom; font-weight: bold; text-align: center"> </td> <td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">For the<br/> year ended</td> <td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td> <td style="vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td> <td style="vertical-align: bottom; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2023</td> <td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td> <td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40C_eus-gaap--EarningsPerShareBasicAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; font-weight: bold; text-align: left">Basic and diluted:</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--ProfitLoss_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 76%; text-align: left">Net loss</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">(6,663,428</td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">(5,681,833</td> <td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt; vertical-align: top">Weighted-average number of common shares</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">10,515,995</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">6,528,959</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--EarningsPerShareDiluted_i_pdd" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 2.5pt">Basic and diluted net loss per common share</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">(0.63</td> <td style="padding-bottom: 2.5pt; text-align: left">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">(0.87</td> <td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zqXrXvzgvELe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - EARNINGS PER SHARE (Details)"> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"><span id="xdx_8B9_z6RXXDElyeka" style="display: none">Calculation of net earnings per common share - basic and diluted</span></td> <td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20230101__20231231_z4ulayPxxhU9" style="vertical-align: bottom; font-weight: bold; text-align: center"> </td> <td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20220101__20221231_zlrzvTe8ibnk" style="vertical-align: bottom; font-weight: bold; text-align: center"> </td> <td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">For the<br/> year ended</td> <td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td> <td style="vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">December 31,</td> <td style="vertical-align: bottom; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2023</td> <td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"> </td> <td style="vertical-align: bottom; text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">2022</td> <td style="vertical-align: bottom; text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40C_eus-gaap--EarningsPerShareBasicAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; font-weight: bold; text-align: left">Basic and diluted:</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--ProfitLoss_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; width: 76%; text-align: left">Net loss</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">(6,663,428</td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">(5,681,833</td> <td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i_pdd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt; vertical-align: top">Weighted-average number of common shares</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">10,515,995</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: right">6,528,959</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--EarningsPerShareDiluted_i_pdd" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; vertical-align: top; text-align: left; padding-bottom: 2.5pt">Basic and diluted net loss per common share</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">(0.63</td> <td style="padding-bottom: 2.5pt; text-align: left">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">(0.87</td> <td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> -6663428 -5681833 10515995 6528959 -0.63 -0.87 <p id="xdx_80C_eus-gaap--SubsequentEventsTextBlock_zeYfXq5aMFq1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 11 –<span id="xdx_822_zzsLOzXCwfyb"> SUBSEQUENT EVENTS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Settlement and License Agreement</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 3, 2024, we settled and resolved certain matters with a third party, including a complaint that had been brought before the International Trade Commission and an investigation instituted by the International Trade Commission in 2023, and entered into a multi-year non-exclusive license agreement covering multiple smart eyewear patents. Pursuant to this license agreement, the Company added licenses for 46 new patents to its portfolio of owned and licensed patents and applications.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Loan to Tekcapital Europe, Ltd.</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 11, 2024, we entered into an intercompany loan agreement (as lender) with Tekcapital Europe, Ltd. (as borrower), an affiliate of our largest stockholder, Lucyd Ltd., whose Chief Executive Officer is the father of our Chief Executive Officer, and Tekcapital Plc, the parent of Tekcapital Europe Ltd. Pursuant to this agreement, the Company loaned 600,000 British pounds sterling (equivalent to approximately $<span id="xdx_907_eus-gaap--LoansPayable_c20240111__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TekcapitalEuropeLtdMember_pp0p0" title="Loans payable">765,000</span>) to Tekcapital Europe Ltd. The loan bears simple interest at a rate of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20240101__20240111__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TekcapitalEuropeLtdMember_pdd" title="Interest rate">10%</span> per annum and is required to be repaid on or before <span id="xdx_906_eus-gaap--DebtInstrumentMaturityDate_c20240101__20240111__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TekcapitalEuropeLtdMember_zNzojCo9ward" title="Maturity date">April 11, 2024</span>. Tekcapital Plc executed the agreement as guarantor for Tekcapital Europe Ltd. on the full amount of the loan. Tekcapital Europe Ltd. repaid the loan in full in March 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>New Convertible Note</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective March 1, 2024, the Company issued a convertible note to Lucyd Ltd., the largest stockholder of the Company, for up to $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20240227__20240301__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LucydMember_pp0p0" title="Number of stock issued">1,250,000</span> that bears interest at <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20240227__20240301__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LucydMember_pdd" title="Interest rate">10%</span> per annum, which includes the option to convert the debt into the Company’s common stock at market price. The note can be converted into shares of common stock of the Company upon the occurrence of certain events, as defined in the note, or for any reason at the sole discretion of Lucyd Ltd. The note has a maturity date of <span id="xdx_906_eus-gaap--DebtInstrumentMaturityDate_c20240227__20240301__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LucydMember" title="Maturity date">September 1, 2025</span>, at which time all outstanding principal and accrued interest is payable in full. As of the date these financial statements were available to be issued, the Company has not borrowed any amounts under this convertible note.</p> 765000 0.10 2024-04-11 1250000 0.10 2025-09-01 During the year ended December 31, 2023, the Company entered into a settlement agreement with a former wholesale customer. As a result of this settlement, $47,646 of accounts receivable were written-off as uncollectible, while the $45,000 collected under the settlement agreement was reflected as a gain within general and administrative expenses in the statement of operations.

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end XML 68 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 69 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 71 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1 html 95 272 1 true 39 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://lucyd.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - BALANCE SHEETS Sheet http://lucyd.com/role/BalanceSheets BALANCE SHEETS Statements 2 false false R3.htm 00000003 - Statement - BALANCE SHEETS (Parenthetical) Sheet http://lucyd.com/role/BalanceSheetsParenthetical BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - STATEMENTS OF OPERATIONS Sheet http://lucyd.com/role/StatementsOfOperations STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 00000005 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Sheet http://lucyd.com/role/StatementsOfChangesInStockholdersEquity STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Statements 5 false false R6.htm 00000006 - Statement - STATEMENTS OF CASH FLOWS Sheet http://lucyd.com/role/StatementsOfCashFlows STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 7 false false R8.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 8 false false R9.htm 995512 - Disclosure - GENERAL INFORMATION Sheet http://lucyd.com/role/GeneralInformation GENERAL INFORMATION Notes 9 false false R10.htm 995513 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://lucyd.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 10 false false R11.htm 995514 - Disclosure - GOING CONCERN Sheet http://lucyd.com/role/GoingConcern GOING CONCERN Notes 11 false false R12.htm 995515 - Disclosure - INCOME TAX PROVISION Sheet http://lucyd.com/role/IncomeTaxProvision INCOME TAX PROVISION Notes 12 false false R13.htm 995516 - Disclosure - INTANGIBLE ASSETS Sheet http://lucyd.com/role/IntangibleAssets INTANGIBLE ASSETS Notes 13 false false R14.htm 995517 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://lucyd.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 14 false false R15.htm 995518 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://lucyd.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 15 false false R16.htm 995519 - Disclosure - STOCKHOLDERS??? EQUITY Sheet http://lucyd.com/role/StockholdersEquity STOCKHOLDERS??? EQUITY Notes 16 false false R17.htm 995520 - Disclosure - STOCK-BASED COMPENSATION Sheet http://lucyd.com/role/Stock-basedCompensation STOCK-BASED COMPENSATION Notes 17 false false R18.htm 995521 - Disclosure - EARNINGS PER SHARE Sheet http://lucyd.com/role/EarningsPerShare EARNINGS PER SHARE Notes 18 false false R19.htm 995522 - Disclosure - SUBSEQUENT EVENTS Sheet http://lucyd.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 19 false false R20.htm 995523 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 20 false false R21.htm 995524 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://lucyd.com/role/SummaryOfSignificantAccountingPolicies 21 false false R22.htm 995525 - Disclosure - INCOME TAX PROVISION (Tables) Sheet http://lucyd.com/role/IncomeTaxProvisionTables INCOME TAX PROVISION (Tables) Tables http://lucyd.com/role/IncomeTaxProvision 22 false false R23.htm 995526 - Disclosure - INTANGIBLE ASSETS (Tables) Sheet http://lucyd.com/role/IntangibleAssetsTables INTANGIBLE ASSETS (Tables) Tables http://lucyd.com/role/IntangibleAssets 23 false false R24.htm 995527 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) Sheet http://lucyd.com/role/CommitmentsAndContingenciesTables COMMITMENTS AND CONTINGENCIES (Tables) Tables http://lucyd.com/role/CommitmentsAndContingencies 24 false false R25.htm 995528 - Disclosure - STOCKHOLDERS??? EQUITY (Tables) Sheet http://lucyd.com/role/StockholdersEquityTables STOCKHOLDERS??? EQUITY (Tables) Tables http://lucyd.com/role/StockholdersEquity 25 false false R26.htm 995529 - Disclosure - STOCK-BASED COMPENSATION (Tables) Sheet http://lucyd.com/role/Stock-basedCompensationTables STOCK-BASED COMPENSATION (Tables) Tables http://lucyd.com/role/Stock-basedCompensation 26 false false R27.htm 995530 - Disclosure - EARNINGS PER SHARE (Tables) Sheet http://lucyd.com/role/EarningsPerShareTables EARNINGS PER SHARE (Tables) Tables http://lucyd.com/role/EarningsPerShare 27 false false R28.htm 995531 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesTables 28 false false R29.htm 995532 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) Sheet http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) Details http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesTables 29 false false R30.htm 995533 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesTables 30 false false R31.htm 995534 - Disclosure - INCOME TAX PROVISION (Details) Sheet http://lucyd.com/role/IncomeTaxProvisionDetails INCOME TAX PROVISION (Details) Details http://lucyd.com/role/IncomeTaxProvisionTables 31 false false R32.htm 995535 - Disclosure - INCOME TAX PROVISION (Details 1) Sheet http://lucyd.com/role/IncomeTaxProvisionDetails1 INCOME TAX PROVISION (Details 1) Details http://lucyd.com/role/IncomeTaxProvisionTables 32 false false R33.htm 995536 - Disclosure - INCOME TAX PROVISION (Details Narrative) Sheet http://lucyd.com/role/IncomeTaxProvisionDetailsNarrative INCOME TAX PROVISION (Details Narrative) Details http://lucyd.com/role/IncomeTaxProvisionTables 33 false false R34.htm 995537 - Disclosure - INTANGIBLE ASSETS (Details) Sheet http://lucyd.com/role/IntangibleAssetsDetails INTANGIBLE ASSETS (Details) Details http://lucyd.com/role/IntangibleAssetsTables 34 false false R35.htm 995538 - Disclosure - INTANGIBLE ASSETS (Details Narrative) Sheet http://lucyd.com/role/IntangibleAssetsDetailsNarrative INTANGIBLE ASSETS (Details Narrative) Details http://lucyd.com/role/IntangibleAssetsTables 35 false false R36.htm 995539 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://lucyd.com/role/RelatedPartyTransactions 36 false false R37.htm 995540 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://lucyd.com/role/CommitmentsAndContingenciesDetails COMMITMENTS AND CONTINGENCIES (Details) Details http://lucyd.com/role/CommitmentsAndContingenciesTables 37 false false R38.htm 995541 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) Sheet http://lucyd.com/role/CommitmentsAndContingenciesDetailsNarrative COMMITMENTS AND CONTINGENCIES (Details Narrative) Details http://lucyd.com/role/CommitmentsAndContingenciesTables 38 false false R39.htm 995542 - Disclosure - STOCKHOLDERS' EQUITY (Details) Sheet http://lucyd.com/role/StockholdersEquityDetails STOCKHOLDERS' EQUITY (Details) Details 39 false false R40.htm 995543 - Disclosure - STOCKHOLDERS??? EQUITY (Details Narrative) Sheet http://lucyd.com/role/StockholdersEquityDetailsNarrative STOCKHOLDERS??? EQUITY (Details Narrative) Details http://lucyd.com/role/StockholdersEquityTables 40 false false R41.htm 995544 - Disclosure - STOCK BASED COMPENSATION (Details) Sheet http://lucyd.com/role/StockBasedCompensationDetails STOCK BASED COMPENSATION (Details) Details 41 false false R42.htm 995545 - Disclosure - STOCK BASED COMPENSATION (Details 1) Sheet http://lucyd.com/role/StockBasedCompensationDetails1 STOCK BASED COMPENSATION (Details 1) Details 42 false false R43.htm 995546 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative) Sheet http://lucyd.com/role/Stock-basedCompensationDetailsNarrative STOCK-BASED COMPENSATION (Details Narrative) Details http://lucyd.com/role/Stock-basedCompensationTables 43 false false R44.htm 995547 - Disclosure - EARNINGS PER SHARE (Details) Sheet http://lucyd.com/role/EarningsPerShareDetails EARNINGS PER SHARE (Details) Details http://lucyd.com/role/EarningsPerShareTables 44 false false R45.htm 995548 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://lucyd.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://lucyd.com/role/SubsequentEvents 45 false false All Reports Book All Reports innovative_10k.htm lucy-20231231.xsd lucy-20231231_cal.xml lucy-20231231_def.xml lucy-20231231_lab.xml lucy-20231231_pre.xml fin_001.jpg fin_002.jpg img_001.jpg img_002.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 73 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "innovative_10k.htm": { "nsprefix": "LUCY", "nsuri": "http://lucyd.com/20231231", "dts": { "inline": { "local": [ "innovative_10k.htm" ] }, "schema": { "local": [ "lucy-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" ] }, "calculationLink": { "local": [ "lucy-20231231_cal.xml" ] }, "definitionLink": { "local": [ "lucy-20231231_def.xml" ] }, "labelLink": { "local": [ "lucy-20231231_lab.xml" ] }, "presentationLink": { "local": [ "lucy-20231231_pre.xml" ] } }, "keyStandard": 223, "keyCustom": 49, "axisStandard": 16, "axisCustom": 0, "memberStandard": 14, "memberCustom": 25, "hidden": { "total": 69, "http://xbrl.sec.gov/dei/2023": 4, "http://lucyd.com/20231231": 25, "http://fasb.org/us-gaap/2023": 40 }, "contextCount": 95, "entityCount": 1, "segmentCount": 39, "elementCount": 496, "unitCount": 4, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 411, "http://xbrl.sec.gov/dei/2023": 42, "http://xbrl.sec.gov/ecd/2023": 4 }, "report": { "R1": { "role": "http://lucyd.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R2": { "role": "http://lucyd.com/role/BalanceSheets", "longName": "00000002 - Statement - BALANCE SHEETS", "shortName": "BALANCE SHEETS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R3": { "role": "http://lucyd.com/role/BalanceSheetsParenthetical", "longName": "00000003 - Statement - BALANCE SHEETS (Parenthetical)", "shortName": "BALANCE SHEETS (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "unique": true } }, "R4": { "role": "http://lucyd.com/role/StatementsOfOperations", "longName": "00000004 - Statement - STATEMENTS OF OPERATIONS", "shortName": "STATEMENTS OF OPERATIONS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:Revenues", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:Revenues", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R5": { "role": "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity", "longName": "00000005 - Statement - STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY", "shortName": "STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R6": { "role": "http://lucyd.com/role/StatementsOfCashFlows", "longName": "00000006 - Statement - STATEMENTS OF CASH FLOWS", "shortName": "STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "unique": true } }, "R7": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true }, "uniqueAnchor": null }, "R8": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2023-10-012023-12-31", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-10-012023-12-31", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R9": { "role": "http://lucyd.com/role/GeneralInformation", "longName": "995512 - Disclosure - GENERAL INFORMATION", "shortName": "GENERAL INFORMATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:NatureOfOperations", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R10": { "role": "http://lucyd.com/role/SummaryOfSignificantAccountingPolicies", "longName": "995513 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R11": { "role": "http://lucyd.com/role/GoingConcern", "longName": "995514 - Disclosure - GOING CONCERN", "shortName": "GOING CONCERN", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R12": { "role": "http://lucyd.com/role/IncomeTaxProvision", "longName": "995515 - Disclosure - INCOME TAX PROVISION", "shortName": "INCOME TAX PROVISION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R13": { "role": "http://lucyd.com/role/IntangibleAssets", "longName": "995516 - Disclosure - INTANGIBLE ASSETS", "shortName": "INTANGIBLE ASSETS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R14": { "role": "http://lucyd.com/role/RelatedPartyTransactions", "longName": "995517 - Disclosure - RELATED PARTY TRANSACTIONS", "shortName": "RELATED PARTY TRANSACTIONS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R15": { "role": "http://lucyd.com/role/CommitmentsAndContingencies", "longName": "995518 - Disclosure - COMMITMENTS AND CONTINGENCIES", "shortName": "COMMITMENTS AND CONTINGENCIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R16": { "role": "http://lucyd.com/role/StockholdersEquity", "longName": "995519 - Disclosure - STOCKHOLDERS\u2019 EQUITY", "shortName": "STOCKHOLDERS\u2019 EQUITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R17": { "role": "http://lucyd.com/role/Stock-basedCompensation", "longName": "995520 - Disclosure - STOCK-BASED COMPENSATION", "shortName": "STOCK-BASED COMPENSATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R18": { "role": "http://lucyd.com/role/EarningsPerShare", "longName": "995521 - Disclosure - EARNINGS PER SHARE", "shortName": "EARNINGS PER SHARE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R19": { "role": "http://lucyd.com/role/SubsequentEvents", "longName": "995522 - Disclosure - SUBSEQUENT EVENTS", "shortName": "SUBSEQUENT EVENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R20": { "role": "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "longName": "995523 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "20", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R21": { "role": "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesTables", "longName": "995524 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "21", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "LUCY:AllowanceForDoubtfulAccountsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ReceivablesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "LUCY:AllowanceForDoubtfulAccountsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ReceivablesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R22": { "role": "http://lucyd.com/role/IncomeTaxProvisionTables", "longName": "995525 - Disclosure - INCOME TAX PROVISION (Tables)", "shortName": "INCOME TAX PROVISION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "22", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R23": { "role": "http://lucyd.com/role/IntangibleAssetsTables", "longName": "995526 - Disclosure - INTANGIBLE ASSETS (Tables)", "shortName": "INTANGIBLE ASSETS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "23", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R24": { "role": "http://lucyd.com/role/CommitmentsAndContingenciesTables", "longName": "995527 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)", "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R25": { "role": "http://lucyd.com/role/StockholdersEquityTables", "longName": "995528 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Tables)", "shortName": "STOCKHOLDERS\u2019 EQUITY (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R26": { "role": "http://lucyd.com/role/Stock-basedCompensationTables", "longName": "995529 - Disclosure - STOCK-BASED COMPENSATION (Tables)", "shortName": "STOCK-BASED COMPENSATION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R27": { "role": "http://lucyd.com/role/EarningsPerShareTables", "longName": "995530 - Disclosure - EARNINGS PER SHARE (Tables)", "shortName": "EARNINGS PER SHARE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R28": { "role": "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails", "longName": "995531 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "28", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "LUCY:BadDebtExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "LUCY:AllowanceForDoubtfulAccountsTableTextBlock", "us-gaap:ReceivablesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "unique": true } }, "R29": { "role": "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails1", "longName": "995532 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "LUCY:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentNetTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "LUCY:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentNetTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R30": { "role": "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "longName": "995533 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "LUCY:BadDebtExpenses", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:ReceivablesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "LUCY:BadDebtExpenses", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:ReceivablesPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R31": { "role": "http://lucyd.com/role/IncomeTaxProvisionDetails", "longName": "995534 - Disclosure - INCOME TAX PROVISION (Details)", "shortName": "INCOME TAX PROVISION (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R32": { "role": "http://lucyd.com/role/IncomeTaxProvisionDetails1", "longName": "995535 - Disclosure - INCOME TAX PROVISION (Details 1)", "shortName": "INCOME TAX PROVISION (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R33": { "role": "http://lucyd.com/role/IncomeTaxProvisionDetailsNarrative", "longName": "995536 - Disclosure - INCOME TAX PROVISION (Details Narrative)", "shortName": "INCOME TAX PROVISION (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:OperatingLossCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:OperatingLossCarryforwards", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R34": { "role": "http://lucyd.com/role/IntangibleAssetsDetails", "longName": "995537 - Disclosure - INTANGIBLE ASSETS (Details)", "shortName": "INTANGIBLE ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R35": { "role": "http://lucyd.com/role/IntangibleAssetsDetailsNarrative", "longName": "995538 - Disclosure - INTANGIBLE ASSETS (Details Narrative)", "shortName": "INTANGIBLE ASSETS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:AdjustmentForAmortization", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:AdjustmentForAmortization", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R36": { "role": "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative", "longName": "995539 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "From2023-01-022023-01-31", "name": "us-gaap:ProceedsFromConvertibleDebt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-022023-01-31", "name": "us-gaap:ProceedsFromConvertibleDebt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R37": { "role": "http://lucyd.com/role/CommitmentsAndContingenciesDetails", "longName": "995540 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)", "shortName": "COMMITMENTS AND CONTINGENCIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R38": { "role": "http://lucyd.com/role/CommitmentsAndContingenciesDetailsNarrative", "longName": "995541 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)", "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "LUCY:LegalMattersLiability", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "LUCY:LegalMattersLiability", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R39": { "role": "http://lucyd.com/role/StockholdersEquityDetails", "longName": "995542 - Disclosure - STOCKHOLDERS' EQUITY (Details)", "shortName": "STOCKHOLDERS' EQUITY (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R40": { "role": "http://lucyd.com/role/StockholdersEquityDetailsNarrative", "longName": "995543 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:PreferredStockSharesAuthorized", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "us-gaap:PreferredStockSharesAuthorized", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R41": { "role": "http://lucyd.com/role/StockBasedCompensationDetails", "longName": "995544 - Disclosure - STOCK BASED COMPENSATION (Details)", "shortName": "STOCK BASED COMPENSATION (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "unique": true } }, "R42": { "role": "http://lucyd.com/role/StockBasedCompensationDetails1", "longName": "995545 - Disclosure - STOCK BASED COMPENSATION (Details 1)", "shortName": "STOCK BASED COMPENSATION (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R43": { "role": "http://lucyd.com/role/Stock-basedCompensationDetailsNarrative", "longName": "995546 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)", "shortName": "STOCK-BASED COMPENSATION (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } }, "R44": { "role": "http://lucyd.com/role/EarningsPerShareDetails", "longName": "995547 - Disclosure - EARNINGS PER SHARE (Details)", "shortName": "EARNINGS PER SHARE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:ProfitLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "unique": true } }, "R45": { "role": "http://lucyd.com/role/SubsequentEventsDetailsNarrative", "longName": "995548 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "AsOf2024-01-11_us-gaap_SubsequentEventMember_custom_TekcapitalEuropeLtdMember", "name": "us-gaap:LoansPayable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-01-11_us-gaap_SubsequentEventMember_custom_TekcapitalEuropeLtdMember", "name": "us-gaap:LoansPayable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "innovative_10k.htm", "first": true, "unique": true } } }, "tag": { "LUCY_AConsultantMember": { "xbrltype": "domainItemType", "nsuri": "http://lucyd.com/20231231", "localname": "AConsultantMember", "presentation": [ "http://lucyd.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Warrants to purchase Common Stock", "label": "Warrants to purchase Common Stock [Default Label]" } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsAndNotesReceivableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsAndNotesReceivableNet", "crdr": "debit", "presentation": [ "http://lucyd.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net account receivable", "documentation": "Amount, after allowance for credit loss, of accounts and financing receivable. Includes, but is not limited to, notes and loan receivable." } } }, "auth_ref": [ "r194", "r659" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://lucyd.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts payable and accrued expenses", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r11" ] }, "us-gaap_AccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableMember", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable [Member]", "documentation": "Due from customers or clients for goods or services that have been delivered or sold." } } }, "auth_ref": [ "r483" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://lucyd.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://lucyd.com/role/BalanceSheets", "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounts receivable, net of allowances of $25,772 and $92,646, respectively", "verboseLabel": "Accounts receivable", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r194", "r195" ] }, "LUCY_AccountsReceivableWrittenoff": { "xbrltype": "monetaryItemType", "nsuri": "http://lucyd.com/20231231", "localname": "AccountsReceivableWrittenoff", "crdr": "credit", "presentation": [ "http://lucyd.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Accounts receivable written-off" } } }, "auth_ref": [] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Accumulated depreciation", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r36", "r118", "r372" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r567" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://lucyd.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional paid-in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r59", "r506", "r663" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r280", "r281", "r282", "r398", "r621", "r622", "r623", "r643", "r666" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r573" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r573" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r573" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r573" ] }, "us-gaap_AdjustmentForAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentForAmortization", "crdr": "debit", "presentation": [ "http://lucyd.com/role/IntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Amortization expense", "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives." } } }, "auth_ref": [ "r3", "r34" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock-based compensation (see Note 9)", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r42", "r43", "r252" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r537", "r549", "r559", "r585" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r540", "r552", "r562", "r588" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r573" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r580" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r544", "r553", "r563", "r580", "r589", "r593", "r601" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivable", "crdr": "credit", "presentation": [ "http://lucyd.com/role/BalanceSheetsParenthetical", "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Allowance", "periodStartLabel": "Balance at beginning", "periodEndLabel": "Balance at ending", "documentation": "Amount of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r125", "r196", "r200", "r201", "r205", "r659" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableRecoveries", "crdr": "credit", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Recoveries", "label": "Accounts Receivable, Allowance for Credit Loss, Recovery", "documentation": "Amount of increase in allowance for credit loss on accounts receivable, from recovery." } } }, "auth_ref": [ "r204" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs", "crdr": "debit", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Write-offs", "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff", "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance." } } }, "auth_ref": [ "r203" ] }, "LUCY_AllowanceForDoubtfulAccountsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://lucyd.com/20231231", "localname": "AllowanceForDoubtfulAccountsTableTextBlock", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of allowance for doubtful account" } } }, "auth_ref": [] }, "LUCY_AllowanceForSalesReturns": { "xbrltype": "monetaryItemType", "nsuri": "http://lucyd.com/20231231", "localname": "AllowanceForSalesReturns", "crdr": "debit", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Allowance for sales returns" } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Amortization", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r3", "r31", "r34" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r545" ] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r304" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://lucyd.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL ASSETS", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r92", "r121", "r146", "r177", "r185", "r189", "r197", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r306", "r310", "r322", "r366", "r432", "r506", "r518", "r634", "r635", "r649" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "TOTAL ASSETS" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://lucyd.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r113", "r130", "r146", "r197", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r306", "r310", "r322", "r506", "r634", "r635", "r649" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current Assets" } } }, "auth_ref": [] }, "us-gaap_AssetsNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsNoncurrentAbstract", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Non-Current Assets" } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r545" ] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r530", "r532", "r545" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r530", "r532", "r545" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r530", "r532", "r545" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price" } } }, "auth_ref": [ "r596" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r597" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "auth_ref": [ "r592" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r592" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r592" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r592" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r592" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r592" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://lucyd.com/role/Stock-basedCompensationDetailsNarrative", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r595" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r594" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r593" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r593" ] }, "LUCY_BadDebtExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://lucyd.com/20231231", "localname": "BadDebtExpense", "crdr": "debit", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Bad debt expense" } } }, "auth_ref": [] }, "LUCY_BadDebtExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://lucyd.com/20231231", "localname": "BadDebtExpenses", "crdr": "debit", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Bad debt expenses" } } }, "auth_ref": [] }, "LUCY_BaseTerm": { "xbrltype": "durationItemType", "nsuri": "http://lucyd.com/20231231", "localname": "BaseTerm", "presentation": [ "http://lucyd.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Base term" } } }, "auth_ref": [] }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of Presentation", "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r77" ] }, "us-gaap_CapitalizedComputerSoftwareNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CapitalizedComputerSoftwareNet", "crdr": "debit", "calculation": { "http://lucyd.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Capitalized software costs", "documentation": "The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date." } } }, "auth_ref": [ "r487" ] }, "LUCY_CapitalizedSoftwarePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://lucyd.com/20231231", "localname": "CapitalizedSoftwarePolicyTextBlock", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Capitalized Software" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://lucyd.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r20", "r116", "r489" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cash Equivalents", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r21" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash at Beginning of Year", "periodEndLabel": "Cash at End of Year", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r20", "r74", "r143" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net Change In Cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r0", "r74" ] }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Significant Non-Cash Transactions" } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r571" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r110", "r122", "r123", "r124", "r146", "r164", "r165", "r167", "r169", "r175", "r176", "r197", "r222", "r224", "r225", "r226", "r229", "r230", "r234", "r235", "r237", "r240", "r246", "r322", "r388", "r389", "r390", "r391", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r420", "r441", "r464", "r477", "r478", "r479", "r480", "r481", "r610", "r619", "r624" ] }, "us-gaap_ClassOfWarrantOrRightAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightAxis", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetails", "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Axis]", "documentation": "Information by type of warrant or right issued." } } }, "auth_ref": [ "r38" ] }, "us-gaap_ClassOfWarrantOrRightDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightDomain", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetails", "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetails", "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Exercise price", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r247" ] }, "us-gaap_ClassOfWarrantOrRightLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightLineItems", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightOutstanding", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Warrants outstanding", "documentation": "Number of warrants or rights outstanding." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightTable", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Table]", "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable." } } }, "auth_ref": [ "r38" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r572" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r572" ] }, "LUCY_CollectionOfStockSubscriptionReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://lucyd.com/20231231", "localname": "CollectionOfStockSubscriptionReceivable", "crdr": "debit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Collection of stock subscription receivable", "label": "CollectionOfStockSubscriptionReceivable" } } }, "auth_ref": [] }, "LUCY_CollectionOfStockSubscriptionReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://lucyd.com/20231231", "localname": "CollectionOfStockSubscriptionReceivables", "crdr": "debit", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Collection of stock subscription receivable" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Commitments and contingencies (Note 7)", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r16", "r52", "r367", "r419" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://lucyd.com/role/CommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "COMMITMENTS AND CONTINGENCIES", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r82", "r216", "r217", "r484", "r633" ] }, "LUCY_CommonStock0.00001ParValueMember": { "xbrltype": "domainItemType", "nsuri": "http://lucyd.com/20231231", "localname": "CommonStock0.00001ParValueMember", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Common Stock, $0.00001 par value" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity", "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r508", "r509", "r510", "r512", "r513", "r514", "r515", "r621", "r622", "r643", "r662", "r666" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://lucyd.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, par value (in Dollars per share)", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r58" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://lucyd.com/role/BalanceSheetsParenthetical", "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r58", "r420" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://lucyd.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r58" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://lucyd.com/role/BalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common stock, shares Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r6", "r58", "r420", "r438", "r666", "r667" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://lucyd.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common stock (par value $0.00001, 50,000,000 shares authorized, and 12,917,239 and 7,307,157 shares issued and outstanding as of December 31, 2023 and 2022, respectively)", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r58", "r368", "r506" ] }, "LUCY_CommonWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://lucyd.com/20231231", "localname": "CommonWarrantsMember", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Common Warrants [Member]" } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r577" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r576" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r578" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r575" ] }, "us-gaap_CompensationRelatedCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CompensationRelatedCostsPolicyTextBlock", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Stock-Based Compensation", "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense." } } }, "auth_ref": [ "r40" ] }, "us-gaap_ComputerEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComputerEquipmentMember", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "Computer Equipment [Member]", "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems." } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r25", "r27", "r46", "r47", "r193", "r483" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r25", "r27", "r46", "r47", "r193", "r385", "r483" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r25", "r27", "r46", "r47", "r193", "r483", "r611" ] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Concentrations of Credit Risk", "documentation": "Disclosure of accounting policy for credit risk." } } }, "auth_ref": [ "r53", "r102" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Concentrations of Credit Risk", "label": "Concentration Risk, Percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r25", "r27", "r46", "r47", "r193" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r25", "r27", "r46", "r47", "r193", "r483" ] }, "LUCY_ContractAssetsAndLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://lucyd.com/20231231", "localname": "ContractAssetsAndLiabilities", "crdr": "credit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 15.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Contract assets and liabilities", "label": "ContractAssetsAndLiabilities" } } }, "auth_ref": [] }, "us-gaap_ConversionOfStockAmountConverted1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConversionOfStockAmountConverted1", "crdr": "debit", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Conversion of stock, amount", "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r22", "r23", "r24" ] }, "us-gaap_ConversionOfStockSharesConverted1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConversionOfStockSharesConverted1", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares converted", "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r22", "r23", "r24" ] }, "us-gaap_ConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleDebt", "crdr": "credit", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible notes balances", "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company." } } }, "auth_ref": [ "r10", "r93", "r658" ] }, "us-gaap_ConvertibleDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleDebtCurrent", "crdr": "credit", "calculation": { "http://lucyd.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Related party convertible debt", "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder." } } }, "auth_ref": [ "r56" ] }, "us-gaap_CostOfRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfRevenue", "crdr": "debit", "calculation": { "http://lucyd.com/role/StatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Cost of Goods Sold", "label": "Cost of Revenue", "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period." } } }, "auth_ref": [ "r68", "r146", "r197", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r322", "r634" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r26", "r193" ] }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentConvertibleConversionPrice1", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Conversion Price", "documentation": "The price per share of the conversion feature embedded in the debt instrument." } } }, "auth_ref": [ "r83", "r231" ] }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateDuringPeriod", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative", "http://lucyd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Interest rate", "documentation": "The average effective interest rate during the reporting period." } } }, "auth_ref": [ "r15", "r48", "r232" ] }, "us-gaap_DebtInstrumentMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentMaturityDate", "presentation": [ "http://lucyd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Maturity date", "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format." } } }, "auth_ref": [ "r108", "r500", "r644" ] }, "us-gaap_DebtSecuritiesRealizedGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtSecuritiesRealizedGainLoss", "crdr": "credit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Realized gain on debt securities (U.S. Treasury bills)", "label": "Debt Securities, Realized Gain (Loss)", "documentation": "Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity) and investment in debt security measured at fair value with change in fair value recognized in net income (trading)." } } }, "auth_ref": [ "r377", "r615", "r616" ] }, "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems", "presentation": [ "http://lucyd.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DeferredRevenueCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredRevenueCurrent", "crdr": "credit", "calculation": { "http://lucyd.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Deferred revenue", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r612" ] }, "us-gaap_DeferredRevenueNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredRevenueNoncurrent", "crdr": "credit", "calculation": { "http://lucyd.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Deferred revenue", "label": "Deferred Revenue, Noncurrent", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent." } } }, "auth_ref": [ "r613" ] }, "us-gaap_DeferredTaxAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsGross", "crdr": "debit", "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionDetails1" ], "lang": { "en-us": { "role": { "label": "Deferred tax assets Gross", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r292" ] }, "us-gaap_DeferredTaxAssetsGrossAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsGrossAbstract", "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionDetails1" ], "lang": { "en-us": { "role": { "label": "Deferred tax assets:" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsNet", "crdr": "debit", "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionDetails1" ], "lang": { "en-us": { "role": { "label": "Net deferred tax assets", "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r641" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic", "crdr": "debit", "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionDetails1" ], "lang": { "en-us": { "role": { "label": "Net operating losses \u2013 state", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards." } } }, "auth_ref": [ "r45", "r642" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign", "crdr": "debit", "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionDetails1" ], "lang": { "en-us": { "role": { "label": "Net operating losses \u2013 federal", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards." } } }, "auth_ref": [ "r45", "r642" ] }, "us-gaap_DeferredTaxAssetsOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsOther", "crdr": "debit", "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionDetails1" ], "lang": { "en-us": { "role": { "label": "Other \u2013 net", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other." } } }, "auth_ref": [ "r45", "r642" ] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "crdr": "debit", "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionDetails1" ], "lang": { "en-us": { "role": { "label": "Stock-based compensation", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation." } } }, "auth_ref": [ "r45", "r642" ] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionDetails1" ], "lang": { "en-us": { "role": { "negatedLabel": "Less Valuation Allowance", "label": "Deferred Tax Assets, Valuation Allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r293" ] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Depreciation expense", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r3", "r35" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r3", "r181" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r532" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r530", "r532", "r545" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r530", "r532", "r545", "r581" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r531" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r519" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r532" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r532" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r566" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r522" ] }, "LUCY_DueFromTekcapitalAndAffiliates": { "xbrltype": "monetaryItemType", "nsuri": "http://lucyd.com/20231231", "localname": "DueFromTekcapitalAndAffiliates", "crdr": "debit", "calculation": { "http://lucyd.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Due from Tekcapital and Affiliates" } } }, "auth_ref": [] }, "LUCY_DueToParentAndAffiliates": { "xbrltype": "monetaryItemType", "nsuri": "http://lucyd.com/20231231", "localname": "DueToParentAndAffiliates", "crdr": "credit", "calculation": { "http://lucyd.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Due to Tekcapital and Affiliates" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://lucyd.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Loss per share, basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r139", "r153", "r154", "r155", "r156", "r157", "r162", "r164", "r167", "r168", "r169", "r173", "r320", "r321", "r363", "r376", "r496" ] }, "us-gaap_EarningsPerShareBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasicAbstract", "presentation": [ "http://lucyd.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Basic and diluted:" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://lucyd.com/role/EarningsPerShareDetails", "http://lucyd.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Loss per share, diluted", "verboseLabel": "Basic and diluted net loss per common share", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r139", "r153", "r154", "r155", "r156", "r157", "r164", "r167", "r168", "r169", "r173", "r320", "r321", "r363", "r376", "r496" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://lucyd.com/role/EarningsPerShare" ], "lang": { "en-us": { "role": { "label": "EARNINGS PER SHARE", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r161", "r170", "r171", "r172" ] }, "LUCY_EmployeeMember": { "xbrltype": "domainItemType", "nsuri": "http://lucyd.com/20231231", "localname": "EmployeeMember", "presentation": [ "http://lucyd.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Employee [Member]" } } }, "auth_ref": [] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "crdr": "debit", "presentation": [ "http://lucyd.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unrecognized stock compensation expense", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement." } } }, "auth_ref": [ "r279" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://lucyd.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unrecognized stock compensation expense, term", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r279" ] }, "LUCY_EmployeesAndConsultants1Member": { "xbrltype": "domainItemType", "nsuri": "http://lucyd.com/20231231", "localname": "EmployeesAndConsultants1Member", "presentation": [ "http://lucyd.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Employees And Consultants 1 [Member]" } } }, "auth_ref": [] }, "LUCY_EmployeesAndConsultantsMember": { "xbrltype": "domainItemType", "nsuri": "http://lucyd.com/20231231", "localname": "EmployeesAndConsultantsMember", "presentation": [ "http://lucyd.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Employees And Consultants [Member]" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r525" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r521" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r521" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r609" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r521" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r606" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r545" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r521" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r521" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r521" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r521" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r607" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity", "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r6", "r111", "r134", "r135", "r136", "r148", "r149", "r150", "r152", "r158", "r160", "r174", "r198", "r199", "r248", "r280", "r281", "r282", "r297", "r298", "r312", "r313", "r314", "r315", "r316", "r317", "r319", "r323", "r324", "r325", "r326", "r327", "r328", "r332", "r380", "r381", "r382", "r398", "r464" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r574" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r537", "r549", "r559", "r585" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r534", "r546", "r556", "r582" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r580" ] }, "LUCY_ExerciseOfWarrantsByStockholdersShares": { "xbrltype": "sharesItemType", "nsuri": "http://lucyd.com/20231231", "localname": "ExerciseOfWarrantsByStockholdersShares", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Exercise of warrants by stockholders, shares" } } }, "auth_ref": [] }, "LUCY_ExercisesOfStockOptionsShares": { "xbrltype": "sharesItemType", "nsuri": "http://lucyd.com/20231231", "localname": "ExercisesOfStockOptionsShares", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Exercises of stock options, Shares" } } }, "auth_ref": [] }, "LUCY_ExercisesOfWarrantsByStockholders": { "xbrltype": "monetaryItemType", "nsuri": "http://lucyd.com/20231231", "localname": "ExercisesOfWarrantsByStockholders", "crdr": "debit", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Exercises of warrants by stockholders (see Note 8)" } } }, "auth_ref": [] }, "LUCY_ExercisesOfWarrantsRelatedToPrivatePlacementTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://lucyd.com/20231231", "localname": "ExercisesOfWarrantsRelatedToPrivatePlacementTransaction", "crdr": "debit", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Exercises of warrants related to private placement transaction (see Note 8)" } } }, "auth_ref": [] }, "LUCY_ExercisesOfWarrantsRelatedToPrivatePlacementTransactionShares": { "xbrltype": "sharesItemType", "nsuri": "http://lucyd.com/20231231", "localname": "ExercisesOfWarrantsRelatedToPrivatePlacementTransactionShares", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Exercises of warrants related to private placement transaction, shares" } } }, "auth_ref": [] }, "LUCY_ExpensesPaidByParentAndAffiliates": { "xbrltype": "monetaryItemType", "nsuri": "http://lucyd.com/20231231", "localname": "ExpensesPaidByParentAndAffiliates", "crdr": "debit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Expenses paid by Tekcapital and Affiliates" } } }, "auth_ref": [] }, "LUCY_ExpensesPaidForByParentReportedAsIncreaseInDueToParentAndAffiliatesAndRelatedPartyConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://lucyd.com/20231231", "localname": "ExpensesPaidForByParentReportedAsIncreaseInDueToParentAndAffiliatesAndRelatedPartyConvertibleDebt", "crdr": "credit", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Expenses paid for by Tekcapital and Affiliates, reported as increase in Due to/from Tekcapital and Affiliates and related party convertible debt" } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair Value of Financial Instruments", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r5", "r9" ] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "presentation": [ "http://lucyd.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Less: Accumulated amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r119", "r214" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "presentation": [ "http://lucyd.com/role/IntangibleAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Future amortization", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r80" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://lucyd.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r212", "r213", "r214", "r215", "r349", "r350" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "presentation": [ "http://lucyd.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Intangible assets, gross", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r79", "r350" ] }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://lucyd.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r349" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://lucyd.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r32", "r33" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "presentation": [ "http://lucyd.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Intangible assets, net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r79", "r349" ] }, "us-gaap_FiniteLivedPatentsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedPatentsGross", "crdr": "debit", "calculation": { "http://lucyd.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Patent costs, net", "documentation": "Gross carrying amount before accumulated amortization as of the balance sheet date of the costs pertaining to the exclusive legal rights granted to the owner of the patent to exploit an invention or a process for a period of time specified by law. Such costs may have been expended to directly apply and receive patent rights, or to acquire such rights." } } }, "auth_ref": [ "r79" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r541", "r553", "r563", "r589" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r541", "r553", "r563", "r589" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r541", "r553", "r563", "r589" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r541", "r553", "r563", "r589" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r541", "r553", "r563", "r589" ] }, "us-gaap_GainsLossesOnSalesOfAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainsLossesOnSalesOfAssets", "crdr": "credit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Loss on sale of assets", "label": "Gain (Loss) on Disposition of Assets for Financial Service Operations", "documentation": "Amount of gain (loss) on sale or disposal of assets utilized in financial service operations." } } }, "auth_ref": [] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://lucyd.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "General and administrative", "label": "General and Administrative Expense", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r69", "r443" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://lucyd.com/role/StatementsOfOperations": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Gross Deficit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r67", "r146", "r177", "r184", "r188", "r190", "r197", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r322", "r498", "r634" ] }, "us-gaap_IPOMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IPOMember", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative", "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "IPO [Member]", "documentation": "First sale of stock by a private company to the public." } } }, "auth_ref": [] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r530", "r532", "r545" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://lucyd.com/role/IncomeTaxProvision" ], "lang": { "en-us": { "role": { "label": "INCOME TAX PROVISION", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r147", "r284", "r289", "r290", "r295", "r299", "r301", "r302", "r303", "r393" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://lucyd.com/role/IncomeTaxProvisionDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r97", "r107", "r159", "r160", "r182", "r287", "r300", "r378" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Income Taxes", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r133", "r285", "r286", "r290", "r291", "r294", "r296", "r387" ] }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "crdr": "debit", "calculation": { "http://lucyd.com/role/IncomeTaxProvisionDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in valuation allowance", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets." } } }, "auth_ref": [ "r640" ] }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "crdr": "debit", "calculation": { "http://lucyd.com/role/IncomeTaxProvisionDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionDetails" ], "lang": { "en-us": { "role": { "label": "Income tax benefit at the statutory federal rate", "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r288" ] }, "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes", "crdr": "debit", "calculation": { "http://lucyd.com/role/IncomeTaxProvisionDetails": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionDetails" ], "lang": { "en-us": { "role": { "label": "State income tax benefits, net of federal benefit", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)." } } }, "auth_ref": [ "r640" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts payable and accrued expenses", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r2" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r2" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 13.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventory", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r2" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherCurrentAssets", "crdr": "credit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 14.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Other current assets", "label": "Increase (Decrease) in Other Current Assets", "documentation": "Amount of increase (decrease) in current assets classified as other." } } }, "auth_ref": [ "r618" ] }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidExpense", "crdr": "credit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses", "label": "Increase (Decrease) in Prepaid Expense", "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods." } } }, "auth_ref": [ "r2" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]" } } }, "auth_ref": [ "r544", "r553", "r563", "r580", "r589", "r593", "r601" ] }, "LUCY_InducementLetterMember": { "xbrltype": "domainItemType", "nsuri": "http://lucyd.com/20231231", "localname": "InducementLetterMember", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Inducement Letter [Member]" } } }, "auth_ref": [] }, "LUCY_InitialPublicOffering": { "xbrltype": "monetaryItemType", "nsuri": "http://lucyd.com/20231231", "localname": "InitialPublicOffering", "crdr": "debit", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Initial public offering (see Note 8)" } } }, "auth_ref": [] }, "LUCY_InitialPublicOfferingShares": { "xbrltype": "sharesItemType", "nsuri": "http://lucyd.com/20231231", "localname": "InitialPublicOfferingShares", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Initial public offering, shares" } } }, "auth_ref": [] }, "LUCY_InitisharesIssuedForConversionOfRelatedPartyConvertibleNoteShares": { "xbrltype": "sharesItemType", "nsuri": "http://lucyd.com/20231231", "localname": "InitisharesIssuedForConversionOfRelatedPartyConvertibleNoteShares", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "InitiShares issued for conversion of related party convertible note, shares" } } }, "auth_ref": [] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r599" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r533", "r605" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r533", "r605" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r533", "r605" ] }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsDisclosureTextBlock", "presentation": [ "http://lucyd.com/role/IntangibleAssets" ], "lang": { "en-us": { "role": { "label": "INTANGIBLE ASSETS", "documentation": "The entire disclosure for all or part of the information related to intangible assets." } } }, "auth_ref": [ "r211" ] }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsFiniteLivedPolicy", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Intangible Assets", "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets." } } }, "auth_ref": [ "r33", "r345", "r346", "r347", "r349", "r493" ] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://lucyd.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest Expense", "label": "Interest Expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r49", "r96", "r137", "r180", "r330", "r449", "r516", "r665" ] }, "LUCY_InternalUseSoftwareMember": { "xbrltype": "domainItemType", "nsuri": "http://lucyd.com/20231231", "localname": "InternalUseSoftwareMember", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "Internal Use Software [Member]" } } }, "auth_ref": [] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://lucyd.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Inventory", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r127", "r490", "r506" ] }, "us-gaap_InventoryPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryPolicyTextBlock", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Inventory", "label": "Inventory, Policy [Policy Text Block]", "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost." } } }, "auth_ref": [ "r98", "r115", "r126", "r206", "r207", "r208", "r344", "r494" ] }, "LUCY_InventoryPrepayment": { "xbrltype": "monetaryItemType", "nsuri": "http://lucyd.com/20231231", "localname": "InventoryPrepayment", "crdr": "debit", "calculation": { "http://lucyd.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://lucyd.com/role/BalanceSheets", "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Inventory prepayment" } } }, "auth_ref": [] }, "LUCY_IssuanceOfSharesFromConversionOfRelatedPartyConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://lucyd.com/20231231", "localname": "IssuanceOfSharesFromConversionOfRelatedPartyConvertibleDebt", "crdr": "credit", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Issuance of shares from conversion of related party convertible debt" } } }, "auth_ref": [] }, "LUCY_LegalMattersLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://lucyd.com/20231231", "localname": "LegalMattersLiability", "crdr": "credit", "presentation": [ "http://lucyd.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Legal matters liability" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://lucyd.com/role/CommitmentsAndContingenciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of future minimum payments due", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r646" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://lucyd.com/role/CommitmentsAndContingenciesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://lucyd.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Lessee, Operating Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r331" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "crdr": "credit", "calculation": { "http://lucyd.com/role/CommitmentsAndContingenciesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://lucyd.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Thereafter (through 2032)", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r331" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://lucyd.com/role/CommitmentsAndContingenciesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lucyd.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "2024", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r331" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "crdr": "credit", "calculation": { "http://lucyd.com/role/CommitmentsAndContingenciesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://lucyd.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "2028", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r331" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://lucyd.com/role/CommitmentsAndContingenciesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://lucyd.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "2027", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r331" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://lucyd.com/role/CommitmentsAndContingenciesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://lucyd.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "2026", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r331" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://lucyd.com/role/CommitmentsAndContingenciesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://lucyd.com/role/CommitmentsAndContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "2025", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r331" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://lucyd.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL LIABILITIES", "label": "Liabilities [Default Label]", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r12", "r146", "r197", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r307", "r310", "r311", "r322", "r418", "r497", "r518", "r634", "r649", "r650" ] }, "us-gaap_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAbstract", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://lucyd.com/role/BalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r63", "r94", "r370", "r506", "r620", "r631", "r645" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://lucyd.com/role/BalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r14", "r114", "r146", "r197", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r307", "r310", "r311", "r322", "r506", "r634", "r649", "r650" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesNoncurrentAbstract", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Non-Current Liabilities" } } }, "auth_ref": [] }, "us-gaap_LiabilityForUncertainTaxPositionsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForUncertainTaxPositionsCurrent", "crdr": "credit", "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Liabilities for uncertain tax positions", "documentation": "Amount recognized for uncertainty in income taxes classified as current." } } }, "auth_ref": [ "r13" ] }, "LUCY_ListedWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://lucyd.com/20231231", "localname": "ListedWarrantsMember", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Listed Warrants [Member]" } } }, "auth_ref": [] }, "us-gaap_LoansPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LoansPayable", "crdr": "credit", "presentation": [ "http://lucyd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Loans payable", "documentation": "Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer)." } } }, "auth_ref": [ "r10", "r93", "r658" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "LUCY_LucydMember": { "xbrltype": "domainItemType", "nsuri": "http://lucyd.com/20231231", "localname": "LucydMember", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative", "http://lucyd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lucyd [Member]" } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "auth_ref": [ "r193", "r502", "r637", "r660", "r661" ] }, "us-gaap_ManagementFeeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ManagementFeeExpense", "crdr": "debit", "calculation": { "http://lucyd.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative", "http://lucyd.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Related party management fee", "label": "Management fee", "documentation": "Amount of expense for investment management fee, including, but not limited to, expense in connection with research, selection, supervision, and custody of investment." } } }, "auth_ref": [ "r50", "r443", "r516", "r664" ] }, "LUCY_MaximMember": { "xbrltype": "domainItemType", "nsuri": "http://lucyd.com/20231231", "localname": "MaximMember", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Maxim [Member]" } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails1", "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "auth_ref": [ "r218", "r219", "r220", "r221", "r251", "r343", "r379", "r410", "r411", "r472", "r473", "r474", "r475", "r476", "r485", "r486", "r499", "r501", "r503", "r507", "r636", "r651", "r652", "r653", "r654", "r655", "r656" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]" } } }, "auth_ref": [ "r572" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure Name" } } }, "auth_ref": [ "r572" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails1", "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "auth_ref": [ "r218", "r219", "r220", "r221", "r251", "r343", "r379", "r410", "r411", "r472", "r473", "r474", "r475", "r476", "r485", "r486", "r499", "r501", "r503", "r507", "r636", "r651", "r652", "r653", "r654", "r655", "r656" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r592" ] }, "LUCY_MobileKioskDisplayMember": { "xbrltype": "domainItemType", "nsuri": "http://lucyd.com/20231231", "localname": "MobileKioskDisplayMember", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "Mobile Kiosk Display [Member]" } } }, "auth_ref": [] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r600" ] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "auth_ref": [ "r193", "r502", "r637", "r660", "r661" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r573" ] }, "us-gaap_NatureOfOperations": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NatureOfOperations", "presentation": [ "http://lucyd.com/role/GeneralInformation" ], "lang": { "en-us": { "role": { "label": "GENERAL INFORMATION", "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward." } } }, "auth_ref": [ "r99", "r109" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash flows from financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r142" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Financing Activities" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash flows from investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r142" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Investing Activities" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash flows from operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r74", "r75", "r76" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Operating Activities" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows", "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Net loss", "verboseLabel": "Net Loss", "terseLabel": "Net Income (Loss) Attributable to Parent", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r66", "r76", "r95", "r112", "r131", "r132", "r136", "r146", "r151", "r153", "r154", "r155", "r156", "r159", "r160", "r166", "r177", "r184", "r188", "r190", "r197", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r321", "r322", "r375", "r440", "r462", "r463", "r498", "r516", "r634" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Recently Issued Accounting Pronouncements", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "LUCY_NewWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://lucyd.com/20231231", "localname": "NewWarrantsMember", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "New Warrants [Member]" } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r572" ] }, "LUCY_NonManagementDirectorsMember": { "xbrltype": "domainItemType", "nsuri": "http://lucyd.com/20231231", "localname": "NonManagementDirectorsMember", "presentation": [ "http://lucyd.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Non Management Directors [Member]" } } }, "auth_ref": [] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r570" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r569" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r600" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r600" ] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://lucyd.com/role/StatementsOfOperations": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total Other Income (Expense), net", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r70" ] }, "LUCY_NumberOfCommonStockPurchased": { "xbrltype": "sharesItemType", "nsuri": "http://lucyd.com/20231231", "localname": "NumberOfCommonStockPurchased", "presentation": [ "http://lucyd.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of common stock purchased" } } }, "auth_ref": [] }, "LUCY_NumberOfOptionsPurchased": { "xbrltype": "sharesItemType", "nsuri": "http://lucyd.com/20231231", "localname": "NumberOfOptionsPurchased", "presentation": [ "http://lucyd.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of options purchased" } } }, "auth_ref": [] }, "LUCY_NumberOfWarrantExercised": { "xbrltype": "sharesItemType", "nsuri": "http://lucyd.com/20231231", "localname": "NumberOfWarrantExercised", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of warrant exercised" } } }, "auth_ref": [] }, "LUCY_NumberOfWarrantsPurchased": { "xbrltype": "sharesItemType", "nsuri": "http://lucyd.com/20231231", "localname": "NumberOfWarrantsPurchased", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of warrants purchased" } } }, "auth_ref": [] }, "us-gaap_OfficeEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OfficeEquipmentMember", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "Office Equipment [Member]", "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine." } } }, "auth_ref": [] }, "LUCY_OfficersAndManagement1Member": { "xbrltype": "domainItemType", "nsuri": "http://lucyd.com/20231231", "localname": "OfficersAndManagement1Member", "presentation": [ "http://lucyd.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Officers And Management 1 [Member]" } } }, "auth_ref": [] }, "LUCY_OfficersAndManagementMember": { "xbrltype": "domainItemType", "nsuri": "http://lucyd.com/20231231", "localname": "OfficersAndManagementMember", "presentation": [ "http://lucyd.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Officers And Management [Member]" } } }, "auth_ref": [] }, "us-gaap_OffsettingAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OffsettingAssetsLineItems", "presentation": [ "http://lucyd.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Offsetting Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_OffsettingAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OffsettingAssetsTable", "presentation": [ "http://lucyd.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Offsetting Assets [Table]", "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements." } } }, "auth_ref": [ "r64", "r65" ] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://lucyd.com/role/StatementsOfOperations": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total Operating Expenses", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpensesAbstract", "presentation": [ "http://lucyd.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Operating Expenses:" } } }, "auth_ref": [] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Federal net operating loss carryforwards", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r44" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsCurrent", "crdr": "debit", "calculation": { "http://lucyd.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other current assets", "documentation": "Amount of current assets classified as other." } } }, "auth_ref": [ "r129", "r506" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://lucyd.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other non-current assets", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r120" ] }, "us-gaap_OtherNoncashExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncashExpense", "crdr": "debit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Non-cash interest expense", "documentation": "Amount of expense or loss included in net income that result in no cash flow, classified as other." } } }, "auth_ref": [ "r76" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://lucyd.com/role/StatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Other Income (Expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r71" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure Amount" } } }, "auth_ref": [ "r572" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r532" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r539", "r551", "r561", "r587" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r542", "r554", "r564", "r590" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r542", "r554", "r564", "r590" ] }, "us-gaap_PatentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PatentsMember", "presentation": [ "http://lucyd.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Patents [Member]", "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law." } } }, "auth_ref": [ "r91" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "auth_ref": [ "r568" ] }, "LUCY_PaymentToAcquirePatentCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://lucyd.com/20231231", "localname": "PaymentToAcquirePatentCosts", "crdr": "credit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Patent costs", "label": "PaymentToAcquirePatentCosts" } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireIntangibleAssets", "crdr": "credit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Capitalized software expenditures", "label": "Payments to Acquire Intangible Assets", "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill." } } }, "auth_ref": [ "r73" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of property and equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r73" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r571" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r571" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r570" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name" } } }, "auth_ref": [ "r573" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r569" ] }, "LUCY_PlacemenAgentWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://lucyd.com/20231231", "localname": "PlacemenAgentWarrantsMember", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Placemen Agent Warrants [Member]" } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r526" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r527" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock , shares authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r57", "r420" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock , shares issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r57", "r234" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred stock, shares Outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r57", "r420", "r438", "r666", "r667" ] }, "us-gaap_PrepaidExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseCurrent", "crdr": "debit", "calculation": { "http://lucyd.com/role/BalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Prepaid expenses", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r128", "r209", "r210", "r491" ] }, "LUCY_PrivateWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://lucyd.com/20231231", "localname": "PrivateWarrantsMember", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Private Warrants [Member]" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromConvertibleDebt", "crdr": "debit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative", "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from related party convertible debt (see Note 6)", "verboseLabel": "Convertible debt issued", "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder." } } }, "auth_ref": [ "r18" ] }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceInitialPublicOffering", "crdr": "debit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows", "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from initial public offering (see Note 8)", "verboseLabel": "Proceeds from offering", "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public." } } }, "auth_ref": [ "r1" ] }, "LUCY_ProceedsFromRedemptionOfDebtSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://lucyd.com/20231231", "localname": "ProceedsFromRedemptionOfDebtSecurities", "crdr": "credit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Proceeds from redemption of debt securities (U.S. Treasury bills)", "label": "ProceedsFromRedemptionOfDebtSecurities" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from sale of property and equipment", "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r72" ] }, "LUCY_ProceedsFromSecondPublicOffering": { "xbrltype": "monetaryItemType", "nsuri": "http://lucyd.com/20231231", "localname": "ProceedsFromSecondPublicOffering", "crdr": "debit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from second public offering (see Note 8)" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromStockOptionsExercised", "crdr": "debit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from exercise of stock options", "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement." } } }, "auth_ref": [ "r1", "r8" ] }, "us-gaap_ProceedsFromWarrantExercises": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromWarrantExercises", "crdr": "debit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows", "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from exercises of warrants (see Note 8)", "verboseLabel": "Cash proceeds", "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants." } } }, "auth_ref": [ "r617" ] }, "us-gaap_ProductInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductInformationLineItems", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Product Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://lucyd.com/role/StatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://lucyd.com/role/EarningsPerShareDetails", "http://lucyd.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Net Loss", "verboseLabel": "Net loss", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r112", "r131", "r132", "r141", "r146", "r151", "r159", "r160", "r177", "r184", "r188", "r190", "r197", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r305", "r308", "r309", "r321", "r322", "r364", "r374", "r397", "r440", "r462", "r463", "r498", "r504", "r505", "r517", "r614", "r634" ] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r4" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "Property and equipment, gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r81", "r117", "r373" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://lucyd.com/role/BalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://lucyd.com/role/BalanceSheets", "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "Property and equipment, net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r4", "r365", "r373", "r506" ] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Property and Equipment", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r4", "r103", "r106", "r371" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r81" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Useful Life", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "us-gaap_ProvisionForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProvisionForDoubtfulAccounts", "crdr": "debit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "(Recovery of) provision for doubtful accounts", "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable." } } }, "auth_ref": [ "r140", "r202" ] }, "LUCY_PurchasesOfDebtSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://lucyd.com/20231231", "localname": "PurchasesOfDebtSecurities", "crdr": "credit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of debt securities (U.S. Treasury bills)", "label": "PurchasesOfDebtSecurities" } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r568" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r568" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails1", "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r218", "r219", "r220", "r221", "r249", "r251", "r275", "r276", "r277", "r342", "r343", "r379", "r410", "r411", "r472", "r473", "r474", "r475", "r476", "r485", "r486", "r499", "r501", "r503", "r507", "r510", "r632", "r636", "r652", "r653", "r654", "r655", "r656" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails1", "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "auth_ref": [ "r218", "r219", "r220", "r221", "r249", "r251", "r275", "r276", "r277", "r342", "r343", "r379", "r410", "r411", "r472", "r473", "r474", "r475", "r476", "r485", "r486", "r499", "r501", "r503", "r507", "r510", "r632", "r636", "r652", "r653", "r654", "r655", "r656" ] }, "us-gaap_ReceivablesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReceivablesPolicyTextBlock", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Receivables and Credit Policy", "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable." } } }, "auth_ref": [ "r627", "r628", "r629", "r630" ] }, "LUCY_RecentlyAdoptedAccountingPronouncementsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://lucyd.com/20231231", "localname": "RecentlyAdoptedAccountingPronouncementsPolicyTextBlock", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Recently Adopted Accounting Pronouncements" } } }, "auth_ref": [] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "auth_ref": [ "r534", "r546", "r556", "r582" ] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative", "http://lucyd.com/role/StockholdersEquityDetailsNarrative", "http://lucyd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r250", "r336", "r337", "r413", "r414", "r415", "r416", "r417", "r437", "r439", "r471" ] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r444", "r445", "r448" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative", "http://lucyd.com/role/StockholdersEquityDetailsNarrative", "http://lucyd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r250", "r336", "r337", "r351", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r413", "r414", "r415", "r416", "r417", "r437", "r439", "r471", "r648" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "label": "RELATED PARTY TRANSACTIONS", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r333", "r334", "r335", "r337", "r338", "r394", "r395", "r396", "r446", "r447", "r448", "r468", "r470" ] }, "LUCY_RentExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://lucyd.com/20231231", "localname": "RentExpenses", "crdr": "credit", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Rent expenses" } } }, "auth_ref": [] }, "LUCY_RepaymentOfAmountsDueToTekcapitalAndAffiliates": { "xbrltype": "monetaryItemType", "nsuri": "http://lucyd.com/20231231", "localname": "RepaymentOfAmountsDueToTekcapitalAndAffiliates", "crdr": "credit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment of amounts due to Tekcapital and Affiliates", "label": "RepaymentOfAmountsDueToTekcapitalAndAffiliates" } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfConvertibleDebt", "crdr": "credit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment of related party convertible debt (see Note 6)", "label": "Repayments of Convertible Debt", "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder." } } }, "auth_ref": [ "r19" ] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://lucyd.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Research and development", "label": "Research and Development Expense", "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use." } } }, "auth_ref": [ "r54", "r283", "r657" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r535", "r547", "r557", "r583" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date" } } }, "auth_ref": [ "r536", "r548", "r558", "r584" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r543", "r555", "r565", "r591" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://lucyd.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "LUCY_RestrictedStockUnitsVestedDescription": { "xbrltype": "stringItemType", "nsuri": "http://lucyd.com/20231231", "localname": "RestrictedStockUnitsVestedDescription", "presentation": [ "http://lucyd.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted stock units vested description" } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://lucyd.com/role/BalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r60", "r85", "r369", "r383", "r384", "r392", "r421", "r506" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r111", "r148", "r149", "r150", "r152", "r158", "r160", "r198", "r199", "r280", "r281", "r282", "r297", "r298", "r312", "r314", "r315", "r317", "r319", "r380", "r382", "r398", "r666" ] }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRecognitionPolicyTextBlock", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue Recognition", "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources." } } }, "auth_ref": [ "r442", "r488", "r495" ] }, "LUCY_RevenueRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://lucyd.com/20231231", "localname": "RevenueRecognized", "crdr": "credit", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Revenue recognized" } } }, "auth_ref": [] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Revenues", "crdr": "credit", "calculation": { "http://lucyd.com/role/StatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Revenues, net", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r138", "r146", "r178", "r179", "r183", "r186", "r187", "r191", "r192", "r193", "r197", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r322", "r364", "r634" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r600" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r600" ] }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockConsiderationReceivedOnTransaction", "crdr": "debit", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Sale of transaction", "documentation": "Cash received on stock transaction after deduction of issuance costs." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative", "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Issauance of common stock", "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionTables" ], "lang": { "en-us": { "role": { "label": "Schedule of deferred tax assets", "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years." } } }, "auth_ref": [ "r90" ] }, "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable", "presentation": [ "http://lucyd.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]", "documentation": "Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits, with individual employees. The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability." } } }, "auth_ref": [ "r37", "r86" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://lucyd.com/role/EarningsPerShareTables" ], "lang": { "en-us": { "role": { "label": "Calculation of net earnings per common share - basic and diluted", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r625" ] }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionTables" ], "lang": { "en-us": { "role": { "label": "Schedule of reconciliation of federal statutory tax rate", "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r89" ] }, "LUCY_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentNetTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://lucyd.com/20231231", "localname": "ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentNetTableTextBlock", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of estimated useful lives of property and equipment" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "presentation": [ "http://lucyd.com/role/IntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Finite-Lived Intangible Assets [Table]", "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r32", "r33", "r349" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://lucyd.com/role/IntangibleAssetsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of intangible assets", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r32", "r33" ] }, "us-gaap_ScheduleOfProductInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfProductInformationTable", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Product Information [Table]", "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r4" ] }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Schedule of Related Party Transactions, by Related Party [Table]", "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r50", "r51", "r444", "r445", "r448" ] }, "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockholdersEquityTableTextBlock", "presentation": [ "http://lucyd.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of stockholder\u2019s equity", "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented." } } }, "auth_ref": [ "r6" ] }, "LUCY_SecondPublicOffering": { "xbrltype": "monetaryItemType", "nsuri": "http://lucyd.com/20231231", "localname": "SecondPublicOffering", "crdr": "debit", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Second public offering (see Note 8)" } } }, "auth_ref": [] }, "LUCY_SecondPublicOfferingShares": { "xbrltype": "sharesItemType", "nsuri": "http://lucyd.com/20231231", "localname": "SecondPublicOfferingShares", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Second public offering, shares" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r520" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r524" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r523" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r528" ] }, "us-gaap_SellingAndMarketingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingAndMarketingExpense", "crdr": "debit", "calculation": { "http://lucyd.com/role/StatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Sales and marketing", "label": "Selling and Marketing Expense", "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services." } } }, "auth_ref": [] }, "LUCY_SettlementAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://lucyd.com/20231231", "localname": "SettlementAgreementMember", "presentation": [ "http://lucyd.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Settlement Agreement [Member]" } } }, "auth_ref": [] }, "LUCY_SettlementAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://lucyd.com/20231231", "localname": "SettlementAmount", "crdr": "debit", "presentation": [ "http://lucyd.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Settlement amount" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://lucyd.com/role/StatementsOfCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows", "http://lucyd.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock-based compensation expense", "verboseLabel": "Stock-based compensation", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r2" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://lucyd.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of restricted stock units granted", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r267" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails1" ], "lang": { "en-us": { "role": { "label": "Expected dividend yield", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r276" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails1" ], "lang": { "en-us": { "role": { "label": "Expected volatility", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r275" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails1" ], "lang": { "en-us": { "role": { "label": "Risk free rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r277" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Option Exercisable", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r258" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Weighted avaerage exercise price per share, Option Exercisable", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r258" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Weighted avaerage exercise price per share, Option Forfeited", "documentation": "Weighted average price of options that were either forfeited or expired." } } }, "auth_ref": [ "r638" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Option Forfeited", "negatedLabel": "Option Forfeited", "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan." } } }, "auth_ref": [ "r262" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Option Granted", "documentation": "Net number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r639" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://lucyd.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock granted", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r260" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://lucyd.com/role/Stock-basedCompensationDetailsNarrative", "http://lucyd.com/role/StockBasedCompensationDetails1" ], "lang": { "en-us": { "role": { "label": "Grant date fair value of options", "verboseLabel": "Weighted average grant date fair value of options outstanding", "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r270" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock", "presentation": [ "http://lucyd.com/role/Stock-basedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Schedule fair value of options granted", "documentation": "Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year." } } }, "auth_ref": [ "r41" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://lucyd.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Options outstanding intrinsic value", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r39" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Option Outstanding at beginnig", "periodEndLabel": "Option Outstanding at ending", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r256", "r257" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice", "presentation": [ "http://lucyd.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Exercise price", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Period Increase (Decrease), Weighted Average Exercise Price", "documentation": "Change in the weighted average exercise price of options outstanding." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted avaerage exercise price per share, Option Outstanding at beginnig", "periodEndLabel": "Weighted avaerage exercise price per share, Option Outstanding at ending", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r256", "r257" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAndExercisableTableTextBlock", "presentation": [ "http://lucyd.com/role/Stock-basedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Schedule of number of share options and the weighted average exercise price outstanding", "documentation": "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding and exercisable options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r7" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://lucyd.com/role/Stock-basedCompensationDetailsNarrative", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Weighted avaerage exercise price per share, Option Exercised", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r261" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Weighted avaerage exercise price per share, Option Granted", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r260" ] }, "us-gaap_SharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharePrice", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails1", "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share Price", "verboseLabel": "Share price at date of grant", "documentation": "Price of a single share of a number of saleable stocks of a company." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails1" ], "lang": { "en-us": { "role": { "label": "Options life in years", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r274" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "crdr": "debit", "presentation": [ "http://lucyd.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Options exercisable intrinsic value", "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable." } } }, "auth_ref": [ "r39" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Weighted avaerage remaining contractual life (Years), Option Exercisable", "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r39" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Weighted avaerage remaining contractual life (Years)", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r88" ] }, "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock", "presentation": [ "http://lucyd.com/role/Stock-basedCompensation" ], "lang": { "en-us": { "role": { "label": "STOCK-BASED COMPENSATION", "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP)." } } }, "auth_ref": [ "r84", "r87" ] }, "LUCY_SharesIssuedForConversionOfRelatedPartyConvertibleNote": { "xbrltype": "monetaryItemType", "nsuri": "http://lucyd.com/20231231", "localname": "SharesIssuedForConversionOfRelatedPartyConvertibleNote", "crdr": "debit", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Shares issued for conversion of related party convertible note (see Note 6)" } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginnig balance, shares", "periodEndLabel": "Ending balance, shares", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "LUCY_ShippingAndHandlingsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://lucyd.com/20231231", "localname": "ShippingAndHandlingsPolicyTextBlock", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Shipping and Handling" } } }, "auth_ref": [] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r77", "r144" ] }, "LUCY_SingleCustomerMember": { "xbrltype": "domainItemType", "nsuri": "http://lucyd.com/20231231", "localname": "SingleCustomerMember", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Single Customer [Member]" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r529" ] }, "LUCY_StateNetOperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://lucyd.com/20231231", "localname": "StateNetOperatingLossCarryforwards", "crdr": "credit", "presentation": [ "http://lucyd.com/role/IncomeTaxProvisionDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "State net operating loss carryforwards" } } }, "auth_ref": [] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r110", "r122", "r123", "r124", "r146", "r164", "r165", "r167", "r169", "r175", "r176", "r197", "r222", "r224", "r225", "r226", "r229", "r230", "r234", "r235", "r237", "r240", "r246", "r322", "r388", "r389", "r390", "r391", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r420", "r441", "r464", "r477", "r478", "r479", "r480", "r481", "r610", "r619", "r624" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity", "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r6", "r17", "r111", "r134", "r135", "r136", "r148", "r149", "r150", "r152", "r158", "r160", "r174", "r198", "r199", "r248", "r280", "r281", "r282", "r297", "r298", "r312", "r313", "r314", "r315", "r316", "r317", "r319", "r323", "r324", "r325", "r326", "r327", "r328", "r332", "r380", "r381", "r382", "r398", "r464" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://lucyd.com/role/Cover", "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity", "http://lucyd.com/role/StockBasedCompensationDetails1" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r148", "r149", "r150", "r174", "r348", "r386", "r409", "r412", "r413", "r414", "r415", "r416", "r417", "r420", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r433", "r434", "r435", "r436", "r437", "r439", "r442", "r443", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r464", "r511" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://lucyd.com/role/Cover", "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity", "http://lucyd.com/role/StockBasedCompensationDetails1" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r148", "r149", "r150", "r174", "r348", "r386", "r409", "r412", "r413", "r414", "r415", "r416", "r417", "r420", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r433", "r434", "r435", "r436", "r437", "r439", "r442", "r443", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r464", "r511" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r538", "r550", "r560", "r586" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://lucyd.com/role/StockBasedCompensationDetails" ], "lang": { "en-us": { "role": { "label": "Option Exercised", "negatedLabel": "Option Exercised", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r6", "r57", "r58", "r85", "r261" ] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://lucyd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of stock issued", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r6", "r57", "r58", "r85", "r398", "r464", "r478", "r517" ] }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "crdr": "credit", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Exercises of stock options", "documentation": "Value of stock issued as a result of the exercise of stock options." } } }, "auth_ref": [ "r6", "r17", "r85" ] }, "LUCY_StockSubscriptionReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://lucyd.com/20231231", "localname": "StockSubscriptionReceivableMember", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock Subscription Receivable [Member]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://lucyd.com/role/BalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://lucyd.com/role/BalanceSheets", "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL STOCKHOLDERS\u2019 EQUITY", "periodStartLabel": "Beginning balance, value", "periodEndLabel": "Ending balance, value", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r58", "r61", "r62", "r78", "r422", "r438", "r465", "r466", "r506", "r518", "r620", "r631", "r645", "r666" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://lucyd.com/role/BalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 Equity" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://lucyd.com/role/StockholdersEquity" ], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS\u2019 EQUITY", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r84", "r145", "r233", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r248", "r318", "r467", "r469", "r482" ] }, "us-gaap_StraightLineRent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StraightLineRent", "crdr": "credit", "presentation": [ "http://lucyd.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Straight line basis", "documentation": "Difference between actual rental income due and rental income recognized on a straight-line basis." } } }, "auth_ref": [ "r2" ] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventLineItems", "presentation": [ "http://lucyd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r329", "r340" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://lucyd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r329", "r340" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTable", "presentation": [ "http://lucyd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Table]", "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued." } } }, "auth_ref": [ "r329", "r340" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://lucyd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r329", "r340" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://lucyd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r329", "r340" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsPolicyPolicyTextBlock", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Subsequent Events", "documentation": "Disclosure of accounting policy for reporting subsequent events." } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://lucyd.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r339", "r341" ] }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]", "documentation": "Different names of stock transactions and the different attributes of each transaction." } } }, "auth_ref": [] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative", "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "us-gaap_SubsidiarySaleOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiarySaleOfStockLineItems", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsidiary, Sale of Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "presentation": [ "http://lucyd.com/role/GoingConcern" ], "lang": { "en-us": { "role": { "label": "GOING CONCERN", "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern." } } }, "auth_ref": [ "r55" ] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r579" ] }, "LUCY_TekcapitalAndAffiliatesMember": { "xbrltype": "domainItemType", "nsuri": "http://lucyd.com/20231231", "localname": "TekcapitalAndAffiliatesMember", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Tekcapital And Affiliates [Member]" } } }, "auth_ref": [] }, "LUCY_TekcapitalEuropeLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://lucyd.com/20231231", "localname": "TekcapitalEuropeLtdMember", "presentation": [ "http://lucyd.com/role/RelatedPartyTransactionsDetailsNarrative", "http://lucyd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Tekcapital Europe Ltd [Member]" } } }, "auth_ref": [] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualAxis", "presentation": [ "http://lucyd.com/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "auth_ref": [ "r626", "r647" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://lucyd.com/role/Stock-basedCompensationDetailsNarrative" ], "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r571" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r578" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_TransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransactionDomain", "presentation": [ "http://lucyd.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "Agreement between buyer and seller for the exchange of financial instruments." } } }, "auth_ref": [ "r492" ] }, "us-gaap_TransactionTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransactionTypeAxis", "presentation": [ "http://lucyd.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Transaction Type [Axis]", "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments." } } }, "auth_ref": [ "r492" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Adoption Date" } } }, "auth_ref": [ "r602" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Arrangement Duration" } } }, "auth_ref": [ "r603" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Name" } } }, "auth_ref": [ "r601" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Title" } } }, "auth_ref": [ "r601" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Aggregate Available" } } }, "auth_ref": [ "r604" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Termination Date" } } }, "auth_ref": [ "r602" ] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfArrangementAxis", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r304" ] }, "LUCY_UnderwriterWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://lucyd.com/20231231", "localname": "UnderwriterWarrantsMember", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Underwriter Warrants [Member]" } } }, "auth_ref": [] }, "LUCY_UnderwritersDescription": { "xbrltype": "stringItemType", "nsuri": "http://lucyd.com/20231231", "localname": "UnderwritersDescription", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Underwriters description" } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r598" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://lucyd.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r28", "r29", "r30", "r100", "r101", "r104", "r105" ] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantMember", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant [Member]", "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount." } } }, "auth_ref": [ "r508", "r509", "r512", "r513", "r514", "r515" ] }, "us-gaap_WarrantsAndRightsOutstandingMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantsAndRightsOutstandingMaturityDate", "presentation": [ "http://lucyd.com/role/StockholdersEquityDetails" ], "lang": { "en-us": { "role": { "label": "Expiration Date", "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format." } } }, "auth_ref": [ "r644" ] }, "LUCY_WarrantsToPurchaseCommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://lucyd.com/20231231", "localname": "WarrantsToPurchaseCommonStockMember", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Warrants to purchase Common Stock" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://lucyd.com/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted-average number of common shares", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r163", "r169" ] }, "LUCY_WeightedAverageNumberOfSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://lucyd.com/20231231", "localname": "WeightedAverageNumberOfSharesOutstanding", "presentation": [ "http://lucyd.com/role/StatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Weighted average number of shares outstanding" } } }, "auth_ref": [] }, "LUCY_WriteoffOfUncollectibleStockSubscriptionReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://lucyd.com/20231231", "localname": "WriteoffOfUncollectibleStockSubscriptionReceivable", "crdr": "debit", "presentation": [ "http://lucyd.com/role/StatementsOfChangesInStockholdersEquity" ], "lang": { "en-us": { "role": { "label": "Write-off of uncollectible stock subscription receivable" } } }, "auth_ref": [] }, "LUCY_WriteoffOfUncollectibleStockSubscriptionReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://lucyd.com/20231231", "localname": "WriteoffOfUncollectibleStockSubscriptionReceivables", "crdr": "debit", "presentation": [ "http://lucyd.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Write-off of uncollectible stock subscription receivable", "label": "WriteoffOfUncollectibleStockSubscriptionReceivables" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://lucyd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r608" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "60", "Paragraph": "1", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "710", "SubTopic": "10", "Section": "25", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483070/710-10-25-11" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(b),(f(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "825", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "985", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "40", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205-40/tableOfContent" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-4" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-5" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "710", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483043/710-10-30-1" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "12", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "9", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "270", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-6" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(2))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//330/tableOfContent" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-1" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483080/330-10-50-4" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350-30/tableOfContent" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "330", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482105/912-330-50-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483256/920-350-50-4" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(3)(d)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r489": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r490": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r491": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r492": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r493": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r494": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r495": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r496": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r497": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r498": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r499": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r500": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r501": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r502": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r503": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r504": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r505": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r506": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r507": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r508": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r509": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r510": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r511": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r512": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r514": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r515": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r516": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r517": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r518": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r519": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r520": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r521": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r522": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r523": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r524": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r525": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r526": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r527": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r528": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r529": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r530": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r531": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r532": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r533": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r534": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r535": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r536": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r537": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r538": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r539": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r540": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r541": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r542": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r543": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r544": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r545": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r546": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r547": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r548": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r549": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r550": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r551": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r552": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r553": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r554": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r555": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r556": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r557": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r558": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r559": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r560": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r561": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r562": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r563": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r564": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r565": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r566": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r567": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r568": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r569": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r570": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r571": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r572": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r573": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r574": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r575": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r576": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r577": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r578": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r579": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r580": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r581": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r582": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r583": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r584": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r585": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r586": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r587": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r588": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r589": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r590": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r591": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r592": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r593": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r594": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r595": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r596": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r597": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r598": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r599": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r600": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r601": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r602": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r603": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r604": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r605": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r606": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r607": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r608": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r609": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r610": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r611": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r612": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r613": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r614": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r615": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r616": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(9)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r617": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r618": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r619": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r620": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r621": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r622": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r623": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r624": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r625": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r626": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13" }, "r627": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2" }, "r628": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1" }, "r629": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-2" }, "r630": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-4" }, "r631": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r632": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r633": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r634": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r635": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r636": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r637": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r638": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r639": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r640": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r641": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2" }, "r642": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6" }, "r643": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r644": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r645": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r646": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r647": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r648": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r649": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r650": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r651": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r652": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r653": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r654": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r655": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r656": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r657": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1" }, "r658": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r659": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r660": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r661": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r662": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r663": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r664": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r665": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r666": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r667": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 74 0001829126-24-001847-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001829126-24-001847-xbrl.zip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�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�,JH00I9VZI%5"_#><"*1%.#U:< MN+"1\^A5@4M+EX)+)4IU<'7WHG?*L%3%NI9(7#M?D6?#-K$%R>LYK#?718O[ M=14P?N@ZZ114@R'RISI!]D)*V!%\E_D[%MN:V]!4AK@:'WFLGC49G8(E@$Z% M,[I("&KTF"F*?(+TL9-KFK ,B)EY> "3 B 7(3N1]9$T>]N]#6=_=CY8[!#% M2^JU:M9P'AOR%EI_*O#@CYMQ/]YGW(.,^^4^X_Y[WMH_<&LIK?MVWKFX%#MS M3;_&(2>+XT99")=%LX26YK0UJ_';N?106S/*1VO02FY[96:W]6^Z57XA@'ER M>9Y7O:Q0N/$A!W^"9A7\&BY8"Z*_E0;[KG*8R.8PBWLYQ@7G=/GNW-.@.S+R<%;@%F( -!E>B+HF9X=' M?SK7"25'Y_XI'":)UL%CN-3[9O"GWO^84L;) M/PO(>"]4:SK=NS7&P6L)91A';& 22]P6_%PRT&>TR(QSTYH+9I&'KI&M,PH3?F.V?8@G?/U'9@?72UE"2J\?\R2"5)"%H7S;9_8T8[,X M=5K(V]/.(I]5'!) ,$^W??%N!*"5@,KEA.9OFF MV\S_WTOH#+]%"970W# MK-HPRR!4Q2%;LR]/#R$S I,:X&A<=FE;_1;_>UXNEQQ+G_.-AB1L,RT]2Z6" M7ZPL/*SZDI\XWF135.(^0"<$]ZW/:(16OP_6IU%^([4;&QE,@V0:(E.[#M0! M*',W3MH+!H+=PFQPI6J!U?@_/ZJNU BYT..64^'??71\>25]6PIX/Q8.PO<9 M2057INRSNEPM[+,Q<-7]\5*[L::OYX6 )3@4%,VT0M+(BE'4I+;9J^-G(F4R MEFHJ'B"V*=L FOGCXSA>NMP1*GA((&8]^%04_,;\+BXW9G<->#UON%+CV[YP^2O M.DGI#3 C5R:#&-U3YS2B-QH(U,E0\O&WG]4F!M*2+C87_RD;,_)_OL3Y#] M>;K/_OQN6O*?AZ\.@_J[HOZE64MJ_Y^O7K[2H-X4YP_.<\^=2O@4SC+PWR1T MG2 1LO94)RY*A8-&KVPS;B^;2@<$U@W6'24?TRF'($4PM:%1=V>+E(H[P+-H MZ,'(1?\@=-\Z5+AWD,"X-#1HR!WC6NRNW[1M9@4-TZP8U8,6L3?O/7FLC4"< MVAY>&H,"D2>.];DM @O)C5+@9/Q!0- K/ NF5;-?#= 0W\F"@<"5S8Z6N!P, MW>,K34PS*,?=N+Q?C&*Q6:*L"H!KT6)8B[]/.%,6F(T>MC*$<9-YN2K,4"7) M67$*27L!_@L,^=P\C7U(*;6UT;A'#@7++D.ZH[2,@3NBQ=OHS6I/Q9Q\.S84 MOPXZ5QE,"DJJX"YED=58WX?C=OY 05[$_VBJ7 :5O**MW1F_S(:N(%=(I1,, MR;QV'&+E/(%42T__M2K;PH.D4H=O33WAAC+9(/^:.W=I-S84^MN.I>A[Z"'A MSZL=964@NKX00WQ*MV9L#CXNG[C(D'PRITLVT>@32+@D5(?/M.<,-"P:)K'^ MO(&EY7O:=18"1\$\Z0;NZ@B@$;W^<4GOH@M&RA"DJZ5%H(15EOD!NEZ^2U\V M3YJN/,"=FM9N%.ZP,V+$XHD_NC@!YK6?^Q'TD@Y7L[R\;O#MN+SJ\ 5C:9Z5&H=A@CX&N9(=K>9V3T^^3(Y2([/O\2/ @M%ST"8$+J] M_P T_N6/BS?0&-H>.* HH]V1#7 1:6&]VKAC0(!0H0",(]7P?4$S3T(+QX,# M\;T+%_IDN9HZ=F86Y:]IT!0M1#(YOC2?_ Z^ZBT>+^\+W_+']2BV4\2?.[AI M@1?OQCZ NTNZJ-Q&.R(YE)%]:6K9"HDU( K$:*"\T'"1A2G0:92[O/A(4EE+ M6A&U%H,_<3IS.D?>)1\^(OR]&+>:'IJ ]<6A/@1@)B P2>?Z#]Q_/PZMZ2?. MZGWM\RL#5%28SXX-SQL QW-R2&K-F_ M99"C@58,D%)D=41WAB3&@UHGC_9=0'#K0:7W"7K]@TY-.F7*$X^Z'I%OR$=$$]A?V-LG&<"Y"%&,0 4M,)S4K! M=(H,^PT='\YIE+7)CL+;"PY5DH_%T[&T @]+KS3GD:+&2-"#B,^-M&H5X'MJJBA[G$U7&[HBFC;!G/W><<;7,0 M,#%4G#V(4?GD47$\#I8/N,<[.0XT34A6KB:LSFY87LKY\@+\P'AHV\M">X8S MFE#><*A6C3[.,5T\BXP4H&C8E%P)\,(@IT);"OXVZS"N4Q M'HNR>3=N'ERE-OPZ./2!!=.5B[+*_"@%:!\?)Z'C_'>"4.C+% ;TQ?N-D6 M(AJ&=:('+NFXNCA?1#SIR"QI2^(6Q0JS](RLV$.F>6'X!(D)E[P"D.ROOICP M8)YU;C1\B93_9I_%TP*Y!*CQ=\)A*EP]!5 \Q2TJL:0WTSJ\WCN+T&S%9Z]: M@R,'/*Y\#[:LNM) BCU2LXBB!"-ABSF[8:[?K+@IX_?OO_S M?X>%#D'ULX5G)'/G:QVZ5!N\=O/FM@N/F+"C,WW6_ECMC]5G<*P-#,9G![@"@ 8VB$M/ZY>&,LF#_^^)S)GO?'9'],/H=C MHJ'C(7N)NX+L()'?"T3/",-)P)@X*S(IM L[9G@Z%4;IA$]@@([WID?09Z[" MPZ-V!D/ #_Y[W4X2!@E7"0>5$8KB4XX75P9@8@-#-5C-0+OK!_J)%7 M2>FQ_C^,.B6EEPM-+-#!C"/_9=6675Y.':F'1S$T M-8<*?6E[EF-PVD@=Y4\ " M9,Y^953$SN!RT)UZM'9Y=^J6_Y=NFB[Y[HYNTHY@WVAI$*-U1/O8W/'*?O<[ MTI!-&_WJPQP\L3N'QN70^'SPZ[;:EY$=.C0VA^:-).'2.AA\$= MW#(L&+^L\K%TIY_]B!UVO\>./X+FA_:^__'%B5NMT63OL4_VWG/ $#;I7/[G M2?NGOVP*COP94O>;S^K#+,PGN'V?B02<[,C"["7@81+P?([XA6RSUKC+ ,BT MEK^N[Z\E^/K9"\L[C-)YE&^[LK[F.--U"S#; 3-Y?I6TUY/')T=GZP'1X?'$G.P@2+>@$B$_EGOT;/C+S?#$E_\16E5.G:X1N=O]_"7 M=ZZ2^];82Q[=]9.K+T>B-E_\Y3@]/C])SRZO'OZZ^PSSW2?S]M^=;9G1T='# MW_;E73\Y^M*4/>9CNZ>/C].3R.'UZ-*YT1N_FS3$]^4W6XIXO>Y\GF%XZ'M=+ M]QS!N(;:N:V_/+Y(CRXO_U ;?S1N[ORQ-O[\_#R]/!V_U-YKX\?T_V\B#.]] MV[W34^W>>X!N_&@WX&_FQ9Q>\I_?XL?=<3]*E=:WQ:RSLBS?^LS>V']O''-MVO?; MKS]06]U3,?V60_@T') MT;@O1BK4OMH9*=J/;3^VO=;Z]+36^UE0VS357[5@ MCYF1HM*YCR9 CT_3IT\OTJN+<:O_;=;\AQS:Z>EXC/EM;ML'7:Z3]/+J(KVX M&'O_>8/MYR'1^G5V?C>-O/P6XZ M&->W.Q)PVJ:.?K(*..$A"(K+/MXQN[@X28^?WO>F_7B'[/P3M)7.3\[2BZM/ M3R$]O:^M^S$-I=/+].P=U^H35T8G%Y^UF;0E;?'3'57MH^NQ #[<'GF0A^:!+]T[?*WQOP]3/W M>ACC#]PF%7\,S$5Z>7J1GAR_3_7GYZ!CS[=X57OHSOW07^GYR5%Z>OE'%Z.G M6[(&>S&Z'Q*5--%Y^G1+:'L/ KN7P_LI8L!^6]S%SB6Z]V/;CVT/K/BC "M" MYK7DL3H:'S%!>'6>'I_?-\K\D27[X/C32Q6,QQ9^]Z7ZE!74>\O8)ZZAZC\M M/@'U]/OD#D 9=GKUM6-A5 7V6801'Y^F1Z?C&:'/-'B\KQDGM_*(M-7E!R@= M_G2W_?B]A/SSV/?CHY/T^'2<_V.?.=B"W;EZ0 #K#Y8[KMU-D_6'"=L=7 M=,Z.'Q _?]]A?[IJ=YM[LX__WB_^^]"+^K-,(GR(N_L/(T,G5Y?IR=,'7/KO M.^S/U XX>?K07-X^C[#3(9W]V/9CV[$HW6>21] _OY-_ZVH?>88KS7C02OR&]N3G(U/GZ<73X_3IZ?TLHL]?IIY>W,]%V\O4=IFZ M(HDZO[J?G_+^$G4?)^6=I>PW=U3N^5Q7$/O;#W;@JGR0'G#_S\%!\GU95/E7 MR7.W''I?6=YYT#?+KY(+ M3%O_8#^XP$X/)U,W[2*K[C6G<,6D6T+\SJ.1=Q[Q.X-9VWR_3GY>+VFJS]IL M@NWX1[8H9$W^T6#VYT?AK_YD/\-'6,H__XD69F2)VB)[(6RZR53G!N!/3E1]HJ(P%/O MDNPF*RM^)(T6&W^8T!S0Q;'I2NX?/\NF?=-V(@\HI"PS/+V9S3KRMB;KI*,E M*&?D(=9T^Y?=E#Q"[DLW*[#WP1Z';=SP.E;>F/^\J)9)WN)M/&'?XYO\RUMN M4JG]*+LY"=1A\K=BS=(E[;M)]-#SCY:A;99+R-N\*%NL-_H2T_-)Z'DQ>!3\ M9YI>*>U0?UQ-UWDR:S/LNPVV6"QIH=LUCX'V6033)B?C^]J-G$[%LJESVTEZ MU/)@M<0,=6,Q3FPL("7'EU]W?IEPS-!!DV= K^A(7D!&1%-:-*X=(C<:&@^1)T5.^2Q[[9^C^R%2($J?9MK+)5/9T7W,?S MO[(Z:M]Y)@+Y'1DE1?)-MB(!P+]_*HI)\\8>@(F@F^A4VTC* Q/4\K:Z'F=/ MDK*+OM2B\6.AT]#^D+;.O*E^_:9T7)L%7CW]UZKL>&]LNV8K=.1-K4\I_G1= M-1/:$Y+=YM8O'IV$FA[!B[4C;2-?L'!5+'1T($H2-II@UO,LPV,\HL(Z)\_1 M*4:[SUE%FX##2TN#;T!W)?]:T=M[.4'358\M."ARNNW[8CJOFZJY7MM2RA'\ M<=T79)T>\2_X'__SHS1$OJ[0FU/[><8=:[EAK='B8+^[\8V M?7__2SJ^=\_HWH5J9_4I^KIM2 =V!3?DQ4(T-4XOC1GWQ&->^<-I\R1-3D^_ MQ'>>+;)_-S7]:9%JB[,O13W@ZJ^JP@E^!QU3=J9$^"9R%D(G1XEN#B]?09-J MO;VZ9)[=B,JJY>)JLV69TT3H1S+-,GTA^0RO%:4'?-C12 SR=6QX]W:4)_"HH#M(,CT[/\:5')Y?G_!I1 MKGPG+UFW5-(;W%^VM UK++=MP&'R@$VG,5PS:1VF^.CJ\FEZ=G2.C7=316MG M62'T'&_J@V@T>MGQ^9A"/)JVM./UZ/CI57IT>39XAOZ$EVAD9H?)LZJRX__H M].E9>G)UBK,I#_"CC21LJVW HHN%O/_0(>^ZJC \1I>_G[?-BE03"Y;T27<* MHEERC%L/AI?Q%SJG\_.S].CBB,T6/4*#J=G3;4M3OY;2VMIW1;Y[,64?3B_. MTJNG%\/?JBZ4'V\LC^W&=_ZLJ2W5RLVX0"=/*]MOV(Y]X?[),C4I]GEP\[V+IN#SW3QR>7Z=/+ M4RR7G>.NJ7*9]_Y$;[59DYY^PB=!#'YO5.B6C4[[MB3)O&ZS?,4.:UY8N*(F M?WB)I:Q[A)\F64<&!;GCM)^+K*PYM@$'L(%^&*NG\2!^3)N1.\K%LL!HG[@,, M@(:U)6*"E],4RFFYQ/;SHF5."/X^[A,9:+PBNR%3$LRSKH#7W!60#^+.!?9$&*>;,[%-8N7TZ#@].3L" MI/ A 4R.RH+$N#7-A(BXRP7/98B9^ %F[ M*Q=QOL]%!+F(XWTNXG<,,M_G5'D-8.HA,$747.&H, +2'5]+W:KJ@^#SU@,Y M$@G2B&,0-Y+89_1F##6KNB88Y>/R";WZF$SEX6_UE;C6!X_IZ.*9!H89PGI5 M*:%!&&1FX-,\'Y?T_'[N8ZRAF8!H)[V%%H\NY'9-1W95T+4XZW$I+\K5PEY( MSWVVNJ;E=V',TS!4R?=^P840I434Z!5<)6$&:*.S(;MSY-9QR^+B%HBJ#P,< MJ>R2[@V;GG@;)C!F_8Q%Z]C.#*WAK2X-UB[^F3\-OFI.ITU-/S(UW#9R(3H<57Y[V#;Q9U <#\VJ)R3]0QKBC@Y#U,#A/U 3$?O MSBU+UQ9+TNK"(.E.!/W'39G+'6F!Y8X.6,'Q4 T6/19IF38K>OZDL+#2;=:V M9%>M4RP";631TF&%A>QL"X^Z>%60^+#Q?^#,YF@S!'I$6(U''(UR*+9F2>KUNVC7YSRM30DT= M^A)0JDXA\]\JY) &Y\P%>-GA'#>@.>Z&V,B,R56[U?2+W BD#SKR MC$M5D;9=[/)A47V&&4E&?-.2@9T>?_-R6S+ERI9U')_ C#:1]AD'&/=CWY#T M)?,BRY']Y2.ND5,W)@12R%M?%!F?Z;*W3)U>CPV(>%>(IJ]:5L$DR>1D_FL% M#[,O"WWMK$"^EK0!:P!XKH@"D%9'NGMAR1VG&N2FB%;'4J2=)8927H?GD@O2 M6$(GBU1"DUO"G665/5\7-* UQ%+4^R& M<%E:G26!![_E1KZ7!YE(@KC(4PZN\ V*^[XJ%Z5$S=+(QE";% "1R_.+]/+J MW(PL&$B++">-MN(T,$,9@LP,)QP]M,%NU?"^%OFPGQT!*4^"'.]S_ZG;NK1 '""M@=*4S4, M'UU=7*5'%V+I.WN-TG5T^38].CM([K?M[B_)\\34_/CMY3O,_3\]]:ND^0WJ-C>JK=?A:E[S:V(+4X=+&DL%( ME.B%S][V4.IU"N9APJ,A+TPP+ "LA$F@A07W[?T=FRX69DDEE(\%"P:^,5Z5 M<+9?-A(9' \($ADJVXV@?$:D>S=P4X5*$KS-=-G1!()R4;2PBF]&A?L<1\3[#;HBV M))[^VM(T,0THC\T[)_L7.[I.IP&3/2ZN)88Q:/+$_0<>H]DDW\4>0(G M3Z\>G'1R2G);>-P078WH\8HOX6Q"XK@;HO3:71K1/M@ZS4H<&+=<4!BCZW7& M2H##BC=%J.W4O=IT944/LA.6!CHK-VM%%: .;N/61W"FEXOL@08 1Y8T'WX; MJ_7PVI/ED.6+YB8^7MW<87&.X$=4\V:DT9!3"2X@0S%^Y#SDQ3X/&>0A3_9Y MR-_Y-O.]1 K72V3';K)F8PI!_HKNBI.3+QD!X;J$O ^,PO6(^,V % %$N:FJ MYI8F\M5.K#ULH:W=MP?BM /38:/H[?.)9>OT2F3+M0!_']ERC;%_*]D:YG@Y M77]7Z1_9:]R8#%=EL5A6S;HH#B(/*54/6'*79$K8P]AKXP1VCU 2%QG*K2\/ MXK1K=MT6&M!EK[1%(ADS?#.O M]$CS7>.18S/D$"[#HA4E)J$TJ6SM%!^U@I])R@TY7T$Q"2["7%&DN!&NMJ=" M5^9,I]79]392Z.NU8K $T(4W'-3SM6FL)JW*/K=T#AQJ#X^FBYS$=H-B#B- M!'?%/A([AZSB55GEOH@WQ=88(-%G^4>B."+@ AG _8[*I" AF ;OB2"#T^:@ M609#IQ]O/'>I/X'?Q.R/3R4W*">ARONY8 M#;I"$/R@;2H'A/7 FIQ>U.Y($3.SI=S5?7N'S)3VCHFP#GRD[9CY3!<9R9]> MN= BR$@@D%WGY5ZK5VGE/"%?;+=(P*Q'8GXLWTVP) M4J<=DI2.%@K>#PX<:=BJ6?+46(GLF*S<-95!7.E"XTH7)^GQT[/W,U_/3\XX MZ?)9L>G%@X.FC'_% MAYU:GJ/F13/K@4"D4=(ESW$>N_, SN'?"+T%&4$.5M]RY#FLT9I'-8SXYVW3 MODG(X&C%!'.&U?/O7O!CGO_\(GD5EXS#Q53EA,B"\CYRD5O)8]2_-6J,XJY8?6]1SF'P2G7*T3C0W M>K'9G(Q@.DQ^J&,%[U?YMI!,.":+M1.70\)46#8R+LGW[9L#_+\;HM@NC'8T MLX%/(Y[_,NO; C$JMM@%I6U9?YUI6 &0%W [Y"+BV:$*E/0)#MK'SG5=[G-= M0:[K=)_K^CUS73^6_UJ5N7$:/1<3*R'3A-%4GF?=//D>C&C?9GWV MU8<9NES-4[H.E(/T/[XX^H+_W2VSJ?W[P:_3,S]MJBI;=B33]E]?DW++^SF> M6C[\:T+\PDU"MDB\'KL+B^^'!-^Z7G:BO[Q35MRW[L]@K3^Y&OS$4YU?7ERDIT?C MXGWG^\:9IW^OB9RF)^07GAV/L]_?8R*_?T.(>RK9,3F3>-\=CXO0V^3F@P[LY/@JO3H?)Z__('+P4=30/;L8CLG)K*S)<[N'/MJUWI\ M@QRGIUS[/ZFB,)\!3^\%TJ M+J[(%CC][5OIO)_Y^]DL[VEZ?DQ*ZNG]3.9W7. /V\3B(Z!KGP4WTP[A:P?7 M+8-,@,L8\0"B_,<]LV82+'59@9B,6DA^^J1J)#H] !XV$?37Y:LM^ASQSWLT MBX<$;L,WCF .TJUY(0DA&_').\$4A[59\;P0F:H*P/J+CP[G/8-*=IIV0E@63E)N(27\[)S,EF02J3W&7>=!RZ. M Z"7F6#@D:/,;W"HC+RG9B\ X7: HJ7FV$-6=J8\]EV$Y7YD&:,"(ZTDD+>O M[M[< ?F?< NFBCH 0KF5)C%TF=-C87$P>7B1:W@AQ@^1W2S:S3-3#W=P-[;+ M+DM9P9>R@B]T!7=*2[V(]QAL)K+/X7TY)3-2TN(E WG&!8<.Y]53 8.A<+]+ MN0JA%',B^)#;];!JX)NR62SHP:P9^$P?HQ2(O^@T!VRN%5F0P,+XC_USPF>D MPICE*+_<\*3^GCF6#L^//.45UY1,Q>W'L7)%Q2+&FRC>R\/3\X0,A8K+7R2_ M3+++E?GT'M:RMVW92^V,=85BP(B-Q9#^A\EW@,Q) Z/!1!CUP\PLKBQ&^G3< M.O9$6F*&W.D_HW5JP&XY^ERL3^UT]-BZ:*^I'SQR)9:':[Q-P3MNNHP"3<[. M#_)LS=1HBFNW :V6K#8B-,PQJA>V;B76[$_ 8(S)P=CC3J[.[GH/#O/N(>V&MON9X4^!:F_IJJ&K)'?( M+)4+5OE,ANHD/5M _+5([R)%7Y#+4V$G63G\5W1EQ+_W#BZM&6KP1EU,+GD3 M/)N9+LYCLWJPU3)7M]"[H?[+"F@VR',JQ5_!UQ@M%I'L"3V(.@[_'F# #!D5 MXLJ4;A#(;:8KS$+4F\=!<>D9O1PX.+Z0%6_AZ[BLU'+:M*ABZ9U+\K%12D_W M**4 I72V1RG]SA;9*_%7=MP@"SRJ"T,]CYMCV9@1=@;.-V^&#:PP_^E;[##_ MQ=&+;>PYT3,>8\B "Y\GOZ.I M!AM,%T]_'B^$T,.RA6%@[GO;;V:%C]AQ;M'X]RF:F/S"G'2-JR'+<@B:QX*=MEUJX"H M*WI,[\8N=^ =1N'QAJ,Q!F"_GTU\?'AZ'-C$.Z%"?C-[[2P]/CY/+YX^97L- M$4GI]4J6FV+B^^CT;3/=&$@]8LV8'?,!K9;)4FCOR-%HT$ QX^U>3:S*&)3-\(=J7U,^_Q0?L0%*5T?QOL&QS"5FH*E M->DYER/+K'D33H*YD#K]!2QY2VZ86Z\6 8D#2AZDWL*[9CH^_BO'!)DEXSX: M0!P*.?P2M.?Y36EC)X4]UV@WMMQZ\2QI@EI,TDPESBIJQ5094X*)XY S5:)K MP8 W<]\#X:-'$#3K<.-KRUI42>+&:@MS(OP>^*'/N3QF@:H1H+>Y%QH8$XME M'\0*9;_/.7*B;C *5#(N(NW1_RK7\UPCOU59,[IV)8LAVP06_FQM#;51L,&$ M:+H@]FI6$<]H&QE +K4N-9H"+FB3#_[FZ151#2SQ0J[-7ZMFTBBVMMP8B.(N MZ8\7?(M]+SQ\.Z4S7L?-Z'R^59+-VNK#%3E;=VG0UQ4%RX# M-JPHU RW[XP[Z"E1_*H&+\?4V>_&?X#@_R:KV.H)FGB/Q2!H=!@QWE8R(<26 M5(@R&0SNV0""&?#FC*9%GI Q5:TZ5^-U1_Z&>?E)$W4K-/LH"S&_9BO7R%4Y M>20]D"'UG76]WM2_TG_<%M4-:@#K?KXC=^U_TO&G(RZ9?14;LR"B?@W:LP"Y M4"B4!9LWYA":5QA&39"$7H*+0XT0>M\9R)/W^'SU-+UR/<79[&DP3;,)CEH@Q+P16+> M&X?IYT:/'U?%\2&W)*$TG_ X!]T2+03"HRI?*\2%GEN$57_HE\N+N:R3.Y#)J[D_.'P![>LK[0'6!D%E/.R M6IE=(?Q":M,W3JQO/,V\\+IWS, M485^BL+?5GG/%9X0GQLG/6']JQMAV?G=5%"2LE.),+EM9TO O[@NKIN>R?;% MZ42)Z](50Z^8RQ3OA/WQ7,7VNFB6354*ZX[$CJ=MHPRO4\>&RX;'5.B Z-"V M*S$J53%<5\W$SP#D,6PO.E*QJ:XQ>*AYA3?K<$/GQXA^4='-5CC_QA\?NS?Y MH-"JSJQ =E6_;0]H0$7M5E?:9_'/:8>QFD'E=W!I0)I@E-SBH?HD\/MH$VAW M5!O6) C(X+1."EXP/)VCN\%YUV>D QB9G =1GN[M:;"NCC@F]5>WY,5OK8L8 MDPEU?NV*'6%X)]OOQ6QV\(T@@Y)7\X(P!(3D8G=J*9]M[[][RD7 M)&=3,X=>!8QPWWH_2#[\CAZ$@/?NZ(Z_.U(?%XM!+&/5.6>/OE"MN])9V".7 M@]J)(W<)3 O'*!3_NNMIH M/]U 7]C3JNE6W+$&#$'!_-LBWJ)Y"3=+VNG]BHPU;4#5I\U4Z[5Z'?H+> +J M@N&!;0E#/PBZ\ 1XHEZ#+4V#Z=E&_J$ \P)W^#25!YL=@W-AQH$T",T,.XL! MN: 1#R)78Z\1L;/L$79OXT\E+/+HE+$0B [ ;O$O#@J<"MX*WJ Q MD8C65SVR-T64EF0?!F==H;[A(2:1FD*S(1W!Z>##Y#^=R(1->F:-!1S>OA3" ME2HIY&4+#U,/0WS47'1:ST;N3D3E,FJH#L@+^*<8G04.=BP,6O4W:YFPD21II1ZE#YLFANI,K$!B'G&E8/5F$& M\*.=ZT0/M!Z=0#DS&"]UT4$74.GIGS *X!J0^^XJHE(G^KY3;U7.Z#I83RM3 M1OXK?G12Q'68_*.1Z)=,D6EC@Y7G3DQ%+O^UU3MU%72[G='!;+<]%RN?"!9I35X=5&(62M]1*VEZ0S7 A7/\E--:7?A[-NY5!(3]/ MC(;55\Q6E=QOINU<'2;-/_FPA?G[H[0_2A_V*#UW.:(@8>W(GBUHI,V%(_!& M6/#PWH?*O3IP\3[*"?LP3OS_S]Z7=K=M)(M^UZ_ TSCW2.]1-!>M=N)S)-E. MG'C16$XR<[_D-(DFB3$(<+"(5G[]JZ6[T0!!BM1*T+B+(U$$NKOVJJX%!T/( MJ2I+*>I>-.IQWH87$2C11Z:I#.P%4Q9 WE'&81%]]L5%(7:5F8%D%/("UH6K MFCM$;GXE3!6RLVBPYA?QK4+S@/[DV&4"FW:YH?6Y*>U!6D8&H:K<:W8XWYKP MKG5?<(GQ,QJF<48S0W?>GEZ>[3JGE^?.T3ZWY[=B'I1\&:@T1+YL]AATN O* M9-(S23 :KOMMF$C9HHBZ&B3:DSSSFU[$210C^ MF3W# 1PH,#1,=4P95K+II MS+XZ]Y;BLQC,P5UG;3FXQ)W]WH;OE1?;V?7VX?U]?93*C<2%\8B!$XEST1E M"_-L:OR'DZTP09/L2!535 (!^5O-C+02Y]AV5/=F/$8(;RVL@B8^GO-92X:"Y%6^R;\KN]PO[EB-,P=(;N5D-7 M^GBKPC7^H7'@&*0&'#2N#PMID!95R&.KJ7Q)77$LP[35"U,\V4D"P2N R<6B\=4PYS% M67*B+/9 H,]CW?=?'^)7BH.7.>:TDL<6VT[HV>I[V-K#CC;D;-S>7J&/^S6 M8<^:GS:$G\K5@\X>L%2_%^>"E\@<]OTY<2"]1EL/IF*TE&4ULZH.3 WURMQ[ MN"1U0G.K\/HWQ):0IG*-(SG<&*_FQIH;-X$;L8WKWB"2,@M^45>DS-I#/IQ) MR*+\ C(:T9[_O7D)AF=$D<5KYV\9A4!'Q(W<(%8-QJ92:H\<5VX62R$@U0YV M+M^28:NZ&9/EZ];L5[/?!K#?6ZI!S"DEE;VSJ,=HN*CK9-X]S'57T#W4K8X/ M,RYGSG+%B>-2MXK+VKKPS%-^L>KCP-__>'KY^O2?:C7=:ZAFU9I5-Y1535[> M FZ].U=.Q1SM.\:\5NR:$&CFG B/7$K<.1;SN\?\!B5LEETG&Y;2JEBM/M_,3< MI0=AL)?[$%D8G5,SVCI.@VS,-<5&O0GU1 4,8Y\G'6*G:QOZR/1PTUTS&C.3 M/53QCDH2I[L9>H M$>3-?MC0M62G8_%W&, GXVI0YI= MT\2\.+N7Y/'DR -$>A$GDV:0"6.9 M5?W-.:8J/\)$$+4R'(;* .G=9D'F=4J+I< Y]&5$PA#70=JA*8KP3:(LIR70JN" MF%O?,39UB>=U5CYGR3>N&1HH&J&^H"N^GY+Q7N+%54S)"HFJ::DG/CR)'\PE@FI*E1)48- ,8.;8 M7*'SJPA2$5W;?>BZU9#+I[ZOSV_?)+*>5?ELA&P?&9ZIY"9]II.P+)5&77)4 MH3;6H"GJC56>GF(*K>E-DRHDLIX<"7] C#V3;-90V6]6XA?5F3]RFE*[3E.R MTI2.ZC2EITUYX*%MQGBV&=9J\89^32!];E!5:E@5K2J^U%&B(.OPK)K'676H ML]I7:2Z[F@YD_Q"[JTK38(Z_JEW?#Y>?+XSSBY'MHH7?P))G$7'>OK+M:?D> MNH<^!E?@1W#B4&@HR]_!AEEQS$U!>>/J/!HD, MO BT)&7,8F9F M2IBG@'6*6*G>-\T)#1M0F4B"L ,#>MI(1BP!"I6NY?6Y3V M-L5H#R3O=U"V,?^L2V*-.X5])W"KZC;".@?X5[ZZW. 48K1XC*P')3_CDY%/ M'DX0PD@/8-4&UW-F+ XPLTK[;2H:HFG5%PEB)G9V+D?A!.D<-Z>=JMP9^5"[ M5AL+RQ?,-DLF;:[6.%;YY6&@TKG+31F=0)@?IZ>/JVH_$%&4IY73DE93/VV\ M(E#H+"#01D525G:WKYIN< "$VI$37+-1,2HMGAS7V'BNU3!@,HFGPG\YFP0' M=@7D8J\FY,C&G'!6/N;@J\[/MJ"SF413U92RO+!%(]HZ0-W8Q9$2_2QYB2]C M*;.$:)DO5TS_Z-AB]_(>\::^V<0DM.MC@4HU$" _S5"ULM64E54PLN@,UI%5 ML)0DC!XNP],$9E?3B,E:&ER%/DB)[/4-771%?4H%M4[!QIS(*,Y_L6L_M\G, MFECJ#9A7ED9X?+S;U'8N47V>T4IX$3V-DJUD1U='X\TTL'3 4B DF*S"KLH4 M(N58*V_//Q@WB7G\\FZ@O021N<[H629("=2U1"GUW'YF'&KM3#>4L+A_#K2/ M5>0X"XJ-A^4X&U^;P636B3:-TQ"M#!M5TH/T*U1^/Z8"DT60H^5J'.Q/R0F6 M?-MBK">:;XH$;G>,CG,C7I@[J=$R=3:Z-N%YGWJHDM6DI4SY^XI#!U1$D]/A MP8*N&S\\\O5W!JS[OSU><,%MJ/%Q+Z^W7QTYKKB.+1=K+%Q9ZEWM:%]DMT[2 M^&ZH]/$)LMM:2)'L^]84^-U0X)K(R5FRQ%:S&#XINEAEMPO.CO"3$8_A5B7: MYB5V_DWN&9[J %8[]Z484-X)F=R/(H$?R%NSPIHJ*E=Z93BE5B1P+ _'RM#% M3725 T(C2Z&9W]+6I BKQJ;F6>,6Y:-C$4\LY/9[M+^FH;@B?! MIA]7GLM=*]D=,J-IE!U'0V"L7 %N?5MLL(;^&](%?2-4SH,5[S3I8W,>][33 MFMA9#/H6&XLMXB:M;9M(]MMW?;M&#V-BN<] XZ7)_O&>=_<;Q MR=%R/0'SS>^JX2M@.;#V)?$4LVU>Y[O8V>NFO0SS_? MP8=W'1*E0A11(:U">U2B=VZLPD:A.RO!F+%#O'+;V MVJV]@Y:>DK= ,)7^"405RGJU/B6T^M=9@W8F?(P67^?FY-$<(3V)/!M;J(M M,=N& U!V]J"!<@9< U0,YV6Q,"^BKBI[/#D)=*.DIO:/G%?0J?,*K+R"XSJO MX.FD+?AFV+3YIVWQ5ZO=A0^>XR-=(L?.T6G3X>_80'/1TB'>>J$X&^RF M[5?_Y+BRX%8&P,/P@:]_?YU-6W!.:5+!!T[<_NS%7]6JS 5"R#K 769-26A03#J9^/0[]IE_ M#0JP4='/\;:IES4%0HIDG!E4&BJ;)?*G'<&;(XR)/% MR0ID<9YU@22SP8O-Y/78^1,O&%6/!AH,B$DI6WH:,2IW%QZ_,Z?_$5#^/KS"S M;HQ\*Z]/-S&GHRDXE E.M>9>;HKXY]27L4JL[HJ]]L&.W*7GVP>N^BT;D?1& M56OA7*&F\[OY/$XG6%1@YG+ITAUR++AWHC4(:VQ&ZM@IT?B7\Y$G!["*[+-7 M\ F'1$I.>N2_9;)'_8VC;6J4C!I1HZ?5\QQ*-5F<6W13FIT> :8W=#,(,5TB M1K,*-0N"S(:8!2Z]6AY09W;+#I'D^F3>\MC%OII+'H,<-YKMJ6&DXET$MX F MC@S@-; 09?Q7)]%^:6GP87:@4S9A7K=]UX+"^81MDS/H?]9FI9$8%0#-IQS/ M<70KGF"R@TE8U=%JK>*U=*'?73"P.4RK@*.HBQMO9YWO,IM[)7DSR,D;^*V4 MAS[-%1P\'P1^!S&#,73-1:'%1=G?L^V&6H"XH>1"H-R\>FZLG3MP//_$-/=X M$O$T8PRXR"@*HRQ%=!")%$.)!G;Q=0S*FS)LQB+!I.)1..79>"RJU+P!%E;8 MPT=-Y35CG5/?SR8P9XV[0]W%+LXE:YDE*2XYEJH:#A-\2^!@ MH%2U2K'6PY/IMWOP)\D'SNJR4)S@R1LX61@,]89.$C&]HJW)BACZIQF]SJ<2 MX,^'/1&8 EEBNB';0_ZR;4=R*"+7BG]Y5KI;*2FKPJW"0,>^[5W,;?Z(L]'I M#* ^)F$L2YM1K]&P9UY>TKDC_=B?"%D$;LP M68,S!D,9\R^4=O,"LQVJ4U0C(H'P8U6BR>?,GUMUP1SQU$/L'\TT9#3US(YB M25U1 :Q9=X*Q!\*$[B(O4<2'%&/^% U%X/TMU"1'%@O8Q,B=BFM^BH>JJFN_ M'[U7G5:[.ZL.266V7](?AES^\C828SD-HZ]X+V U!+_IM"4&S/(@QRK",C.F M/#I>#<[Y@@ [#8+4V!D(QK=8L-UN[?V6J2EUM47WFX!LE#D>90'S,YI\LYMY M$'H>UJUD[=WL'O\>+)")Q:5QT'1*+"FU!XT>N\.RM=-\+PWS\&I;MBURJM(& MD--5SS>IFGEEV?J:O(G2\*O4O=^J#['41H@%0N.Y1_,49<]'5)/B)01-O'// MD[UY7<89QOQ^,"G4!24;JWD=4C6XYRLF&GF)OU+6^?D(K)9KYTQ^%1(.]?[] M134X9Y5@@!7\6MW8KTAXX M5PRM?SQ[ZLAI%61>4 W@2U SX 5'"]YI%+Y%Y M"^G,FG/*HZK1> TC]CN427;M\#0,GGE=^'YCCG185C!5 D?YD-[1S(W/R=D* M4;U/E"CS+J B"FY)4[5XG@''-_?;7R>MP[^D[+M[>^@NMEN]@_9I%)VZ(5K' M;WTQ_,OMO?VKCW37;K7:?_U%/\'__?6W=]'_5_JF\[_7[<$VEW#R*R>C(/GK M\\_^W__N?+OJ=_^X_M_+T^3=&S_M=_RO__NO=\,_?OEU]+\_^^G_7I^=]8-? M1[VQZ_?^_"-U?_EP.KN_,[6_CV&P\A:#2?CG9;P__OO7XX?_3O\]]7H7]^.3XZW/_[]8?]>=^A]>Q&$P4][3#+_;3M?4M>],+0ER(8"#^6 MVW34MZ*?M.!_]H^VG0#LY)^VXU%:5+=.B[+2HD[JM*C'M@KYN$4;^<262!>GG[\X[]Z]JZ"!"V?IM&:D:[NU MDG15PXT:L[>&'((_UZ-NG)_13T(GJ7HY&E]R?0JYIDG/-TVR:A0O\WNL0!8U M3Z,9E^"MNAG J'R\&$C6+2O#L6FX\U5>9R.E'FRB3[$.JUBGM?)RUXZN/\]SI+&#WUWMD4RV%P@>N?61!6>5C S M.VG;DJ_D%0^T<2VI3H=/MO,E=WBA)DS2&J;XZB8* 'J"Y891",(':2J,7CC1 ML+?3:>TW.MWC1N?@8'>62A85QG6Q7O"&]MA[NGI.PPJ_DQ7O_2(BL!^!V3\W MG9^QW50IW#2U_[ 0NO..K9X^^:$CF0W 8U9?C8;R_]VGD0GTFQ>3).N1N\7XLK MSW7>H.=\'HYD\"#P/K@[O+_(_B@ . VO[P_@CTC5$5Y/!" M\ZO[$PI/0J_OP]2+G7,1)U'X(# \/'A,&#X>"7[RO2M/..=XYQXEODR2-0-? M52J[P04S)H6R)WJO\+HJ#,P8A$%([A?=L;X+@O"*JVG>6%TY\>Z+"KVID.^F MO$ZJV-9NB1IO; ^[Z8##VU!]K;&1>$H#WJUN@N9B3+7CX=:<$7<0OY)^.,'+ MY:9SH8NO\=::'1JZ=19)R4$:7,Q7V,@1/CZ[N0]1DW\EH.FS@T.FAZN:2>MV M2D^?@%*>RC.6+E#T_X@Q,,?O_P*>$'AU..!.DL[[Q&VR_T;]L^*$JQ)'8/.J MYQ$\/KP-\UZT'Y=D>L;4S7.S="P6BA+3VM@C\0,!E9,U""I?Y->^F-#?+MZ?FX:PV<>F+>S.^T\?7SA?WORV"_XQS@G! MX^%9\3*6FL5A#@2<"AL 7*L)+ 1 2M'0/>%5TI<-V/PVWJ3X"N>]-_;HMAAA M97#.U\&(Y:R2DR@ROG/:*I7"JE*R,UYBX MJ*4!G1G+RC(.P_,J#'X"MK81V,6_7V)V7PZO^S,XQ$PJT^XTDCB''##G7\<\ M %LX?X!0^QLSQ]\%_:9IQ!?:I^-T$U<_SWF?A@*Y+P D46-./(_J*83'*<7(F8&BB[68\, MU-T\[35;>8"40CF<>]1 H2=BA&ZI @/31"93S#GZ-0VDI4\0?+^F_K419BV+ M$+9;)7T^B*@_,N ^ MQ*?R""B%]I1XYV<_[,'FK)H_K3IPEY\QB2^EP;5GJ/YBG46EVDWO?/SWY9L7 M_[S\3!ICG/KP!OTW;)X-+PG=HC"W8*L5J,B7'&)+2V ]3";DS.JS-,(M_<:Y M]Z;OH%(D'SS7]>$W7)":3@^PP8ZS\^;#F]-=Q>##R<6HLS5,(-W MO08!@4FY)0):@M^0A'M8>&,?&-^@NBM:M(!3F50J)&<]7Z$\-C/MG;[O%>1W MGI'0!L"42HM4%7=SE?B9""A-V4CD/P6AXK(_"D.BS3? =^'8Z\>FM:ISCDJ0 M)/ %[RTK':V,/)R-F-RG^3\;YU#"TO'"OD :SZG17&:Z@H_K@"@A &':R IN]D;626@$^,X!N MG> ;BB;:(AA=@%%)ACZQP5C\#>8U%Q2>@M&$S5.%V;:N-%1_F(&-LP"M[ MVIK ! )V%BCQWS3>;="7[";)XS# G%TR272/2ZO"<1SVL$6P_3"]4QMS/R@WZ)8Q9QQI@B#CV8GO* M&[?AH3(CXR[U]$JZE5BL3$IJ^,!%_,XO,F=C7J)8P]S1%!-5+_MLQ!F9=MH7 MKAR3_W&&%RLB_<;0#YP/].@I4Z/+?.O!F0+ED%KIEXA?APLG$ MR#*-'[FGS7Z=O)$E;QRVZN2-)_4T2J+DL[X&J=DMKF!6U_2E_D2G#;8-VC?F M;?2FS@%EH<=*O=B^&WPOZ(](2I+)I=-5'TZ (-Y $&"""_AU&7YUSGC1GPF[88I$@- +* M41!52L]A:+Z==190-6Z=@IKU<[Y9'NQYXT%Y#-G9S(G)^KT0,?KI.J.?X"D, M#!NP0R]R")QJ0!U#>LL>9J35:&SIT2$O:YSSO+\5 %1*PVV9&L0)B3DUF.UU MR]KKK$?5:I%'90^E4_9#'DRH,E4*B8OOO_3\49A*\ 6*[@16)C+>YQZ[&-PK M(:H7QB#]D'O)9SED#^R2&F JWX1=9W)O]$,S,]B+";8( D(=^10?]FD3,EK7[E6---'HK MBS7E0TFY.54L/9A>B1KMKV[QT>>%C=?+N8*O+E #^2N^.0K R2F K;D*P%BE M]#KR0@,+4,M)@Q^BDA$5,&4EUNBGEKW3B/ M-;5Z-I4L\PUUAEIN99 = M+YR=]FXN.F/L7X0 %^,5+X'R%7PL5W8ZNUN?(DRG=CYP4P8*_NY\N?S7WA_* M/#U]]^'%IP_O*.ZBSPY@\;D"&!T*[*H+UC@Y_I=ABGV>*%%=E.VKCV)Y+$P5 M)9^?MCBK'G:Z<,QPW ^=-[ $2.")W^?+@R^?/NR2> L]7VU'F)G2EK\YZSS. MAU!^^79CB\;Z[N\Z?V#O8%CK7$7T, E20^G%'^?G#!OUQPD&-599MB#OC?Z< M]>,[6\6 VV%CALBF>>D!9YCGKK;W9P)XAP5U,*\YSA:ZJS["YQ/ GPGE9QSX MZO<1%A_!>8O0PQF$_91[U,#>I!@3NDB-XJ 8G/(MXAGT*;%D&246'*P+M9+;HJ#TDF-PLXT87R2'Y :2)\(PW[X+0 XGJ;JY,>(OU^$-3H+C'4'E M,H7\R;W-67FZ87NE8 MKG>99%_UXFAKCC+/?S\+SAKI;RZ3])1MU72B5 ?=DPY^-)5>EGQR=\].ORN3 MPO-,)F0.*@#>;['W9^X4=/)!A),-LKR#+>Q=C-&:_=%03E^9%];)MC+HL SY9)J163+D2^BZ@)XA1IQ- M+!-\)HZQ 0]I>!BY2_RF$P4X.2!S'?1U X?9M/#8LLYG.@71ZPI.$EWSH;]: MMJLE&^ZK]-@=E'@C CCJ/G89<,G]#14 M:'6(W;K#B%,\X)5)C#:$9I[HVJ8KBBL(91J:J /BK-UAKIQ)CI@AEUQD/0<# M)P^#K1QX[6UDG(@R0*6;Z-T@MK#M 'K")4+&"AUG/=L%>+_T'A[;8WA T:MF M,Y$ M^]CY@_LG?0@#5/L3(HJY06/%S[ MY/A(7^V=GGVB AO6DOJ^+RA\#JPGO@)@M^:ORUD?%^#ALXC,A>3/?1"]>8U= MX-!5U/76S;YW45"OF1\]7^%^9.I$1'R1.&H9Z)0U1O:3JOTRU6&5*?3Z5%JK MQ0,98[90!]1'A_PB-:W:? MYV#";@!FU,I'Y^Q94\=IT$^68QAC&Q-^.)+C\$K//E"O+>GM1B^0V(', 98/ M7,5*$;5"HA8\OIA6I+,;PCPT=)8#N6KH5()""I+-XBQI3U3FW?N/7Q%8K M-=4FYV:L45M=#Z-RE%PWP93 " >F/_*-WT%]XV?=^+7K&[\GS:71&OF=:>:F MTHM,;T+C;9QIMJV>POK1*S]I968C?2K$VZE3)K5B-0/85&/&#V VVP%\MN%G M;W;9@L6_J=B L>)05ZB\2JO%GTJLM&0V]QG_>'KY^O2?CD]!$[S4@]>B.:[G M7IN03KYF@^; 47/$K(D@OY Z$9O7T(@X.B@5 11/*\%$UO0)]K^4VN;0'W)Z M7]9H$Y:=?S947:;U*[;DY%LLU?ZX=;HSWL70>4G#8^,.1-@O&;VY<>H/=8OS M2/+1\$M9=_9YD&LZ;[%[&X8U,K9#YV?AX:>A?71RM'5;-O 7V"O+P*"W^S$< M4\*GNF@O:T.P+/ 6DT,U;":0$PSN3/I51D1H/F$V,&/+^N5R_$61,QIS2(7E MQ$ITTG3>6)3)UIZU#0'LDN\&&G.O9C#"(_Q.H&.NCN!&5[KU99GIJ9D@*Q:Z M$IY/S1K"(#=4&C@&\#N=3IN^FB[-+7#GF*1CC-JPW5NCU6Q5Z^RYN M:!DMLM[^P%+S9#4GE*0450'QES5 U9?\(N%<+)D%""/IRRL1)%:\ MZ86SX^%< ]9B1GC"2Y=M]TY *^LL_Q)>#>_&7>G>]2CTJ)\P)T:I0(:5_DL3 M@=$.LMY/@U&#@$V2+ _7[K/,HR$\[- :4T9^53 MVAWAAG_"*K:_Z4=\K>K#3MV<2[KG'J(TNP-&5%R54]WL M*(O"9!C$=4EITDOZWLZ)P!Y1"K%BZ@V"?OLZ.]FG;/- M;TSJAA0;!2[.2KY,2GL6^5>CN;.VY7-HB%^B1VV8I/0226KP,>]T-+9$]9.' MC8Q#Q*L*O>&U5X,&(8\Q"*:&>V<"FD<&#?5]?,@#B$98FLT4ESEB&:#P*VD< MZ[*M'!@='@R[& RJ!37P"5!MZF=Y&>9W?M!3CV*V4@S?$M[OS3.4PL"\K(/F5KJ4NMW(KE^S86/E#2OPV_RZLNYYV4VH M!?4]_G M!6=WHNMZ:;P[V@Q(7W0\-TTH[WL!$DPQ+XW6!D+&NPDT 5UKXWG":\*9"P[A\GXL!@'$[HY;B6:4TLUT%7SY^@;WIL87K M41H=DW3EUZCNGI[1\5HHE5LH@6BV: M7K23BO%3NYR2O(D3#@Y2L5@U>8;>@J;T1PJ]5&I#QJGR$_P8#A,9 ZDTIG25V$2 M'34(.6>+@B[:K2B=.ZN_B;[:6 U=U^V);65M3D^=OK#-.E:@X07&+3;#V M^R-G9ALD5!30\@'93'3@^P9I%&!+ =@6[;4?3CR^@D(;O 0Y>O/POFLZ8S78 MB>L&)6?!FN=<(09.2"1!.57G&#"Y83"%X\8)(S>A2(.P-:*E^=5);3'J$NBH5/%H'(\=\'DGG46$3U/TJ M.CHCZDH&MQ9O-8P,#(TGH]U%"I1X8\\',LKBRC1!>7*M:2X'8Y[D1Y6R&*_O MJ;8]Q6M;MEJ46'Q'E!R:>,"\2]U*H [3A$7LBO\JI_2UJ;GZ()+(^_8P-+A6 M@PRH&S[]K/W%)7O[\Y>MQKVP'([+^&F[O;^]T*TM]N)?RR97S!_X\!*FE:\5V9+2S=8ON?%@XN)C&.R=4:?>&H:W MA>%K#Y,B$T<-3I38.\_%F1AK*(AO-SNB.-N@73[<0'U<.C!A.2V._1:<=R\4 M!)UWJD'[K2:6: RM-."D;$3"FJXW]P5E7X[0OMO,O3W$S(][('@]*JI3.BK* MLDWO.HRJ71S+I0FQL_C=9=M:8K7J[NF6;R_.^F)R??Y]'V*S% YHG-=RC!D< MDY'7=\[,CBNA"&K%4RN>!:.IME]Q#_U MR(),&1+1F\ER*TF[PJ2]Z.(^!)* M]T7\%0C\H^![VDC_I$F_$A184WP%*?Y1!7KLU:3\Y.2RSGNKHO#^Q<- '=C? M(+;?8S;*MTJ07$WB%23QQY36R@3Y14R%Y['U?2&X)]*[&'NWJOG)ZTYX-:%7 MD-"?2)83?]V)RLHCA0]"T(^P5$W+%1/:7Z8A"NH/F+_[66"?.?CM34)SI3!C MMA(2M);8%:3R)Y+8[W\^^_+/_U<),JO)NH)D_9C">R8CH[[=64N"6N>]&6)_ M3EG2CUBA>U17Z%H5NMVZ0O?IJA(P(.=X[D_;XJ]6IPT?/,=/, 'M72+'3KO= M=/@[-M!SAEYPQ0:61&Z_*F__H-[8K$R1S9=<2S&NH(@E=RC077&&PX@; M .2[1@C/U>4V\WI;F#8/5BD6]HW"1M;EU0)JX$"G@TV$@-X\%QM]84]8*BSD M!F.TYG)M-71/(6L.]DQ_B(;UQ]G)5:;GR+PIVI4IR9G?Y<0B5XNS/Z>^W-/< M;.:4KGA_2Y4>J@&#PD?]:TN?W"8? M#'3?2<'2F./!"C6IA M9+-J*#.T'F#?BQ.D;SB.IJG%NWX";)BL\AL.\&]0"QL&]%ODZ3\A BZ%CS43 M<3IYM=/>A0/!#S_VHN>O=I[M;AABJKGK:I'361BD<4T_:[3K:M'/)?;IH+W3 M2++O@I2JL.%;4]&]$] MC/ ;(R"S\8^; 8;3Z\!@1/I4I$HZM(/3-)0:M8$Y M85@2/-?E"$6^FE2=2JLI#*HEH3^&@:2.DD3ZIJLDG08[2]+'N<#8=R#"*[/K MRM&:&;M)9/1:M1@K)[(W(@JP&5]-<6NTZVI1W*GOT\X_86_'62HC%;]?N\GK MM^MJD1EU^-DL^BG)J;B[X7B;I*(5C>I[*8[O')?6&2^$9'YV8.-^_$2K!GOA MXAJ'][CFT9Q*^87[X#9A]WKRE1'Q +!8CUTMU@9"HZ:#6A+4%%!30$T!RU+ 0>-@ M_V #85%3P2I4T#D^:>SO'ZT?-+[/Z-.*8)N3!'T?V'Q$\KU-C.F>XAE/R+1K MLO12;D-[OW%T<%SQ<]>X?4!#L,9JC=4:JS56:ZS66*VQ6F.U$F>LL5IC=?W\ MFT>*?,SI>K+.X8[*\\%2T8T-9,(UY_^-./;W<,8:M1M[QAJU&WO&&K4;>\8: MM1M[QAJU&WO&&K4;>\:*H[;.^E@";+^%021$T_NK=2Z71.D=$[J^F M:$WX5U)8+>[7"K?U#<;ZG['&:HU5+M=I-[H'M1Q>_S/6'%MC MM<9J-=?"WUUPJWM8FV_F>LL5ICM<9J-L4;MQIZQ1NW&GK%&[<:> ML>*HK;,^E@#;:W'EN7O'R1_5$ QQE>US4O%>7/-1<-1ZU&YZBVO=?_C+655F.UQFHU MSEACM<9JC=5JG+'&:HW5&JO5.&/%W1L3^'B>B)XO7VUM_3A9?1MC$0T]V$(K M6V*"K_H_>WO.6T_Z[@OG<^K+O0LQE,[>WJL?7>]*KZ)&]78.<%JR]7DOC%P9 M[27AY(5SYHO^5Z<-&XE#WW-?.M;!VO;!X/E7ZE]K[>>YQ6%?=%:'5_AIN[7M M]*7O U#Z7C TOZM("OV^,D3T .)6ZX>7:B$, OEB$L.>]4_;MXPYW25N5!H) M4MMM-3E:5"2K0K2I-2>BM/UJI[U[1XJ^,5#UGS1.O,'U[):V7UT*7T37CAB' M:9#$3CP*IP&02N1\B)I,(92TXWA!WT]=Z3SK[F/QF3,1G@L?.ACH:3B1C">R MCU.,_>L&K%]\6L2.P'>X#/\?2?5].9[X MX;643A@XG_I)V),1O[3=H'6;!#?G#H'(>R>*VU-!YRFIX!UC%_"?A" UPDGB M 7Z<803XD2XA5,9Q%#>=GZ,PAC6S]L6 *)<3NQ!-OXH@!7I2:.H2GKKX_"2- M^B,12^>DU6BU6@WS7WS\D'X&XA- 2$XX<)*1A'>.0>3"JXX[[:.7,5#,>!P& MO,,BQ8F$Z.6;C/H>K $$U9?XGF?M9N?HP)G(B%^^4133W0B*>2W[ M *QOV[]*G-]Q/: ^I!L,7B'^8!ONM1G)8#;?O59#B2IPX]A M(IT.@8)^/)E'Y2)U/>2Z@6FM%BI+#?P>?.,;\)U.UI +; M=SY+1 'RX]LP&L.I]WXC*\#UXKX?QFDD]=I7 K1UBJ^-T['B^K$ RP#>S7_W M4Z&1F1,.S;M"^!Z1!:^: _T?>Z_>D-V!T'-.(Q!H0P7)J0>$&::1\^:;[*_6+B"(O!@219/[QN5>-G7\*G--T"+\I3<%&(/P[E0Y= M21)] ]L8RY$P*(:1)/PQ^O*'1RZ+971EJ+!_8DF--ZJ-%BMKI1V1P?-(Y!C2&SX1LC.18H-&D)/A^+0D?X M<6@6&8'R&D3AF)[Q B]!II^D/=_KPX,@/\ +"F9#@O@%@8I$ NNQLX*KCT=>?T1_PF5M0]?@]=*W)L7 ML+S#!XJKP9-F;]602E_F -D9:=>*20!/SDB!+Q#F8D5 GL]_!161D$=%2 1O MRT4( VU'L2))0BC0$!E*3$1IX(,U-XLFM]?/.-L1O5[;4B0# M>*^1],8]X&Y9?*M&Q?FGL\^G8!_+L9<"S\/NX#RQV;D+K]9L15^UK&\@*S&4 M+Y%4&@YX+-FJDRB\\MR9-4E(6^#"KXI^/TH!D#I(@8JBN>)@ M;#1@]MME[BQEFF[G@H'ZO"^=+]<3..II)'I>_Z7S48PEP^1CB*<_W,^%$/5C M%+X$4'*4<19$P'-?]WH2Z G>-B$(KPB66Y\RP[.].?L05@ATO54$6';%V5+? MF6U7/'YFW8G8LN9F&E 7K#E4C@+H,$KV$C@%2FL/Y279&MF2/=D'\K)'C90E3,SLI?/-S':+ M#+I;V7& A)P!A]M::+N5;NA^[3?;^JX$B;\-?3^(4"1[:"MJ>D?$]V1AO1RS1'-V0.&U:Z9E MM!3SAMVM"%$XL?<-G#,7S ^U?;(P$QF 3DQ4_$[OE2@EPJ ?8()_A?-%H)0\ MD"=DDI9L&]\S\ #3::SYTGI# ]_H%6S9Y6!KG<.&'[P<110+*+H+18 8'F@@ M#Y1X3(@?2;9QR1G(V.])K /OR("".R#8BE^9>P#WCC?&4P7728:8NLK^J$@B0=&*,4@ M07PFGE]ZF4@,%2!C4_R$XB)CD#B#U/?9#O E"!HR%C+R:CJ_2/1/4.^[).:0 M8'M2,E5E#\\4 L2X*?Q2P 2O-TRN%2[]K+W/,1A6H/YU(5B%@@EDPN-H='6- M6VOSQ]3FZHYLGB:G/S^,%E?HKI(&YRW?17O/A>>#:VXEV!Y(:^??OA8:^V90 M?_?:NO<* 2J#V&#@-1 %**X*738A60PR24D99+%,*'2(=[PD"ZU#TEVP\GN# M,-B#)05?ONE[!'*N8YL1,,;MH!W@%E()NJS8NR_N'U1\DF+"6S$A;N7EYN:\ MY7+CB@EPY:64LSD'I9%(*S]P7DDFY0U.)7(S?NB[92F4& DLS2R8]]:RB)VN MP]1;;&/4;F;Y#!?V<@ JS-#\:;NS_< 'UO6/;R7@\HV(0"S]V(N>O]H"@77! M67'\^[F(1_S3SK/RM(O' L[&X^*2\@Q.IR CXAKDCP+R3^Q0U3!_1)A_!)WX M!HS#Y)H!_B[ OZ!]<^$+)74#D?89*0$?P7 '[D#;H8Y(\XAROX M+_C.Z)\HC?$:,[TB_=LLXE"[ !1J]GH<-)Z"/?H)/;-Y^*@Q\, 8^!(FPG]2 M6)>D^=YGKY)[Z$"B7($N5LG,&N)O(Q%\=3[+N(]!CU((:E_BAX5$9KY5MLK- MSQT5GE-57@<8T7R(]? YA85_=+KMMYW6[9ZZ_6D7O4>=?N\Q]E)#HH9$#8D: M$C>?J9+R_TX*>LX4N0?I"_9;Y,5XK?&A[XMT./+!.[#/O0B&*P&\#,KSP;S2 MJU=@E#M1Y*U9XAY7?=+3=5J-[DEWHX^XV0BL3[?DJ@\I]HX.YG+1PZF41_'Y M9K?_/DR]V#D7<1*%CP;@;JO6*Y4Z7?>@<7A\O-%'W&P$5D3REF_SR;=U.)_\ M-\/'^.1[5YYPSIO.F8@23%!\--BV.SR$O-8%%3E=[6/4I_L^3O>@)G"G<7)\ M%Q_CH9O&S52HGM05JE:%ZD%=H?IDZ: F_5=?3V(V=Q Z?A@,9>2(7)(GUFQB MTFMI3FF'1O47NE-6OG\6]LV*FU;,V,[C)F>?VSG@E[3)E^N5I3MD M=0^R3EF=1VRO5@&TO%XA>;BA,.,(RG,K ;4%5AN$W*)E)%PN!II$\@K;)OG7 MN19I>=2J?HI4]AQ)9QRZE"N$WX1S2.ZVX<&&OTT\E9A/W3FHQNG7U%=DUFEG M/=1F/MWG9'WJ_H*)U2"D!P+>B6V;I+,3R7XX#+R_L9@I=M WP66HH10<:J]' M#6-R.=NP&?A9FIJ!&T&ZRQ5DV%JK?88VO" M2E8WE*9ZE:68W;''=>DZ12^E),7LMLN:'+SVT=))>#=NYQ:0X71OVI90;+F. M0-I_4B!1&<)ZP6CI4.;]%0RM"-DE>K!S==&3PW*6WI9/C'T(:; M-9+7".!^-_W S"<#/5)183@MK!/WO&^F6094/K%CX M>E;C:VEKY.%P9*O(7.!EG:"T)E1=T%!ROBM99GZX/758P.8U(PXAL:[9%JSTQWHW'- MU9N$?>9[Q/%$7(=IDG'__5##6LB"]<_\U:/>;JH<6B**HD/A)1V\SN2 M93=ISZ5LIM;^\U;[.>90++%B9YUIK.;^&C,U9FK,U)BI#F;6WU6]=[3=,\4] M.)G=E;;V6ZV;/,Q'/L/FP[Q3P_S18;Y0AGYGT%[H[MTY9-4\./Q>8+V<"W?P M'/X/7+B#-=EUS8\UM&MHU]"NH5V[1#5!S:YP=-0X^GYLF+4 >:?3Z.PO#''7 M(*^TV%QO:-<.T6,Z1.WV\_;-=UKK12$U/];0KJ%=0[N&=NT0?7<$U:VO*QX; MY(T:VC6T M:X?HNR.H@]HZ?VR0M^NU1U3S M8PWM&MHUM"L.[3MY1(\YVNB66+DK-N^=/%8EAT?R!U; MG*\-3+XSM-6PJF%5P^J13-A'">K?T6K_+0PBX=*^7HM>%$[CKU[M,64K[!\V M#O>_F[2%M0!YN]OH'G36Z B;#_(Z"O-($?^Z**3(['512,V/-;1K:-?0W@!H MK[^[5!-47112-9#712$;+C;7&]IU46[S/C=0U(95$6PVK&E8UK![)A*U"35Q2T:VC6TJP[M]7>7 M:H*Z(T%UZGR<.NMLXT%>*ZE'DVNMWN&AUA\T&.EW*'1VMTA,T'>:VD'LDAJFM"9F^(ZIJ0FA]K:-?0KJ%= M>6@;A^AY(GJ^?+6U]>/$?OJ%TVY-$N>+-Y:Q\U%.G<_A6 0-_J#A7,K(&[QT MQB(:>K"%5K;$!%_U?_;VG+>>]-T7SH48RI?P_?^F,NC#?HY@]W\(/X4?V\[> MGCJIZUWIU7MAY,IHC]VQ%\Z9#_Z8TX&]Q*'ON7K-/7":7CB'D\1\H!\XQ ,7 M#Q.$T5CX2YUI5C'FUVR5K-FB-:U3Z_.^=+Y<3^"HIY'H>?V7SD M_O#0?NJY?@S_A*#\\3D I@1$D11?]WIR$$;PM@E!>$6PW/J4&9[MS=F'P-,1 M9N^5I.[RJCQ2_Y/&B3>X!FCT7GV:)%X8.&^^R:COQ? R$;C.91("R?TAXT2Z M/S[OO;J''3S\8;Z,9"2=*?X3A$Y(YXH=J0[F.KUK)TPC_*"?)MZ5=,+!P.O+ M*';<-/*"H9.,I',M!7P@ Q<>>"W[.*'UU(Z9S*0 R]Q+GP1Q)5!ZY_2Z:=1!!SJ7SN3*+SR7.F,I/"3D>,%<1H) M%!?]\$I&R'9)2%@>I+Z_E\!"SI]['4@5*X=X<>A MWB"P$6P)5H4=!(F(KIWA]=@9$SG%(V^"K\^V&"=B,*@,/7T,@[W_IO"'@4=, M,I" '9? ((-8(" K0UQP%I0#+!@TD8 ^P?"D-T%<>P$R_$B O!#]?I@&B=,3 M/M)3:>1>@88&J!D5N99@"3O$SX#(2 M?F6VC(PQ'_+.%*2]<,$D8%9":CL+1>023X@)LDMF(,0C$^?+8 VB_TA@\B9I-$D1(T!8@1?O& ;\%[DSAUO%RP,=#ILNJ>](/O$:2_V M0-%$'JLAD221 +[&OT<2!0(]EH!938M:R@UX-D[]1 0):CKXONM%(!)".,AT M% *W@^(S?"V5CIMA/#\,AGN@5D&;QFD?!%W\$O8,F]9BQ=/'4LQ,V*!7:79= M96,H@I(1@% +8AL!+^G;L#HO/PX3!IK:F ;ZC.Q(8Y0U<67$QFO+"KF1D"K# MEL@G@]#WPRE*>W?VC!,PO%'1^@ZJAV5XR$/3*D['8S2JB&5B)U-(P!O(0O@ ML,JU9G8TM6B'-R]0$8KQ7IVZH$Z]&&0# A2V[;TBN70#[-13,F*!1V:J,B% M$(;(P$82DHQLH/)7,H<^,$SF>H!/B:LW\E)U!\7M!(S?/@JY!OT%G^JT7A9V M9!TBC.@K[9>[3>#A>R[0%TM0)<%!=DE<04SAN("UG5[Q#;QEI$\0?:['OBC*1-$? M\6,-%*-^BM?CQDE%?N@#P$"R)O@Y['@BHP&&;LC)@1T#?8A&[E/XV0M=%JLY M2*EE=OKVYJ8C28:<7@*?*EN#3=Z>E*"V^B-/@H*$5[F[: 6#G1D))8BMK:I3 MB!XX1P#9< #[%-?H ($0B/ ;OIBPF$<= 4=58 D:QL"<(A3&H0M4CI\)>-K- MP"QW29,D42J9]U'=@ >7W$@9&:P),FJ+C,H01)"/+[S&K\'[D3^"/OZ&FBM" M345_16.]CS8I+OXG0.77]+=P[,4Q2C;%*A-2^'KSCAB"LXF@>*G6P4,0 M:/"4^H]PQ 'KN=0? H0;#("&TOUQW\/_IKX*TT1RF/J"@1A)_ G/QSPC8A13OLD.@*4MM8SKR@, +!G\(=.0$$A4V2FT\ ML7N%A.)+HHS;[#>#;>P,P5A!L84;DFD =@.;: M% 3I,Y+*[0,Y#A0QXC/!Y&5@0I;X8T\#DCP,HD@8&.L4<7[;7IG *\70E8H:?' M HRP)9XC<07>'*A77+^'T@Q9->=OZ0A'YO6"D589+?A%6\&G1 I+J4$3H]&T M1_2#+XDI[JE"APU%S$@H/B. :.8"NC7)OG]Y^MGZOI:A^O6SGSAIX%F/?[[\W7K<%OID<1LQFP4*^B(> M[?4$1D]1OA,TU>_ZR_!Y'RP\('8 C0^D+S0B[IN %EVIM.LK%>M*Y:B^4GE* MF71)W/19QC*ZDBR13D$3)$ K$D4":H5.ZP?M[H+=D$H.181I$H.33%(:]4X8 M*$8&!@4- %)(7 G/SRE.([R4,B3]MQ%.SKM!)HKG"L>Y4@_5']IE),@4;$@? MAM% @HT+5E4?A1_(+I9NWR;@,SK, / ?VRZG+\0R27SV,=&?9&^#)&=LZ_LX MU19^S $7,<20S0SN$.TD?)="F/-N,'O0,-+K*QI*)WB)H>TWI(E @9".#AS> MA[='F=6A;8!)&N%N$K9Z%(@P>DNZ,B87+Y+PK3YX4))!C\L/\#8$ /*#;T@>9]H$8;H@K!/E_.Q\L!!0 )1Q>!T MX,LQ]D3O%M^DLJSY760ND3U/)PK"!,X#C'JW,U6"&2_SA+;$N;3AI$SJOY'J MT@2YD]^A4(5B# DG!<^ /ZH&0$[)["R_(]96$%]+(BEU&B<')XVC3LL<>T"7 M-T!\?-E.]]:6_&_@-]@ ;3?:QP=8>&EX64D7?$3[/D6&CCQV5\BWH@@W*![E MIK"_UVX'C0 )N2OPR&Y;(/;P)NDRS1X.2D T@]GH?4 MO%10%V(L0 A&MK:N#G3 Q,DXG0^JLDC>>^ JL\4#IBBYR,D()$&'R)=(> ZD MM).U@G@A99>3[/!2],(J \4W%&:D4!0#[8VYF-W) E8ZR ^&]Z^ZEN5[ JE MH:,+^HJ%0I61)""B$>KU34*#$1"HN-'E5R$H<^ETS>0-H-S1H<(@G *,/1/G MP^^23X$9&6"3 (%[\4AB;#"R8JM\ M!04CBO13(V<]WA1E1,2RW>3X>(%'\J'=8G>(C#GA87 N^BH3YPI]^AE9H=C> MQ9@=_(W((W=GX*,8HMWVI78@,F,/=\#Y'!2;PU>DE)#3;JGT+V0G,O#4'2_2 M!7L'<1C")YC3@#O@%_)-I;D540SGZ+ HI@DIU/!+,6*.,"6$X!E6#@8&N97I M0,M8N8!D#.A@S*:AKUT7KV4.A<*%XM/T6)% BK!PA \6G0M<.:4P&CX#%DA? M2A>SKD+,JK+2J6+A2XU]M55> 55M%*9#\*>< ,C!.AR\S$5E"OS;N[9$@W&A2TY3LN=9FZR+C-+PY"R/^66L VK5Z@KQ3 MDA-%3@?!A/X(THX !*(]@<8,G%L;*98^(E,;=#. "W1NHPA7$Y]I$"O032H& M_^68'XS1_B\"DF;3<*II(LV.BHQ__6\ M-P@P*WSD/]3+)(KQ'M3BP8(HP5UWS;U-LUEZ7Z=0AG-X1- M6>@=(,6S:";I,2O]J\+3#)!3.XSUF<)8R,%-H[5GXUS9I06I#?CCQ$-;QXAQ MH]JUPV>>Q^M*!_F7KR+FZODE[LQR67QERF;^'89FFF5L0/OFY4%LA05POC_K MP"!IH6F =SKW9!?\/A/]P[\\ MS"?) $=P)'8&\E%LB$:F8C_-DKFK#/*L[+Q#*ZD*'5*F-$_J?$AS."_6%[B5 M8=4+*T.'^Z6+U&:AKHZW=SH M=^BTW7Q&HEGF!954X!=FG9N(B6\/*"IDH]M51[<4EW#FP+KHZQLV5A41E#S@RO#".0JQ4Y7% 2?Z1*=EXV3OC(BXF %X8_8G!R)8 M/&9OSB6,,'MX%-WQIB&ZISL7$P^#691*E?;PQ992^4Y=]5TI1 M&AM"/4D.+#WI_2VX*"$S*83.HP*^3#"5!?S'6.8_Y%^T]F$/&/UI0 )X<2 Z MHFO,!I^$G/L.Q!,KBX8!'FL)4=A%),-H* +S^UA&0QEQ311Z@>IC2VLW.!^) M3]9 ;:UBF;BP(*:CF"UI8K*!5#).,O M2GMPWB35=BO>'!2WQ42B\O;$HF\Z8I 0(3GA!+D'=3[!)0N01/9#W0/162$VC"K.XGIXI_#U3L=OG8LJD$ M:AACI^@VJ+!P8M;VC06$0>+>M2I'[U,.@"MCV+:F.GZ#0K\OIJ0XL3A1NSXN M;DJ5OB]92<(7CF8_BI ,\0CX4H"Q85->I$+W%;V;/,6R).,J?LG\W-ZH$KK="9P^ON[5)8Q:UWH5<:RA"#*A :X9_8\J?Q6^H$+W9 MB9(HBVK'*7V=>,G/CW7"&&"\/Z(59S9AM9(!J9W>:X/8$!1S=.I!N M!=)/ZD#ZTTDW:B/GN3]MB[]:G0Y\H)K&]5Z]2\"!:W>:3J[5'+W%E?V02Q=? ML-7K@R;;?G4I^RE5$WZ:!JKS#]Y0*M/L3*LH7_V=I.D'$0"LC'#]K-+/R;-4 M N2#2 WL=I9LS+] -A1!Y:5($4IZ.0%%#M1B5FNG4@/!E.JO(*LAP#UZL-( M'E7O40NH[ 6"-/D'$8&RZ'0H776CC!"MQ[)*;%__WW*YA0SZ$K28FXQ>T.7Y]@UMX&>:L1OT%7LRJI>V MFMC5??OYXK^7M6S\GW^<'!Z=O+QQ8K+9 3DK*N'F:X#I,]092948E^$7<9ME MU!R8JBO;1L@2(6P*X&TY#]LGLJ:)^Z$)A=5 C#E+M=CB+]=SAB*G-78K@5VZ MZ2UOVYCO(X3Q-P?'5DR:CX':!^J6 V02J;P8HFNE\-$\SZ[K"NK0OJ;.FFA@ ML7^?/1QP,]KMDU;+.?/BOK@.P"GQK]PF; P<"ND<=EL-YR-ITP^>&'L-YZT? M1IXK&DZWVSYN5\,KO9 1FJQH9F:*/1ZACB@'&X)%U;8'8-4U3MI'C4[WQ-(& M19O 5AH/ )0'DA;*=<(J?6R_\L+1/ZTD(UBVS$J$4L>LG3EF\X;,4(/FJ<1K M2OS0=\ND!3I&B(BBH5PJ/O2L&;V5-DK!F64RF-NO )"@*?W3=F=[V8/=< S M4:#WRJ3>_-B+GK^R+XKH@^QP_C5]@$?DMKMQ.L$7[+1WV<2GW^_[[&L-/L75 M*P/O?@ZX_D.3EF8C%UL\*PWZR=:@K[4&S0%M$:64:?6EOJR:P-_UU>NXMSM1 MRI\C4,,/0AY*P!\=_E!&%[^(*/+0E?HY"N.8I,U.9W>!F-'ZXH>%@#+?*C< M;WKNI/"D<-@[WVP^QYI.Z'BDBFV9W_%@:1 ($C>E$X MC;]Z3'#=,H)[2!9OG^PW3HZ.UU/^M)O[)TN^^!X(X>$$S^QV7XLK#Y10Y/6= M\W D \;^_J-C?[\-0N1@7;'?6I8N*RP&(KH =3[TWXMT./(]10J*$/"? ^OG MQR:0;IM'^JTC??S?S10-[\,4?/%S$2=1.$,+AT]("P>'-2T\G:#XY'M7GG#. M1)3X,DEF*..HEA)/31F/*26H!VH6[@W*X_PF"NSL'*J;HGCW\11XX_"XV^@< MKJM]T6X>=#=,;BP5 3GXP;X_KT,=&QCJ*#$KTOZUZ[Q/W.:,ZCA^2J.BT3X^ M:;2.UU1&[ .8EU5L!1GQT),4/Z>^W-.)1';JDPJ8= Y^V'Y5DC5&%Z7E$6@> M$=FVQ][G=TPB&:AI0%UWKVN5.*A<+YS:\T:G59[V*86S M?=+=I\HX2NS$*UG5)]\NA\Q7S>4ZNJC*!M>+)V'LD<7#?R@6.<=F#TV=>)W= M" >AR7<\[$=7PH!B::?R;;S@_ A&&!_\0-9EV*>"?Z]Z$< 1R/VP!CJ_G MX_N1P-6]%;@XL'OOP#(!ZS4&V/ZM ,:QT'L'&,5W[Q=8RRK066 MKWJ+8%6? M:+.T-ES9._^*9]B MF-\3Z1]M*.GKJ.,:$_[Q"H3_17Y5=GT:X8LF1,OU4<>_[ M,'!-#[4WIA*9FAAB1N:NKA96Q+84OO/&L M8:NK"Q:OG(D/WQL,T'@F^XQ-]?.1)P>SR3L% !-259??@:!"2"R%T"_.9WHT M*+-QSHL?)7MV42G8?ET*EI6"';7J4K U*07KSI:"=5H&1$.< MJ_#ZDJO+MW/SG'?PG@F&#@#WE:OZ^A0X8;\O:#KB5$TJ#X9"-2508-%35E3_ M @L4//V.NT#-_Q;/8RC.81D5SP5D)F@$6>P_:* S[52W):L2P9\"?GQ[:GBK@;1/B*)"#L(3%F[X M:0S:%_X:1KX[Q?':OCIXUH^-@ER9P:"ZL< NL+]=;!6&YGL]-TQ/[C0V;2GX M-3V@"+M'6AR'V >7MR9IGA_&X+#UC$0*XHYP5'>Y@P^HD8(S.,IF^&(UR\R? MD5FB\%KXR?7> #YKT"@M;%_O81>RAAY'.Y&TO(;$P+1U4>#2!]+20VTM;RA: M@YO>!4%X)7,-W"? MDLCFA8!1W33OFK]"(SB2NQ#&Y.=B<8Q;("K2W$3 M\$!$L6!"8%)V1,*S$B?69KJ-HX/B!)1B?0F(E<#Y!/QMALX<\,1Y1C@-Z,PF M>>G<\8Q9>/?"P8]<\P"Y',-A?(N?9"A[- %(CRHB46S41CIO. M!79LQXII [J57?X[-FC1PP.T&"M1 M1HV'XC/]KE&)?:&]X=5J8GU1OJ H04\U;V(D#OMK?;D M4%"?4UP-5V4TH1(*^Z9=&=LP:#[UYE(]?A/XJ2=!>P^J@<,_:> VFF@XW66? M%:'J0&M=WZKN2XR@\GE]!&_$N[JJ1TC,XCQ>3OB])$F#&AUON8^V0Y]ZL7UQ^K43>VJ6<)!:A'-SU+ =$ M%9V5SM)M'AS>>!:4H?O[)_/.4A6R^1A>S? E@]MV?K7*UKVO*0S ..1#-' MMX/*&-/JCJL%%D^;RO/JLZ[^C?!?V,_A7?%_TFHW.D?MA?@?W ;_G8-NHWUX M.)>6%XR\A7^?=3!EM7,"T$1_5^:CI!9%/G+;P(/ZKLBZ*VK7=T5/&O--A_"; MD@0'VMG@QLN![*M6I=C^'2\< H_D@;J&!W^3(OBWEQPHI3J-SO%B/5B4'4?- M@YOU8.?PL'%R-%\/+I = (!GA^U&%R34$XB.!\#S.S!=1) YE3P2') &HB8* MITK_*-\.L/9L_[C1WM=YPI3C6C07\7MT:S M*P=IQ ,'2-FIJS*SWRR#69&%NA.@EX\%=N"GO) RD[C+!!V$YMT/VR+I@;IN MT5'1UT\#2CO!-.F1(%1Z%#4#8SS2AE2KV?J!6$8$ <;7*8!M!V,L1K7&>(/@ M&]D> 0:-^OT(?8E>FL#*A'"]W"YSXDP'*C7,2/K2#%.R8L:4WZ3O1"2W"\ZL M&1J=@&,^<4++@%C1R]AO5W?$UH-:53HZ64JA)MJ,6QT#N'Z8^A0N5]_)KC/5 MJU)C;F7M^#D8M9/-4%%C:D,G4 "3D,1QO+:'=1,(F^I\1PM+MJ7'WK_N/JW,O=;/4" M<\J4!:)ZD6=_W;(/ !T!TJ+^H,T_IB$(98&(ASG2E%AJ3, M'$"AJ"$8]RA\%GMH'VT9T4P#ZC/Y;$EG#K9:S=&Y4:S2KMP#G4W?W(V]0GRS M (W,QP2H;%GCTF)G"&0# CY'F%^'):P@=HZL8 M]UH)%@/Y\ 9P%_+LC.R^L3(RXC*[1_W14UE@[:;%3.=6R@#.0M WJ?DNU#(# M@B&CF&5%/E63"+C8.*DRN+[$R(N>8W!!Z5*5P30FG0U2M'[S>5P]F4RE#/!" MAK/%(M-]H)'U)R E3W/+)ZJ#H27!E<&?A??M8>PZ3TS-D<0)$3PM9B"N0AYT M0H65QNH*>PG[512M2@/S+A097N2:O!$SN+J73Y0KR88SZ8:)U7(!5(WCAC2Q M@H>P6M:Q,B1SD*+U1B%;TGT<]TP^)W?SI6N1ADY@\X$[T,-%^]OG@6G9#G)_ MK ;M?PE5,_(XT3#%=N6^=#&-7MUCL6K%J:DCO')6]]%T0]2PA]D(&EVI^MU3 M;2:I92!,500]*TP-K8O8K:,"H9"BR9,-)B$UQ5WZ5 M?1E/&\-W1U*I7,$7SPT>IH=?L\*O8.:&_A5U[NY+Z;+1@D3/1LNS=H3J QN3$$\VEHQ5F4OY"!7UW2\DX1 M0IH->&I*H>^(@6.LYSWH(<1 _F!^%%K5XR]9H2R9(%:E0K%;/>$']ER:,F96 M'DL]C@V/:'P3D!J JVO]'O5G-'@X04MU2&E0M:W-T#L6 >;2X!3'SNG"K>2 M-3 OC3A5KZ?2CA[BBFI1B/BP#A%;(>).'2)^>*6P?1\6SE(U"?NS-0G[*]0D M7)APU&D?]2O5V;^5RE90.7!ZS QWI%[RS5F10@6T-<".$^_QZ)4Q4&E<@ G3 M4WJLRDM"10=Z? #2EH/0)LDEHJA$5A_QSC*S/LLAU@#B7R\X[&43A8=)9>>@ M$D"HG\FO F.![]]?9"GF@B"H5!0ZW[!NIE9C[0G$#54!D6DS/08UIX>S!_0 M25+(^$26:P6>,1A%2EVSPB(X<#T&V48HA]FLX0"MBDR*[&B8F%MV2X,[2!.= MQ:7FIN&O:%X'0YHMS74LO,T54WS*KTNL,I9OWIB#B\_:[:/&(9@_E&!T?$P7 MT-5,#B(VV],%3U5C-VUQ%]!S<-PXXO03FPEOPV&<0D0PTL4+AG4U>5ENPB(B MZY@>,YI[D-%T:C98=.A..%CA+$E8]"5X)20A3-$$;O\M,)!SN==6--^8?V]) M=F"*,]H!<&149&^E")[EKZP1G+J5X9TOXEME.:: \P=24(Q[ !,Y=A[>E#;H M=\S'[>NK3?A]XH."(MD_2RQ+9F=6AFPPCO6)5.,&$4\0!GMLP_ZKF@J6,B(YP3*;E7&=W;<0(&F7I4 MPR747?=(6M''+-?"CDA&&6$I/5BP)RM#'3]ZKS@NC_'F(H O(KEWJF<5 QCX M[PCK"X1T'*LD[V"/_Z(=1ORNS8?TUS#"ZY!*$QQ=).8K B< (HZE4XLZO-@S M0.*9X&BMAA>]*NAN0(V7 M#?W$NOQ5)H85ALE$&C@KG8EO^6V'6@4(5H/,3!L(JVK" M4&GA;(\;J*Z]L]4E?, =W^]76[=MMZO]9823N7=IR3G%^PAZU M)4"=/HW$9/Z,73-^D!/O&*>Y77\,E?32?21+CG/[5IZ%?;1Y'YH&;EAV[:#8 MXNV_SMJ?E)R!VR;>@IQ6F)]RKSBB+J[M9OO_/A -C#W7]>7L$(H[+5+:'G;> MRC\*9Q3)P4_;HR29O'C^?#J=-F/9;P[#J^>G47_D@4_W7+I#$3T':2^>MX]; MQ]VCH^>M5JM]W#EI=PY!,<#FV]WGGFG<([EOSU_R6WNOW1PEX^U7OZ/XG&)N M$$GPN/ * M1ZC<(Q7BPO0GGZ4W+L^)B*BW\KNPJ]/V]1W1#JP81A/4 >PN :3 @T(+')2@ M$AD.T(=VQ<]5VZS/=/6*42.Z(CK>^\W9>>M1.*CI .3V]MO=$S O!O!9?B.F M,XDU, &/;(8FD%]&-P/Y31_SIG=_?"X>E.WL&37WSVO=A^,U>O_C,QHM>R]< MUFH='G5*N:RKN0R()L3>4E:%]V==X7V*^_)U_%'3M2JMF<=NR_) -^,!O3A' M(]02F5%,)&\XXW*O_?P4//V,.[K=[E[GL W_J]AC)98(BU4JK4=BBT?31MUF MI^:06W!(ASFDE#7.KGTQY1YR-1^LLWK8K]7#?.*'_QSGB1\(?U^K!B(SH/#/ M.3O)!'W_%!&6:%GFV'($OW\G@N^L3/!EQ%XH.=\TB;]?2_Q;>!Z&\,L)/G=2 M3?RJ>Q70<\'#:"J?(6]R'ZWF)^S/^ FY3:SD,WSO?L)^LUOSQ(J*H)-7!.=< M*,-33"YT8P'%"LO3=*<6_P\M_O=K4B\E]6ZKM=\Y:)>0^F&>U+5\QX8CR]#T MH:;I.;1L47&1@H\Z1]VC60I^=;6CWNA=2LOA@]JVER1-H_RM'GAB[Y4 M!?_X[ZJT>K0YM/J((O6P)ML5R?:X7*0BT?:O;;=Q2;H]WARZ?6@9>[3)M#I7 M0+[.3U+(C,"-$4/M5AW.ND4LM]W2KOWL9 W=?V3A]:'=45JY]24#B9:\_&ME M7OVRGD\=Y;V1+^J(UZWX0E]RZ/$ZV#[]OG@D7_)SI)L?+\TFG>^/31Y3DW1K MAKD%PW2983YD%1DK\LF\,4#,,R6SAI;FE^[WQR\/KE:.:K5R&RY1X;2RYH0Z M:VLI9BD.6BZY4VFOK%=N"M9M()\\IEXYKEGF-BQS=$\L4^QN>4],4 %D:N.>!)=4:AP M>/C(5HL5Q_R$7)3TSAON@ ^? ?AERY\/./R,:M6E11 1;R+=JNVE6Y%\SI[ M76!ZNIVOA=]_!?(.QP[)SJ^>VQYB&VH:@_/$-U?V4+JOT=AGT? MS^^H$WUOQ4LSV;[GH4NU4&^2D==?F.&^+.7OU_<=]T[M)\WV)A-[\8JW?:+) M]!WWJ#*#AB9J"L*&B+%.]_M";,<4HIVK=IHH@DK:XJ[4M:;:S-W9WVP:^,4TKF14K+F,)6B ME,<3+YWO3+QT[BQ>VL?.[\W+YGD3R09>S@O"%X^4M Y]\44,67&Z557')3V8<(P<[OI!?$&TL._SCZ_ M!^QRFU7G==A/,9JT 1R\ )-Q?[2IF/PBOH5!.+X&5DV /RE$V!_)L-R>"[^/@W\ N[E-O/>"KSTL)_X^V-B5@XU']6LYH.DVP,<:N]\+ M)_NBM_'H?2]ZTG\ZS#X]#T\BN8E(MG%\8=VKWT92RWN$D0*V:!%;/$ M;@F&A:ENN=0QX@2+RTJINK2M\5:!OM1+6UZP_7SN'YN=@V)G;.P*N_W*NHZW M'BM=^ )G&(9I[%_S'2\]J8B(B$F1T;JWALO1Y;@A.U4A"/4G/$4[,D' F5IPF&7FQHZ'VN ,E M3NJL7ROK]^#[R/J],]GK*1 //61BA:G!E^]^_GCZY??/;RZK-D_@(B<)S+0< M,\BF$+O%J4CM@QUW5W=QGG=-!']NGW3W&^JEG(T$RZ!X";2,[_+3=N05$EEQW7B2Z8-JL(YA?=ZV1])@0VGYU=OVB=*&''"I1?@7DO7H>/R^4A?(@Q!IC M3[56$1OKCPDKC[]S0!G!^YN'EO.1)P>SF1&5]ZTI?5 9M#?9B4O:@IFQAX9@ M#XM%E+W7DWXXU7;> ,R=<$IIQV#OA4&,YJ R!=5BEDV)Z4=J7F1?H$UF,M5# M_A1K2G .+F8QU.;A=VOJK(ERS=M!M:)=P[6JIV@W%1-S="M7$H("ZB=AY%0! M0=^%);2CD@.QY5(19;M5P-*FLE'M;5?!VRYVE*G-@*==:Q8?-2Z>UA"823FO M DJ^-]6?(0FMM*QDE/906P-KM5:-@?6U!B(LO@Z<#_WW(AV.?"^H[8$GM@=* M,++^V/@NU(^.!50!(9O*'K5:J8):>1^F7NR<"VS 52N4IUTKCXOUQT.M2M8, M(9O*&+4JJ8(J^>1[5YYPSIO.F8@27R9)K5">=JTRC*P_-KYGM5*2%I1+OI]- MO<_GGBPNL3ANU2465HG%85UBD0?_/>:5E58^+H=*;SQTXJ@/JWG!7ZU6N_F? MR7#;$7[RT[9)E1I);SB"K1P>3KZ9#)K.06OR;?OY'4HM[K!KNSB$"AH'8NSY MUR]N6M(N?LPA656.W"TY[8;RQ=)*EWL[R8^]5Y\IO6\K'*S:2;+WZO$A8)(> M[R>I\C8KWQ_POX1;F.QX%HK(Q2Q)K7 X%9*&R8]"'PMH[@SH=>":K.YCJU#W ML0&'^^#!@XVMMWX8>:ZH&>.N4NG3Q NPM%XE!&\*F14SR2DK.WYS;LW\&'_^.0,_G,9PWLB1HC_2B>#7L-L8?PH<5#:N4UAU*P@3@-\. MYDAC,>.5]%4#==1&28CGL$XY,*21[58?N0E <<(T@JT3.7%U8]D3CAJ4X R$ M%_G7C2TO 'O&!W( )8A?A3]/8#=Q\163,/9TI[W$*NN^$=C6L>/49PAC 64& M9?S&%GZT"C!AW_TP@*^-<:@)=807F>:>Z%Z L3.4 2SD8R%FOR\GB30Y^;\' M1(;$:;2MTS' H"_N+JF_>['V9CP9B=B+T=SZ()($\V$V1(I]&209:S-@%$X MMGBT"6C4\TZ5' 19 N(ZWHK@Z8A:\?L>2$87^7%,.(>WP\:%'X>Y?3N\[Z;S M*9-8CA=35XAQZ'H#3\]X4,+(=(/@U];\>6?^/"/F1"&K#)!-8L]8;I7R)!*C M4D03(&FOY_E(JWF%9HA[;.B=";7P%% C4*7\AOH4N<@0LK+D"J\KWQ$V4*)B M,-3=9!8!H_TIF6V<"3NDEEH;@$.J"LS(936#4)3OJAG=\F$_75%C@E'"_M?6 M3D[K[3H[RKRX.#_]=):94" 59=!,T*!1 5N(7#+GS"ZQ M[:XSD"[JXZTX*\KSQ30V9H*83. H5+<684MO^@.<6?4,+"OJFS?[1;^2SE9+ MC3M;[Z"3W)0:^&3T.@_7V)/5!8(S^&(D.%]&86S_55$8?$4 34G2*80X4#UH MW3%-X%)(9&$O$:#X(BGB," :0:T:T=*B%Z;PBI'$_AOS#6 DZT$D:<21L7J1 M8O17&N8=;DISC, @!T$)_S>(8"-X!$/I6TIMV7R"JK^!H68X#JP%9Y+!$$0) M_5&="JUB=2IE#GL8\@H$&P-1Z#LA,*YU JY.!8XFBP L"GHRPT-C:RIG6);! MA6MQ@Q*$.@H%FNFTY'H-IP=@Q4.BND"P3M)H@DB$MRCYA^_,1*!V9N5@P'Y- M@")RCIA=Y=Q$9O C^"T$5B5\@]")4W05>/FG9/3[8K>7CFIR^%FZI+"U!-D( M+3US.OM<]R:P/MDRBAJ-&:'"+F+8EVX*%+1%OG:,I$3F@1=_C>=*!TW'Y=;V M0LG1L.5:?@LD_K;8Q'!9FR*'T5::SB52M_5EAH13:Y_IV)*Z>_1X/VT'E0H-MD*>-)4&D7S]G++2(6H&3&:JFMT# M,X!_,WRL__C'8OH/!R75YOT-/"GZ6'&\CT=:X+2?$JZ'%?6T93^ $7:J#:GA M/514@O7UOL(EHB'T3'3]/]@S+KP$L@=T6(0&/BZY$ZI/=8FND23$VWNFA#S$C9:1.!W^2X'^= MZ=/HZ^/H,?OE^R_-B[X""P.-<8*A?=HA4WMY#S\UQM231W4*./$MCHRXL,PA M?NLT(\'_')/^+,FG6>F$;N9"Z3D9^']Y^+X!O$^U]8%-8ZH5CZ?X3&$OW M[]^A!5TA)LR>L1@^(P86ZVKT*7]=?6]GJ\W[SS^E;9Y2CC@EV];)AT*QN.!@ MOP\"S@:W?Y=S!9"N$$:Z*Y/-RHE&N]95^^QQ.*D6>H7-(%@V L'<+9Q\:"O M[ )QQ.U@V^NKNCR'[#]^^M@?Z(0XKGQ(*Z=E99Y5][]%^:R4RVS89=WK#M[U MS,WDX^P%M_X[)(8VT/EK=6/KDO2/T!Q1-^I[_"1OHON[IF)>G*9)QI2.N9A; MR\5N>5:XJC6I-:'VLU=JM M;:_FYDLP>,XE36RE2W?L^12N!IG-5#J2!+KAU/YX0RYO;I0R&/^\53]]Y+V? MIB2<"F$0IN@EN+!]8*+I%HPV5LT"FAU(H=&HUGOA-/-.8O,L.(A.,74>IUQD MB_37*X=IL-D7$1G\R[+Z8WW NYE<60ZH[N6?]5NU<9\MW_MV(=-<%'7%Y/-81GGDW> M-7751T&7W8=FTJSH9[ZJ]FK1UB*V$<7$$/W6/G+$^2(V\.="6'X-" =+LCR* MS5QTR-@^?5"4T>EIQ;:)8U>ZV.:VYW2TL\[TR^AZ4+W]_/7QFIPD9\P+1GDE MY]'\UY$\>@78&2VWF^W*E5!IM:@2L*#\*CYVQEHS_?NK>6/:#:S/[+?%RF<1 MLSR'F%5,<#,<'S\S$F#HU>US^>)F>#O\44J!H>NI#DNPW\H^ M[RT:8TH!C*DJ]J!BJ/B?VJ^Q]J3HL.%7%LC"[DQK&@$%RO3-4JM-)-].9 MCH>_:D3.RYB%OSO MLE?*?T4R->Z#OD 2QA@OTE9,5\61*E3'FSEQ#-/LZ# H/#SN5/,M/5/91@>:<2!8/0U!<%YQ]@NAW-D/GO;,BI%H2-^^B% M:9V;XZ[3'^OS\&+1*&H)CD:9$5RMHSEX-._U55@8;YT$O* 8'PUM@":)0$@Y M+Q:+<@0VLO P\MXYV%VD@YW\2K"+)N'R^K KRV(A5U@$.]'-.:;U4CO30%: M<0D;2(!XN;3\KYP594F*Q_Q>79G;,"BC\3"?%I22E &UK+0!6$9+CWR RF^P M-$A3:R\C8M@D6FP0[5&??M1&WK\KF/!3XP3!#%T^V.R-F.6Y%PCL^?193 M*XE9*0L\;1-(=4A C*3,8FHE3P;*+!2SVZ3,WM@&0CH]K1M/<"C3FM##3H;S M9*FKF;SVR=&>+Y0]U^:\L[!*Q$EX5ONKH-+57?7[^P@8)R#%U*(R*X.Q(&<. MFA03P2^:"M/+QW)1+.8W ;]H*CP+R$?OB* "S%I3SX7*YW%AETTW952J_@YL9C9A(H?37:2 M+_S.QP23/-ODL:>,-$?1*X9:Z?"?;!Z:^'/;Q:;2428MG!6"(4<;W7E)H,!GOU":]4^WE=*"I@#GO M!5>CQ$)4R'Z)RMQ0[L!XSF)X(5Y)\+!:WG[_A!+2832TOR_$#"Y&! M_D1 ^R-O+%)*E]);%\ ^?&\6/MY6QQD=RZ\"PE"X@M84=M$&;XD6OY[(G9:+E1(S87$@E00BX68 M[JLC(TIZ7]$\*+65E4,6)!:S,8V%]=C0?J9ZO;IF^N? M_7AU_>-'M_KS4*RIDP_L7,#^;>P38I#7]L&[XFD!Z.,K%N7T 9U20M= MX7/W6G[Y]-#.[;F3,' \T/?8N1C)[@F:+8=_ J)=*S\BLY$H[$%",YIV4]M6 MFX/F:B_EC87M7)W)C:Z :F:HF+(YPK#A8LI]:?:_O=3Z+]K5P?@M,?F$G9.Z M]XE[R'V2N4=UXNBDZ%W$M[+727QAD H*=_C"3R5%4?J:H)KCKDYB5K1&E_VL__4$SN\$S"MUY*T@RE)) M+!:BBBYBD (]>DR()BNW/=Y\/ Z8VB+-B85262R54DJNE#>_5A!D/?5J[2+W M _$;[_/>H@5C-2 8KS2%CHK0B UF27#*78W.CPJT3SA@(7GRX:I>.:M?U=OU M6DNH-,Z%5KM9_?RQ>75>NVVY$[-J7^[J[>_Q..:QG\+KXG!V 0Z'8WG-II0S MM!^DUBJ\4BPO9LYUX A[?R'[O+?5L8$ I.<[<,B ,^W<1#! KRWQ?I4JY,[WY5/SV,AGJ M@][CSIE2J@+[$3LB&[?$#KF)FLEHQ3^Y"A__(N);>%+Z/+22))9+KY>;OB=0 MC;2>I-398G(Q+Q8*VZOGJ@0H^YP/-[TE3\08DV@BOCUK#R7EYKG=2Y.5NC$I MD:BVQ!W::K&#[4EH)!K<"4@U=5 D)XOYS&'76*8 8B1ERJDK<;(9,;,1($83 M9KCBJVW>*%1EFZGU LJDK45\^AS*]8DSR7[)M>6]%K+G; 33'I1[Q:M2DF1Y MG2JEUZ,4MW M$H42$$J"!*B%;7>R,J@(F\@H6YVS6#4-BHD@P\])UXD69@5R MV?JNU[[_^JP>BC"[Y3/1<<3@!&_//25<0=>)A.3!A?+B4F1^!44>HZ S"561 M-)& !Z0V#@J2F(U;M[JI,&A^J?,#G1Z\^@I9 ;*$NG[6F9H7D\^MZ?EES4H3 M'-U=U=5L@=4B!\COB*\_[WK4E@LO.KZ>DTV0K+7(8L_F MQ5S<;F)'A6>=*XS4>[()LJX676%AJU>8R/0*=+Q _C14KBJMVO0Q(W>FUZU: M[:OUH,M/:5C5JR9LK4A$#23@['].XE:72&HF)&!UJ>-KA7Q9+&=3FG2_8U;J M_F- -*=,;]13!IG20GR-[-1-FXWS_"SB.)')6P>B5N_SWJ+E9R$4R!@.-6=( M1W<8:A6N!NZ0&#TN3^N=Z:='HM]=-VJYA]T7<"=K\Q(X"QMP$SR-\*9A.D0H MOMV[T!\.2][ST%_(>LJTCC]HECY(#/&I9^GQ&2I- OTNN%-R]EQ)/ M3['W5[//>XLGVDR#@G]FD%NVW>Q,G[KC']]?IB/]/$V^Z,;X36()9R(GAC,) M;T:*)3SAR>;'"5$P5_NC68( MYSB=V;*%$0%NC=]XZ\H)?Q=2BEW(Z^]B191ZY3[B6X:YN)&C>N,B;!GTVTHK)QRT.7[S;S#MLF!#57#!Z8),WMVD6-4K1J,'6J8R=@6EA9Y98B$DO M'E0^[ZUY3"PG6&X5!D8M%_<29Q>,CVKYN!E2X1?*'V&-6=X)7T5M4>WV_VP7[QQ%P M,AY\7N E!WN"2@O@'9\:TX_3!,Z4ETNB),7LR[+G1)D$DM'B)3U?RXG9;$;, MYK9'HT'M^)8XBF80M:98!E"&7>GUQL,Q+0TX)WVMISDSY%J>E'7IMJ:9=AIR M?0UGRH)DH,!)X3[H47^+9)(WRU%[]84GX!<)@J4V[/'_3D[GT+T@E@ME,2=M M-K7V[?$J%UYE-,-*,M%[P54"U\KDQ7)ILZ.,WB[A9)6EL0/:K8ZG,CJ,?053 MA;)/U]6/4_+ENIIFMN3V*C12I0I)?J)0PLX\AT84RVEB'@OBL[,D@Y\79V;5R%9 F8Y@:RPX]-/7\#[(CFR1M(/'_EQI]_ M.]B_Y\-__O/O*(@IP.PS /:V-B2VT"#/PJTY5 R1_4(46L32^O\(0\5ZT.#S M&?_;HW4_%=YX#Q@RL4X^M C!WE+F<*08$W0E8Q*^%&>0!L;)%?8V+TR'NA)/\C4 'NM,\T -KYF)6#.#:UZ< M!L_MGO@?H3T9P6$K%M!2[Q^A 13&H-(P\?QR\*6_W;?P+PC+?_\&R$3 R"+* MXVF7 $G!QT84Q GADOJ8_D4'-Q<\!!Z.7NV>D\J_W0_U1J/YM=*N?ZT)M>^U M^UKE5A3JC2J01/?#-M=MM2OMVG6MT6X)S0NA>5.[A4TT&ZUMKWMA6I0/3 CF MT!!0XU0ORL2@/1=JVM"69FZ3,E/8F:YS/DT9/O[;'BD]]]^N9IS-%#N2E.U, M[R\*%WV[V;"<,@B*\1 ^/Z&/O/<9FG J+ +O2?(#<';4P[2CD0W4YO[TC_"L MJO(KGE;V3LW#\M%O]]""USQN-;'9G)VZ M15@;Q4R6[#C^9R+5L=@7!12$L?3_._%[$J]R1"S:V@JMT#WT=V";0@VYYK]= MZ^\/\ZQS;7A$WO;RIMFQL^A_GPN7=W7AR,)>XT[_* C+KTTUH2Z)@9 HK;.V M:]2>3IO;XZ^-V!MUPA:)8^"NZ4QO;S_QHNYGWI;^6XI+W5'Q_ M W^E_%<*)X*[[;"SX,(RA]25E)'@?XZYT*V4.KE%$J6\+.;B#DM:"I4XT#P8 MF,L,Y@M=->DK7_-EL5B*.66V<<\IS9-$T#V@9+_ M1OW2F5;EV^^7C>;E-RL-&UDM^>.9^R7%Y/R=KCF M_.:]_0CNAM[O/93W>6\Q)" M3%<190)K8@ZB^;*825^\%#='_9;81+%Z SCQ.9C:NCG"P/5"NKS2+NYOO[;D M!U)Z!9'I;I;2H^IO=U^P9RDP4Q)EZ@*X0D$6I;@I:GM,DLF!NHHJTP\"E'-B MH;P5F@PVS;E6#.6!)I!XO%6<)K6ML[VKBV8_9\L\*93WM"GS M<1CSP: 6]4:/7[+R4S/3*S]MZ9FOM4.+_:X!CTV-8AW:G MB>\ MX1O\= ML3G^#\=Z1?J2ZY?,_AZ:9.[V797H3Y"J,U>6DLY29_YEQ4S:"1Q_LBX4Y]96 M:4+IK>8,\,9B5)O9[9A>P03"I7*6)0,AH_&2@?IG0_UV\LT:3Q[VR_R*%,6+ MTX4/#7^7H^^&Q;R4/ONP+(N2E+)*^?=O_+&""R6[QA7\2$K2R65!8ME.&-/1 M0-NKO:V.X+$4O2O3MMU\42H:IKN*ZG3S7D_B@9Q!-Q2+-S< M2 ^+N,4,"3\5CU7X=Y"2Q:^?=HHI'%DQ)Z?,-.<]*=(JG+_]%:YB[QO(=A4+ M)4DL95-ZX%9HEE\MD-Z8QLNY/3TGE8.$K4"-X;=.L98Z-OLSS=? MGV;OI-[+S8^;IKZ!&J,/[KJ"PA86#+HREA#QGN&!1N&O[&>[NJM^?Q\74"F9 M=-R\@06-_S-B7LJ+Y7+,OJ*OCL_; O0J5KK>"(@";?MC7S<"?=GGVM?6W<03'QACGT-[7E%:I())!3\JQ$ MPTHB-9.8TZ(6@#K=MN5$XSJ6;SOSKA"E4BV=B;&#'+G4Y%B-18ZS[5]>C1PS M,VR2^,4F[9^'->>VB7JVWWQX[*2[HI'C1D:1< M9YK_U+[+CBYDJ5F*WTEQP1W\?QSZA]->D5[JIN<^'XCG:W-[\_QF9]5.8/X& MQQ[6([H*0M8T4(167C3;?RPP[^R:$DUGFFG].F^>-4O-GWK*7HD[/_=%XG,O M&"GEPL#\<4YN;[]^;Y4/!03YN"!P':ML9..X:_GZNCF^KA9^' H9,8DR8'=OC'KX\OAN7C=[M>98W ML>M_T_8TW0"G7W>@P._;#Y5/F*44O?;1#[M-YIJ0],4"ZRR+PD&H&T>@K@-4 MAI<4GD%YQ.>R3_K\!\ MN7\XO6T9RI6A.3:B,Z6/,-Z4PA@Q*/L(Y T#V;>GCW#>)IRCVK >@;QA(#,? MRFMK0YZK(UN.3&-9/GZXU9G>/]CMI_K3Z"HWV(.QG/,9Y=S9+I?^BHL@D5K< MR8,'G9OLS%E\9-BC!5K(O!82.0]!EK!KX.;,?%Q^6K)/%_E4BYX]7.I MH7#S4=@2UU6XU%O^LVX6G<^%]I?/NI>R<48>-,/0'@"%Z"V(/&4T-K$&A@YL M8H#DBM3$\,1(][2=N<.&.7K_G;0F_R[5?>\UPM!H3( M@Y_+LLJ6%,TN/>.R.CF_2BZN1R&7J'YNSC$EHS%82-WG?"_JE$/:4A+2W>Q- M9%/W[S^"/P[X$_A'LJG[_DM%L9"+V5CE]>\CIM\@6URG6^9>G:2T]R?9'8TL M+JK.IN]&#_B_D6ZQT9J6'*D'W"N6I8 4/YL$#=[.5&I->C\^OWSOMML[5-2LW/YKE:JLY MF-.YE@%J+H*83OM:?NP-JV&)NB_,QP?ELEB4#Z9+S]2;9$$XL5JESJN#W' M]RWJ5'E?X+<('$Z]&7=UK=?L]XE%6\7UJI/;6^VE]50M'HZ3BAU%&-&S@++ M#K,;%:JV'*+;5IOLGYDOU?SWEU:.>&I3-#C65)06'VZS4CJ_7I^WG)C/))B1 MM<_L*0KB&X9U^K#?;]"M< /P3: %Y5//8,J)DI07"[^=%I3/[KWN$/;(8+'BDT_MU.8H7MJ$,S5:\3E;ZDSB8TG;YHVE/<%/-[K2HP*Y#7^VV58Z MT_R/>N'QL?%L?MG@5,,=NI@L/GS5,841.ZCPX")(;LA9U4J.&U6=2@DZO\WW_4X_YLH:2FO9,-Z7&H7_F%' M$W=X PDTO4+JP3S9LB3*A9B3P5[_3F)J1P5I[[6CN">1]_XD.Z63Q:I@(;6O MG=' ]A3!\T#^5D7]"1H(;9_:-A=0.)587<4F*JH.!,#".H*!-F�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